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Abstract
Ageing is a widespread phenomenon limiting the lifespan of almost all species. Virtually all organisms
age, however what controls the ageing process remains enigmatic.
A lot of human disease and death are affected by ageing or age-related diseases. Understanding the
ageing process is crucial to benefit humanity including intervention of human disease or life extension.
The work presented here allows to gain insights into the ageing process which can be manipulated by
targeting ageing genes via genetic modifications, environmental factors, or pharmacological interventions.
Biological information is increasing at an exponential pace. Information technology is also advancing at a
fast pace. The combination of these two trends may allow us to understand biological processes such as
ageing.
Ageing is plastic; many studies have shown that the ageing process can be sped up, slowed down,
stopped, or even reversed. For example, the ageing process can be slowed down by dietary restriction
(DR), the most powerful non-genetic intervention known to counteract the basic ageing process. In
addition, the ageing process can be modulated by genetic as well as environmental means including
dietary as well as pharmacological interventions. Here it is hypothesized that ageing genes do not only
play an important role in the ageing process but also in its modulation by diet.
In this thesis, functional genomics approaches are applied to genomic data such as transcriptomics and
interactomics. Graph theoretic concepts like guilt-by-association and shortest path are applied on ageing
and its dietary manipulations. This methodology enabled to gather new insights into the underlying
mechanisms of the ageing process and its interference with interventions like dietary restriction, as well as
to predict original hypotheses, new ageing genes, and novel pharmaceuticals.
Firstly, a curated knowledge base was established which includes loss- and gain-of-function experiments
that impact on lifespan of organisms including human, mouse, fruit fly, nematode, and yeast, among
others. Genes controlling the ageing process (ageing genes) were classified based on their effect on
lifespan resulting from genetic manipulations in the common biomedical model organisms as well as in
humans. Those classes were characterized for common associations and potential novel ageing genes
were predicted by applying graph theory like the guilt-by-association principle. Specifically, this thesis
classifies ageing genes that control the ageing process into two main classes: 1) gerontogenes that
mediate the ageing process, therefore decrease lifespan of the organism; 2) ageing-suppressor genes
that suppress the ageing process, thus increase lifespan of the organism. Further analysis shows that:
Gerontogenes are associated with translation, positive regulation of apoptosis, inflammation, TOR
signalling, positive regulation of multicellular organism growth and development, as well as transcription
regulation.
In contrast, ageing-suppressor genes are associated with DNA metabolism (including DNA repair,
telomere maintenance, and chromatin organization), stress response, negative regulation of apoptosis,
protein homeostasis (including protein repair, regulation of protein stability, lysosome/autophagy, and the
ubiquitin-proteasome system), and endocytosis, as well as transcriptional regulation.
Thus, gerontogenes were found to be involved in growth/development and translation, while
ageing-suppressor genes are involved in stress response and diverse repair processes.
Secondly, a class of genes, denoted here as dietary restriction-essential genes (DR genes for short),
which are necessary for the lifespan-extending effect of dietary restriction in commonly used biomedical
models organisms was found. DR genes were defined and characterized as well as new candidate genes
predicted. It was found that DR genes are evolutionary conserved on the molecular (sequence) level more
than expected by chance (even more than ageing genes which are conserved) and are more likely to
interact with each other based on molecular interactions than expected by chance. The predicted genes
were experimentally validated and prediction accuracy was found to be up to 89%. The new DR genes,
which were predicted by guilt-by-association, include FRE6, RCR2, and OPT2. FRE6 and OPT2 were
found to be induced on the transcriptional level upon DR, while RCR2 found to be transcriptionally
repressed. OPT2 was one of the greatest upregulated genes upon DR. Potential transcription factors
controlling the DR response were identified.
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Thirdly, tissue-specific and common molecular signatures of gene activity changes during ageing and
dietary restriction for different organisms (human and common biomedical models) were generated.
Those signatures were characterized for their associations and the associations common to multiple
species identified. Ageing commonly upregulates inflammation, MAPK and TOR signalling, and
downregulates proteostasis, cell cycle, and epigenetic modifications. Accelerated ageing commonly
upregulates inflammation as well as Notch signalling and downregulates Wnt signalling. Cellular
senescence commonly upregulates inflammation and negatively regulates cell cycle and apoptosis. DR
commonly upregulates specific gene regulation and nuclear processes including chromatin silencing while
downregulating MAPK signalling and other transcriptional regulation. DR in particular modulates stress
response, circadian clock, and proteostasis.
Lastly, via graph theory and pattern matching, drugs that target specific classes of ageing genes as well
as potentially reverse ageing-related gene expression changes or mimic the effect of dietary restriction on
the level of the transcriptome were predicted. Drug mesalazine, among others, was predicted as the top
compound to transcriptionally mimic the effect of dietary restriction while others like LY-294002 seem also
capable of additionally reversing ageing, accelerated ageing and cellular senescence. Among the top
drugs and supplements were well-known anti-ageing compounds as well dietary restriction mimetics
validating the approach.
The ageing process and its modulation by diet appear to be governed by specific gene classes, that are
conserved and interact with each other. These features can be used to identify lifespan extending
processes, functions, components, and entities via the utilization of different omics like interactomics and
transcriptomics that allow to investigate the interactions and activities of genes. Gerontogenes by their
very activity drive processes that mediate ageing, while ageing-suppressor genes control processes that
counteract ageing. DR genes mediate the effect of a restricted diet to modulate those activities in order to
slow down ageing. Small molecules were identified that potentially target specific ageing gene classes,
reverse ageing, Hutchinson-Gilford progeria syndrome, and cellular senescence, or mimic the effect of DR
and may therefore enable to intervene with the ageing process pharmacologically.
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1   Introduction
1.1   Ageing
1.1.1   Definition of Ageing
Ageing is one of the oldest biological enigmas and a major biomedical problem of the 21st century. Ageing
is an almost ubiquitous though not universal phenomenon in nature. It has been a research puzzle for
decades as to why lifespan is limited and evolution has not eliminated this phenomenon. To understand
ageing it is important to define it as precisely as our current understanding will allow. However, a
consensus on a simple definition of ageing has not been achieved, evidence of the lack of an
understanding of the mechanisms underlying the ageing process (Li, et al., 2014).
Increase in Probability of Death. Ageing is an increased liability to die, or an increasing loss of vigour,
with increasing chronological age, or with the passage of life cycle (Comfort, 1960). Ageing is
accompanied by deteriorative changes with time during postmaturational life that underlie an increasing
vulnerability to challenges, thereby decreasing the ability of the organism to survive (Masoro, 1995). The
ageing process renders individuals more susceptible as they grow older to the various factors, intrinsic or
extrinsic, which may cause death (Maynard, 1962). Ageing can be defined as the increase in the
probability of death within a period of time. In humans, from 0 to 9 years there is a decrease in the
probability to die in the following year. After age nine the age-specific mortality rate increases and there is
an exponential increase in this rate from around 30 years (Arking, 2006). Ageing therefore seems to be a
natural phase in many organism's life cycle.
Natural Deterioration. Ageing is the observed natural deterioration of bodily functions, organs, and organ
systems, thereby increasing the onset of disease and pathology, with a resulting loss of function eventually
leading to death.
Functional Decline. By teleological criteria, development can be viewed as consisting of early processes
that enhance the functional capacity of a system, whereas ageing consists of later processes that diminish
or have no effects on ability to function (Kohn, 1978). Ageing is the progressive decline in several but not
all physiological functions, resulting ultimately in the thermodynamic equilibrium, i.e. death. Ageing
decreases most aspects (functionalities), although some kinds of cancer are less severe in elderly people
as a result of diminishing rates of mitosis. Therefore defining ageing simply as functional decline is not
sufficient.
Passing of Time. Ageing is generally used to describe a host of time-related alterations in biological
entities from molecules to ecosystems (Finch, 1990). Ageing is a progressive, i.e. a time-dependent
phenomenon. Ageing is (for a normally developing organism) just the passing of time. It starts when the
survival probability curve has reached its maximum (i.e. lowest age-specific mortality rate) and ends with
death. However, ageing is fundamentally an event-dependent phenomenon, rather than a time-dependent
process (Arking, 2006). Physiological biomarkers are a much more useful index of ageing than is the
simple passage of time (Arking, 2006).
Ageing as a Disease. Is ageing a disease? Disease is very much a social construction that takes into
account statistical data and available therapy. Regarding statistics, ageing is not a disease because it
affects all individuals of a species. Statistically speaking, it is a common feature of most living beings.
Regarding available therapy and symptoms, the rate of ageing can be modified but the process is not yet
treatable, as all humans eventually die and if they are lucky they die of old age, i.e. the result of ageing.
Developmental Process. Usually each human follows the same path of growth, development, maturity
and senescence (Arking, 2006). The changes from maturity through senescence constitute the ageing
process (Rothstein, 1982). All the parts of the life cycle are continuous with one another in process and
mechanism (Arking, 2006). Ageing is a naturally developing biological process which limits the adaptive
possibilities of an organism, increases the likelihood of death, reduces the lifespan and promotes age
pathologies (Frolkis, 1982).
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Overall, ageing is a process, that involves changes of the structure of an organism. It is multi-factorial and
multi-dimensional at its root, occurs gradually, but is degenerative in its consequences as it leads to loss of
functionality and ends with death. Ageing could be defined as every irreversible change of living
substances as a function of time (Smith, 2002), but are all those processes really irreversible? This seems
not to be the case. Most definitions of ageing acknowledge that it is related to changes in the organism
leading to a loss in adaptability. This loss in adaptability leads to a higher chance of death. Ageing is a
time-independent series of cumulative, progressive, intrinsic, and deleterious function and structural
changes that usually begin to manifest themselves at reproductive maturity and eventually culminate in
death (Arking, 2006).
1.1.2   Measuring Ageing
It is important to measure ageing, the rate of ageing and the process of ageing. Otherwise it would not be
possible to know whether an organism ages faster or slower than others. Nor would it be possible to know
whether an anti-ageing intervention is actually working. In practice two different measurement standards
are used dependent on whether ageing is measured in a population or in an individual (Arking, 2006).
Ageing in population is measured by using the observed age-specific mortality rates to calculate the
number of surviving organisms that will likely die in the next time period. On a demographic level ageing is
associated with increased mortality with increasing age as well as increased susceptibility to age-related
disease. If the death number increases, then the population is composed of ageing individuals, i.e. ageing
population. The rate of ageing can be calculated based on how long it takes for the mortality rate to double
(Arking, 2006).
In individuals, ageing is measured by documenting changes in physiological traits, or biomarkers, known
to be important to normal functioning and capable of predicting remaining lifespan. The search for such
biomarkers of ageing is an important quest of biogerontology. Biomarkers of ageing are usually surrogates
of mortality statistics. None have been shown to be predictive of future survival that are better than the age
of the individual. A combination of multiple biomarkers (like derived from genomics or other omics) utilized
by mathematical models might have the potential to overcome this, e.g. epigenetic markers are promising
candidates for being able to reliably predict future mortality (Christiansen, et al., 2016). In the case the
observed changes are altered in the direction of loss of function, then the individual is ageing at some
calculable rate of loss of function (Arking, 2006).
1.1.3   Plasticity of Ageing
Although ageing is quite widespread across species - it is not an universal phenomenon. Ageing is actually
an incredibly plastic process which can be sped up (e.g. by mutation), slowed down (e.g. by dietary
restriction), totally stopped (e.g. by genetic knockout), or even reversed (e.g. by overexpression of genes)
(Berger, 2014; de Magalhaes, 1997). The exact mechanism of ageing is an enigma. Understanding why
certain species exhibit ageing and others do not (negligible senescence and biological immortal species)
would revolutionize medicine.
Although defining what exactly is ageing is difficult, yet it is possible to measure it at least reliable on the
population level. From this it is clear that the ageing process is quite plastic, which means it varies from
species to species and from individual to individual within a species. In fact, there are quite large
intraspecies and even bigger interspecies differences in the lifespan of an organism and the rate of ageing.
The rate of ageing varies substantially across different species. This is mainly because of genetic
differences. Some species live just about a day (e.g. mayfly), while others live centuries (e.g. sharks,
whale). Yet others do not appear to have age-related changes, i.e. exhibit negligible senescence (rockfish,
lobster, turtle, etc.), and there are even species which have been declared to be immortal (sea squirt,
jellyfish, hydra, flatworm, etc.). The naked mole rat might be the first mammal that has been declared to
exhibit negligible senescence. Although it lives 9 times longer than similarly sized mice and only shows
slight age-related changes with no decline in fertility nor was it observed to develop any spontaneous
neoplasm (Buffenstein, 2008), the naked mole rat dies still of old age.
Ageing within a population is not uniform either. There is a genetic heterogeneity as well as environmental
influences that lead to a profile of different lifespans.
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The ageing process within a single organism can be altered. In particular the genetic makeup and
epigenetic modifications play important roles, i.e. genes and their activities affect the ageing process. A
variety of alterations in specific genes can extend lifespan quite substantially in model organisms and
under laboratory conditions. Those increases are dramatic in simple budding yeast and nematodes, less
so in fruit flies and less again in rodents.
Manipulating just single genes can accelerate ageing or slow down ageing hence greatly extend lifespan
like up to 10-fold (Shmookler Reis, et al., 2009). It has been demonstrated that it is possible to reverse
ageing, even by simple ectopic overexpression of just single transcription factor out of two (IME1 and
NDT80) in a model organism such as Saccharomyces cerevisiae (Unal, et al., 2011). In humans single
gene mutations can lead to accelerated ageing (progeroid syndromes). On the other hand, many genetic
differences were found to be associated with longevity in centenarians and some in supercentenarians
(Fortney, et al., 2015).
Ageing genes appear to be extremely conserved across species. For example, the sirtuin family of genes
has a significant effect on the lifespan in many organisms. Their effect seems to be strong in yeast
(Kaeberlein, et al., 1999) and nematodes (Tissenbaum & Guarente, 2001), and weak in fruit flies (Rogina
& Helfand, 2004) and mice (Price, et al., 2012). Further a substantial number of non-genetic interventions
including single compounds were found to affect ageing and extend lifespan (Vaiserman, et al., 2017).
Ageing is a widespread and almost ubiquitous phenomenon that affects virtually all biological species. For
species that age, ageing appears to affect most aspects of an organism in a negative manner and
increases its probability of health problems and death with increasing age. Though people live longer
today through medical and safety improvements, the ageing process itself still leads to age-related
disabilities and causes increasing physical, psychological, and economic burdens. While ageing has been
an inevitable phenomenon for centuries, it now becomes more and more of a problem that can be
understood (by science) and solved (via technology). Not only could ageing be solved as a theoretical
problem, but it could also be treated as a medical condition.
However, the precise mechanisms of ageing remain largely unknown. Despite advancements in
understanding the mechanisms of ageing (from a "backwater" of biology, full of anecdotes, to a serious
discipline) and the possibility to interfere with the ageing process by changing just a single gene, applying
dietary interventions (even with a single type of molecule) (de Magalhaes, et al., 2012) or simply repairing
the damage (via regenerative medicine), the actual evolutionary theory ("why") and
molecular/physiological mechanism ("how") of ageing remains unknown. To understand the biology of
ageing requires posing testable and reasonable questions like (Arking, 2006):
• Why do even two closely related species have such very different lifespan, despite their huge
physiological similarity?
• What causes the deteriorative changes during the lifespan of each of these species?
• Are the causes the same between various species or are they different?
• Can deteriorative changes be postponed or even reversed?
• Is it feasible to reliable predict individual lifespan?
• Is it possible to prolong the lifespan of humans by utilizing insights from other species?
Some anti-ageing mechanisms are species-specific (private mechanisms), while others appear to be
highly conserved across phylogenetic lines (public mechanisms). In the latter case, insights obtained from
investigations on one species of laboratory invertebrate organism can be translated to rodents or to
primates and perhaps humans. Although all ageing mechanisms are of particular interests, conserved
mechanisms have the greatest significance because they may imply possible interventions into human
ageing.
Biology does not deal only with mere facts, but rather with developing an understanding of underlying
mechanisms. There are three types of evidence (Arking, 2006): 1) Correlative, 2) Loss-of-function, and 3)
Gain-of-function.
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Loss-of-function and gain-of-function are quite common approaches in genetics, while correlative
evidence is dominating genomics. Correlative evidence is derived from observed temporal or spatial
correlations between two or more events. Loss-of-function evidence is based on deactivation of an entity,
e.g. the inactivation of a gene by knock-out or knock-down. Gain-of-function is the strongest type of
evidence in which some technique is used to specifically increase the activity of an entity. All three types
of evidence are used to infer causality among events, while it is challenging for correlative evidence,
causation is more likely to be inferred from loss-of-function and especially gain-of-function data. However
uncertainty of inference remains.
1.1.4   Age-Related Diseases
While humans died in the past mostly in the perinatal period (i.e. death in the first five years of life) or due
some infectious disease, today people suffer from age-related diseases and more than 100,000 individuals
die daily due to the consequences of the ageing process, either directly (as a primary cause via
age-related diseases) or indirectly (as contributory cause due to reduced functionality) (de Grey, 2007;
YourTribute, 2013).
Ageing is the underlying cause of almost all major human diseases, such as atherosclerosis, cancer,
cardiovascular defects, cataract, type 2 diabetes, dementia, macular degeneration, neurodegeneration,
osteoporosis and excessive muscle loss leading to sarcopenia (Rattan, 2007; Holliday, 2017). Ageing is by
far the leading cause of death (though it acts mostly indirectly and in a gradual manner). Of the 150,000
people dying every day, two thirds die of age-related disease. The proportion is even higher in
industrialized nations where it is reaching 90% (de Grey, 2007).
Ageing is directly associated with numerous age-related diseases (e.g. neurodegeneration, metabolic and
cardiovascular diseases, cancer, etc.) and the single risk factor common to all of the leading causes of
death is age (Hayflick, 2007; Fontana, et al., 2014). Therefore the research in animals and humans should
be refocused to find ways to prevent and treat ageing (Fontana, et al., 2014). Slowing down the ageing
process by even the slightest degree could dramatically increase the general health much more than the
elimination of any single disease. Hence understanding ageing as the root cause of many diseases would
be far more efficient than tackling age-related diseases one-by-one (Hayflick, 2007; Fontana, et al., 2014).
If ageing could be slowed down even slightly the improved health of humans and the economic benefit
would be significant.
The research on numerous diseases has demonstrated that an underlying risk factor for many illnesses is
age. In fact, the single risk factor common to many diseases is age. The susceptibility to the effects or
severity of a disease is significantly modified by ageing. Further, chronological age is the most important
risk factor for the development of diverse diseases, including degenerative diseases and cancer (Brett &
Rando, 2014). Ageing causes disease and loss of function that in turn causes death. The difficulty with this
is that one is more or less forced into defining the boundary where the disease or loss-of-function begins,
which is almost impossible because it always begins very subtly. It is therefore useful to define ageing as
the über-disease encompassing all late-life dysfunctions, such that disease and functional deficits of old
age are simply facets of the later stages of ageing - they are part of ageing rather than being distinct from
it. Thereby ageing does directly cause death, and one can subdivide the specific sequences of events that
lead to death in a given individual.
Whether ageing should be acknowledged as a disease is debatable (Gems, 2015; Bulterijs, et al., 2015).
Arguments for this acknowledgement are that 1) ageing actually fits very well most definitions of disease,
and 2) this acknowledgement could have an impact on making it easier to develop anti-ageing drugs.
On the contrary, one of the arguments against defining it as a disease is that it is almost universal, i.e. it
seems to occur in every member of a species. However this universality is questionable as there exist
species that do not appear to show population ageing. Another counterargument is that it is normal as it
occurs in every human, while disease is more often associated with abnormality. However, an infectious
disease, like one caused by a virus, could theoretically affect most or even all individuals of a population
or perhaps a species. Although having this disease is the norm, it is still a disease. Quite often ageing is
semantically understood as a neutral term (especially in English) that just means the passage of time and
includes development. However, it still has a negative sentiment and often refers to the later phase of life
that is associated with deterioration which some people refer to as senescence. One could also argue that
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there is no point in calling something a disease as it can not yet be treated. But this is not true as there are
already interventions that counteract ageing and on the other hand there are also diseases that have not
yet any cure and can not really be treated. Others argue often that ageing-related changes are not always
negative and that it also has positive aspects. Overall this does not hinder its classification as a disease
as diseases are also associated with certain changes that have no negative influences (or are not known
to be negative). Sometimes the complexity and heterogeneity of the phenotypes or symptoms of ageing
are used as a counterargument to classifying ageing as disease, because diseases often have very
well-defined symptoms. This argument ignores the heterogeneity of humans themselves and the fact that
a disease also affects individuals differently depending on their genetic disposition and lifestyle as well as
environment. Yet, another argument states that ageing requires research on things that maintain health
and everything that increases health counteracts ageing. However most likely even when living as
healthily as possible by any current recommendations individuals will still age and die.
If ageing was to be declared as a disease, it would have little effect on the scientific quest of seeking the
underlying molecular mechanisms that cause and control the rate of ageing, it may however make it
easier to develop drugs that counteract ageing as an indication rather than some specific age-related
diseases.
Overall there are no contradictions in defining ageing as a disease, although ageing IS NOT a single
disease as it manifests itself in many different sub-diseases. It is somehow an Überdisease. It is the root
cause and major risk factor of many diseases. One can conversely view each age-related disease as only
one symptom of the overarching master disease commonly referred to as "ageing". Even if one symptom
could be cured the next age-related disease would strike soon as long as its main underlying causative
mechanism, i.e. ageing, is not addressed.
1.1.5   Age-Related Changes
There are myriads of changes happening during ageing but only few might be the drivers of the process
while others are merely symptoms. Ageing is not simply the sum of the aggregate pathologies and of
disease-induced changes, and conversely, not all the changes in structure and function that are correlated
with age may be appropriately considered as fundamental age-related changes (causes) per se. A
fundamental age-related change must meet the following four conditions (Strehler, 1982):
1. Deleterious, reduce function
2. Progressive, take place gradually
3. Intrinsic, not the result of a modifiable environmental agent
4. Universal, all members of a species should exhibit such gradual deficit with advancing age
However the concept of universality seems to be invalid as there is so much individual variation in ageing
due in part to our genetic heterogeneity and in part to chance alone (Finch & Kirkwood, 2000) that it is not
possible for all members of a species to exhibit ageing in an identical manner. The concept of intrinsic
change, while being valid, is being narrowed in light of the fact that various lifestyle practices modulate
events that were assumed to be completely intrinsic. Nonetheless the concept of deleterious progressive
and intrinsic changes is useful, such as in the investigation of stem cell ageing or cellular senescence.
1.1.6   Mechanisms of Ageing
There are many possible mechanisms involved in ageing. Over the last decades, theories about ageing
have emerged and faded. The true nature of the ageing process however, is still uncertain. What is exactly
happening on a biochemical, genetic, and physiological level still remains to be understood. What we see
in an ageing person is a great deal of change in appearance, a decline in overall fitness and an increased
chance of getting age-related diseases. These are, however, only the visible sides of the changes that
start at the molecular level, then the cellular level, then progress to the tissue and organ level until in the
end the whole physiology is affected. What are these processes that result in ageing? Although ageing is
undoubtedly complex, it may be regulated by common mechanisms that are simpler than the effects they
produce (Arking, 2006).
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Defining ageing clearly is challenging. Our understanding of how and why we age will originate from the
study of the processes that happen in the cell and observable biological markers of ageing.
1.3   Cellular Senescence
Cellular senescence is an irreversible growth arrest that may be an evolved antitumour mechanism.
Senescence is a natural mechanism restricting propagation of cells, which passed through genotoxic or
oncogene stresses, by epigenetic reprogramming. It is a kind of program or a state, basically subroutine,
which the cell adapts after damage, stress or some kind of damaging signal. Senescence is a general
purpose mechanism that is used for repair systems. Cellular senescence prevents the proliferation of
preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound
healing (Baker, et al., 2016). It is a primitive and very ancient process that even occurs in single cellular
organism.
Cellular senescence is induced by short telomeres (replicative senescence), but it can also be induced by
various stressors (stress-induced premature senescence). There are more than 50 oncogenic or mitogenic
alterations that are able to induce senescence (Gorgoulis & Halazonetis, 2010).
There are certain phenotypes associated with the state of cellular senescence such as obvious
morphological changes. Senescence cells enlarge and become resistant to apoptosis. Cellular
senescence is frequently characterized by the expression of the p16 protein. There is also the formation of
senescence-associated heterochromatin foci.
Cellular senescence exhibits a distinctive secretory phenotype (Baker, et al., 2016). This associated
secretion profile (Senescence-Associated Secretory Phenotype; SASP) of senescence cells depends on
the type of insult. Senescence markers show already up during development. However senescence cells
accumulate in various tissues/organs over time (Baker, et al., 2016). It is a growth arrest that for some
reason occurs because either the cell is damaged or due to some regenerative response. The type of
profile of secretion depends on the context of damage/triggering signalling.
It is commonly believed that cellular senescence underlies organismal senescence in mammals.
1.4   Biomarkers of Ageing
Ageing is a dynamic process that does not only depend on the species, the genotype and phenotype, but
is also dependent on environmental influences. The ageing/age of an individual can not yet be directly
determined.
Biomarkers of ageing are biomarkers that better predict functional capacity at a later age than
chronological age (Baker & Sprott, 1988). Biomarkers of ageing would give the true biological age, which
may be different from the chronological age. Validated biomarkers of ageing would allow for testing
interventions to extend lifespan, because changes in the biomarkers would be observable throughout
lifespan of the organism (Baker & Sprott, 1988). Ideally, biomarkers of ageing should assay the biological
process of ageing and not predisposition to disease, should cause a minimal amount of trauma to assay in
the organism, and should be reproducibly measurable during a short interval compared to the lifespan of
the organism (Baker & Sprott, 1988).
Although greying of hair increases with age (Van Neste & Tobin, 2004), hair greying cannot be called a
biomarker of ageing. Similarly, skin wrinkles and other common changes seen with ageing are not better
indicators of future functionality than chronological age. Biogerontologists have continued efforts to find
and validate biomarkers of ageing, but success this far has been limited. Although maximum lifespan
would be a means of validating biomarkers of ageing, it would not be a practical means for relatively
long-lived species such as humans.
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Levels of CD4 and CD8 memory T cells and naive T cells have been used to give good predictions of the
expected lifespan of middle-aged mice (Harrison, 2011; Miller, 2001). Biological clocks, for example the
epigenetic clock, are promising biomarkers of ageing (Horvath, 2013). Ideally changing this biomarker
itself is known to increase the lifespan. Though this is not necessary. The methods should be non-invasive
or as less invasive as possible. If erythrocytes can be obtained, one could for instance measure
glutathione disulfide/glutathione (GSSG/GSH) ratios (i.e. oxidation state of glutathione). Also circadian
parameters might be interesting, as the circadian clock is disturbed as one gets older and interventions
that extend the lifespan, such as dietary restriction, make this clock tick much more robust. It is of
particular interest to establish methods that can be automated so that they are easy to be taken
continuously or periodically and can be scaled to many individuals. A comprehensive inventory of possible
biomarkers of ageing need to be established to better assess the impact of established or potential novel
manipulations of ageing.
1.5   Dietary Restriction
1.5.1   Background
The most powerful non-genetic intervention to retard the biological ageing process is commonly known as
dietary restriction (DR) which includes calorie/caloric restriction (CR) and other form of restricted diets. A
reduction in dietary intake without malnutrition robustly extends the lifespan of many species from yeast to
rodents. It is the only regimen that extends the lifespan and healthspan in as wide a spectrum of
organisms as yeast, nematodes, mice, rats, dogs, and possibly non-human primates (Colman, et al., 2009;
Mattison, et al., 2012; Weindruch, et al., 1986).
Dietary restriction can slow down ageing and extend youthful healthy lifespan in evolutionarily very
distantly related species from unicellular lifeforms (yeast), to invertebrates (flies, spiders, rotifers,
nematodes), rodents (mice, rats), dogs, and possibly rabbits and monkeys. Restriction of energy intake
extends the lifespan of mice and rats relative to nonobese ad libitum controls up to and including a 50%
reduction, which increases lifespan by approximately the same proportion. As a side effect, many
age-related diseases (neurodegeneration, metabolic disease, cardiovascular disease and cancer) and
other changes are effectively postponed, progression decelerated, or even prevented totally. Although DR
does not stop the ageing process, it definitely delays and/or retards the ageing process in many
experimental animals (de Magalhaes, et al., 2012).
There are several DR regimens for which some evidence of age-retarding effects exists.
1.5.2   Regimens
Lifespan extending DR regimens can be quantitative (caloric intake), qualitative (particular nutrients) or
temporal (fasting) in their very nature:
• Calorie Restriction
• Protein Restriction
• Amino Acid Restriction
• Tryptophan Restriction
• Leucine Restriction
• Methionine Restriction
• Water Restriction
• Intermittent Fasting
Dietary restriction (DR) is a non-genetic intervention that slows down ageing across taxa. DR has clear
positive effects on nematodes, flies and inbred mouse strains as well as rats. However results in
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wild-caught mice, primates and human populations indicate that the genetic background, the age of onset
of DR, and the composition of the diet affect the longevity-promoting effect in mammals (Swindell, 2012).
DR of total food intake, calorie or caloric restriction, robustly extends lifespan and hence implies that the
energy intake is the crucial factor, but intriguingly restricting only particular nutrients, notably some specific
amino acids, was also effective in slowing down ageing to an extent comparable to CR, without a reduction
in total caloric intake (Grandison, et al., 2009; Wu, et al., 2013; Lee, et al., 2014; Min & Tatar, 2006;
Emran, et al., 2014; Troen, et al., 2007). This raises the possibility that CR extends lifespan actually by
lowering the level of specific nutrients (e.g. amino acids). Alternatively it is also possible that energy intake
is not the only way to slow ageing and extend lifespan by dietary modulation. It is therefore logical to
assume that diverse DR regimens either control the same effectors modulating ageing or different
regimens may modulate different ageing systems. Nevertheless, by comparing different DR regimens
which are effective in retarding ageing it will be possible to dissect the common affected processes
(drivers) from the less important ones (passengers).
A diet containing a third less calories than usual extends the lifetime of mice and other mammals by up to
40% and drops their body temperature by half a degree or more (Pearson, 2006). A calorie restricted diet
lowers IGF1 levels, promotes apoptosis over cell proliferation and slows down tumour progression.
Restoring normal ad libitum IGF1 levels in mice under DR abrogates the protective effect of DR in
particularly on neoplastic progression (Dunn, et al., 1997).
Neither a reduction in fat nor in mineral content altered survival of rats under constant energy intake
(Iwasaki, et al., 1988b; Kubo, et al., 1987; Shimokawa, et al., 1996). But, by reducing the total amount or
just the amount of a particular nutrient such as carbohydrate (in yeast, worm, fly and rats), proteins (in rats
and mice) or amino acids (in yeast, fruit fly, mouse and rats) lifespan was extended (Place & Cruickshank,
2010).
1.5.3   Caloric Restriction
60% CR in mice increased lifespan by up to 65% (Weindruch, et al., 1986). CR increased lifespan in
species as diverse as fruit flies (Min, et al., 2007), guppies (Comfort, 1963) and dogs (Lawler, et al., 2008).
CR exerts beneficial effects including delayed immune senescence, retardation of cancer development,
alteration in gene expression, improved antioxidant protection and enhanced DNA repair (Orentreich, et
al., 1993). CR increases insulin sensitivity (Wang, et al., 2009) and heart function, and decreases
inflammation and muscle wasting of ageing. It also prevents age-related diseases such as cardiovascular
diseases (Willcox & Willcox, 2014; Lopez-Lluch & Navas, 2016), metabolic disease (Lopez-Lluch & Navas,
2016), neurodegeneration (Willcox & Willcox, 2014) and cancer (Weindruch, 1992; Willcox & Willcox,
2014). In essence, it is effective against many kind of diseases especially age-related diseases. It may be
interesting to identify any age-related physiological change or disease that is not affected by DR. This
might give insight into its mechanism of action since the obvious question would be, why are these
changes/disease not affected by DR?
CR mice have a higher metabolic rate. Therefore, the anti-ageing action of CR is not due to a reduction in
metabolic intensity or to a decreased intake of energy per unit of lean body mass, but rather involves a
total organism response involving the nervous and/or endocrine system (Masoro, et al., 1991). CR initiated
after the age of 6 months (almost completely matured) was as effective as at 6 weeks of age in extending
lifespan in rats (Yu, et al., 1985), indicating that CR slows the growth and development program in
adulthood (Masoro, et al., 1991).
CR alone is sufficient to extend lifespan. Parasitoid wasps have a simple diet consistent of carbohydrate
only. Only dietary dilution showed an effect with highest longevity at 80% sucrose (w/v), while there was
no effect on fecundity (Ellers, et al., 2011).
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1.5.4   Protein Restriction
Protein restriction extends lifespan in yeast and flies, but it was originally not clear that it does so in
rodents aside from as a side effect of CR (Iwasaki, et al., 1988a). 40-85% protein restriction increases
maximum lifespan by up to 20% in 16 out of 18 studies in rodents (Trepanowski, et al., 2011; Pamplona &
Barja, 2006; Leto, et al., 1976; Goodrick, 1978; Stoltzner, 1977; Fernandes, et al., 1976; Barrows &
Kokkonen, 1975; Yu, et al., 1985; Horakova, et al., 1988; Davis, et al., 1983; Ross & Bras, 1975; Miller &
Payne, 1968; Ross, 1961).
The type of protein fed to rats has an impact on lifespan. For instance substituting soy protein for casein
protein in rat diet increases the mean, median and maximum lifespan while caloric intake was the same
(Gilani, et al., 2009).
1.5.5   Methionine Restriction
Methionine restriction (MR) extends lifespan in flies, mice and rats and a couple of other species, but is
not as widely documented as CR.
Methionine restriction extended lifespan in flies (Grandison, et al., 2009; Troen, et al., 2007; Lee, et al.,
2014), mice (Miller, et al., 2005; Sun, et al., 2009) and rats (Orentreich, et al., 1993; Richie, et al., 1994;
Zimmerman, et al., 2003). Lifespan in Drosophila can be modified by varying the glucose and methionine
concentration in a chemically defined diet (Troen, et al., 2007).
80% MR (0.86 to 0.17%) restriction extended lifespan by 30% in rats. MR abolished growth, although food
intake was actually greater on a body weight basis. Increasing the energy intake of MR rats failed to
increase their rate of growth, whereas restricting control to food intake of MR rats did not materially reduce
growth. Thus, food restriction (i.e. decreased calories) was not a factor in lifespan extension (Orentreich,
et al., 1993). Methionine restriction resulted in 42% increase in mean and 44% increase in maximum
lifespan in rats (Richie, et al., 1994).
Methionine restriction lowered IGF1, thyroxine (T4), insulin (25%) and fasting glucose (50%) (Miller, et al.,
2005). MIF (migration inhibition factor) mRNA are increased in young adult mice of long-lived Snell dwarf
and Ghr KO mice as well as under CR (Miller, et al., 2002). Methionine restriction also increased mRNA
and the protein concentration of MIF (Miller, et al., 2005).
Food restriction limited to the first 20 days of life extended median and maximal lifespan. Methionine
restriction initiated at 12 months in mice increases mean, median (7% increase), and maximum lifespan.
CR mice had increase in phosphorylation of Erk, Jnk2, and p38, as well as a decrease in phosphorylation
of Akt, mTOR, and 4Ebp1. Methionine restricted mice did not exhibit a decrease of phosphorylation at
mTOR and 4Ebp1 (Sun, et al., 2009).
MR downregulates IGF1 and upregulates IGFBP1 (Takenaka, et al., 2000). Methionine supports protein
synthesis and has the capacity to maintain IGF production (shared by all essential amino acids), function
as a methyl donor (via S-adenosyl methionine; SAM) and as precursor for taurine, polyamines, glutathione
and sulphate. MR protocols have not included cysteine or most other non-essential amino acids (McCarty,
et al., 2009).
Lowering the content of sulfhydryl-containing amino acids by removing cysteine and restricting the
concentration of methionine extend all parameters of survival and maintain blood levels of GSH without a
reduction of energy intake (Zimmerman, et al., 2003). Methionine restriction exerts its beneficial effect, e.g.
increased adiponectin and triiodothyronine without energy restriction (Malloy, et al., 2006). Although MR
may not be associated with energy restriction, if protein synthesis is affected by methionine restriction, the
digestion, absorption and metabolic use of dietary energy may be affected. Cysteine supplementation can
reverse positive effects mediated by methionine restriction (Elshorbagy, et al., 2011).
80% MR in rodents (without CR), like DR, increases maximum longevity and strongly decreases
mitochondrial ROS generation and oxidative stress as well as lowers the degree of membrane fatty acid
unsaturation in rat liver. Similar 40% MR in rats decreases mitochondrial ROS production and percent free
radical leak at complex I during forward (but not during reverse) electron flow in brain and kidney
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mitochondria. MR induces changes to mitochondria in rat brain and kidney similar to caloric and protein
restriction (Caro, et al., 2009).
1.5.6   Tryptophan Restriction
30-40% tryptophan restriction starting from weaning can delay ageing in Long-Evans females rats. The
mortality was greater in the juvenile period, but substantially less than normal if fed at late ages (Ooka, et
al., 1988). Mice on a tryptophan restricted diet exhibit greater survival and reduced growth (De Marte &
Enesco, 1986).
The effect of tryptophan restriction is somewhat unclear in rodents, as it causes very high early mortality,
and is again not as widely documented as CR. Tryptophan restriction is confounded by involuntary CR (as
measured by reduced food intake and/or body weight) in all of the cases.
1.5.7   Water Restriction
Water restriction implemented similar to the protocol for the original caloric restriction experiment (McCay,
1933) extends lifespan of rats (Sprague-Dawley females from Taconic labs) even more than caloric
restriction (Clifton, 2010). Usually it assumed that it is detrimental not to have ad libitum water and it would
be very healthy to drink a lot of water. From an evolutionary point of view it makes sense that drought
(when water resources are limited) should delay reproduction and ageing.
The lifespan extending effect could be due to "voluntary" caloric restriction, as the lack of water could just
be inducing them to eat less. But caloric restriction might be causing animals also to drink less; CR
studies normally do not control for water intake. Replication of lifespan experiments under water restriction
is required.
1.5.8   Intermittent Fasting
Prolonged fasting started at middle-age extends longevity, lowers visceral fat, reduces cancer incidence
and skin lesions, rejuvenates the immune system, and retards bone mineral density loss (Brandhorst, et
al., 2015). In rodents intermittent fasting only works as a side-effect of CR (the degree of lifespan
extension is exactly what one would expect from the degree of unintentional reduction in energy intake)
(Anson, et al., 2003).
1.5.9   Invertebrates
In yeast caloric restriction is usually applied by reducing the sugar content from 2% (ad libitum) to 0.5%
(moderate CR) or even to 0.05% (severe CR). Though there is also extreme CR which is basically
starvation in water without any sugar added.
Genetic manipulations in nutrient-signalling pathways mimic the effects of dietary restriction. It seems that
caloric restriction requires mitochondrial respiration to increase longevity (chronological ageing), but not
always (for replicative ageing) (Kaeberlein, et al., 2007; Dilova, et al., 2007; Chen & Guarente, 2007;
Piper, 2006; Longo, 2009; Longo, et al., 2012).
In the nematode, dietary restriction can be accomplished via a variety of protocols like reducing bacteria
on liquid or solid media in plates. In fact, multiple methods of DR are used in C. elegans, including
mutation that reduce pharyngeal pumping (food intake impaired eat-2 mutants), removal of the bacteria
food source, dilution of live or dead bacteria, and axenic culture (Mair & Dillin, 2008).
Several dietary restriction regimens can extend the lifespan of fruit flies. Different laboratories use different
diets and techniques to implement DR. However DR seems to fail in species like medflies and houseflies
(Szafranski & Mekhail, 2014).
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1.5.10   Vertebrates
1.5.10.1   Rodents
Reducing the food consumption 25-60% without malnutrition extends the lifespan of rodents up to 50%
(Weindruch, et al., 1986) and delays the onset of age-related maladies (Colman, et al., 2009; Koubova &
Guarente, 2003). In mice and rats, DR can extend longevity by up to 50%, delay physiological ageing and
postpone or diminish the morbidity of most age-related diseases (Masoro, 2005). DR elicits major
metabolic reprogramming towards efficient fuel utilization and the reduction in oxidative damage to
macromolecules (Anderson & Weindruch, 2012; Sohal & Weindruch, 1996). DR triggers global
reprogramming of mitochondrial protein acetylome (Hebert, et al., 2013). DR has to be applied
continuously to produce the effect on maximum lifespan. If rats are refed at least up to 12 months of age,
all the effects of DR on extending survival is lost. Therefore DR is acting as some type of metabolic brake.
Mice placed under CR live longer and exhibit resistance to age-associated diseases (Omodei & Fontana,
2011; Trepanowski, et al., 2011; Fontana, et al., 2010). These mice also consume most of their food within
a few hours, however their peripheral clocks are well synchronized with the suprachiasmatic nucleus
(which determines time of day in mammals) (Froy & Miskin, 2010). The synchrony observed in mice under
CR could be the source of lifespan extension (Froy & Miskin, 2010). Longevity-conferring diets cause
major metabolic changes in normal mice, but not in mice whose growth hormone receptor was knocked
out (Westbrook, et al., 2014). Some inbred mouse strains do not live longer on DR. This has been found to
be the case for DBA/2 male mice (Hempenstall, et al., 2010) and several strains among the ILSXISS
recombinant inbred panel. DR does shorten the lifespan in even more ILSXISS strains than it extends
(Liao, et al., 2010). Dietary restriction does not appear to extend the lifespan of wild mice (Harper, et al.,
2006). All rodent studies might be biased to the effects of laboratory breeding (Swindell, 2012). However
the problem with these studies using the ILSXISS panel of mice is that too few animals (about 8-12) were
used to determine lifetime survival in each group. About 50, preferably over a 100 are needed for robust
survival statistics in lifespan studies.
Reducing the amount of calories fed to rats nearly increases their mean and maximum lifespan by up to
50%. In rats, DR increases median lifespan by 14-45% in half of all experiments (Swindell, 2012). Severe
DR extends lifespan of rats by nearly 50% (Abalan, et al., 2010).
1.5.10.2   Primates
Whether DR also prolongs lifespan in primates is questionable. Studies in monkeys and humans indicate
health benefits associated with a restricted diet and maybe also an extension of the lifespan.
1.5.10.2.1   Monkeys
Initial studies in rhesus monkeys indicate a longer lifespan, due to an overall reduced mortality (Wisconsin
study) (Colman, et al., 2009). However this was only true if censorship due to non-age-related diseases
was applied to the survival data. Another study conducted by the "National Institute of Aging" (NIA) did not
reveal any average lifespan benefit from a 30% DR in rhesus monkeys. DR improves some test results,
but only in monkeys put on the diet when they were old. Still an effect on maximum lifespan remains
unknown (Kolata, 2012; Mattison, et al., 2012).
The Wisconsin monkeys received a much higher sucrose content in their food than the NIA animals.
Wisconsin control animals could eat as much as they like, while the NIA control were given a set amount
of food.
1.5.10.2.2   Humans
When done correctly, DR appears to confer health benefits for humans, such as lowering the risk of heart
disease. Moderate CR in humans ameliorates multiple metabolic and hormonal factors that are implicated
in the pathogenesis of age-related disease such as type 2 diabetes, cardiovascular diseases, and cancer
(Most, et al., 2016). People on DR have hearts that function more like those found in people two decades
younger (Stein, et al., 2012).
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There are three types of evidence that DR works in humans:
1. Okinawa Diet
2. Biosphere 2
3. Caloric Restriction Society
1.5.10.2.2.1   Okinawa Diet
First of all, inhabitants of Okinawa (a Japanese island) practice a DR-like lifestyle as part of their culture,
and Okinawans enjoy simple lives (Morgan, 2003). Okinawans are the longest-lived (Willcox, et al., 2007a)
and most disease-free population (Bernstein, et al., 2004) on the globe. Okinawa has a high centenarian
prevalence (Willcox, et al., 2008a). In fact, Okinawa has the highest prevalence of exceptionally long-lived
individuals in the world (Willcox, et al., 2006a). Okinawan centenarians exhibit a high functional status
throughout their 90s (Willcox, et al., 2007b).
Okinawa centenarians have low plasma lipid peroxide implying protection against oxidative stress. Vitamin
E tocopherols is also lower in Okinawa centenarians, but intracellular beta-tocopherol is higher.
tocopherol/cholesterol and tocopherol/lipid peroxide (LPO) ratios were not different between age groups,
although there was a correlation between α-tocopherol and LPO in septuagenarians but not in
centenarians (Suzuki, et al., 2010). Epidemiological analysis on Okinawans found a low-caloric intake and
negative energy balance at younger ages, little weight gain with age, lifelong low body mass index (BMI),
relatively high plasma dehydroepiandrosterone (DHEA) levels at older ages, low risk for mortality from
age-related diseases, and survival patterns consistent with extended mean and maximum lifespan
(Willcox, et al., 2007a).
Epidemiological evidence indicates that CR might have contributed to an extension of average and
maximum lifespan and lowered risk for age-associated chronic diseases (Willcox, et al., 2006b). Okinawa
supercentenarians display an exceptionally healthy phenotype where clinically apparent major chronic
diseases and disabilities were markedly delayed, with little clinical history of cardiovascular disease and no
history of cancer or diabetes (Willcox, et al., 2008b).
Whether the remarkable longevity of Okinawans is mainly due to their diet or because of their genetics is
still an open question. This could be resolved by studying any Okinawans who migrated to another
country and adopted the diet of the new country. Such studies have been used to show the effect of diet
on morbidity rates in Japanese subjects who emigrated to the USA.
1.5.10.2.2.2   Biosphere 2
Secondly, the Biosphere 2 crew, who lived in isolation for two years, had a low-caloric diet and
experienced many physiological, haematological, hormonal and biochemical (e.g. Insulin, T3 glucose and
cholesterol decreased) changes, which resemble those of rodents and monkeys maintained on DR and
remained in excellent health and high physical and mental activity. Additional variations in several
substances, not hitherto studied in DR animals, like androstenedione, thyroid binding globulin, renin, and
transferrin were also observed (Walford, et al., 2002).
The problem with this study is that the subject numbers were so low and the experiment had to be
terminated when they could not produce sufficient food to support survival.
1.5.10.2.2.3   Caloric Restriction Society
Thirdly, ongoing studies on dietary restricting human volunteers (e.g. Caloric Restriction Society) already
showed that it exerts beneficial effects on health and that, in particular, moderate protein restriction evokes
similar adaptive responses as in dietary restricted rodents and monkeys (Fontana, et al., 2008).
The Comprehensive Assessment of the Long-term Effects of Reducing Intake of Energy (CALERIE)
research program is a systematic investigation of dietary restriction in nonobese human individuals
(Rochon, et al., 2011). It was found that the dietary restricted humans had lower insulin resistance, lower
LDL cholesterol levels, lower body temperature and blood insulin levels as well as less oxidative damage
to the DNA (Economist, 2006).
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CR decreases serum IGF1 (40%), protects against cancer and slows ageing in rodents. While severe CR
without malnutrition did not change IGF1 and IGF/IGFBP3 ratio levels in humans, total and free IGF1 were
lower in moderately protein restriction (1.67 to 0.95g/kg body weight per day) (Fontana, et al., 2008).
1.5.10.2.3   Caloric Intake
It is not yet know what the optimum of food intake is and which factors are most important to restrict and,
as one can easily assume, these vary by species as well as strains and in humans by individuals. For
humans, the usual recommended diet for adult males is about 2500 calories/day.
The caloric intake of Okinawans was 1785 kcal/day (Willcox, et al., 2007a), which is 15% and 40% less
than the average of mainland Japanese (2068 kcal/day) and US (2980 kcal/day), respectively.
Biospherians consumed 30% less (from 2500 to 1784 kcal/day) for the first 6 months and then 2000
kcal/day for the remaining 12 months, which was combined with high level of physical activity of 70-80
hour work/week (Walford, et al., 1992). Caloric Restriction Society members eat about 1800 kcal/day,
which is 30% less than a typical Western diet (Holloszy & Fontana, 2007).
1.5.11   Side Effects
In humans a severely restricted diet can lead to low testosterone levels and problems with maintaining
bone density in male individuals (Naik, 2012). A moderately restricted diet is assumed to not reduce the
quality of life. Rodents under DR are usually more active on the physical and mental levels even into
advanced ages. Volunteering people practising DR report that they experience much higher concentration
levels.
It is actually exactly the opposite; eating too much reduces the quality of life, making individuals tired
during the daytime period and causing problems sleeping well during the night time. However severe or
extreme DR may result in serious deleterious effects.
1.5.12   Mechanism
Dietary restriction is associated with a variety of changes like metabolic, transcriptional and epigenetic
reprogramming. Those changes can be used as surrogates for biomarkers of longevity. How dietary
restriction interferes with ageing is still unknown but several potential mechanistic explanations exist.
Genome Stability. Mice under dietary restriction accumulate longer telomeres (Biocompare, 2013).
Dietary restriction seems to attenuate telomere erosion (Vera, et al., 2013). CR promotes genomic stability
by increasing DNA repair capacity, specifically base excision repair (BER) and completely reverses
age-related decline in BER capacity in many tissues (brain, liver, spleen and testes), which is
accompanied by a reversal in age-related loss of β-pol protein, mRNA and activity levels. BER capacity,
β-pol protein and mRNA were already upregulated in young (4-6 months) (Cabelof, et al., 2003).
Hormesis. DR extends median and maximal lifespan. It does it actually by slowing down ageing.
Starvation is the most extreme form of malnutrition and when prolonged can seriously damage an
organism. However, the DR response has some similarities to starvation and it was proposed that DR (i.e.
low nutrient state) utilizes a low level of stress which enhances defences and repair systems. These
beneficial effects of a low stress stimulus is conceptualised as “hormesis”.
Genetics. The longevity promoting effect of DR seems to be mediated by specific signalling pathways.
Defined genes appear to be essential for the lifespan-extending effect. Genes that mediate the effect of
DR on longevity are designated as DR-essential genes. Sequences of DR-essential genes do not vary
across species, but rather they appear to be conserved. It is probable that DR-essential genes are likely to
change their activity under DR (i.e. become up- or downregulated). Upon DR, Insulin/IGF1/GH axis and
TOR signalling are downregulated, while AMPK, sirtuins and FOXOs become upregulated.
Epigenetics. Epigenetic mechanisms have been recognized as major contributors to nutrition-related
longevity and control of ageing. Dietary restriction affects DNA methylation and histone modifications via
activation of DNA methyltransferases and histone remodelling which primarily includes histone acetylation
and methylation. This in turn reverses certain ageing gene expression changes and ensures the
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maintenance of the chromatin stability, resulting in delay of ageing and age-related diseases (Li, et al.,
2011).
Evolution. The most accepted evolutionary explanation of dietary restriction is that in times of famine
when nutrients are limited, organisms trigger a specific genetic program to slow down ageing and
reproduction in order to survive. A restricted diet might also trigger the higher turnover of molecules, cells
and tissues and therefore provoke a light form of rejuvenation.
A variety of dietary regimens have been shown to be effective in interfering with the ageing process in
multitude of evolutionary distinct species. How DR interferes with ageing and which kind of regimens work
well in human is not yet certain. As DR works in almost all species (but not all strains/individuals) tested
so far, it would be really surprising if it did not work at all in humans. It is therefore hoped that research on
DR will reveal which factors in the diet are crucial for a healthy lifestyle. By making policy-makers aware of
it, they could identify and define healthier diets. Further, understanding the actual mechanism underlying
DR's anti-ageing effect could lead to the identification of supplements or even development of
pharmacological products mimicking the effect of DR without severely restricting one’s diet (i.e. DR
mimetics).
Research on dietary restriction might enable the identification of genes and molecules that mimic the effect
of dietary restriction without the necessity to restrict the diet. Dietary restriction mimetics are genetic
interventions or components (i.e. pharmacological interventions) that mimic the biochemical or functional
effects of dietary restriction (Madeo, et al., 2014). The aim of research on dietary restriction is not enabling
of living longer, but being in a young and youthful state. Staying youthful and healthy longer is definitely
not a wrong aim. Generally, a low-caloric, nutrient-dense, diversified diet low in fat and proteins
(preferential mainly plant-derived) and without any extra added sugar is beneficial. However, for interfering
with the ageing process with a greater extent powerful anti-ageing drugs are needed.
1.6   Anti-Ageing Drugs
1.6.1   Background
Medicaments could one day slow down and reverse the ageing process in humans. Among the most
ignored medical findings are that the biological ageing process is the greatest risk factor for life-threatening
diseases such as atherosclerosis, cancer, dementia, and diabetes (Perez-Jimenez, et al., 2005). Logically
it follows that it should be interfered with the ageing process, instead of trying to treat one disease after the
other. Anti-ageing strategies can therefore be viewed as an extension of medicine.
A review of recent research results indicate the following: Firstly, defined genetic mutations can prolong
the lifespan and delay age-related disease (Mari, 2011). These genes could be targeted by therapeutics. A
change in the receptors for growth factor hormone can for instance increase the lifespan of mice and
inhibit tumourigenesis in humans (Coschigano, et al., 2000; Bonkowski, et al., 2006; Arum, et al., 2009;
List, et al., 2011; Coschigano, et al., 2003; Zhou, et al., 1997; Kinney, et al., 2001; Guevara-Aguirre, et al.,
2011). Secondly, in humans who are older than 100 - a feature that is partly inheritable - age-related
diseases occur in later years (Deluty, et al., 2015). Thirdly, a significant reduction in caloric intake extends
the lifespan and delays the incidence of chronic diseases in a range of animal species (Tocchetti, et al.,
2010). Fourthly, compounds such as metformin (Martin-Montalvo, et al., 2013), acarbose (Harrison, et al.,
2014), and rapamycin (Anisimov, et al., 2011a) among others extend the lifespan and delay the
occurrence of cancer and dementia in mice. From these observations it is possible to draw the conclusion
that age-related diseases can be treated all at once, by modifying the basic ageing process using a
therapeutic approach.
There are several major research programs to experimentally test compounds to determine their effect on
ageing. The US National Institute of "Aging's Intervention Testing Program" (ITP) is a multi-institutional
study on investigating treatments with the potential to extend lifespan and delay age-related disease and
dysfunction by utilising lifespan experiments in mice (Nadon, et al., 2016). Secondly, a more recent
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international effort known as the Major Mouse Testing Program (MMTP) has been initiated from crowd
funding campaigns (MMPT, 2016).
Drugs that counteract ageing are often referred to as anti-ageing drugs or geroprotectors. Geroprotectors
are therapeutics that aim to affect the root cause of ageing and thus treat age-related diseases all
together, and therefore prolong the lifespan of organisms including humans (Fedichev, et al., 2011).
Modification of the genome is very risky and extremely difficult to perform with prevision. Compounds that
interfere with gene activity and metabolism are a more adequate approach.
1.6.2   Drug Discovery
A number of bioactive agents have been identified to have promising "anti-ageing" (geroprotective) effects.
Usually a substance is considered to have ageing modulating activity if its efficiency can be confirmed in
vitro or in vivo.
A compound, or an intervention more generally, can be found to slow down the progression of a certain
age-related change or reverse the change by reducing the quantity of this change / these changes.
However, genuine anti-ageing drugs need to fulfil the criteria of being capable of extending the lifespan of
an organism and especially prolonging the maximum lifespan.
Anti-ageing drugs can be identified in a variety of ways. One way is via molecular interactions with the
protein products of ageing-related genes. Another approach is utilising gene expression data that is based
on the effect of the compounds on gene expression that might either mimic the effect of dietary restriction,
long-lived mutants, germ line expression (which is said to be immortal or have rejuvenating effect) or
reverse age-related, progeroid or senescent cell gene expression. Another method may be based on a
higher level of abstraction where those compounds would have shown previously to reverse a specific
age-related change (i.e. not only on the gene expression level).
As anti-ageing drugs interfere with the ageing process they are often effective against numerous
age-related diseases. Further, the ageing process seems to be a very ancient and evolutionarily
conserved process. Drugs that are shown to be effective in slowing down or reversing ageing in multiple
model organisms, including rodents, might also be effective in humans. Lifespan experiments in humans
are feasible, but not practical. Therefore biomarkers of ageing are necessary that can serve as proxy
indicators of the rate of ageing [Biomarkers of Ageing]. Thus drugs can be tested for their efficiency in
reversing certain age-related changes or effectiveness in alleviating age-related diseases. Aged
individuals are suitable for any such clinical trials in order to test whether those compounds are capable of
reversing the ageing process for these individuals as those individuals have already experienced the
effects of ageing. To acquire evidence that the rate of ageing can be slowed would require young
individuals being given such drugs. Also the possibility to affect premature ageing diseases or cellular
senescence would be a good indication. Although premature ageing may be a special condition not
indicative of ageing in the general population.
1.6.3   Classes of Anti-Ageing Drugs
With regard to the mechanism of action, anti-ageing drugs might be classified into defined groups broadly
based on the type of anti-ageing strategy. This is primarily attributed to their assumed mode of action.
Possible geroprotectors include resveratrol, sirolimus (i.e. rapamycin; and its derivatives), metformin,
spermidine, aspirin (including membrane penetrating aspirin), NAD, lipoic acid, ibuprofen, and carnosine,
among many others. Many of those compounds can be classified to be belonging to multiple of those
classes (not an exhaustive list):
• Antioxidant
• AGE-inhibitor/breaker
• Pharmacoperone
• Hormetin
• Senolytic
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• DR mimetic
• Telomerase-Activating Component
• Sirtuin-Activating Compound (STAC)
• Histone Deacetylase Inhibitor (HDACi)
Most of those have been shown to extend the lifespan in at least one of multiple model organisms. For
instance, Drosophila fed a biotin diet exhibit a 30% increase in lifespan (Smith, et al., 2007). While others
have been found to affect specific types of age-related changes. For example long-term treatment with
epithalamin in humans decelerates ageing of the cardiovascular system, prevents age-associated
impairment of physical endurance, normalizes circadian rhythm of melatonin production and carbohydrate
as well as lipid metabolism. Epithalamin significantly lowers mortality in coronary patients, which indicates
that it has a geroprotective effect (Korkushko, et al., 2011).
Antioxidants scavenge free radicals. Supplementation with some specific antioxidants failed to extend the
lifespan, but certain antioxidants that were specifically targeted to the mitochondria were found to
moderately extend lifespan in specific strains of mice (Anisimov, et al., 2011b).
Yet other kinds of compounds were discovered based on their ability to reduce/eliminate specific types of
accumulations of harmful aggregates. Glucose and other reducing sugars tend to react nonenzymatically
with proteins leading to the generation of advanced glycosylation endproducts (AGEs) and induce
AGE-derived protein cross-linking. AGEs build up slowly and accumulate with ageing which contribute to
various pathological events and age-related disease (including nephropathy, retinopathy, vasculopathy
and neuropathy). AGE inhibitors and breakers are components that inhibit the formation of AGEs or
disrupt the preformed AGE protein cross-links, respectively. AGE breakers in particular are a class of
drugs that break the bonds of advanced glycation endproducts. The AGE-inhibitor pimagedine and the
cross-link breaker ALT-711 have been shown in animal models and preliminary clinical trials to reduce the
severity of pathologies of advanced glycosylation (Vasan, et al., 2001).
Pharmacoperones are small pharmacological chaperones that enter cells and serve as a molecular
scaffolding in order to fold and route misfolded proteins. For instance, the amyloid-binding dye Thioflavin T
can profoundly extend the median (60%) and maximal (43-78%) lifespan of Caenorhabditis elegans and
therefore slow down ageing (Alavez, et al., 2011).
Many compounds have been identified by a reductionist approach of being able to stimulate or inhibit a
certain class of gene/protein product that itself exhibits aging-suppressing (anti-ageing) or gerontogenic
(ageing-promoting) effect. Resveratrol was identified based on its ability to stimulate sirtuins (hence the
term Sirtuin-Activating Compound; STAC) (Bonkowski & Sinclair, 2016). Metformin activates
AMP-activated protein kinase α (AMPK) (Onken & Driscoll, 2010). TA-65 (a.k.a. cycloastragenol) was
specifically developed to activate telomerase (Bernardes de Jesus, et al., 2011; Salvador, et al., 2016).
Sirolimus (rapamycin) was found to inhibit the target of rapamycin (TOR) (Anisimov, et al., 2011a). Sodium
butyrate is a histone deacetylase inhibitor (Vaiserman, et al., 2012).
Other compounds were found to induce certain kind of processes that are known to have
rejuvenating/repairing activities. For example, spermidine was found for its ability to stimulate autophagy
(Eisenberg, et al., 2009).
Senolytic drugs (senolytics), like dasatinib and quercetin, are drugs that selectively induce death of
senescent cells. Dasatinib eliminates senescent human cell progenitors. Quercetin eliminates senescent
human endothelial cells and mouse bone marrow stem cells (Quick, 2015).
Anti-cancer drugs selectively kill cancer cells. Some natural compounds, such as curcumin, exhibit
cancer-killing properties.
Another class of drugs are those that mimic the effect of dietary restriction (so called dietary restriction or
caloric/calorie restriction mimetics) such as alpha-lipoic acid which can mimic or even block the effect of
dietary restriction. Alpha-lipoic acid is also an inhibitor of histone deacetylases leading to hyperacetylated
state of a range of proteins as does the classical dietary restriction feeding regimen (Merry, et al., 2008).
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Mixtures of components are found to be effective in lifespan extension even when the active ingredient is
unknown. For instance, cranberry extract (Guha, et al., 2013; Guha, et al., 2014) promotes healthspan and
increases the lifespan by 8.2-80.9% in C. elegans. Similar different Ilex paraguariensis extracts robustly
extend average lifespan to varying degrees (Lima, et al., 2014).
1.6.4   Brute-Force Drug Discovery: Drug Screening
A way of identifying new anti-ageing drugs would be to screen small molecule libraries via lifespan tests in
lower model organisms. An issue would be the selection of the correct dose and the test species. Any drug
can be toxic if applied at too high a dose, which would mask its anti-ageing effect. Similarly if too low doses
are used no significant effect might be detected. It is advantageous to start screening with a model
organism that has a short lifespan. One could start screening in one of the simplest eukaryotic organisms
such as budding yeast. Assays can be conducted to increase its replicative and/or chronological lifespan.
Such compounds identified could be screened in nematode species, which have a lifespan of about 30
days and also in the fruit fly which have a lifespan of 80 days. An important consideration is the amount of
labour required to conduct lifetime studies. Ideally robots can be used to conduct the lifespan assays in a
high-throughput manner. Promising compounds identified would then be required to be tested in a
short-lived mammal, such as a number of mouse strains, to verify its effectiveness in retarding mammalian
ageing. In order to get results in a quicker time frame it is suggested to start applying the drug in adult
organisms and see to what extent they are able to modify the remaining lifespan. Biomarkers of ageing
and health can be used even earlier to detect anti-ageing properties and reverse signs of ageing (i.e.
rejuvenate). In humans starting with already old individuals and assessing ageing biomarkers seems to be
the most practical way of testing the effect of anti-ageing drugs. Drugs can for instance quickly be tested
for the ability to rejuvenate the immune system in already aged humans (Mannick, et al., 2014).
Without performing lifespan assays drugs can be tested for the ability to reverse different classes of
age-related changes. Gene expression profiling can be used to check whether those candidate drugs are
able to reset gene expression patterns to that of a young organism when applied to old ones (Merry, et al.,
2008).
1.6.5   Targeted Drug Discovery
Targets for small molecule interventions can be identified using bioinformatics. For instance proteins in
pathways containing the greatest numbers of genes responsible for lifespan control are attractive targets
(e.g. via guilt-by-association).
Modern structure-based drug discovery then enables the identification of novel compounds readily testable
in in vitro models of age-related diseases in experiments that measure lifespan in multiple organisms. An
initial screen can be conducted via genetic means, such as with knockout/overexpression libraries or via
gene silencing with whole organisms or just single cells (cell culture). The identified target genes can be
used to test drugs that are known to specifically act on those or new drugs can be developed that are likely
to enhance or inhibit those gene products.
1.6.6   Pitfalls
There are several pitfalls that need to be taken into account for developing effective anti-ageing drugs:
• Interventions that target "private" mechanisms of ageing
• Involuntary DR
• Hormetic response
• Dose
• Drug-drug interactions
Some common pitfalls in drug discovery for anti-ageing are that the compound may only extend the
lifespan in a single type of model organism as it affects a private mechanism of ageing only operating in
this model organism type. Therefore validation in multiple organisms is a good indication that it acts via a
shared mechanism across phyla.
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Some pharmaceutical interventions may provoke DR simply due to suppression of appetite or reduction of
nutrient intake and therefore indirectly lead to lifespan extension but primarily via DR (Masoro, 2007). For
this reason when testing for the lifespan effect of a compound it is useful to measure the food consumption
and compare to controls in order to rule out lifespan extension by sole involuntary DR.
Another problem is hormesis. Even toxic substances might lead to lifespan extension by stimulating repair
systems. Whether the hormetic response is additive is rather questionable. It may be so if different
hormetins stimulate different repair systems.
A further and important issue is the one regarding the dose. Identification of the ideal dose of a drug
requires the assessment of a dose response curve by testing different concentrations of the compound
(Paracelsus, 1965).
Lastly, the combination of many drugs might need to consider network effects as possible unwanted
drug-drug interaction may occur and different drugs may cancel each other out. Ideally would be the
identification of drugs that are synergistic with each other and do not cause any unwanted side effects
when combined together. The transition from reductionism to a systems-oriented perspective and
utilization of systematic approaches in modern biogerontology may result in the development of ageing
modulating treatments (Vaiserman, 2014).
Developing anti-ageing drugs is possible and harbours a huge potential. There are different ways of
developing drugs against ageing. There are also different types of drugs that can be found to slow down
and reverse certain classes of age-related changes. Defined pitfalls need to be paid attention to discover
genuine powerful anti-ageing drugs. Testing in multiple model organisms and the assessment of
biomarkers of ageing are recommended. Because of the huge search space (number of components and
tests to perform) computational approaches are desirable to narrow down the number of potential
candidates and needed experiments in order to speed up effective drug identification.
_
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Figure 1: Overlapping Fields. Disciplines that are on the intersection of informatics and biology have
similar but also different focus and scope as well as utilize overlapping methodologies. Fields are
depicted as triangles and laid out in an oversimplified way to illustrate their overlap which is not true to
scale for illustrative purpose only.
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1.7   Computational Approaches
Various disciplines utilizing computational approaches that lay on the intersection of informatics and
biology are overlapping fields, through each discipline has a different focus as simplified illustrated below
[Figure 1 Overlapping Fields] and differentiated in this section in the following.
1.8   Computational Biology
Computational biology is at the interface of computer science and biology. It involves the development and
application of data analytics and theoretical methods, mathematical modelling and computational
simulation techniques to the study of biological, behavioural, and social systems (Huerta, 2000).
Computational biology is the application of core technologies of computer science (e.g. algorithms,
databases, artificial intelligence, etc.) to the problems arising from biology. Computational biology builds
theoretical models of biological systems, just as mathematical biology does with mathematical models.
Molecular biology is now a high-performance and high-throughput science. One now deals with tera- and
petabyte amounts of data. This huge amount of data also takes a lot of computing time. Typically it
requires computer clusters.
With the large-scale generation and integration of various omics such as genomics, transcriptomics,
proteomics, metabolomics, and interactomics, complex biological systems (which are just machines) and
processes could be reverse engineered from data.
Computational biology is particularly exciting today because the problems are large enough to motivate
efficient algorithms and the demand of biology on computational science is increasing. The problems are
also accessible and are expected to yield medical advances. Overall biology, and molecular biology
especially, is increasingly becoming an information science.
Developments in biology are coming astonishingly quickly, generating remarkable possibilities.
Computational biology is increasingly of interest in both life science and computational science
departments. Many solutions to difficult problems go from biology to computer science: e.g. fragment
assembly, sequence analysis, algorithms for phylogenetic trees, evolutionary algorithms and neural
networks. In reverse many possible solutions to difficult problems go from computer science to biology:
e.g. sequencing by hybridization, DNA computing, etc.
The goal of computational and systems biology is to apply large-scale numerical methods to the study of
molecular, cellular and structural biology. The release of the human genome sequence has focused
attention on the increasing importance of computational and systems biology for the analysis of gene
function. However, only a small fraction of the information generated in modern biology laboratories has
been subjected to systematic computational analysis. Thus, the future of systems biology lies not only in
improved methods to study sequence information but also in the development of entirely new approaches
to the numerical analysis of proteins, cells and organisms.
The cost for DNA sequencing is decreasing at an exponentially pace. The development of ever new
techniques of sequencing that power this trend have been termed Next Generation Sequencing. Usually
reference genomes are assembled from millions of short reads or nowadays even single molecule
sequencing via nanopores (pores of nanometer size) is possible (Maitra, et al., 2012). Genome-wide
association study (GWAS) analysis can identify human variants associated with disease. RNA-seq reveals
both RNA expression levels and isoforms (transcript variants, i.e. splice variants). Chromatin
immunoprecipitation followed by sequencing, or ChIP-seq for short, reveals where key genomic regulators
bind to the genome. Quantitative Trait Loci (QTLs) can predict phenotypes. Chromatin accessibility
changes can reveal genome functional elements.
One in over 1000 base pairs is different from individual to individual. A fundamental question is which
location in the genome has variants that are highly associated to a specific trait or disease and how is that
difference causing certain phenotypes?
Computational biology develops large scale computable models for biological research. It uses large scale
data from different omics and bioinformatics in order to conceptualize the raw data.
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1.9   Bioinformatics
Biological informatics (abbreviated bioinformatics) is an interdisciplinary field that develops methods and
software tools for understanding biological data. As an interdisciplinary field of science, bioinformatics
combines computer science, statistics, mathematics, and engineering to study and process biological
data. Bioinformatics is the research, development, or application of computational tools and approaches
for expanding the use of biological, medical, behavioural or health data, including those tools required to
acquire, store, organize, archive, analyse, and visualize such data (Huerta, et al., 2000).
It is impossible to do much with this gigantic volume of data unless one uses computer tools to decipher
and to find meaningful patterns in the data. Bioinformatics essentially is using computers to analyse a
wide variety of biological problems. Bioinformatics is the transformation of data into knowledge and
understanding in the area of biology. Bioinformatics started as a small and obscure discipline. Today it is a
huge field that is making a digital revolution in biology.
Bioinformatics and computational biology have similar aims and approaches, but they differ in scope
where bioinformatics is mostly more general and computational biology problems are often more specific
in their focus. Bioinformatics organizes and analysis basic biological data, while computational biology
builds theoretical models of biological systems. To be more precise, bioinformatics usually deals with
genomics and other omics while computational biology is totally focused on building accurate
computational simulations. The aims of bioinformatics are three-fold:
1. Storage: At its simplest bioinformatics organises data in a way that allows researchers to access
existing information and to submit new entries as they are produced.
2. Analysis: Further bioinformatics aims to develop tools and resources that aid in the analysis of data.
3. Interpretation: The third aim is to use these tools to interpret the results in a biologically meaningful
manner.
Today bioinformatics aims to conduct global analysis of all the available data with the aim of uncovering
common principles that apply across many systems and highlight novel features. The computational goals
of bioinformatics are:
• Learn & Generalize: Discover conserved patterns (models) of sequences, structures, interactions,
metabolism and chemistry from well-studied examples.
• Prediction: Infer function or structure of newly sequences, genes, genomes, proteins or proteomes
from these generalizations.
• Organize & Integrate: Develop a systematic and genomic approach to molecular interactions,
metabolism, cell signalling, gene expression, etc.
• Simulate: Model gene expression, gene regulation, protein folding, protein-protein interaction,
protein-ligand binding, catalytic function, metabolism, etc.
• Engineer: Construct novel organisms, functions or regulations of genes and proteins in silico.
• Manipulation: Target specific genes via in silico mutation/knockdown to change phenotype.
The central paradigm of molecular biology is:
DNA -> RNA -> Protein -> Phenotype (Symptoms)
The corresponding central paradigm of bioinformatics is:
Genetic information -> Molecular structure
                          -> Biochemical function -> Phenotype (Symptoms)
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Bioinformatics is a fast-growing interdisciplinary field. As a result of the rising research effort in
bioinformatics, the global bioinformatics market was valued at 4,110.6 million USD in 2014 and is
expected to reach 12,542.4 million USD in 2020 (Hare, 2014).
Genomic sequencing capabilities have increased exponentially (Lander, et al., 2001; Venter, et al., 2001;
Kircher & Kelso, 2010), outstripping advances in computing power (Kahn, 2011; Gross, 2011;
Huttenhower & Hofmann, 2010; Schatz, et al., 2010; Cloud, 2012). The rate of available genomic data is
increasing approximately tenfold every year, a rate much faster than Moore's Law for computational
processing power (Kahn, 2011).
Human genomes differ on average by only 0.1% (Venter, et al., 2001). One thousand human genomes
contain less than twice the unique information of one genome. Thus, although individual genomes are not
very compressible, collections of related genomes are extremely compressible (Christley, et al., 2009;
Brandon, et al., 2009; Maekinen, et al., 2009; Kozanitis, et al., 2010).
Compressive algorithms for genomics have the advantage of becoming proportionally faster with the size
of the available data (Loh, et al., 2012). As computing moves toward distributed and multiprocessor
architectures, this ability must be considered for new algorithms to be run in parallel.
Bioinformatics is very useful as it forms a basic for other disciplines at the intersection of biology and
computer science, as it deals with the raw data and provides algorithms to operate on it, and gathers
meaningful insights into biological phenomena. It is, for instance, utilized heavily in functional genomics to
infer the functions of biological entities encoded in the genome.
1.10   Functional Genomics
Life comes with information. All information for an organism is encoded in its genome. Functional
genomics is molecular biology that utilizes the vast wealth of data produced by genomics (and other
omics) to describe the functions of genes and their gene products (including proteins) as well as their
interactions. Functional genomic approaches involve the use of large-scale and/or high-throughput
methods to understand the function, of major biomolecules, and infer functions from the genome to the
phenotype of an organism. In contrast to genomics, functional genomics has a focus on the dynamic
aspects such as transcription, translation, gene expression regulation and interactions among biological
entities like proteins, as opposed to the more static aspects of genomic information that include DNA
sequence and structures. Functional genomics seeks answers to questions about the function of DNA at
the level of genes, transcripts and protein products. The key characteristic of studies involving functional
genomics is their genome-wide approach to answer those questions, usually involving high-throughput
methods rather than reductionistic "gene-by-gene" approach.
1.10.1   Aims
The aim of functional genomics is to generate an understanding of biology in order to bridge the gap
between an organism's genome and its expressed phenotype.
Functional genomics is frequently used to refer to the many possible approaches to understand the
properties and activities of an organism's genes and gene products. It involves the study of natural
variation in genes, RNA and proteins over time as well as both natural or experimental functional
interruptions affecting genes and their gene products.
Overall it synthesizes data from various omics (genomics, transcriptomics, proteomics, metabolomics, and
interactomics) into an understanding of the dynamic properties of organismal processes and activities. It
provides insights into how biological function arises from information encoded in an organism's genome.
As the name suggests functional genomics investigates functional-related aspects of the genome such as
analysis of mutations and polymorphisms as well as the measurement of molecular activities.
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1.10.2   Techniques/Applications
Functional genomics relies heavily on bioinformatics to make sense of the vast amount of data being
generated. Among the techniques utilized are data clustering or dimensional reduction (e.g. principal
component analysis) for unsupervised machine learning (class detection). Also used are support vector
machines and artificial neural networks for supervised machine learning (class prediction, classification).
Functional enrichment analysis with ontologies is used for instance to determine the extent of over- or
under-expression of genes.
The new generation of sequencing technologies provides unprecedented opportunities for high-throughput
functional genomics research. These technologies can be applied in a variety of contexts, including
whole-genome sequencing, targeted resequencing, discovery of transcription factor binding sites, and
coding/non-coding RNA expression profiles as well as epigenetic marks (Morozova & Marra, 2008).
1.10.2.1   Genome
Systematic pairwise deletion/overexpression of genes or inhibition/activation of gene expression can be
utilized to identify genes with related function, even if they do not interact physically.
The ENCODE (Encyclopedia of DNA Elements) project builds a comprehensive parts list of functional
elements in the human genome, including elements that act at the RNA and protein levels and regulatory
elements that control cells and circumstances in which a gene is active. It is intended as follow-up to the
Human Genome Project to map all functional elements in the human genome.
1.10.2.2   Epigenome
Bisulfite sequencing is the utilization of bisulfite treatment of DNA to determine its pattern of modifications
such as methylation and hydroxymethylation.
ChIP-sequencing (ChIP-seq) is a technique to analyse protein interactions with DNA. It combines
chromatin immunoprecipitation with massively parallel DNA sequencing to identify the binding sites of
proteins associated with DNA.
1.10.2.3   Transcriptome
Microarrays measure the amount of RNA in a sample that corresponds to a probe DNA sequence or
gene.
An alternative method of gene expression analysis is SAGE (serial analysis of gene expression) that is
based on RNA sequencing rather than hybridization.
1.10.2.4   Proteome
A yeast two-hybrid (Y2H) screen assesses a "bait" protein against many candidate interacting proteins
("prey") to identify physical protein-protein interactions.
Affinity purification and mass spectrometry (AP/MS) is capable of identifying proteins that interact with one
another in complexes.
1.10.2.5   Loss/Gain of Functions
Mutagenesis is commonly used to alter genes. The function of genes can be investigated by
systematically "knocking out" or "overexpressing" genes one by one. This is done either by disruption of
function (via deletion or insertional mutagenesis) or by enhancing function (via inserting multiple copies or
rendering promoters more active).
RNAi (RNA interference) is a natural biological process in which RNA inhibits gene expression or
translation by neutralizing a target mRNA. This process can be used to transiently knock-down the
expression of a gene of interest using targeted short double-stranded RNA. The knock-down can also be
made permanent if DNA expressing interfering RNA is introduced into the cells.
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Functional genomics uses genomics data to study gene and protein expression and function on a global
scale (genome-wide or system-wide), focusing on gene transcription, translation and protein-protein
interactions, and often involving high-throughput methods. Overall, functional genomics has the goal to
understand the relationship between an organism's genome and its phenotype. Functional genomics
helps to lay a solid foundation for the systems biology approach.
1.11   Systems Biology
Systems biology is an approach in which experimental biology is closely integrated with mathematical or
computational modelling in a synergistic way to answer biological questions that would not be possible by
empirical approaches alone. One of the goals of systems biology is to discover new emergent properties
that may arise from studying the system as a whole, leading to more rapid and deeper understanding of
how the system is controlled and how it responds to external stimuli. This level of understanding will
greatly facilitate the future of biological systems.
Systems biology aims to develop hypotheses based on integrated or modelled data. A systems biology
project may be performed at a number of different biological scales or it may integrate across scales. The
systems biology cycle is composed of modelling and experimentation. Models should be both descriptive
and predictive (Antezana, et al., 2013). Systems biology provides an understanding of biology from a
system perspective, moving from components and interactions into groups or sets of components that are
associated with a function and how these subcellular functions give rise to cell- and tissue-level functions.
There has been a vast amount of knowledge that was gained. This knowledge allows now to gain a
perspective where one can start at the level of genes, and go to the level of the cell, tissue and organismal
level and understand how the information in genes is decoded to form proteins and how proteins interact
with the subsets of lipids and sugars and so on. All of these together give rise to cellular tissue and
organismal function. It is this kind of integrated study that is called systems biology.
The word system itself is an amorphous term. It can mean systems at various levels of biological
organization. Some might have a system at the level of a cell or the level of a tissue or an organ or the
level of the whole organisms, or going back to the other end, it may be subcellular levels, either
mitochondria or the nucleus can also be called systems. So there is not one fixed definition of what
systems biology will be and different people can have different perspectives of how the field is growing
and focused on.
Focusing largely on systems biology at the cellular level, and mostly mammalian cells, provides a natural
entry into how cells become tissues and organs, and allow systems approaches to the study in medicine,
pharmacology, and therapeutics. Systems biology requires a sense of how quantitative reasoning can be
used to deal with large datasets and an understanding of what kind of mathematical representation is
appropriate for different kinds of biological questions and systems. Mathematical analysis can provide a
deep understanding of how behaviours occur and emerge, and how one can get predictive value from
computational analysis of for instance high-throughput data generated by molecular profiling.
1.12   Molecular Profiling to Decipher Ageing
1.12.1   Background
A molecular profile can be defined as a snapshot of a defined biological state. Such a profile can be a
representation of some property of different types of biological entities (RNAs, proteins, metabolites, etc.)
and it can be an explicit determination (exact numbers/concentrations) or a relative examination (e.g.
intensities).
A molecular signature in contrast is the result of comparison of two states such as old vs. young, diseased
vs. healthy and mutant vs. wild type. High-throughput techniques, in particular transcriptomics, have been
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widely used in recent years to generate genome-wide profiles associated with disease states or particular
processes (de Magalhaes, et al., 2009a). A widespread problem, however, is the difficulty to distinguish
cause from effect, to uncover which molecular changes reflected in a profile are the most important ones,
i.e. drivers, and which are non-crucial, i.e. passengers (de Magalhaes & Toussaint, 2004).
_
Figure 2: Transcriptional Profiling for Drug Discovery: Defined processes or diseases are
transcriptional profiled and enriched processes (i.e., functions common to multiple genes) are identified.
Common signatures can then be generated by meta-analysis of multiple individual experiments. A
signature is composed of different transcriptional programmes, which can be dissected by follow-up
transcriptional analyses. Interaction networks focus on the underlying hierarchy in gene regulation and
the mechanistic basis of the process under study, which in turn enables the identification of the most
suitable drug targets and regulatory genes. A signature can be used for pattern matching in drug
databases in order to identify drugs which induce or counteract this gene expression pattern.
Comparative analysis of molecular profiles (typically gene expression) can identify highly robust patterns
that occur most consistently among multiple experiments. A signature can therefore be defined as a
common pattern, like a fingerprint, reappearing in the comparison of multiple profiles. Because they
incorporate multiple profiles, often from disparate experiments, signatures have improved statistical power
and are hence more reliable. Comparing multiple profiles can uncover which signatures are shared and
which are unique, for instance in different tissues, different species or across pathological states. In the
context of the ageing process it is of particular interest, for instance, to identify signatures common across
tissues or even between species (public mechanisms) as well as shared by multiple lifespan-extending
interventions.
Transcriptomics with DNA microarrays and RNA-seq have generated a huge amount of molecular profiles.
These can be integrated, reanalysed and interpreted in context of biological significance to generate
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signatures, identify pathways that may underpin a given process or disease, identify biomarkers, and thus
derive new causal links and even identify new targets for drug discovery [Figure 2 Transcriptional Profiling
for Drug Discovery].
1.12.2   Methodologies
There are various statistical methods to analyse microarray data to determine which genes are
differentially expressed across two groups of samples in order to derive transcriptional signatures. Among
those methods are the t-test, regression modelling approach and mixed model approach as well as
empirical Bayesian method and Significance Analysis of Microarray (SAM), limma and many others (Pan,
2002). Because of this complication it is wise to assemble profiles in such a way that it is flexible and easy
to derive signatures via these different methods or any other future statistical approaches. Such an
approach would identify which methodological approach was superior.
The identification of differentially expressed genes (i.e. derivation of molecular signatures) in experiments
with small sample size, high dimensionality, and high variance remains extremely challenging, which limits
the usability of tens of thousands of publicly available, and possibly many more unpublished gene
expression profiles (Vasiliu, et al., 2015). A variable selection algorithm for ultra-low sample microarray
studies using generalized linear model-based variable selection with a penalized binomial regression
algorithm (penalized Euclidean distance) has been proposed (Vasiliu, et al., 2015).
For deriving a signature from molecular profiles in the context of ageing, usually individuals are sorted into
four distinct age bins (developing, young, middle-aged, and old) and age-related genes are identified by
comparing each group to the consecutive one (Berchtold, et al., 2008). Modelling age-related gene
expression data using regression models can increase the statistical power to identify gradual changes
across lifespan (Yuan, et al., 2012). Logistic regression-based approach in combination with an
intensity-based Bayesian moderated t-test was used to identify sex- and ageing-related functional groups
of differentially expressed transcripts (Liu, et al., 2013). A regression-based differential expression
detection algorithm can be used for profiling studies with ultra-low sample size (Vasiliu, et al., 2015).
Different comparisons of gene signatures were implemented. A non-parametric methodology can be used
to detect statistical significance of overlaps of ranked lists of genes and estimate the number of genes with
a common expression profile. This has been used to build a conserved health span signature and found to
depend on tissue type (Antosh, et al., 2011a).
Gene-set enrichment analysis is a statistical functional enrichment analysis commonly applied to identify
enrichment of biological functional categories in sets of ranked differentially expressed genes from
genome-wide expression profiles (Clark & Ma ayan, 2011). An alternative approach of deriving consensus
signatures and calculating the similarity of signatures would be based on gene sets, rather than individual
genes. While individual genes might be different across various signatures of a defined phenomenon,
those signatures might regulate the very same process in the same way but just act on, or by different
genes.
Transcription factors that are responsible for the observed transcriptional signatures can be identified
either via target gene collection or consensus motif scanning of the regulatory regions of the differentially
expressed genes within the signature. Transcription factor knockout and overexpression signatures as well
as transcription factor binding signatures can be used for this purpose as well. While a comparative
analysis of transcription factor regulation inferred from mutant experiments is possible, functional assays
are required for accurate identification of transcription factor binding site interactions (Kahana, et al.,
2010).
Meta-analysis is used to derive signature from published data. It is possible to perform meta-analysis of
transcriptomics studies with arbitrary experimental designs by deriving global expression features rather
than decomposing studies into multiple phenotypes comparisons (Caldas & Vinga, 2014).
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1.12.3   Types of Signatures
Molecular signatures are an important and flexible concept capable of providing significant insight
concerning the underlying process when analysed from high and low-throughput omics data.
High-throughput 'omics' technologies such as genomics, epigenomics, transcriptomics, proteomics,
metabolomics and metagenomics are enabling detailed investigations of molecular changes and are thus
revealing information about biological processes, activities and locations that change with age.
Molecular signatures can be classified based on the type of molecular entity they represent as well as
sources they were derived from:
Molecular Entity:
• Genomic Signature
• Epigenomic Signature (Epigenetic Signature)
• Transcriptomic Signature (Transcriptional Signature)
• Proteomic Signature
• Metabolic Signature
Source:
• Single Source Signature (i.e. same platform and same laboratory, etc.)
• Consensus Signature (Combined Signatures)
• Tissue-Specific Consensus Signature
• Cross-Tissue Consensus Signature (Multiple Tissue Common Signatures)
• Cross-Species Consensus Signature (Multiple Species Common Signatures)
Global gene expression analysis utilizing microarrays or RNA-seq allows to understand biological
processes at a system level. With the parallel increase in generated data, and in precision and coverage of
this technology, reconstruction of molecular mechanisms from data becomes more feasible (Vasiliu, et al.,
2015). Instead of focusing on one or even several pathways in studying the molecular processes of
ageing, an increasingly powerful approach has been the global screen of the entire genome for
age-associated genes and genetic pathways. Microarrays and RNA-seq can be used to screen the
transcriptome and with this basically the genome of several organisms, for genes and pathways that
change in expression levels with age or under conditions that counteract ageing (Zahn & Kim, 2007). DNA
microarrays and RNA-seq enable the generation of transcriptional profiles for the ageing process and
interventions that interfere with it. It is a very promising approach for identifying biomarkers of ageing.
Other omics data that can be used to derive molecular signatures and which is becoming more plentiful
are epigenetic profiles such as DNA methylations, proteomic profiles and metabolomic profiles. Genetic
signatures can be established from genome-wide linkage and genome-wide association studies (GWAS).
Epigenetic signatures can be created for DNA methylation and DNA hydroxymethylation as well as from
histone occupation and histone modification profiles for various post-translational modifications of histone
tail residues. Epigenetic signatures can be derived from bisulfite sequencing (DNA methylation and DNA
hydroxymethylation) as well as ChIP-chip and ChIP-seq against histones and their modifications as well as
chromatin remodelling binding patterns. Distribution of DNA-binding molecules and histone modifications
have been profiled in models organisms such as the fruit fly (Schwartz, et al., 2006) and mice as well in
various human cell lines and tissues, which provide valuable resources to derive further kinds of molecular
signatures. It would be to interesting to use it for gene-set analysis as well. Transcriptomic signatures are
generated mainly from DNA microarrays and RNA-seq. Most transcriptional profiling do not provide
information on non-coding RNA such as microRNA, for which special arrays are usually employed.
Proteomics and metabolic signatures can be derived from mass spectrometry.
While transcriptional signatures give significant insight into the underlying processes they represent on a
genome-scale level, the restriction onto transcript levels only would be insufficient to detect subtle changes
that are not reflected in the transcriptome. It would be informative to also derive proteomics signatures.
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However, even proteomics signatures have some limitations. The overall abundance of some proteins
remains unchanged during ageing but subcellular location, post-translational modification state, or splice
form varies (Ori, et al., 2015). Some protein-level differences appear to be a generic property of age, the
majority are specific to one organ. They may be the consequence of the physiology of the organ or age of
the cells within the tissue (Ori, et al., 2015).
A major challenge is the genome-wide integration of different omics such as transcriptome and epigenome
(Natsume-Kitatani, et al., 2011). Combining microarray expression profiles with other data sources such as
motif and ChIP-chip data enables insight into the transcriptional regulation that leads to certain phenotypes
such as ageing or lifespan extension (Cheng, et al., 2007). Genetic, epigenetic, transcriptomic and
proteomic signatures could be combined as all of these could be mapped mostly to genes. Alternatively,
signatures of heterogeneous entities composed of genes, transcripts, proteins, and metabolites could be
established, but their processing and analysis is non-trivial.
1.12.4   Opportunities
Molecular signatures can be used to derive biomarkers of ageing and interventions such as dietary
restriction. Genes that are down-regulated during ageing and up-regulated under lifespan-extending
interventions are candidates for anti-ageing targets to be enhanced. Genes that are up-regulated during
ageing, but down-regulated under lifespan extension could also be potential targets of suppression in
anti-ageing interventions.
A range of omics approaches and different study designs are required to investigate human ageing in
order to recognize molecular changes that are relevant to the process. Some of these study designs can
assist to establish causalities. Discriminating between cause and effect may require the integration of
multi-level omic data with varying phenotypes over time.
1.12.5   Challenges
Most molecular profiling of human gene expression changes were produced by cross-sectional studies,
i.e. a molecular measure is obtained in a group of individuals of different ages. These studies estimate
changes with age from the differences between individuals of different ages and the results may be
confounded by unknown inter-individual differences, therefore resulting in inaccurate estimates of
age-related changes. In model organisms this issue is not so severe as such studies usually utilize
genetically identical individuals and can follow the same individuals throughout the life (longitudinal study).
Another important issue is that molecular profiles are analysed with respect to chronological age, which
may not reflect the biological age of the individuals profiled in cross-sectional study designs. Individuals
have different ageing rates, which should be taking into account when grouping individuals or applying
mathematical models.
Sometimes raw data is not available and eventually only significant genes in an article or supplementary
material are presented if at all. One could try to contact authors to request the raw data, but that is very
cumbersome and might not be so fruitful. Preferentially one could be able to integrate at least those
results reported in the article or supporting material if no raw data is obtainable. Moreover, ideally one
could be able to combine high-throughput with low-throughput experiments all together.
Gene expression profiling studies should always incorporate age as a parameter even if studying a
specific disease whenever using samples from individuals with different age. Also time of day should be
considered if possible in order to account for circadian changes in gene expression.
1.12.6   Tissue-Specific Signatures
Complex multicellular organisms such as humans have different types of tissues, with very different
functionality and patterns of gene expression and therefore the process of ageing might manifests itself in
different ways in different tissues (Arking, 2006). However there are only a few basic types of tissues such
as epithelial, connective, muscular, and nervous tissues (Kinne-Saffran & Kinne, 1994). Basic
tissue-specific signatures therefore, might be appropriate. There are various subtypes of tissues within
each of these primary tissues.
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Tissues are composed of cells. The body has many different kinds of cells. A tissue-specific signature is
therefore usually an average of the gene expression patterns of a mixture of cells in this tissue. Although
their appearance might be very different, most cells have chemical and structural features in common. In
humans, there are around 200 different types of cells, and within these cells there are over 20 different
types of structures and organelles. The cellular composition of tissue may change and changes detected
in molecular signatures might merely represent the changes in the abundance of cell types rather than
changes in the gene expression patterns of the cells within the tissue. This means that the cell type
abundance can change, i.e. some cell types become more abundant while others become less and this
might be reflected in the expression signature. Signatures that characterize a cell type might be useful to
differentiate the effect of cell population changes within a tissue.
In aged mammalian organisms there is a mixture of senescence and non-senescence cells. A signature of
an old tissue is therefore reflecting the average expression levels in non-senescence and senescence
cells. There are many different ways how cellular senescence can be induced. Although the state of
senescence established by these different triggers is very similar and the phenotype almost identical,
there are also subtle differences which maybe important differences. A signature representing
senescence would be useful, but also senescence type-specific signatures (e.g. replicative senescence
signature, oncogene-induced senescence signature, etc.) might be required as well as senescence cell
type-specific signatures. Because of the high number of signatures that could be established, a
consensus signature seems to be most practical and intuitive.
With the advent of single-cell sequencing, cell-type specific signatures could be established. This could
help to determine the changes in defined cell types and the change in abundance of certain cell types as
well as in senescence cells.
Gene expression changes with age are usually assumed to be tissue-specific (Zahn, et al., 2006).
Similarly the response to dietary restriction is often associated with tissue-specific changes.
Tissue-specific molecular signatures of ageing do not only correlate with chronological age but also with
measures of physiological age (Zahn, et al., 2006).
Similarly as with gene expression changes with age, DNA methylation changes have been assumed to be
different from tissue to tissue. However ageing-differentially methylated regions in one tissue have been
replicated in totally different tissues (Rakyan, et al., 2010).
1.12.7   Gender-Specific Signatures
The relative importance of gender-specific age-related changes is not yet certain. Whether there are
common age-related changes between male and female organisms is an open question. There is
evidence supporting the importance of gender-specific changes but also evidence supporting
gender-common changes. For instance in human skin age-related changes in gene expression seem to be
sex-specific (Swindell, et al., 2012).
Some transcript levels are changing in the opposite direction during ageing in males and females (Liu, et
al., 2013). So these cases might be considered to be sex-specific signatures. Further, there is overall
evidence that females age slower than males and therefore females life is usually longer than males
(which is maybe true in humans, but it is not always the case in different species). This is observed in
humans as well as in many model organisms. This means that it would maybe be better to not pool male
and females while deriving molecular signatures of ageing as females tend to age slower and therefore
similar chronological aged females might actually be biological much younger than their male
counterparts.
1.12.8   Tissue-Specific Consensus Signatures
Several attempts have been made to create consensus signatures of normal and accelerated ageing as
well as dietary restriction. A variety of approaches have been tried to derive tissue-specific as well as
common consensus signatures. For example AGEMAP project catalogues the changes in gene
expression as a function of age in 16 tissues in mice (Zahn, et al., 2007).
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1.12.8.1   Blood
Datasets of genome-wide gene expression levels in human peripheral blood mononuclear cells were
compared for the effect of ageing and chronic social stress. It was found that the direction, although not
the magnitude of the significant gene expression changes tends to be shared between the datasets at the
level of individual genes as well as gene functional categories of genes and ageing implicated molecular
pathways (Snyder-Mackler, et al., 2014).
In an integrative network-based approach, multiple large-scale expression studies in human blood were
combined with molecular interaction data to detect consistently coexpressed interaction modules that may
reflect the change throughout ageing (van den Akker, et al., 2014). This meta-analysis of blood
transcriptome identified coexpressed protein-protein interaction modules as robust biomarkers of
(chronological) ageing in humans (van den Akker, et al., 2014).
1.12.8.2   Skin
The ageing of skin is associated with processes that compromise the structure of the extracellular matrix
and promote loss of functional regenerative capacity. Mouse and human skin ageing were compared at
the level of the transcriptome and the overall correspondence was found to be weak. Ageing does not
uniformly heighten inflammatory status across all tissues (Swindell, et al., 2012).
The ageing process in human skin is connected with deregulation of numerous cellular processes such as
cell cycle control, cytoskeletal changes, inflammatory responses, signalling and metabolism (Lener, et al.,
2006). In the derivation of a human skin ageing signature, the young group was defined too young: 3-4
years corresponds in humans to developing (not yet fully matured) individuals, while 68-72 years
corresponds to old adults.
1.12.8.3   Breast
Transcriptomic profiling of breast ageing and cancer were performed in combination with network analyses
to identify age-specific signatures. Using cross-species comparative genomics approach molecular
alterations during cancer progression in young and old females were studied. Differential expressed genes
were found to be associated to immune response, tissue morphology, cellular growth and proliferation, cell
death and cellular movement (Colak, et al., 2013).
Meta-analysis of female breast tissue leads to the generation of breast-specific consensus signature of
ageing. It was found that epigenetic transcriptome changes, more than genotype variation, account for
age-associated differences in sporadic breast cancer (Yau, et al., 2007).
1.12.8.4   Heart
The heart of humans is capable of functioning for decades despite minimal cell turnover or regeneration
(Kaushik, et al., 2015).
Transcriptome data was integrated from multiple cardiac-specific transcriptional profiles derived from
independent studies in mouse and human together with proteome and micronome (interactome of
microRNA transcripts) interaction data by deriving multiple independent weighted networks. Through
modularization of those weighted networks generated modules that were redefined to form consensus
modules across datasets that change substantially during lifespan. Such modules were proposed as
signatures (Dimitrakopoulou, et al., 2015).
1.12.8.5   Brain
A tissue specific meta-analysis for brain has been generated. It was found that Alzheimer's disease and
frontotemporal lobar degeneration exhibit a significant difference between physiological and chronological
ages and hence exhibit prematurely aged expression profiles (Cao, et al., 2010).
Significant differentially expressed genes across age in male rats (Fischer 344) were identified by
meta-analysing hippocampus gene expression data that may explain memory impairment with old age
(Uddin & Singh, 2013).
29
Gene expression with age in the human male and female superior frontal gyrus (SFG), part of the
prefrontal cortex; the postcentral gyrus (PCG), part of the somatosensory cortex; the hippocampus (HC)
were subjected to meta-analysis. Polynomial regression was used for identifying age-related gene
expression changes. It was found that age-related gene expression changes occur earlier, or at a faster
pace in females compared to males. Thus this may indicate that those brain regions age faster in females,
which may explain why females tend to get Alzheimer's disease earlier than males (Yuan, et al., 2012).
Meta-analysis of brain ageing and neurodegeneration quantified the similarity and differences in
genome-wide gene expression profiles using non-linear regression. It applied a computational method for
assessing an individual's physiological age via the comparison of global expression profiles across a range
of normal human brain samples and found that neurodegenerative disease tissues exhibit prematurely
aged expression profiles (Cao, et al., 2013).
Prefrontal cortex (brain) of human and rhesus monkey over developmental and ageing intervals of their
respective lifespans were profiled for mRNA changes via RNA-seq and protein expression change as well
as human brain ageing meta-analysed. A substantial decoupling of mRNA and protein expression levels
was found during ageing, but not development (Wei, et al., 2015)
Integrated miRNA and mRNA expression profiles of human brain across lifespan (i.e. development and
ageing) were meta-analysed and age-related miRNA were detected via polynomial regression models. A
miRNA-mRNA regulatory network was constructed by pairwise correlation coefficient analysis between
miRNA and mRNA expression profiles. Age-related miRNA models were identified (Li, et al., 2013)
Age-dependent differential expression was detected in human prefrontal/frontal cortex ageing in a
meta-analysis via fitting quantile regression (constant, linear and piecewise linear) models to the
expression profile of each gene (and selected the least complex model that fits the data best) to capture
linear and non-linear changes. In addition, age-differential variability was identified by fitting and
comparing two quantile regression models to the expression profile of each gene. Such a model-selection
approach might be more robust than standard linear regression to discover age-dependent patterns and is
applicable to many ageing and other time-series datasets (Ho, et al., 2009).
Meta-analysis of human frontal cortex ageing gene expression data found gene markers that assembled
into a transcriptional module in a gene coexpression network. A subnetwork of transcription factors were
found to regulate the age-dependent module. Causal contributions of these master regulators were
verified using ChIP-seq data. The interaction of the key master regulators were found to be preserved in
protein-protein interaction network. These master regulators seem to be essential for regulating microglia
homeostasis in the frontal cortex of adults in addition to their crucial roles in haematopoiesis and myeloid
cell-fate decisions during embryogenesis (Wehrspaun, et al., 2015).
Inflammation has often been observed to be upregulated in multiple tissues during ageing. In the
neocortex and cerebellum of mice, ageing results in gene expression changes indicative of an
inflammatory response, oxidative stress and reduced neurotrophic support and dietary restriction
selectively attenuates the age-associated induction of genes encoding inflammatory and stress responses
(Lee, et al., 2000). Age-related neurodegenerative disorders are characterized by degeneration of neurons
in specific brain regions (Mattson, et al., 2001) that may be caused by the upregulation of inflammation
with age and the downregulation of neurotrophic support. The transcriptome of irradiated microglia seems
to exhibit ageing-like changes (Li, et al., 2015).
1.12.9   Tissue-Common Consensus Signatures
1.12.9.1   Normal Ageing Signatures
Ageing is characterized by a decline in physiological function in different organs that in turn is associated
with altered gene expression. Multiple microarray studies of ageing have been performed with the aim of
identifying biomarkers as well as genes and pathways differentially expressed that may give insights into
the underlying mechanisms of ageing (de Magalhaes, 2009).
By and large, gene expression changes with age are modest and age-related gene expression profiles
generated by different studies often do not overlap (de Magalhaes, et al., 2009a). Different mechanisms
may operate in different tissues and even common mechanisms may trigger different responses in
30
different organs. A few studies, however, identified common signatures across ageing tissues in mammals
and invertebrates and these provide clues into conserved mechanisms of ageing.
A transcriptional signature derived from human muscle tissue performed consistently in other non-heart
muscle tissue samples, skin and brain tissue. The signature is insensitive to confounding lifestyle
biomarkers and diagnostic for health (Sood, et al., 2015).
By meta-analysing large-scale transcriptional changes in ageing from DNA microarray profiles of multiple
tissues in mouse (AGEMAP), a modular decline in co-expression with age was found. Specifically, gene
co-expression networks for 16 and 24 months old mice were derived and a number of functional gene
groups were identified that change co-expression with age. It has to be noted that 16 and 24 months old
ages are both classified to be old adults. It was found that within these changing groups there was a trend
towards declining correlation with ageing. Specific transcription factors (NF-kappaB, MEF2, RREBP1, AP2
and MZF1) were identified where gene expression correlated with age. Further targets of NF-kappaB
transcription factor that decreased expression with age were computationally identified. Genes that are
prone to decline in co-expression tend to be co-located on the same chromosome (Southworth, et al.,
2009). The loss of coexpression and increased gene expression variability was noted also in other studies.
A method was developed to identify biomarkers of ageing that are networks of genes selected based on
age-dependent gene expression changes and the graph-theoretic property of modularity (which measures
the strength of division of a network into modules/groups/clusters/communities). This method was applied
on C. elegans ageing time-series transcriptome data. The modular biomarkers can be used to assign
novel ageing-associated functions to uncharacterised ageing genes (Fortney, et al., 2010).
Transcriptional changes during ageing in brain, eye, kidney, muscle, skin, and blood were meta-analysed
to create a common signature of ageing and compared to a common signature of cancer (Wang, 2012).
Most age-related gene expression changes were found to be tissue-specific and few were found to be
common to multiple tissues (Wang, 2012). A large proportion of ageing signatures are universally
differentially expressed among tumour phenotypes (Wang, 2012).
Tissue-specific transcriptional ageing signatures were derived (by using the AGEMAP). Coordinated
ageing processes across different tissues were identified in cross-tissue coexpression networks built
based on both genes and pathways. Thereby a cross-tissue common signature of coordinated ageing
across different tissues was established (Huang, et al., 2011).
Gene expression changes with age are usually quite noisy. A meta-analysis tried to identify common
consensus signature of ageing across tissues and different mammalian species. For this a common
ageing signature in mammals was derived from 27 different studies of transcriptional profiles conducted in
mice, rats and humans via a meta-analytic value counting approach (de Magalhaes, et al., 2009a). The
conserved signature is composed of discrete transcriptional programmes and revealed an overexpression
of immune response and inflammation, lysosome and apoptosis associated genes, while collagen and
energy metabolism (especially mitochondrion and oxidative phosphorylation-related genes) were
underexpressed with ageing. Genes known to be overexpressed in senescent cells, such as fibronectin,
p21, clusterin and apolipoprotein D, were also found commonly overexpressed during ageing in
mammalian tissues, hinting that the accumulation of senescent cells does occur in vivo. The ageing
molecular signature reflected a combination of patterns accompanying degenerative processes
(decreased energy metabolism and collagen gene expression) as well as the activation of protective
responses (e.g. APOD, CLU, MGST1, lysosomal and detoxification genes). The upregulation of genes and
pathways with protective functions suggests they are part of transcriptional responses to ageing. In other
words, these may be processes that fend off normal ageing and it is thus possible that upregulating these
genes earlier in life will have later life health benefits (de Magalhaes, et al., 2009a).
Specific signatures were identified for ageing, Alzheimer's disease and amyotrophic lateral sclerosis
mouse model. The gene expression signature of microglia priming was determined by comparing the
transcriptome of microglia in ageing, Alzheimer's disease and amyotrophic lateral sclerosis mouse models
using Weighted Gene Co-expression Analysis (Holtman, et al., 2015).
A meta-analysis of neurodegenerative disease profiles identified a common transcriptional signature of
neurodegeneration (Li, et al., 2014). Mouse models rarely mimic the transcriptome of human
neurodegenerative diseases (Burns, et al., 2015).
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Age-related gene expression changes in nine tissues were meta-analysed. Ageing gene expression
signatures were found to be very tissue-specific (Yang, et al., 2015).
A derived muscle signature was meta-analysed with human kidney and brain and subsequently with
mouse and fly data (Zahn, et al., 2006). Analysing transcript expression of human muscle tissue generated
a molecular profile consisting of 250 genes (Zahn, et al., 2006). The signature correlated with
chronological age as well as with measures of physiological age. Comparing the transcriptional profiles of
muscle with those of kidney and brain revealed a common signature of ageing in these diverse tissues.
This common ageing signature consisted of six genetic pathways, of which four pathways increase
expression with age (extracellular matrix, cell growth, factors involved in complement activation and
components of cytosolic ribosome), while two pathways decrease expression with age (chloride transport
and subunits of mitochondrial electron transport chain). The age-related decrease in electron transport
chain was also common to the transcriptional profiles in human, mouse, fly and worm (Zahn, et al., 2006).
The same authors later systematically analysed 16 tissues from mice of age 1, 6, 16 and 24 months. This
study (AGEMAP) revealed that some tissues display considerable transcriptional differences (e.g. thymus)
in old mice, while others had few or no changes (e.g. liver and striatum) in expression with age.
Interestingly, gene expression changes with age in different tissues correlated with each other in individual
mice, suggesting that different tissues age in a coordinated fashion. Cell cycle inhibitors (e.g. p16INK4a)
had an increasing trend in expression with age in mice and humans, which may imply a reduced ability of
cells to proliferate in old organism (Zahn, et al., 2007).
1.12.9.2   Premature Ageing Signatures
A meta-analysis of a premature ageing syndrome (Hutchinson-Gilford Progeria Syndrome; HGPS) and its
comparison to normal ageing in fibroblasts was conducted. Changed signalling of HGPS were found to
strongly resemble that from cells of middle-aged and old individuals (Aliper, et al., 2015).
A common transcriptomic signature of premature ageing mouse models was derived. From this profile a
strong suppression of thyroid hormone signalling in specific peripheral organs in premature and normal
ageing was found (Visser, et al., 2016).
1.12.9.3   Cellular Senescence Signatures
Molecular signatures of human cellular senescence and tissue ageing were compared by utilizing
transcriptomics data from human cell- and biopsy-based DNA microarrays studying cellular senescence or
in vivo ageing, respectively. Certain genes and pathways (such as cancer, Huntington's disease, MAPK
signalling, focal adhesion, actin cytoskeleton, oxidative phosphorylation, and metabolic signalling) were
found to be co-regulated during cellular senescence and in vivo tissue ageing (Voutetakis, et al., 2015).
Replicative senescence is associated with highly reproducible epigenetic modifications. The state of
senescence can be monitored by continuous DNA methylation changes at specific genomic sites and
therefore provides an epigenetic biomarker to determine the state of senescence in cell preparations
(Koch, et al., 2012).
1.12.9.4   Dietary Restriction Signatures
Ageing is surprisingly plastic as it can be manipulated by genetic and environmental factors. One of the
most widely studied non-genetic interventions is dietary restriction (DR) of certain factors in the diet, such
as calories or certain amino acids, which without malnutrition can robustly extend lifespan and delay the
ageing process in several model organisms (Lee, et al., 1999). The exact mechanisms of DR remained
poorly understood and so unbiased gene expression studies of DR can provide insights. Early studies of
DR using microarrays showed metabolic alterations (Lee, et al., 1999) and many more studies have been
conducted to date revealing a complex array of DR-induced changes. Meta-analyses incorporating these
multiple studies have the potential to uncover conserved signatures that include signalling pathways
responsible for the life-extending effects of CR.
One meta-analysis comparing and contrasting the signature of the ageing (22 tissues) and DR (17 tissues)
in mouse showed that DR broadly induces expression of genes regulating oxidative balance,
anti-inflammation (e.g. inhibition of NF-KappaB) and cell proliferation, while it suppresses expression of
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extracellular matrix components and inflammation. Clearly, DR opposes age-associated expression
patterns with respect to gene subsets associated with certain biological processes (e.g. immunity and
inflammation). Discrete functional coexpression modules, formed commonly by up- and/or down-regulated
genes, were identified, suggesting that DR and age-related gene expression patterns exhibit strong
modularity. Among the DR coexpression modules were histone cluster, period (gene) homologs as well as
mRNA processing and transcriptional regulation factors (Swindell, 2009).
Another meta-analysis study found that merged gene expression profiles for both ageing and DR from
multiple tissues were both enriched for immune response and cell adhesion, while DR attenuated them.
Lipid metabolism was suppressed by ageing and becomes more active under DR. Functional modules
with consistent expression patterns in a coexpression analysis revealed systemic interactions among
biological processes, such as a negative relation between lipid metabolism and immune response. Lipid
metabolism was also inversely related to cell cycle, cell proliferation and muscle development, while the
immune response exhibited positive correlation with these systems. Transcription factor binding sites of
the CCAAT box and forkhead family were shared by ageing and DR profiles (downregulated genes during
ageing and upregulated genes upon DR). Further cooperative activities of transcription factors such as
Elk-1 (which was found to regulating significant number of ageing upregulated genes) and CCAAT box
might modulate stress response genes during ageing (Hong, et al., 2010).
Intersection of the whole-genome expression profile in response to DR, mutations mimicking DR, heat
shock and H2O2 exposure in yeast based on functional terms, indicated that the mitochondrion and the
electron transport chain appear to be major hubs (i.e. nodes with high degree, hence many connections) in
the gene expression program under these conditions. Genes involved in respiration and transport of metal
ions (iron and copper) were up-regulated. Upon DR feeding the levels of iron and copper fall in cells, which
elicits a transcriptional response upregulating the genes involved in their uptake to maintain cellular
homeostasis (Sharma, et al., 2011).
Acute DR alters mortality rates within days in flies (Selman, et al., 2006a). This implies that profiles of
animals put on acute DR should already obtain the necessary changes for lifespan extension relatively
quickly.
Gene expression profiles from eight tissues of mice subjected to dietary restriction were analysed and a
common transcriptional signature was identified that includes genes associated with mitochondrial energy
metabolism, inflammation and ribosomal structure. This signature is detected in flies, rats, and rhesus
monkey on dietary restriction. Further, the signature was also detected in mouse genetic models of slowed
ageing (Barger, et al., 2015).
A DR transcriptional signature that is shared across multiple tissue types was derived by meta-analysing
gene expression profiles from 10 different tissues types (liver, heart, muscle, hypothalamus, hippocampus,
white adipose tissue, colon, kidney, lung and cochlea). Such a signature characterizes a common
response to DR that includes 28 genes for which expression response to DR is most shared among
tissues. This response consists of both activation and inhibition of stress-response pathways (Swindell,
2008d). Co-expression and network properties of DR-regulated genes were investigated using data
generated from many microarray profiles. It was found that genes downregulated with DR are highly
connected and located in dense network regions, while DR upregulated genes are weakly connected and
positioned in sparse network regions (Swindell, 2008c).
The transcriptional responses to dietary restriction in 17 mouse tissue types were examined, as well as the
changes with ageing in 22 tissues. DR was found to induce the expression of genes associated with
oxidative stress, inflammation and tumourigenesis. Ageing was found to upregulate granulin and secreted
phosphoprotein. This lead to the derivation of a common consensus signature of DR and ageing as well as
the finding that DR does not simply induce a genome-wide reversal of age-associated gene expression
patterns (Swindell, 2009).
A multiple comparison approach using whole genome transcriptional profiles (dietary restriction and
genetic and pharmacological DR mimetics) was used to identify genes and pathways involved in
DR-mediated lifespan extension. One gene, named takeout, that is commonly upregulated under lifespan
extending intervention when overexpression is capable of lifespan extension (Antosh, et al., 2011b).
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Evolutionary conserved genes were identified in transcriptional profiles of dietary restriction. Subsequent
testing of 16 genes that are upregulated under DR led to the discovery of 8 genes that abolish the
DR-induced heat stress in C. elegans and three were also found to be DR-essential as their mutations
abolish the increased lifespan in response to dietary restriction (Barger, et al., 2008a).
Gene expression signatures were derived from gene expression changes that occur across species when
lifespan is extended via different interventions. Heterogeneous datasets from different measurement
platforms and organisms were used and a non-parametric methodology that can detect statistical
significance of overlaps in ranked lists of genes was applied to estimate the genes with a common
expression profile (Antosh, et al., 2011a).
A meta-analysis of dietary restriction transcriptional gene expression profiles in mammals was performed.
DR was found to differentially express growth hormone signalling, lipid metabolism and immune response
as well as retinal metabolism, copper ion detoxification, and circadian rhythm. A putative regulatory role of
Srebf1 and Ppara in the DR response was found (Plank, et al., 2012).
It is controversial whether DR reverses ageing gene expression patterns. Some studies suggested this to
be the case while others did not substantiate this. Using comprehensive molecular consensus signatures
can reveal light on this controversy (Swindell, 2009). However DR certainly does not totally reverse ageing
gene expression changes, as animals upon DR still age, but more slowly.
1.12.10   Cross-Species Signatures
Ageing is an apparently complex multifactorial process during which the different scales of biological
systems such as molecules, compartments, cells, tissues and organs undergo changes over time,
resulting in loss of function, increased morbidity and eventually death (Fontana, et al., 2010). Most of the
current knowledge of the molecular mechanisms of ageing has been derived, to a large extent, from
studies on lifespan and longevity of simple model organisms (for example yeast, nematodes, and flies).
Many of those mechanisms are conserved in mammals and may thus be relevant to human ageing.
Analysing gene expression from different species is a powerful way to identify evolutionary conserved
transcriptional programs. For instance, meta-analysis of microarray data from heat stress experiments
performed in eight different species identified several well-known evolutionary conserved transcriptional
responses (Kristiansson, et al., 2013). Ageing is assumed to be an extremely well conserved process, so
by doing cross-species gene expression meta-analysis the common mechanisms of ageing shared
between different species could be identified. Gene expression data from all those species that were
profiled for age-related changes could be gathered into cross-species common signatures. Several such
signatures could be derived, e.g. from phylogenetically closely-related species and even together with
more distantly related species. Life stages and ages have to be aligned to each other for this comparative
biology approach. In order to enable this kind of cross-species common signatures, homologous
relationships of genes need to be utilized or signatures have to be derived on the basis of functional
categories. The latter method is not yet feasible practically as gene annotation is quite different in
coverage for different species and in many species it is too sparse. It could be overcome if functional
categories can be derived from data itself (i.e. from coexpression data), but this requires extensive omics
data that have to be available for all those included organisms. Therefore, meta-analysis based on
homologous genes appears to be the most broadly applicable way of accomplishing the creation of such
signatures.
1.12.11   Cancer Signatures
Some ageing-related and human embryonic stem cell-related molecules are highly expressed in cancer,
which may indicate important mechanisms common to ageing, stem cell and cancer. It has been
suggested (Wang, 2013) that cancer is a developmental and evolutionary disease that is strongly related
to ageing. Initiation, proliferation and metastasis of cancer is associated with deregulation of stem cells
(Wang, 2013). Stem cells themselves are deregulated during ageing (Chambers, et al., 2007; Jung &
Brack, 2014; Li, et al., 2011).
It might be intriguing to determine whether certain defined classes of genes have a tendency to be
differential expressed or regulated with ageing such as cancer genes, i.e. proto-oncogene and
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tumour-suppressor genes. Further it would be insightful to check whether interventions known to interfere
with ageing also impact on those classes, e.g. dietary restriction and rapamycin treatment as these are
known to postpone cancer incidence and severity.
Mutations accumulate with age at an organ- and tissue-specific rate. The spectrum of age-accumulated
mutations differs greatly from organ to organ and similar initial mutation spectra of different tissues diverge
significantly over the lifetime of individuals (Vijg, 2004). How the mutation rate of a tissue is related to the
rate of change in the transcriptome and epigenome is an intriguing question.
1.12.12   Longevity Signatures
The genetic makeup of the organism dictates the species-specific rate of ageing and the maximum
lifespan. The genotype is converted to phenotype through gene expression regulation including epigenetic,
transcriptional and translation regulation as well as localization and post-translational modifications. A
group of gene regulatory factors (including transcriptional factors and epigenetic modifiers) play a critical
role in controlling the initial rate of transcription of specific genes directly by interacting with regulatory
sequences at gene promoters and enhancers as well as neighbouring regions (Roy, et al., 2002).
Animals that exhibit maybe negligible senescence like the naked-mole rat (although it still ages and dies)
and the long-lived sea urchins do not exhibit alterations in their gene expression profiles with age as much
as other organisms do (Kim, et al., 2011; Loram & Bodnar, 2012). Molecular signatures of species that are
extremely long-lived, or even exhibit negligible senescence, or declared biological immortal can be used to
determine what are the differences that between a species that ages and one that does not.
1.12.13   Biomarkers of Biological Age
The study of ageing and the development of interventions to retard it requires the establishment of
effective biomarkers of ageing and thus biological age. Biogerontologists have been seeking for robust
biomarkers of ageing for decades, though most putative markers were not better than chronological age.
By utilizing molecular signatures however, it is possible to establish predictive biological markers of
ageing.
The regulation of gene expression is coupled with the regulation of lifespan (Rogina & Helfand, 1995). The
transcriptional stability is an important determinant of longevity (Kogan, et al., 2015). The rate of change in
gene expression correlates with changes in longevity under various conditions. Therefore, ageing gene
expression signatures may be indicators of physiological age (biological age) and provide thus valuable
biomarkers (Seroude, et al., 2002). Similarly, the dietary restriction gene expression signatures can
provide valuable biomarkers for anti-ageing interventions that mimic the effect of dietary restriction per se
on ageing.
Gene expression data can be used to identify candidate genes involved in ageing and longevity as
potential differentially expressed genes (Seroude, et al., 2002). Those candidates can be used as
biomarkers of ageing and anti-ageing interventions.
The length of telomeres have been proposed repeatedly to be excellent robust molecular biomarkers of
ageing. However, the telomere/telomerase system is not limiting lifespan in all ageing organisms equally.
For instance, the short lifespan of GRZ strain of fish is not caused by reduced telomerase activity nor
accelerated ageing by telomere shortening (Hartmann, et al., 2009).
Gene expression profiling suggests that both DR and anti-ageing compounds such as resveratrol may
retard some aspects of ageing through modifications in chromatin structure and transcription (Ludewig, et
al., 2014). Methionine restriction seems to decrease the degree of methylation of genomic DNA
(Sanchez-Roman, et al., 2011). Profiling of those changes is warranted.
Chromatin states and long-range genomic segments impact on ageing via DNA methylation (Sun & Yi,
2015). Epigenome-wide association studies systematically identify epigenetic variants across the genome
that associate with complex phenotypes such as ageing. Such studies exhibit challenges related to
methodology, design and interpretation because of the dynamic nature of epigenetic variants over time
(Tsai, et al., 2012). The most likely candidate for the long-term adaptive changes mediated by dietary
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restriction is the epigenome. It has been suggested that larval nutritional stress may lead to the induction
of adaptive epigenetic rearrangements which extends the lifespan (Vaiserman, et al., 2013).
Epigenetic marks are reset twice during the lifetime of most multicellular organisms. Once during
gametogenesis and once during early development. Cellular reprogramming involves the erasure of the
epigenetic modifications that mark the differentiated state. It is unclear whether reprogramming of cells
reverses all signs of cellular ageing or whether there is an ageing signature remaining in induced
pluripotent stem cells (Rohani, et al., 2014).
In order to understand the ageing process, molecular profiles of ageing, DR and long-lived mutants need
to be integrated into molecular signatures spanning different organs and species. Age-related gene
expressions changes, although exhibiting tissue-specific components and being heterogeneous, share a
common signature across various tissues which, at least to some degree, is coordinated in systemic
fashion. Gene expression signatures of ageing are characterized by a reduction in expression of genes
related to energy metabolism that is common to multiple tissues and species. It is also clear that ageing
and DR signatures are modular in nature as they possess defined transcriptional programmes of
coexpression networks. The alteration of the redox state and its modulation by DR appears to be the most
conserved process common to multiple mammalian tissues as well as shared with various organisms.
Follow-up analyses of these signatures to understand their underlying transcriptional regulation can reveal
key regulators and potentially new drug targets [Figure 2 Transcriptional Profiling for Drug Discovery].
DNA microarrays provided the first genome-wide signatures of molecular changes with age and gave
insights into the mechanisms governing ageing and its modulation. Emerging next-generation sequencing
technologies, however, now allow deep molecular profiling of the transcriptome, DNA-protein interactions
and the epigenome (de Magalhaes, et al., 2010). These platforms therefore provide a superior
understanding of molecular changes with age. Moreover, a more efficient data analysis and integration, for
example with genes previously associated with ageing such as those in the GenAge database (de
Magalhaes, et al., 2009b), will improve the understanding of the regulation of gene expression changes in
ageing, DR and other relevant processes (de Magalhaes, 2009).
Overall, molecular signatures based on microarrays have provided mechanistic insights as well as
biomarkers of ageing and DR, and could be used to identify ageing retarding interventions without the
need of performing full lifespan experiments. Future studies employing ever more powerful experimental
and computational techniques promise to contribute even further to unravel the transcriptional changes
during ageing and therefore increase the understanding of ageing mechanisms and how to manipulate
them to improve human health.
1.13   Objective
The objective of this work is to apply functional genomics and bioinformatics approaches to the study of
ageing and its interferences via dietary (i.e. dietary restriction) as well as pharmacological (i.e. anti-ageing
drugs) means in order to gain insights about the underlying mechanisms and predict possible
interventions that are likely to slow down ageing and/or reverse age-related changes.
More specifically, the aims of this work are to
1. classify, characterize, and predict ageing genes (i.e. gerontogenes and ageing-suppressor genes) as
well as genes essential for lifespan extension mediated by dietary restriction,
2. derive and characterize molecular signatures of ageing and dietary restriction in human as well as
model organisms,
3. discover small molecules or drugs that affect the ageing process.
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2   Ageing Genes
Abstract: Many genes regulate the ageing process in a positive or negative manner.
Gerontogenes can speed up ageing by their normal activity, therefore decrease
lifespan if hyperactivated and increase it if inactivated, while ageing-suppressor
genes slow down ageing normally, hence decrease lifespan by lack of activity and
their overactivation increases lifespan. Here a curated knowledge base that includes
loss- and gain-of-function experiments that impact on lifespan of organisms
including human, mouse, fruit fly, nematode, and yeast was established. It classifies
ageing genes that control the ageing process into two classes: 1) gerontogenes that
mediate the ageing process, therefore decrease lifespan of the organism. 2)
ageing-suppressor genes that suppress the ageing process, hence increase
lifespan of the organism. Gerontogenes and ageing-suppressor genes were found
to have very different as well as common associations. Regarding the common
associations, gerontogenes and ageing-suppressor genes tend to regulate them in
different directions. Gerontogenes were found to be involved in regulation of growth
and development, promotion of TOR signalling, translation, and inflammation, while
ageing-suppressor genes are involved in stress response, TOR signalling inhibition,
MAPK signalling and diverse repair processes as well as proteome homeostasis
and chromatin modification.
2.1   Background
Life comes with instructions. An organism is encoded in its genome consisting of genes and regulatory
elements as well as structural regions and epigenetic decorations. Genes determine the traits as well as
the life cycle including lifespan. Inheritance (i.e. genetics) determines the lifespan of humans at least to
approximately 25-32% (Herskind, et al., 1996). The greatest effects on ageing rates appear to be caused
by genetic variability, as evidenced by the large variation in ageing and lifespan among related species.
For instance, in the primate order, one of the shortest-lived members is the mouse lemur, with a maximum
lifespan of about 15 years (when in human care). In contrast, it is not unusual for humans to surpass 90
years. Ageing appears to be controlled greatly by genes and specific genes are affected by environmental
influences (Wei, et al., 2008). The lifespan extending effect of dietary restriction can be mimicked and
cancelled out by mutating certain genes (Wuttke, et al., 2012).
Many studies have proven that ageing has a genetic basis (Curtsinger, 2007). Some mutations of defined
genes cause premature ageing (called progeroid syndromes), where kids suffer from rapid ageing and die
of age-related diseases (often even before becoming teenager). In contrast, mutations of other single
genes extend the lifespan of animals up to tenfold (Ayyadevara, et al., 2008). Manipulation of only one
defined gene can make old organisms young again (Unal & Amon, 2011). However the genes that are
involved in the ageing process are poorly classified.
2.1.1   Classification of Ageing Genes
The genetics of ageing has advanced from knowing just a single gene involved in ageing to thousands of
genes in different model organisms that are involved in ageing. However, a systematic classification of the
genes under study in biogerontology is lacking.
One of the most general concepts is that of an ageing-associated gene, which is a class of genes that are
associated with the ageing process with some evidence that might be even be only correlative. It is a
subclass of a gene. The next important class is the one of the ageing gene which affects the rate of ageing
(obtained from loss-of-function and gain-of-function evidences). This class can be subdivided into
gerontogene and ageing-suppressor gene (akin to the distinguishment of oncogenes and
tumour-suppressor genes in cancer research). Thus there are genes which accelerate ageing
(gerontogenes) and genes that antagonize ageing (ageing-suppressor genes). Consequently, suppressing
gerontogenes and activating ageing-suppressor genes will have the potential to increase the lifespan and
perhaps restore youthfulness.
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Ageing genes are assessed by testing whether their genetic perturbation impacts on the lifespan of an
organism or not. In general it is expected that decreasing the activity of gerontogenes will increase
lifespan, while increasing their activity will decrease lifespan. On the other hand, enhancing
ageing-suppressor genes are expected to increase the lifespan, while decreasing their activity will result in
shorter lifespan. This classification of ageing-associated genes is shown in [Figure 3 Ageing-Associated
Gene Classification].
_
Figure 3: Ageing-Associated Gene Classification. Classification of ageing-associated genes. This
hierarchy provides definitions of ageing gene which is a subclass of ageing-associated gene (which
itself is a subclass of a gene). Ageing genes have two discrete subclasses, namely gerontogene which
enhances ageing and ageing-suppressor gene which suppresses ageing. Based on the type of
evidence gerontogenes and ageing-suppressor genes can be further subclassed into genuine and
uncertain ageing genes dependent on whether there is gain- or loss-of-function supporting the
assignment and whether there is lifespan extension or shortening associated with those experiments.
Genuine gerontogenes and genuine ageing-suppressor genes result in lifespan extension by their
loss-of-function and gain-of-function, respectively. True positive ageing genes (i.e. genuine ageing genes)
therefore are composed of genuine gerontogenes and genuine ageing-suppressor genes. Uncertain
ageing genes are (indefinite, indeterminate, potential, or counterfeit; could be false positive) gerontogenes
and ageing-suppressor genes which shorten the lifespan upon their overactivation and inactivation,
respectively. As increasing lifespan (and especially maximum lifespan) is a much stronger indication of a
gene manipulating the ageing process than decreasing lifespan, there is less confidence that uncertain
ageing genes are acting on ageing or rather are involved in the limitation of lifespan in some other way
(e.g. sickness).
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2.1.2   Approaches for Identifying Ageing Genes
2.1.2.1   in vivo
Ageing genes are usually identified via genetic permutation experiments that involve loss- or
gain-of-function mutations of a single gene and measuring the lifespan of a cohort of mutant organisms in
comparison to a cohort of "wild-type" or otherwise genetic identical control group. A significant change in
the lifespan of the mutant organism is an indication for the interfered gene to be an ageing gene.
Common biomedical model organism used for lifespan experiments are Saccharomyces cerevisiae
(budding yeast), Caenorhabditis elegans (nematode), Drosophila melanogaster (fruit fly) and Mus
musculus (house mouse). In yeast ageing genes can be identified via replicative and chronological
lifespan assays even in an automated fashion (Jo, et al., 2015). In nematode individuals are declared as
dead if they stop moving in an agar plate Petri dish or liquid culture. Those animals are synchronized prior
to the lifespan experiment and usually unfertilized via either genetic modification or chemical treatment
(with Floxuridine; FUdR). Lifespan assays can be performed in an automatic fashion via modified
document scanners (Stroustrup, et al., 2013). For fruit flies larvae are synchronized to provide
age-matched adults for analysis. Newly hatched males and females are allowed to mate for two days
before they are separated into veils in constant density so gender specific effects can be measured.
Throughout their lives the food supply is separated nor more less than every two to three days and death
is recorded in order to document the time course of mortality (Linford, et al., 2013). Mice are housed in a
special facility called a vivarium and hold in groups of the same age. Food and water is normal provided at
ad libitum and cages are cleaned regularly. Enrichment is provided within the cages, like running wheels in
order to allow physical activity. Death mice are counted and removed from the cages regularly. Lifespan
experiments in fruit fly and mouse have yet to be automated.
Rather than lifespan, other phenotypes, like age of maturation, have been suggested as surrogate for
identifying ageing genes (Flurkey & Yuan, 2012). However, lifespan remains the gold standard for
assaying effects on ageing.
2.1.2.2   in silico
Identifying new ageing genes is basically a problem of class prediction. Data sources like annotations,
interactions, and omics data can be used to derive features for predictive algorithms. Already known
ageing genes can be used to feed into such an algorithm to predict novel ageing genes.
2.1.2.2.1   Genomics
Genomic data can be used as inputs. A genome-wide linkage study (GWLS) is used for genetic mapping
and to identify loci associated with a trait. It measures markers and trait values in families and sees which
segregate similarly to identify the underlying loci of the trait.
A genome-wide association study (GWAS), also known as whole genome association study (WGA study,
or WGAS), is an examination of many common genetic variants in different individuals to see if any variant
is associated with a trait. GWAS typically focus on associations between single-nucleotide polymorphisms
(SNPs) and traits like major diseases.
Different omics data such as GWLS, GWAS and genome-wide expression profiling if integrated with
interactomics can be used for rank-based gene prioritization. Common genetic signals obtained from
different platforms might serve as a robust markers for evaluating the role of established genes and
identifying new genes involved in a certain process of interest (Talwar, et al., 2014).
An increasingly amount of genes are found to be associated with longevity as well as with age-related
disease. Age-related disease genetic variants help to inform on identifying longevity-associated variants
and genes (Fortney, et al., 2015).
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2.1.2.2.2   Interactomics
The genes in a genome give rise to biological networks on several levels of abstractions. The interaction
between genes (genetic interactions; epistasis) as well as their gene products (physical interactions or
complexes) have been used for characterising their associations and for predicting candidate genes
including those on ageing. Several attempts to utilize interactomics data have been made so far with
fruitful insights.
The interactions of gene products of lower model organisms ageing genes have been found to follow a
power law distributions, i.e. there are only few genes with many connections (so called hubs) while the
majority have only a few connections. Proteins of ageing genes have a significant higher connectivity than
expected by chance (Promislow, 2004). As ageing genes have been confirmed to exhibit this trend of
higher number of connections (i.e. they tend to be hubs), it has been suggested to use this network
property to prioritize candidates (Ferrarini, et al., 2005). This concept has been adapted to other model
organisms and used to make ranked list of candidate ageing genes (Witten & Bonchev, 2007). Genes
found to affect the lifespan of model organisms have been repeatedly and independently compiled and
human orthologs used to project their functions (under the assumption that ageing is a highly conserved
process across phyla (Smith, et al., 2008). Most of the hubs in networks of genes derived from orthologs of
model organisms ageing genes have been found to be involved in at least one and many in several
age-related diseases (Budovsky, et al., 2007). The first order interactors of known ageing genes are likely
to participate in the regulation of ageing more than random chosen genes. Networks in worm and humans
have been found to pose high predictive power for identifying ageing genes (Tacutu, et al., 2012). In such
first-order networks of ageing genes, hubs and centrally located nodes have higher likelihoods of being
associated with ageing and longevity than do randomly selected nodes. Essential genes for living have
been used as another criteria to prioritize candidate selection (Tacutu, et al., 2012). Rules have been
manually crafted from different sources of evidence to evaluate whether a given gene is likely to be a
ageing gene (Callahan, et al., 2015). Besides this, Nearest Neighbourhood, Decision Trees, Naive Bayes
and Support Vector Machine Classifier have been trained on predicting ageing genes, and therefore
eliminating the need for handcrafted rules (but not feature engineering) (Wan, et al., 2015; Fabris, et al.,
2015). Ageing and age-related diseases have again been found to share more genes than expected by
chance. Genes that promote ageing have been found to be associated with different age-related diseases
than those that suppress ageing (Fernandes, et al., 2016). Protein complexes involved in certain
processes can be predicated from networks as well by including interactions between protein complexes
(Le, 2015).
In graph theory and network analysis, indicators of centrality identify the most important nodes within a
graph. Such indicators include node degree, closeness, betweenness, and eigenvector centrality.
The simplest centrality measure is based on node degree, i.e. the number of edges connected to a node.
In connected graphs there is a natural distance metric between all pairs of nodes, defined by the length of
their shortest paths. The farness of a node is defined as the sum of its distances from all other nodes, and
its closeness is defined as the reciprocal of the farness.
Betweenness centrality quantifies the number of times a node acts as a bridge along the shortest path
between two other nodes. Eigenvector centrality (eigencentrality) is a measure of the influence of a node
in a network that assigns relative scores to all nodes in the network based on the concept that
connections to high-scoring nodes contribute more to the score of the node in question than equal
connections to low-scoring nodes.
The guilt-by-association principle states that nodes that have unusual high number of edges with nodes
that are members of certain class are also likely to belong to this class. In such, it can be used to find
potential additional members of a class like ageing genes.
In addition to node degree, other metrics like closeness, betweenness, and eigenvector centrality can be
used for guilt-by-association of interactomes to predict candidate nodes. The higher the centrality to the
seed nodes the higher the chance for the node to be related to the seed nodes (Witten & Bonchev, 2007).
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2.2   Methods
Genes that were found to impact lifespan upon their genetic perturbation were compiled from the literature
for most of the common biomedical model organisms, including Saccharomyces cerevisiae (yeast),
Caenorhabditis elegans (worm/nematode), Drosophila melanogaster (fruit fly), and Mus musculus (mouse)
as well as Homo sapiens (human). As information in public databases like Aging Genes and Interventions
Database (Kaeberlein, et al., 2002), GenAge (de Magalhaes & Toussaint, 2004), Lifespan Observations
Database (Olsen & Kaeberlein, 2017), and AgeFactDB (Huhne, et al., 2014) among others are distributed
to many portals, not up-to-date, inaccurate and not in a proper graph format, references of those resources
were looked up and related articles in PubMed/MEDLINE were followed. The compiled list of genes were
classified into genuine/uncertain gerontogenes and ageing-suppressor genes.
Guilt-by-association based on physical and genetic interactions (derived from BioGRID Version 3.4.140)
was performed to assess genes for their association with ageing. This was done for individual subclasses
as well as the superclass ageing genes.
For guilt-by-association a ratio was first calculated which corresponds to the number of interactions with
the genes in the defined classes divided by the number of all genes it interacts with. It therefore gives a
measure of specificity and corrects for the number of connections (i.e. being a hub). The higher the ratio is
to one, the more specific does the gene interact with genes within the defined class. In order to test
whether the specificity is higher than expected by chance, the hypergeometric distribution is utilized, which
is a standard approach (Eden, et al., 2009). Given the total number of genes N in the genome of a species,
with B genes interacting with a particular gene and n of these genes belonging to the seed set of interest,
then the probability that b or more genes from the seed set are associated with this specific gene is given
by the hypergeometric tail:
Prob(X>=b) = hypergeometric_test(b, N, B, n)
           = Sum(min(n,B), i=b)
             ((n, i) × (N-n, B-1)) / (N, B)
N = Total number of genes in a genome
B = Total number of interactors
b = Seed genes that are interactors
n = Seed genes
The p-values from the guilt-by-association were corrected for multiple hypothesis testing via the
Benjamini-Hochberg correction (Benjamini & HochBerg, 1995). These corrected values are termed
q-values.
In an ontology, a member (subclass or instance) of a class inherits all relations of its superclasses/types
("true path rule") (Valentini, 2009). For functional enrichment the ontological information about processes,
functions and location of gene products is utilized and all implicit relations were made explicit during
reasoning. Therefore, in a hierarchy of classes there exists a redundancy for annotations (hierarchical
redundancy).
Similar functional enrichment can be tested for in the same way as associating genes. Given again the
total number of genes N in the genome, with B genes associated with a particular term and n of these
genes in the seed set, then the probability that b or more genes from the seed set are associated with the
given term is also given with the same equation. Here as reference set, all genes within this species,
annotated with this kind of property are used.
For functional enrichment, ontologies of genes about biological processes (processes), molecular
functions (activities), and cellular components (locations) are used which are directed acyclic graphs with
edges like "is a", "part of", "regulates", etc. (Ashburner, et al., 2000). The respective annotations were
retrieved from NCBI FTP (File Transfer Protocol) server. Orthologs were retrieved from NCBI
HomoloGene also via FTP. The Database for Annotation, Visualization and Integrated Discovery (DAVID)
cope with this kind of hierarchical redundancy by using clustering of semantic similar terms (i.e. redundant
and heterogeneous terms are clustered into groups) and condensing large gene lists into gene functional
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groups. More specifically it measures relationships among the annotation terms based on the degrees of
their co-association genes to group the similar, redundant and heterogeneous annotation contents from
the same or different resources into fuzzy annotation groups (Huang, et al., 2007; Huang, et al., 2009a;
Huang, et al., 2009b). Here in this work clustering by automatic graph layout, based on force directed
graph layout, is utilized. The force-directed graph layout algorithm draws graphs in an aesthetically
pleasing way. Its purpose is to position nodes of a graph in a two- or three-dimensional space so that all
edges are of more or less equal length and there are as few crossing edges as possible. This is achieved
by assigning forces among the set of edges and nodes, based on their relative positions, and then using
these forces to simulate the motion of the edges and nodes or to minimize their energy (Kobourov, 2012).
The significant genes and associations are visualized together with the ageing genes as interaction
networks by using a force-directed graph layout. Unconnected nodes were connected via shortest path
algorithm. Corrected p-values (q-values derived by the Benjamini-Hochberg correction as described
above) of the significance to be an ageing gene or being associated with ageing genes are used for the
node size. For this q-values were converted to size scale by adding to the minimum size of 5 the log10 of
the q-value. Similar, terms that are significantly associated with certain gene classes were assigned the
colour of the respective class combination.
2.3   Results
Associations were assessed for ageing genes as well as specific subclasses (gerontogenes and
ageing-suppressor genes) within a species and tested for their significance with other genes, processes,
functions, and locations according to the Gene Ontology. Guilt-by-association was applied with a q-value
threshold of 0.05 (0.0005 for visualization) if not stated differently. Unconnected nodes were connected
via the shortest path algorithm. Nodes were colour coded the following way:
Nodes are grey by default, Gerontogenes are filled light red, ageing-suppressor genes are filled light blue
and ageing genes are purple. Processes are green, functions are orange, and locations are yellow. Halos
indicate respective significant associations with the same colour code. Association with both gerontogenes
and ageing genes is indicated with dark red while ageing-suppressor genes and ageing genes is indicated
with dark blue. Membership/association with both gerontogene and ageing-suppressor gene is indicated
with brown. Physical interactions are pink, genetic interactions are green and other edges like, is involved
in, exhibits and is located in are grey. Node size represents significance. The most obvious associations
with relevance are summarized for each species grouped by gene class and type of association in text.
2.3.1   Human
In humans there are a few genes established to be ageing genes (such as WRN, BLM, LMNA, etc.),
mostly due to fact that mutations in those genes lead to premature ageing diseases (accelerated ageing),
like Hutchinson-Gilford progeria syndrome (HGPS). Additionally there are human genes tested by
transgenic overexpression in lower model organisms. All those human ageing genes were collectively
characterized for their associated genes, processes, activities and locations [Figure 4 H. sapiens Ageing
Gene Network].
Human gerontogenes interact physically specifically with SENP1, CDK2, CTCF, MAST3, among others.
Human gerontogenes participate in positive regulation of cell ageing, neuronal death, negative regulation
of mitochondrial functions, negative regulation of telomere maintenance via telomere lengthening, and
neurofibrillary tangle assembly.
Human ageing-suppressor genes physically interact specifically with with H2AFX, BLM, DKC1, ATM,
WRN, TP53, among others. Human ageing-suppressor genes participate in ageing, stress response,
replicative senescence, telomeres/telomerase, DNA repair, regulation of protein stability, negative
regulation of apoptotic process, positive regulation of transdifferentiation, and negative regulation of
production of siRNA involved in RNA interference. Human ageing-suppressor genes are located primarily
in the nucleus, nucleoplasm, nucleolus, nuclear chromosome telomeric region, but also extracellular
exosome, RNA-directed RNA polymerase complex, mitochondrion, TERT-RMRP complex, Golgi
apparatus, and focal adhesion.
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Human ageing genes participate in stress response, mitotic nuclear envelope disassembly, mitotic nuclear
envelope reassembly, protein SUMOylation, and regulation of autophagy. Human ageing genes exhibit
activities related to protein and DNA binding. Human ageing genes are located in the nucleoplasm,
telomere, and mitochondrion.
_
Figure 4: H. sapiens Ageing Gene Network. Network of human ageing genes.
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2.3.2   Mouse
Mouse, as a mammal, is the closest model organism to human that has been extensively studied for the
genetics of ageing. The ability to create transgenic mice via embryonic stem cells and the possibility of
conducting lifespan experiments within a few years (3-4 years) has lead to the discovery of quite some
genes to be involved in ageing. Novel ageing genes in mouse were predicated via the guilt-by-association
concept with murine ageing genes as seeds. Murine ageing genes, gerontogenes and ageing-suppressor
genes were characterized for their enrichment in processes, functions, and locations respectively [Figure 5
M. musculus Ageing Gene Network].
_
Figure 5: M. musculus Ageing Gene Network. Network of mouse ageing genes.
Mouse gerontogenes participate in (cell) ageing and determination of adult lifespan, insulin/IGF1 and
growth hormone signalling, positive regulation of glucose import, gene regulation, growth and cell cycle,
apoptosis, TOR signalling, positive regulation of MAPK cascade, positive regulation of reactive oxygen
species metabolic process, regulation of telomere maintenance, inflammatory response, negative
regulation of proteostasis. Mouse gerontogenes exhibit insulin-like growth factor receptor binding, various
activities related to gene regulation, translation elongation factor activity, ubiquitin protein ligase binding,
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and signal transducer activity. Mouse gerontogenes are located in insulin receptor complex, transcription
factor complex, replication fork, and nucleolus.
Mouse ageing-suppressor genes participate in ageing, stress response, telomere/telomerase, DNA repair,
circadian clock, cellular senescence, free radicals, stem cell control, proteostasis, positive regulation of
canonical Wnt signalling pathway, wound healing, gene regulation, negative regulation of ERK1 and
ERK2 cascade, epigenetics, and negative regulation of TOR signalling. Murine ageing-suppressor exhibit
telomerase activity, helicase, transcriptional activity, proteostatic activity, chromatin remodelling activity.
Murine ageing-suppressor genes are located in nucleus, nucleoplasm, nuclear chromosome telomeric
region, (nuclear) chromatin, nuclear matrix, transcription factor TFIID complex, perinuclear region of
cytoplasm, and chromatoid body as well as extracellular exosome.
Mouse ageing genes are involved in translation, development, growth, MAPK cascade, positive and
negative regulation of telomerase. Mouse ageing genes exhibit E-box binding RNA polymerase II core
promoter sequence-specific DNA binding, RNA polymerase II core promoter proximal region
sequence-specific DNA binding, and transcription corepressor activity. Mouse ageing genes are located in
nuclear envelope, nuclear euchromatin, and CHOP-C/EBP complex as well as autophagosome.
2.3.3   Fly
The easy of genetic manipulation of fruit fly allowed researchers to identify a number of ageing genes.
Guilt-by-association was applied with fly ageing genes as seeds to predict novel ageing genes in fly.
Ageing genes in fruit fly were assessed for their associated processes, functions and locations [Figure 6 D.
melanogaster Ageing Gene Network].
Fly gerontogenes participate in processes related to growth and development and signalling as well as
apical protein localization, and positive regulation of immune response, negative regulation of autophagy,
and histone H3-K27 methylation. Fly gerontogenes exhibit protein and PI3K binding, core promoter
binding, and histone methyltransferase activity (H3-K9 specific). Fly gerontogenes are located in
ESC/E(Z) complex, nuclear inner membrane, nucleus, histone methyltransferase complex and
mitochondria.
Fly ageing-suppressor genes participates in stress response, protein homeostasis, as well as negative
regulation of signalling and growth. Fly ageing-suppressor genes exhibit NAD binding as well as
antioxidant and (NAD-dependent) histone deacetylase activity. Fly ageing-suppressor genes are located
in microtubule associated complex, nucleus, AP-3 adaptor complex, and HOPS complex, TSC1-TSC2
complex, and pre-autophagosomal structure.
Fly ageing genes are involved in gene silencing, regulation of histone acetylation, positive/negative
regulation of transcription DNA-templated, and TORC1 signalling, exhibit transcription regulatory region
sequence-specific DNA binding, and are located in nucleoplasm, Sin3 complex, and peroxisome.
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_Figure 6: D. melanogaster Ageing Gene Network. Network of fruit fly ageing genes.
2.3.4   Nematode
In Caenorhabditis elegans genetic interference is extremely easy due to the possibility to simply feed this
animal with plasmids expressing RNA interference constructs against defined genes. This has led to the
discovery of a plethora of ageing genes. Guilt-by-association was applied on nematode ageing genes to
find novel ones. Processes, functions and locations enriched for nematode ageing genes were
investigated [Figure 7 C. elegans Ageing Gene Network].
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Worm gerontogenes participate in determination of adult lifespan, development, translation as well as
growth, TOR, apoptosis, cell division, protein homeostasis, and gene regulation. Worm gerontogenes
exhibit translational activity, transcriptional activity, signalling, ATP-dependent RNA helicase activity, and
hormone activity. Worm gerontogenes are located in ribosome, TORC2 complex and mitochondrion, and
nuclear envelope.
_
Figure 7: C. elegans Ageing Gene Network. Network of nematode ageing genes.
Worm ageing-suppressor genes participate in adult lifespan determination, transcription regulation, RNA
interference, and stress response as well as proteostasis. Worm ageing-suppressor genes exhibit gene
regulatory functions, helicase, antioxidant activity, RNAi, peroxiredoxin activity, proteostatic activity. Worm
ageing-suppressor genes are located in proteasome, vacuolar membrane, phagocytic vesicle, nuclear
envelope, ESCRT II complex, transcription factor complex, and NuRD complex.
Worm ageing genes are involved in ageing, programmed cell death, positive regulation of ubiquitin-protein
transferase activity, negative regulation of transcription factor import into nucleus, nuclear-transcribed
mRNA catabolic process, regulation of actin cytoskeleton organization, and animal organ senescence,
exhibiting DNA repair, chromatin DNA binding, ubiquitin-protein transferase activity, actin binding,
DEAD/H-box RNA helicase binding, and are located in vacuolar proton-transporting V-type ATPase V0
domain, lysosome, and proteasome regulatory particle base subcomplex.
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2.3.5   Yeast
_
Figure 8: S. cerevisiae Ageing Gene Network. Network of yeast ageing genes.
Saccharomyces cerevisiae, as a unicellular model organism with only about 6500 genes and the
availability of deletion and overexpression mutant libraries, enabled researchers to discover so far the
largest number of ageing genes in a single organism. Ageing genes in budding yeast were characterized
for their enriched associated processes, functions, and locations. Yeast ageing genes were used as seeds
for guilt-by-association [Figure 8 S. cerevisiae Ageing Gene Network].
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Yeast gerontogenes participate in translation, and isocitrate metabolic process, MAPK cascade involved
in cell wall organization or biogenesis, and regulation of cell size. Yeast gerontogenes exhibit ribosomal
and DNA binding. Yeast gerontogenes are located primarily in ribosome as well as actin cortical patch.
Yeast ageing-suppressor genes participate in telomere maintenance, epigenetics, positive regulation of
RNA polymerase II transcriptional preinitiation complex assembly, DNA repair, autophagy, and
proteolysis. Yeast ageing-suppressor genes exhibit ATP-dependent DNA helicase activity, protein kinase
activity, protein serine/threonine kinase activity, and proteasome-activating ATPase activity. Yeast
ageing-suppressor genes are located in telomeres, and proteasome.
Yeast ageing genes participate in replicative and chronological cell ageing, age-dependent response to
oxidative stress involved in chronological cell ageing, maintenance of cell polarity, chromatin silencing at
telomere, regulation of endocytosis, mitochondria-nucleus signalling pathway, exhibit oxysterol binding,
histone acetyltransferase activity, and are located in endosome (membrane) and Atg1/ULK1 kinase
complex.
2.3.6   Cross-Species
2.3.6.1   Human Orthologs
The human orthologs of model organism were used as seeds for guilt-by-association with a strict q-value
cutoff of 5e-20 [Figure 9 H. sapiens Ageing Gene Orthologs Network].
Human gerontogene orthologs participate in translation, respiration, apopotosis, regulation of mRNA
stability, and regulation of signal transduction by p53 class mediator. Human gerontogene orthologs
exhibit polyA RNA binding, ribosomal translational activity, and NADH dehydrogenase ubiquinone activity,
translation initiation factor activity, ubiquitin protein ligase binding, and rRNA binding. Human gerontogene
orthologs make up ribosome and are located in nucleus, nucleoplasm, and mitochondrion.
Human ageing-suppressor gene orthologs participate in ageing, stress response, ubiquitin-proteasome
system, autophagy, mitochondrion organization, rhythmic process, MAPK cascade, regulation of mRNA
stability, negative regulation of transcription DNA-templated, DNA repair, negative regulation of apoptotic
process, and Wnt signalling. Human ageing-suppressor gene orthologs exhibit NAD, (double-stranded)
DNA, transcription factor, histone deacetylase, and chromatin binding. Human ageing-suppressor gene
orthologs are located in nucleoplasm, extracellular exosome, and mitochondrion, proteasome, perinuclear
region of cytoplasm, nuclear chromosome telomeric region, and inclusion body.
Human ageing genes orthologs are involved in protein stabilization, regulation of transcription
DNA-templated, transcription from RNA polymerase II promoter, response to estradiol, and protein
stabilization, exhibit structural constituent of ribosome and translation initiation factor activity, and are
located in nuclear chromatin and lysosomal membrane.
2.3.6.2   Common Associations with Ageing Genes Across Species
Significant associations of guilt-by-association applied to ageing genes in individual organisms that are
common to multiple organisms are graphed together [Figure 10 Common Ageing Gene Network].
Gerontogenes and ageing-suppressor genes are both commonly across species involved in determination
of adult lifespan, multicellular organismal process, single-multicellular organism process, anatomical
structure development, single-organism process, developmental process, single-organism developmental
process, animal organ development, regulation of developmental growth, and response to extracellular
stimulus. Gerontogenes are associated with ageing, growth regulation, translation, apopotosis, signal
transduction including TOR, and transcription regulation.
Ageing-suppressor genes are associated with cell ageing, stress response, oxidation-reduction process,
regulation of protein stability, lysosome/autophagy (in particular mitophagy), MAPK cascade, negative
regulation of insulin receptor signalling pathway as well as antioxidant and helicase activity, ubiquitination,
transcription DNA-templated, nucleus, chromatin binding, nuclear matrix, NAD-dependent histone
deacetylase activity, and telomeres.
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_Figure 9: H. sapiens Ageing Gene Orthologs Network. Network of human ageing genes orthologs.
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_Figure 10: Common Ageing Gene Network. Network of associations with ageing genes commonly
shared between multiple species.
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2.4   Discussion
Here the class of ageing gene was defined as well as discrete subclasses, namely gerontogene and
ageing-suppressor gene. Genuine ageing genes are those that if manipulated can lead to lifespan
extension (especially maximum lifespan extension). Ageing genes in commonly used biomedical model
organisms and humans were characterized. By doing so, processes, activities and locations (based on the
Gene Ontology) related to already known ageing genes and more specifically only for either of its
subclasses (gerontogenes and ageing-suppressor genes) were identified. By utilizing interactomics data,
a guilt-by-association method was used to find novel ageing genes. Genes not yet known to be involved in
ageing but ranked high (low q-value; big node size) are highly likely to be involved in ageing as well.
Semantics and causality are still missing.
For each of the commonly used biomedical model organism as well as human guilt-by-association was
applied with the known ageing genes as seed classified into their respective subclasses. Association that
are common to all ageing genes in this different species have been addressed with two approaches. First
with retrieving all human homologs of model organism ageing genes and applying guilt-by-association.
Secondly by applying first guilt-by-association for each species and than identifying the shared terms.
Numerous of the above results are in accordance with prior literature while others are new. Many
associations make sense in light of previous knowledge about ageing while some are surprising and
appear novel.
2.4.1   Genome
In mammals, ageing genes are associated with being involved in DNA metabolism and also function in
activities related to DNA binding and modification. This is particular true for ageing-suppressor genes
[Figure 4 H. sapiens Ageing Gene Network; Figure 9 H. sapiens Ageing Gene Orthologs Network]. They
are involved in the maintenance of telomeres [Figure 4 H. sapiens Ageing Gene Network; Figure 5 M.
musculus Ageing Gene Network; Figure 8 S. cerevisiae Ageing Gene Network; Figure 10 Common Ageing
Gene Network]. Gerontogenes however are commonly significantly associated with negative regulation of
telomere maintenance, while ageing-suppressor genes are commonly significantly associated with positive
regulation of telomere maintenance and telomerase activity [Figure 4 H. sapiens Ageing Gene Network;
Figure 5 M. musculus Ageing Gene Network; Figure 10 Common Ageing Gene Network].
Telomeres/telomerase is a known ageing system operating in many species to limit cell division and
modulate gene expression among other roles (Geserick & Blasco, 2006). Ageing genes, especially
ageing-suppressor genes participate also in the response to DNA damage as well as its repair [Figure 4 H.
sapiens Ageing Gene Network; Figure 9 H. sapiens Ageing Gene Orthologs Network]. DNA damage is
often claimed to be a primary driver of ageing because of its irreversibility. While there are repair systems,
certain damages if not repaired timely (like DNA double-strand breaks) lead to mutations which can impact
on gene expression, therefore increase transcriptional noise, and may give raise to cancer (Gorbunova &
Seluanov, 2016).
Ageing-suppressor genes are commonly significantly involved in nucleotide-excision repair.
Ageing-suppressor genes are commonly significantly associated with being involved in DNA repair,
base-excision repair, recombinational repair, double-strand break repair, and double-strand break repair
via homologous recombination [Common Associations with Ageing Genes Across Species].
Gerontogenes and ageing-suppressor genes are both commonly significantly associated with being
located in nuclear chromosome telomeric region. Ageing-suppressor genes are commonly significantly
associated with (nuclear and condensed) chromosome, chromosome segregation and organization, and
chromosome organization involved in meiotic cell cycle [Common Associations with Ageing Genes Across
Species].
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2.4.2   Epigenetics
Both gerontogenes and ageing-suppressor genes have significant associations with epigenetics and gene
silencing. However, ageing-suppressor genes especially are associated with various aspects of
epigenetics, including chromatin [Figure 5 M. musculus Ageing Gene Network; Figure 7 C. elegans Ageing
Gene Network; Figure 8 S. cerevisiae Ageing Gene Network; Figure 10 Common Ageing Gene Network].
Gerontogenes are commonly significantly associated with being involved in epigenetic alteration [Figure 6
D. melanogaster Ageing Gene Network; Figure 7 C. elegans Ageing Gene Network; Figure 8 S. cerevisiae
Ageing Gene Network; Figure 10 Common Ageing Gene Network] and regulation of gene expression
epigenetic [Figure 7 C. elegans Ageing Gene Network; Figure 8 S. cerevisiae Ageing Gene Network;
Figure 10 Common Ageing Gene Network]. Similar but to a greater extent, ageing-suppressor genes are
commonly significantly associated with epigenetic alteration [Figure 5 M. musculus Ageing Gene Network;
Figure 6 D. melanogaster Ageing Gene Network; Figure 7 C. elegans Ageing Gene Network; Figure 8 S.
cerevisiae Ageing Gene Network; Figure 10: Common Ageing Gene Network], epigenetic modification
[Figure 6 D. melanogaster Ageing Gene Network; Figure 7 C. elegans Ageing Gene Network; Figure 10
Common Ageing Gene Network], and regulation of gene expression epigenetic [Figure 5 M. musculus
Ageing Gene Network; Figure 6 D. melanogaster Ageing Gene Network; Figure 7 C. elegans Ageing Gene
Network; Figure 8 S. cerevisiae Ageing Gene Network; Figure 10 Common Ageing Gene Network], as well
as negative regulation of gene expression epigenetic [Figure 5 M. musculus Ageing Gene Network; Figure
8 S. cerevisiae Ageing Gene Network; Figure 10 Common Ageing Gene Network].
The plasticity of ageing suggest that lifespan may be controlled epigenetically by specific alterations in
chromatin state (Greer, et al., 2010). During ageing, changes in the chromatin state alter gene
transcription and result in expression of genes that are normally silenced (Jiang, et al., 2013).
2.4.2.1   Chromatin
Gerontogenes are commonly significantly associated with chromatin, nuclear chromatin as well as
chromatin binding, chromatin organization, covalent chromatin modification, and regulation of chromatin
organization [Figure 10 Common Ageing Gene Network].
Ageing-suppressor genes are commonly significantly associated with chromatin, chromatin binding,
chromatin assembly, chromatin assembly or disassembly, chromatin silencing at rDNA, chromatin
organization, regulation of chromatin silencing, regulation of chromatin silencing at telomere, covalent
chromatin modification, heterochromatin organization, nuclear chromatin, nuclear heterochromatin,
regulation of chromatin organization, nuclear telomeric heterochromatin, chromatin remodelling, positive
regulation of chromatin organization, heterochromatin, chromatin silencing, negative regulation of
chromatin organization, telomeric heterochromatin, and chromatin silencing complex [Figure 10 Common
Ageing Gene Network] as well as chromatin organization involved in regulation of transcription [Figure 8 S.
cerevisiae Ageing Gene Network].
The repressive chromatin environment at telomeres gives rise to the telomere position effect, which is the
epigenetic silencing of telomere-proximal genes (Tennen, et al., 2011). Silencing of ribosomal DNA (rDNA)
is tightly linked to suppression of rDNA recombination and the control of cellular lifespan (Machin, et al.,
2004).
2.4.2.2   DNA Methylation
Ageing genes including gerontogenes and ageing-suppressor genes are significantly associated with DNA
methylation [Figure 4 H. sapiens Ageing Gene Network; Figure 5 M. musculus Ageing Gene Network;
Figure 6 D. melanogaster Ageing Gene Network; Figure 7 C. elegans Ageing Gene Network] as well as
regulation of DNA methylation [Figure 4 H. sapiens Ageing Gene Network; Figure 5 M. musculus Ageing
Gene Network; Figure 6 D. melanogaster Ageing Gene Network; Figure 7 C. elegans Ageing Gene
Network; Figure 10 Common Ageing Gene Network].
Ageing-suppressor genes are commonly associated with DNA methylation [Figure 6 D. melanogaster
Ageing Gene Network; Figure 7 C. elegans Ageing Gene Network; Figure 10 Common Ageing Gene
Network], DNA methylation or demethylation [Figure 6 D. melanogaster Ageing Gene Network; Figure 7 C.
elegans Ageing Gene Network; [Figure 10 Common Ageing Gene Network], and regulation of DNA
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methylation [Figure 5 M. musculus Ageing Gene Network; Figure 6 D. melanogaster Ageing Gene
Network; Figure 10 Common Ageing Gene Network].
DNA methylation involved in embryo development is associated with ageing-suppressor genes [Figure 6
D. melanogaster Ageing Gene Network] as well as maintenance of DNA methylation [Figure 5 M.
musculus Ageing Gene Network], while gerontogenes significantly associate with regulation of DNA
methylation [Figure 4 H. sapiens Ageing Gene Network]. Ageing-suppressor genes are associated with
DNA hypermethylation [Figure 6 D. melanogaster Ageing Gene Network; Figure 5 M. musculus Ageing
Gene Network; Figure 10 Common Ageing Gene Network] and in particular hypermethylation of CpG
island [Figure 5 M. musculus Ageing Gene Network]. Overall, ageing-suppressor genes are associated
with methylation-dependent chromatin silencing [Figure 5 M. musculus Ageing Gene Network].
Gene silencing in general was shown to be correlated with lifespan extension. Loss of gene silencing is a
component of normal ageing observed in multiple organisms (Jiang, et al., 2013).
2.4.2.3   Histones
Gerontogenes are commonly significantly associated with histone modification [Figure 8 S. cerevisiae
Ageing Gene Network; Figure 10 Common Ageing Gene Network]. Ageing-suppressor genes are
commonly significantly associated with histone binding and modification, histone mRNA catabolic process,
regulation of histone modification, and negative regulation of histone modification [Figure 10 Common
Ageing Gene Network].
H2AFX is the most significant candidate of a human ageing gene and ageing-suppressor gene (but not
gerontogene) based on physical interactions. H2AFX was found to be associated with longevity in humans
(Soerensen, et al., 2012). The histone protein family member X (H2AFX) is important in maintaining
chromatin structure and genetic stability (Lu, et al., 2008). H2AFX knockout mice are growth retarded and
exhibit signs of genomic instability, a hallmark of ageing (Celeste, et al., 2002). Therefore H2AFX might be
an ageing-suppressor gene.
2.4.2.4   Histone Acetylation
Both gerontogenes and ageing-suppressor genes are involved in regulation of histone acetylation [Figure
6 D. melanogaster Ageing Gene Network]. Gerontogenes are associated in positive regulation of histone
acetylation [Figure 6 D. melanogaster Ageing Gene Network; Figure 8 S. cerevisiae Ageing Gene
Network] while ageing-suppressor genes are associated in negative regulation of histone acetylation
[Figure 4 H. sapiens Ageing Gene Network]. Ageing-suppressor genes are significantly associated with
negative regulation of histone H4-K16 acetylation [Figure 5 M. musculus Ageing Gene Network].
Ageing-suppressor genes are commonly significantly associated with histone acetylation, histone
acetyltransferase activity, regulation of histone acetylation, including negative regulation of histone
acetylation [Figure 10 Common Ageing Gene Network]. Specifically, ageing-suppressor genes are
commonly significantly associated with being involved in histone H3 acetylation, regulation of histone
H3-K9 acetylation, regulation of histone H3-K14 acetylation, and negative regulation of histone H3-K14
acetylation [Figure 10 Common Ageing Gene Network].
2.4.2.5   Histone Deacetylation
Ageing-suppressor genes are significantly associated with histone deacetylation [Figure 8 S. cerevisiae
Ageing Gene Network], including histone deacetylase binding [Figure 5 M. musculus Ageing Gene
Network; Figure 6 D. melanogaster Ageing Gene Network], protein deacetylase activity, histone H3
deacetylation [Figure 5 M. musculus Ageing Gene Network; Figure 6 D. melanogaster Ageing Gene
Network], NAD-dependent histone deacetylase activity [Figure 5 M. musculus Ageing Gene Network;
Figure 6 D. melanogaster Ageing Gene Network; Figure 10 Common Ageing Gene Network] as well as
NAD-dependent histone deacetylase activity H4-K16 specific [Figure 8 S. cerevisiae Ageing Gene
Network].
Ageing-suppressor genes are commonly significantly associated with histone deacetylation, histone
deacetylase complex, histone deacetylase activity, NAD-dependent histone deacetylase activity [Figure 10
Common Ageing Gene Network].
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2.4.2.6   Histone Methylation
Gerontogenes commonly significantly exhibit histone methyltransferase activity, histone-lysine
N-methyltransferase activity, and H3-K9 specific histone methyltransferase activity [Common Associations
with Ageing Genes Across Species]. Gerontogenes are associated with being located in histone
methyltransferase complex [Figure 6 D. melanogaster Ageing Gene Network]. Histone H3-K27
methylation and histone methyltransferase activity H3-K27 specific is significantly associated with
gerontogenes [Figure 6 D. melanogaster Ageing Gene Network].
There is a maturation-dependent switch in the expression of functionally homologous proteins of
epigenetic modifiers. For instance the ratio of histone methyltransferases, EZH1 to EZH2 is high in aged
and low in young. The same is also observed for the polycomb repressive complex 1 subunits CBX7 and
CBX8 (Weng, et al., 2014). Ezh2 is associated with ageing-suppressor genes [Figure 5 M. musculus
Ageing Gene Network].
Ageing-suppressor genes are commonly associated with methylated histone binding [Figure 10 Common
Ageing Gene Network]. Mitochondrial stress causes widespread changes in chromatin structure through
histone H3K9 dimethylation which is associated with gene silencing (Tian, et al., 2016).
2.4.2.7   Histone Demethylation
Ageing genes are significantly involved in histone demethylation. Histone H3-K4 demethylation is
associated with gerontogenes, trimethyl-H3-K4-specific histone H3-K4 demethylation is associated with
ageing-suppressor genes and gerontogenes [Figure 7 C. elegans Ageing Gene Network].
Excess H3K4 trimethylation, a mark associated with active chromatin, is detrimental for longevity (Greer,
et al., 2010). An increase in ubiquitylation at H2BK123 and methylation at both H3K4 and H3K79 is
observed at telomere-proximal regions of replicative aged yeast cells coincident with decreased Sir2
abundance (Rhie, et al., 2013).
H3K4me2 increases at promoters and enhancers globally during postnatal development and ageing and
those correspond to gene expression changes in cis that are enriched for stress responses, such as the
DNA damage response. In support for this there is an increased expression of SETD and DPY30 in aged
rhesus monkey brains (Han, et al., 2012). DPY30 is associated with ageing-suppressor genes [Figure 4 H.
sapiens Ageing Gene Network].
2.4.2.8   Histone Phosphorylation
Ageing-suppressor genes are commonly significantly associated with being involved in positive regulation
of histone phosphorylation [Figure 10 Common Ageing Gene Network]. This would mean that histone
phosphorylation suppresses ageing and histone dephosphorylation could enhance ageing.
Histone phosphorylation decreases with ageing in human lymphocytes (Lutz, et al., 1977). H1 histones, for
instance, are normally greatly phosphorylated and the phosphorylation of H1 is implicated in regulation of
chromatin remodelling. However, there is a significant age-related dephosphorylation of H1.4 and H1.5
and an increase in heterochromatin protein HP1alpha as a function of donor age in human peripheral
lymphocytes. Dephosphorylation of H1 histones may be related to an increase in senescence-associated
heterochromatin formation during the in vivo ageing of human peripheral blood lymphocytes (Happel, et
al., 2008). Ageing-suppressor genes may counteract this trend and the loss of ageing-suppressor activity
may be responsible for this type of age-related change.
2.4.2.9   Chromatin Remodellers
Ageing genes, gerontogenes and ageing-suppressor genes are located in the Sin3 complex [Figure 6 D.
melanogaster Ageing Gene Network]. Ageing-suppressor genes are located within the NuRD complex
[Figure 7 C. elegans Ageing Gene Network; Figure 6 D. melanogaster Ageing Gene Network]
Ageing-suppressor and gerontogenes are located in the ESC/E(Z) complex Figure 6 D. melanogaster
Ageing Gene Network; Figure 5 M. musculus Ageing Gene Network].
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SIN3A/Sin3a/SIN3 itself is associated with ageing-suppressor genes. Actually in fruit fly it is a known
genuine ageing suppressor [Figure 5 M. musculus Ageing Gene Network; Figure 8 S. cerevisiae Ageing
Gene Network].
2.4.3   Transcription Regulation
Ageing genes, both gerontogenes as well as ageing-suppressor genes are associated with transcription
regulation. These associations are very prevalent and it seems like that gerontogenes and
ageing-suppressor genes are both associated with positive and negative regulation of transcription, like
they are both modifiers of transcriptional regulation. Overall, ageing-suppressor genes appear to have
more associations with transcription regulation than gerontogenes. There are some aspects of
transcription regulation that are unique to each class [Figure 10 Common Ageing Gene Network].
Gerontogenes specifically are significantly involved in transcription from RNA polymerase I promoter as
well as RNA polymerase II transcription factor activity sequence-specific DNA binding [Figure 10 Common
Ageing Gene Network]. RNA polymerase I transcripts ribosomal genes which makes sense given the other
associations of gerontogenes found here in promoting translation [Translation].
Ageing-suppressor genes are significantly associated with being involved in stress response transcription
regulation (regulation of DNA-templated transcription in response to stress, regulation of transcription from
RNA polymerase II promoter in response to stress, and positive regulation of transcription from RNA
polymerase II promoter in response to stress) as well as transcription factor binding/activity (transcription
factor activity, transcription factor binding, RNA polymerase II transcription factor binding, transcription
factor binding, transcription factor activity protein binding, nucleic acid binding transcription factor activity,
regulation of sequence-specific DNA binding transcription factor activity, positive regulation of
sequence-specific DNA binding transcription factor activity) [Figure 10 Common Ageing Gene Network].
Ageing is associated with reduced capacity to cope with various forms of physiological stress. Old animals
do not upregulate stress response when confronted with challenges (Zhang, et al., 2002). Different types
of moderate stress can extend lifespan presumably by upregulating repair/maintenance systems (i.e.
hormesis) (Anderson, et al., 2016).
2.4.4   Stress Response
Ageing-suppressor genes are strongly associated with stress response [Figure 4 H. sapiens Ageing Gene
Network; Figure 5 M. musculus Ageing Gene Network; Figure 6 D. melanogaster Ageing Gene Network;
Figure 7 C. elegans Ageing Gene Network; Figure 10 Common Ageing Gene Network]. Stress resistance
is known to be strongly correlated with long lifespan as it was confirmed in various phenotypical assays.
The resistance to multiple types of stress peaks during early adulthood and declines with advanced age
(Dues, et al., 2016). Gain-of-functions of ageing-suppressors might make cells more stress resistant by
upregulation of their associated stress responses. This is also the proposed mechanism of how hormesis
is capable of lifespan extension (Gems & Partridge, 2008).
2.4.5   Signal Transduction
Ageing genes have significant associations with various kinds of signal transduction and signalling.
Gerontogenes associate significantly with signalling so do ageing-suppressor genes. However they do
regulate individual signalling pathways in different directions.
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2.4.5.1   TOR
Gerontogenes are significantly associated with TOR (TOR signalling [Figure 5 M. musculus Ageing Gene
Network; Figure 7 C. elegans Ageing Gene Network; Figure 8 S. cerevisiae Ageing Gene Network; Figure
10 Common Ageing Gene Network], TOR complex [Figure 5 M. musculus Ageing Gene Network; Figure 6
D. melanogaster Ageing Gene Network; Figure 7 C. elegans Ageing Gene Network; Figure 8 S. cerevisiae
Ageing Gene Network; Figure 10 Common Ageing Gene Network], TORC1 complex [Figure 5 M.
musculus Ageing Gene Network; Figure 6: D. melanogaster Ageing Gene Network; Figure 7 C. elegans
Ageing Gene Network; Figure 8 S. cerevisiae Ageing Gene Network; Figure 10 Common Ageing Gene
Network], and TORC2 complex [Figure 5 M. musculus Ageing Gene Network; Figure 6 D. melanogaster
Ageing Gene Network; Figure 7 C. elegans Ageing Gene Network; Figure 10 Common Ageing Gene
Network] as well as regulation of TOR signalling [Figure 7 C. elegans Ageing Gene Network] and positive
regulation of TOR signalling [Figure 7 C. elegans Ageing Gene Network].
Ageing-suppressor genes are also associated with TOR complex [Figure 5 M. musculus Ageing Gene
Network], TORC2 complex [Figure 5 M. musculus Ageing Gene Network], TOR signalling [Figure 6 D.
melanogaster Ageing Gene Network], TORC1 signalling [Figure 6 D. melanogaster Ageing Gene
Network], regulation of TOR signalling [Figure 5 M. musculus Ageing Gene Network, Figure 6 D.
melanogaster Ageing Gene Network; Figure 10 Common Ageing Gene Network], negative regulation of
TOR signalling [Figure 4 H. sapiens Ageing Gene Network; Figure 5 M. musculus Ageing Gene Network;
Figure 6 D. melanogaster Ageing Gene Network; Figure 10 Common Ageing Gene Network], negative
regulation of TORC1 signalling [Figure 4 H. sapiens Ageing Gene Network; Figure 5 M. musculus Ageing
Gene Network; Figure 10 Common Ageing Gene Network].
2.4.5.2   MAPK
Gerontogenes and ageing-suppressor genes are associated with MAPK signalling [Figure 10 Common
Ageing Gene Network]. However, ageing-suppressor genes are further associated with regulation
including both positive and negative regulation of MAPK cascade [Figure 10 Common Ageing Gene
Network]. This may imply that MAPK components are both gerontogenes and ageing-suppressor genes
whereas ageing-suppressors modulate components activity. Indeed ERK-MAPK has been found to shown
to promote longevity by regulating the localization of transcription factors encoded by ageing-suppressor
genes (Okuyama, et al., 2010).
Human ageing gene orthologs most significantly physically interact with NTRK1 encoding neurotrophic
tyrosine kinase receptor which is a membrane-bound receptor that, upon neurotrophin binding,
autophosphorylates itself as well as members of the MAPK pathway.
2.4.5.3   Wnt & Notch
Wnt and Notch are predominant signalling in stem cells. Ageing-suppressor genes are significantly
associated with negative regulation of Notch signalling pathway [Figure 6 D. melanogaster Ageing Gene
Network] while gerontogenes are also associated with Notch signalling pathway [Figure 5 M. musculus
Ageing Gene Network] and in particular with positive regulation of Notch signalling pathway [Figure 7 C.
elegans Ageing Gene Network]. Ageing genes are significantly associated with Wnt signalling [Figure 4 H.
sapiens Ageing Gene Network; Figure 5 M. musculus Ageing Gene Network; Figure 6 D. melanogaster
Ageing Gene Network; Figure 9 H. sapiens Ageing Gene Orthologs Network]. Ageing-suppressor genes
are associated with positive regulation of Wnt signalling pathway [Figure 9 H. sapiens Ageing Gene
Orthologs Network]. It should be noted, that in HGPS there is an upregulation of Notch and downregulation
of Wnt (Meshorer & Gruenbaum, 2008). Wnt signalling mediates the regenerator phenotype of the
biological immortal organisms like hydra (Heber-Katz, et al., 2006) (Lengfeld, et al., 2009).
2.4.5.4   TGF-Beta
Transforming growth factor (TGF) beta receptor signalling pathway is commonly significantly associated
with gerontogenes [Figure 10 Common Ageing Gene Network]. TGF-beta is downregulated under DR
(Kim, et al., 2016).
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2.4.6   Protein Homeostasis
2.4.6.1   Translation
Gerontogenes significantly associate strongly with translation and ribosomal components [Figure 5 M.
musculus Ageing Gene Network; Figure 7 C. elegans Ageing Gene Network; Figure 8 S. cerevisiae
Ageing Gene Network; Figure 9 H. sapiens Ageing Gene Orthologs Network; Figure 10 Common Ageing
Gene Network]. Gerontogenes are significantly associated with translation, cytoplasmic translation,
regulation of translation, positive regulation of translation, translation elongation factor activity, regulation
of translational elongation, translation factor activity RNA binding, and eukaryotic translation initiation
factor 4F complex. Ageing-suppressor genes are associated with regulation of translation and specifically
negative regulation of translation and translational initiation [Figure 10: Common Ageing Gene Network].
Ageing-suppressor genes are also significantly involved in circadian regulation of translation [Figure 5 M.
musculus Ageing Gene Network].
Inhibiting protein synthesis slows down growth and development but extends lifespan. Dietary restriction
also inhibits protein synthesis (Kapahi, 2010).
Ageing-suppressor genes are involved in other processes related to protein homeostasis such
chaperones, autophagy and the ubiquitin-proteasome system [Figure 4 H. sapiens Ageing Gene Network;
Figure 5 M. musculus Ageing Gene Network; Figure 6 D. melanogaster Ageing Gene Network; Figure 7 C.
elegans Ageing Gene Network; Figure 8 S. cerevisiae Ageing Gene Network Figure 9 H. sapiens Ageing
Gene Orthologs Network; Figure 10 Common Ageing Gene Network]. Ageing-suppressor genes are
strongly associated with positive regulation of autophagy and proteasome, while gerontogenes were found
to be associated with negative regulation of those processes [Figure 5 M. musculus Ageing Gene
Network; Figure 6 D. melanogaster Ageing Gene Network].
2.4.6.2   Aggregation
Gerontogenes are significantly associated with being involved in neurofibrillary tangle assembly, which is
the aggregation, arrangement and bonding together of a set of components to form a neurofibrillary tangle.
Neurofibrillary tangles are basically aggregates of hyperphosphorylated tau protein that are most
commonly known as a primary marker of Alzheimer's disease [Figure 4 H. sapiens Ageing Gene Network].
However, their presence is also found in numerous other diseases which are collectively known as
tauopathies.
Gerontogenes are significantly associated with aggresome assembly, while ageing-suppressor genes are
significantly associated with aggrephagy, a form of macroautophagy that selectively degrades protein
aggregates [Figure 5 M. musculus Ageing Gene Network]. Therefore it seems like that gerontogenes are
involved in the generation of aggresomes and ageing-suppressor genes are involved in there elimination
(Hyttinen, et al., 2014).
2.4.6.3   Lysosome
Although gerontogenes are at least associated to be located in the lysosome [Figure 7 C. elegans Ageing
Gene Network], ageing-suppressor genes are associated with lysosome [Figure 4: H. sapiens Ageing
Gene Network; Figure 5 M. musculus Ageing Gene Network; Figure 6 D. melanogaster Ageing Gene
Network; Figure 7 C. elegans Ageing Gene Network; Figure 10 Common Ageing Gene Network]
lysosomal transport [Figure 6 D. melanogaster Ageing Gene Network; Figure 7 C. elegans Ageing Gene
Network; Figure 10 Common Ageing Gene Network] endosome to lysosome transport, lysosomal transport
[Figure 6 D. melanogaster Ageing Gene Network; Figure 7: C. elegans Ageing Gene Network; Figure 10
Common Ageing Gene Network], protein targeting to lysosome [Figure 6 D. melanogaster Ageing Gene
Network], lysosome organization [Figure 6 D. melanogaster Ageing Gene Network], protein localization to
lysosome [Figure 6 D. melanogaster Ageing Gene Network], lysosomal lumen acidification [Figure 7 C.
elegans Ageing Gene Network], regulation of lysosomal lumen pH [Figure 7 C. elegans Ageing Gene
Network], autolysosome [Figure 5 M. musculus Ageing Gene Network], and secondary lysosome [Figure 5
M. musculus Ageing Gene Network] as well as lysosomal microautophagy [Figure 8 S. cerevisiae Ageing
Gene Network]. An early increase in lysosomal (vacuolar) pH limits mitochondrial function and lifespan
(Hughes & Gottschling, 2012).
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Lysosomes are organelles that degrade macromolecules and recycle metabolites as well as participate in
diverse processes that regulate cellular homeostasis and lifespan. Longevity requires maintenance of
lysosome integrity (Li, et al., 2016).
2.4.6.4   Autophagy
Both ageing-suppressor genes and gerontogenes have significant associations with autophagy, but while
gerontogenes are associated with negative regulation of autophagy and macroautophagy,
ageing-suppressor genes are associated with autophagy, macroautophagy, nucleophagy, mitophagy,
regulation of autophagy, macroautophagy, and mitophagy, as well as positive regulation of autophagy and
macroautophagy [Figure 10 Common Ageing Gene Network]. Autophagy is a self-renewal process in cells
by recycling redundant materials through lysosomal machinery (Wu & Yan, 2011). Therefore, autophagy is
a major clearance mechanism that degrades organelles and large protein aggregates to maintain cell
survival and protein homeostasis (Emanuele, et al., 2014).
Autophagy was suggested to be the pivotal mechanism of various lifespan extending intervention
(especially those that are based on environmental signals). Numerous lifespan extending interventions
converge on autophagy (Melendez, et al., 2008). Enhanced autophagy is associated with human longevity
and serum levels of the autophagy biomarker beclin-1 are increased in healthy centenarians (Emanuele,
et al., 2014).
2.4.6.5   Chaperone
Although gerontogenes are associated with exhibiting chaperone binding [Figure 7 C. elegans Ageing
Gene Network] ageing-suppressor genes are significantly associated with a wide spectrum of
chaperone-related entities/activities like iron chaperone activity [Figure 5 M. musculus Ageing Gene
Network; Figure 6 D. melanogaster Ageing Gene Network, [Figure 10 Common Ageing Gene Network],
metallochaperone activity [Figure 5 M. musculus Ageing Gene Network; Figure 6 D. melanogaster Ageing
Gene Network; Figure 8 S. cerevisiae Ageing Gene Network; [Figure 10: Common Ageing Gene Network],
endoplasmic reticulum chaperone complex [Figure 7 C. elegans Ageing Gene Network],
chaperone-mediated protein folding [Figure 6 D. melanogaster Ageing Gene Network],
chaperone-mediated protein complex assembly [Figure 8 S. cerevisiae Ageing Gene Network], regulation
of chaperone-mediated protein complex assembly [Figure 5 M. musculus Ageing Gene Network], and
positive regulation of chaperone-mediated protein complex assembly [Figure 5 M. musculus Ageing Gene
Network]. Molecular chaperones influence lifespan as part of the stress response machinery (Walker &
Lithgow, 2003).
Lifespan extension by reduction of translation may be due to a decreased load of misfolded and damaged
proteins, which are primarily eliminated by chaperones and proteases. Reduced translation results in
spare chaperone and proteolytic functions which can easily deal with the modified proteins (Hipkiss, 2007).
2.4.6.6   Proteasome
Ageing-suppressor genes, but not gerontogenes are commonly significantly associated with proteasome
(proteasome complex, proteasome assembly, proteasome regulatory particle base subcomplex,
proteasomal protein catabolic process, and proteasome-mediated ubiquitin-dependent protein catabolic
process [Figure 10 Common Ageing Gene Network]. Elevated proteasome activity extends lifespan (Yao,
et al., 2015).
Murine ageing genes are most significantly associated with Ubc [Figure 5 M. musculus Ageing Gene
Network], which encodes ubiquitin C and participates in ubiquitin homeostasis. Human ageing genes also
significantly associate with physical interactions to UBC [Figure 4 H. sapiens Ageing Gene Network]. Ubc
is significantly downregulated during ageing in rat liver (Chen, et al., 2006). UBC was found as pivotal
protein to interact with diverse Alzheimer's disease-associated pathophysiological molecular factors and
which implies the reduced ubiquitin proteasome degradation system as one of the causative factors of
Alzheimer's disease (Manavalan, et al., 2013).
Yeast ageing genes most significantly physical interact with RKR1, encoding a ubiquitin-protein ligase
involved in chromatin organization, chromatin silencing at telomere, as well as ribosome-associated
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ubiquitin-dependent protein catabolic process, and rescue of stalled ribosomes. RKR1 is already a known
ageing-suppressor gene.
 
Although maintaining protein homeostasis is crucial for life and health, which type of autophagy and
ubiquitin-proteasome system is most limiting the lifespan is unclear. Nucleophagy and mitophagy are
commonly associated with ageing-suppressor genes. Moreover, in the organism with the highest number
of known ageing genes, ageing-suppressor genes are associated with piecemeal microautophagy of
nucleus and the nuclear proteasome complex [Figure 8 S. cerevisiae Ageing Gene Network]. Those
subsystems have not yet been investigated in context of ageing much. However, it was observed that the
nuclear pore complexes which are composed of long-lived proteins (i.e. proteins with low turnover)
deteriorate in an age-dependent manner and cause loss of nuclear integrity and result in increased
uncontrolled permeability (i.e. leakage) especially in postmitotic cells (D Angelo, et al., 2009). Proteolysis
of parts of the nucleus could counteract this deterioration.
2.4.7   SUMOylation
Ageing-suppressor genes were also associated with protein SUMOylation [Human]. SUMOylation is
basically a reversible post-translational modification that conjugates small peptide SUMO (small
ubiquitin-like modifier) to a larger target protein.
The global protein SUMOylation and expression of components involved in SUMOylation are altered
during the ageing process. Also key factors that control cellular senescence are known to be targeted by
SUMOylation (Gong, et al., 2016).
2.4.8   Apoptosis
Gerontogenes are commonly significantly associated with cell death, programmed cell death, regulation of
cell death, regulation of programmed cell death, positive regulation of cell death, positive regulation of
programmed cell death [Figure 10 Common Ageing Gene Network]. Ageing-suppressor genes are also
commonly significantly associated with all those, but additionally also commonly significantly associated
with ectopic germ cell programmed cell death, programmed cell death involved in cell development,
negative regulation of cell death, negative regulation of programmed cell death, negative regulation of
oxidative stress-induced cell death [Figure 10 Common Ageing Gene Network].
Therefore, it appears that ageing-suppressor genes prevent cell death especially cell death that is induced
by stress. However, gerontogenes are commonly significantly associated with negative regulation of
extrinsic apoptotic signalling pathway [Figure 10 Common Ageing Gene Network].
Ageing enhances apoptosis and susceptibility to apoptosis in several types of intact cells, while ageing
suppresses the apoptosis of damaged, malignant and, senescence cells (Higami & Shimokawa, 2000).
The increased resistance to apoptosis enhances the ageing process (Salminen, et al., 2011).
Gerontogenes are also significantly associated specifically with positive regulation of neuron death which
might be related to the occurrence of neurodegenerative disease like Alzheimer's disease and Parkinson
disease or the general decline in cognitive functionalities during increasing age [Figure 4 H. sapiens
Ageing Gene Network].
2.4.9   Cellular Senescence
In mammals ageing genes are significantly involved in cellular senescence including replicative and
(oxidative) stress-induced premature senescence as well as regulation of cellular senescence (positive
and negative regulation) [Figure 4 H. sapiens Ageing Gene Network; Figure 5 M. musculus Ageing Gene
Network]. Ageing-suppressor genes are commonly associated with senescence, cellular senescence,
replicative senescence, regulation of cellular senescence and in particular negative regulation of cellular
senescence [Figure 10 Common Ageing Gene Network].
Interestingly, while ageing-suppressor genes are involved in negative regulation of cellular senescence,
gerontogenes are involved in positive regulation of cellular senescence [Figure 4 H. sapiens Ageing Gene
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Network; Figure 5 M. musculus Ageing Gene Network]. This makes perfect sense considering that cellular
senescence is a kind of ageing hallmark in mammalian organisms. Preventing or eliminating senescence
cells is usually associated with lifespan extension. Interventions like dietary restriction are known to
prevent the accumulation of senescence cells (Wang, et al., 2010; Liu, et al., 2012). Further, genetic or
pharmacological elimination of senescence cells in mice is capable of lifespan extension (Baker, et al.,
2016; Zhu, et al., 2015; Zhu, et al., 2016).
2.4.10   Hormones
2.4.10.1   Insulin/IGF-1
Gerontogenes were found to be associated with insulin/insulin-like growth factor signalling (including
insulin binding, insulin receptor substrate binding, insulin receptor binding, insulin receptor complex,
cellular response to insulin stimulus, insulin-activated receptor activity, and regulation of insulin-like growth
factor receptor signalling pathway) while ageing-suppressor genes in particular were found to be
associated with negative regulation of this specific type of signalling (including negative regulation of
insulin secretion involved in cellular response to glucose stimulus) [Figure 5 M. musculus Ageing Gene
Network; Figure 9 Common Ageing Gene Network]. This confirms the observations that insulin/insulin-like
growth factor signalling is a control circuit of ageing and that its enhancement result in lifespan shortening
and its suppression is resulting in lifespan extension. Dietary restriction is usually correlated with reduced
insulin/insulin-like growth factor signalling as well (Chiba, et al., 2007; Bartke, 2008).
The evolutionary conserved insulin and insulin-like growth factor signalling (IIS) has a crucial role in control
of longevity. Studies on the genetic and metabolic characteristics that are associated with healthy
longevity and old age indicate that the conserved and ancient IIS also participates in human lifespan
control (van Heemst, 2010).
2.4.10.2   Somatotropin
Gerontogenes are also associated with somatotropin secreting cell development and differentiation [Figure
5 M. musculus Ageing Gene Network] which with the former is the cellular development process whose
specific outcome is the progression of a somatotropin secreting cell over time. A somatotropin secreting
cell produces growth hormone (a.k.a. somatotropin).
Gerontogenes are associated with positive regulation of growth hormone secretion, while
ageing-suppressor genes are associated with negative regulation of growth hormone secretion [Figure 5
M. musculus Ageing Gene Network]. Growth hormone seems to mediate ageing in mammals in a systemic
fashion (Hill, et al., 2016). Human dwarfs (dwarfism) with growth hormone deficiency tend to live longer
and stay free from many age-related disease like cancer and diabetes. Dietary restriction lowers
somatotropin levels as well (Bartke, 2012).
2.4.11   Mitochondrial Dysfunction
2.4.11.1   Mitochondria
Gerontogenes are commonly significantly associated with mitochondrial DNA metabolic process and
mitochondrial respiratory chain complex III biogenesis. Ageing-suppressor genes are associated with
mitochondrial nucleoid, organization, and disassembly [Figure 9 Common Ageing Gene Network]. Further
gerontogenes have significant associations with negative regulation of establishment of protein localization
to mitochondrion, mitochondrial fission, and ATP biosynthetic process [Figure 9 Common Ageing Gene
Network].
More specifically gerontogenes are significantly associated with negative regulation of mitochondrion
organization, while ageing-suppressor genes are commonly significantly associated with positive
regulation of mitochondrion organization [Figure 9 Common Ageing Gene Network]. This may indicate that
gerontogenes participate in mitochondrial dysfunction and ageing-suppressor genes counteract it.
Mitochondrial dysfunction and decreased mitochondrial biogenesis are believed to participate in metabolic
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abnormalities and loss of organ function, which will eventually contribute to ageing and decreases lifespan
(Tocchi, et al., 2015).
2.4.11.2   Reactive Oxygen Species
According to the free radical theory of ageing which was a rather recent theory of ageing more than 30
years ago (Koster, 1986), free radicals (that are produced as by-products of metabolism) are driving
ageing by damaging biomolecules. There are a variety of types of radicals, but the predominant ones in
biological system are derived from oxygen and collectively called reactive oxygen species. A radical is an
atom or molecule that has one or more unpaired electrons. Radicals are formed as necessary
intermediates in a variety of biochemical reactions and also function as signalling molecules, but when
generated in excess or not appropriately controlled, free radicals can wreak havoc on a wide range of
macromolecules.
Gerontogenes are significantly and commonly associated with regulation of reactive oxygen species
metabolic process [Figure 9 Common Ageing Gene Network], especially, positive regulation of reactive
oxygen species metabolic process [Figure 4 H. sapiens Ageing Gene Network; Figure 5 M. musculus
Ageing Gene Network; Figure 9 Common Ageing Gene Network]. Ageing-suppressor genes were found to
be associated with negative regulation of reactive oxygen species metabolic process and removal of
superoxide radicals, in particular positive regulation of removal of superoxide radicals as well as
oxidoreductase activity acting on superoxide radicals as acceptor [Figure 5 M. musculus Ageing Gene
Network; Figure 9 Common Ageing Gene Network].
2.4.12   Regeneration
Ageing-suppressor genes are associated with regeneration [Figure 5 M. musculus Ageing Gene Network;
Figure 6 D. melanogaster Ageing Gene Network; Figure 7 C. elegans Ageing Gene Network; Figure 9
Common Ageing Gene Network], specifically of liver [Figure 4 H. sapiens Ageing Gene Network; Figure 5
M. musculus Ageing Gene Network], [Figure 9 Common Ageing Gene Network], neuron [Figure 5 M.
musculus Ageing Gene Network], [Figure 6 D. melanogaster Ageing Gene Network; Figure 7 C. elegans
Ageing Gene Network, [Figure 9 Common Ageing Gene Network], dendrite [Figure 6 D. melanogaster
Ageing Gene Network], axon [Figure 5 M. musculus Ageing Gene Network; Figure 6 D. melanogaster
Ageing Gene Network; Figure 7 C. elegans Ageing Gene Network; Figure 9 Common Ageing Gene
Network] as well as myoblast differentiation involved in skeletal muscle regeneration [Figure 5 M.
musculus Ageing Gene Network]. Regeneration is the growth of anew or lost tissue or destroyed parts of
organs.
The regrowth of a lost or destroyed body parts, such as an organ or tissue is vital for tissue/organ
maintenance. This process may occur via renewal, repair, and/or growth alone. Regeneration decelerates
with age. Long lived or immortal organisms often have an enormous regenerative potential which is
mediated by Wnt signalling (Galliot & Chera, 2010; Heber-Katz, et al., 2006; Lengfeld, et al., 2009).
2.4.12.1   Stem Cells
Ageing genes have significant associations with stem cells. In particular ageing-suppressor genes are
associated with positive regulation of stem cell proliferation [Figure 5 M. musculus Ageing Gene Network;
Figure 4 H. sapiens Ageing Gene Network], and negative regulation of stem cell differentiation [Figure 5 M.
musculus Ageing Gene Network]. Further, ageing-suppressor genes are associated with stem cell division,
germ-line stem cell population maintenance, and intestinal stem cell homeostasis [Figure 6: D.
melanogaster Ageing Gene Network]. It seems like that promoting stem cell proliferation and preventing
their loss from differentiation is a mechanism in which ageing-suppressor genes can counteract
organismal ageing.
Similarly ageing-suppressor genes are significantly associated with hematopoietic stem cell proliferation
and differentiation [Figure 5 M. musculus Ageing Gene Network] in particular negative regulation of
hematopoietic stem cell differentiation [Figure 4 H. sapiens Ageing Gene Network]. Hematopoietic stem
cells are multipotent stem cells that replenish the body with new blood cells. Having a greater reservoir of
hematopoietic stem cells would provide the organism a higher capacity to renew its blood. Hematopoietic
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stem cells are themselves ageing, so generating new hematopoietic stem cells through differentiation into
this lineage would enhance this stem cell population (Geiger, et al., 2005).
Adult or tissue-specific stem cells are not immortal. Their efficiency is limited by natural ageing in common
with most other somatic cell types (Nurkovic, et al., 2016). There cannot be anything related to stem cells
in yeast as a single-cell organism, but replicative cell ageing is assumed to be a model of stem cell ageing
and is also more strongly associated with ageing-suppressor genes [Figure 8 S. cerevisiae Ageing Gene
Network].
2.4.12.2   Wound Healing
Ageing genes are significantly associated with wound healing [Figure 5 M. musculus Ageing Gene
Network; Figure 6 D. melanogaster Ageing Gene Network; Figure 7 C. elegans Ageing Gene Network].
Ageing-suppressor genes are significantly associated with wound healing including wound healing
spreading of epidermal cells, while gerontogenes are associated with negative regulation of vascular
wound healing [Figure 5 M. musculus Ageing Gene Network; Figure 6 D. melanogaster Ageing Gene
Network].
With higher age wound healing is delayed (Pittman, 2007). Enhancing wound healing might expect an
organism to increase its capability to live longer.
2.4.13   Circadian Rhythm
Ageing genes are associated with circadian rhythm, gerontogenes and ageing-suppressor genes
specifically as well. Gerontogenes are associated with entrainment of circadian clock by photoperiod and
circadian behaviour. Ageing-suppressor genes on the other side are associated with regulation of
circadian rhythm, positive regulation of circadian rhythm, and circadian regulation of gene expression and
translation [Figure 6 D. melanogaster Ageing Gene Network; Figure 5 M. musculus Ageing Gene
Network].
There are well known age-related effects on circadian rhythms including reductions of rhythm amplitude,
alterations in re-entrainment and increased fragmentation (Pang, et al., 2004). Lifespan extending
interventions like dietary restriction are known to reset the circadian clock and make circadian rhythmicity
more robust (Froy, et al., 2008).
2.4.14   Cytoskeleton
Both gerontogenes and ageing-suppressor genes are commonly significantly associated with cytoskeleton
organization and cytoskeleton-dependent intracellular transport. Ageing-suppressor genes are specifically
associated with regulation of actin cytoskeleton organization, actin cytoskeleton organization, microtubule
cytoskeleton organization, actin cytoskeleton reorganization, and establishment or maintenance of
cytoskeleton polarity [Figure 6 D. melanogaster Ageing Gene Network; Figure 10 Common Ageing Gene
Network]. Cellular ageing is characterized by the appearance of various cell dysfunctions. However the
possible involvement of the microtubules in the ageing process has no yet been extensively investigated
(Raes, 1991).
atl is the most significant association based on physical interaction of fly ageing genes. atl encodes
atlastin, a GTPase homologous to mammalian ATL2, that is involved in endoplasmic reticulum membrane
fusion and microtubule depolymerisation. atl is also significantly associated with fly gerontogenes. Loss of
atlastin induces age-dependent death of dopaminergic neurons in Drosophila. atl null flies are paralysed
by mechanical shock such as bumping or vortexing and exhibit degeneration of dopaminergic neurons
(Lee, et al., 2008). atl and spastin mutants display similar adult phenotypes including short lifespan,
impairments in locomotor activity, and age-dependent neurodegeneration (Lee, et al., 2009). Note that atl
nor spastin were yet classified as ageing-suppressor genes, nor ageing genes. Hence this is a in silico
validation of a candidate.
The most significant physical interaction partner of worm ageing genes is atn-1 which encodes an
alpha-actinin homolog [Worm]. atn-1 exhibits actin binding and involved in mitotic nuclear division.
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2.4.15   Immunosenescence
Ageing genes are involved in different aspects of the immune system. Ageing-suppressor genes are
significantly associated with humoral immune response mediated by circulating immunoglobulin [Figure 4
H. sapiens Ageing Gene Network], and somatic recombination of immunoglobulin genes [Figure 5 M.
musculus Ageing Gene Network], regulation of cytokine secretion [Figure 5 M. musculus Ageing Gene
Network]. Gerontogenes are significantly associated with immune system process [Figure 7 C. elegans
Ageing Gene Network], regulation of innate immune response [Figure 7 C. elegans Ageing Gene Network]
as well as positive regulation of immune response [Figure 6 D. melanogaster Ageing Gene Network;
Figure 5 M. musculus Ageing Gene Network] and prostaglandin secretion involved in immune response
[Figure 5 M. musculus Ageing Gene Network].
Ageing genes have clear and significant associations with inflammation and its regulation. Gerontogenes
are directly significantly associated with inflammatory response, including positive regulation of acute
inflammatory response, positive regulation of leukotriene production involved in inflammatory response
[Figure 5 M. musculus Ageing Gene Network]. Ageing-suppressor genes are significantly associated with
regulation of cytokine production involved in inflammatory response [Figure 5 M. musculus Ageing Gene
Network], negative regulation of inflammatory response [Figure 5 M. musculus Ageing Gene Network],
negative regulation of acute inflammatory response [Figure 4 H. sapiens Ageing Gene Network; Figure 5
M. musculus Ageing Gene Network], negative regulation of respiratory burst involved in inflammatory
response [Figure 4 H. sapiens Ageing Gene Network].
Ageing of the immune organs and hence deterioration of the immune system promotes systematic
inflammation and age-related disease (including autoimmune diseases and cancer) as well as reduced
responsiveness to vaccination and increased susceptibility to infections (Sidler, et al., 2013; Chen, et al.,
2014). When the immune organs developmentally driven degenerate (e.g. mammalian thymus) it mounts
strong systematic inflammation (Chen, et al., 2014). Immunosenescence is caused by age-specific
changes in the nuclear lamin expression which contributes to heterochromatin loss of genes involved in
the immune response (Chen, et al., 2014). Altered gene expression, DNA and histone H3K9
hypomethylation, increased genome instability and apoptosis are observed in the primary and secondary
immune system organs of aged organisms. Alterations in gene expression and epigenetic regulation occur
already in early ages (Sidler, et al., 2013).
With increasing age tissue become more and more inflamed. While acute inflammation is good in
response to injury and infection, chronic inflammation has negative effects. This phenomenon is so
predominant that it got its own name, inflammageing. By their very activity gerontogenes could lead to
inflammageing (Franceschi, et al., 2007).
2.4.16   Nucleus
Gerontogenes and ageing-suppressor genes have both significant associations with the nucleus. The
nucleus is like the central processing unit of the cell.
The nuclear matrix is mostly significantly associated with ageing-suppressor genes as a location [Figure 4
H. sapiens Ageing Gene Network; Figure 5 M. musculus Ageing Gene Network; Figure 6 D. melanogaster
Ageing Gene Network; Figure 10 Common Ageing Gene Network]. The nuclear matrix is poised to play a
critical role in the ageing process as it is important for DNA organization and nuclear structural
morphology. The nucleus increases in size and becomes more round with age. There appear to be
quantitative (but not qualitative) alterations in the prominent nuclear matrix proteins with age (Pienta, et al.,
1992). Thus ageing-suppressor genes could counteract these trends by stabilizing the nuclear matrix.
Beyond this, the mitochondria-nucleus signalling pathway is significantly associated with
ageing-suppressor genes [Figure 8 S. cerevisiae Ageing Gene Network]. Dysfunctional mitochondria
signal to the nucleus to induce the expression of a set of genes (retrograde regulation/response) that
increases lifespan (Osiewacz & Kimpel, 1999).
Ageing-suppressor genes are associated with (late) nucleophagy [Figure 8 S. cerevisiae Ageing Gene
Network; Figure 7 C. elegans Ageing Gene Network], piecemeal microautophagy of nucleus [Figure 8 S.
cerevisiae Ageing Gene Network], nuclear ubiquitin-proteasome system and nuclear proteasome complex
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[Figure 8 S. cerevisiae Ageing Gene Network]. Among the different proteasomal systems, the nuclear
proteasomes are affected most profoundly by ageing possibly triggering significant changes in cellular
signalling and transcription (Rodriguez, et al., 2010).
2.4.17   Growth and Development
The regulation of growth rate is yet another process controlled by ageing genes. Ageing genes have
significant associations related to different scales of growth. Gerontogenes alone are significantly and
commonly associated with regulation of cell growth and organ growth including positive regulation of cell
and multicellular organism growth [Figure 9 Common Ageing Gene Network]. Gerontogenes are clearly
involved in positive regulation of growth processes, while ageing-suppressor genes have a tendency to be
involved in negative regulation of growth [Figure 6 D. melanogaster Ageing Gene Network; Figure 7 C.
elegans Ageing Gene Network; Figure 9 Common Ageing Gene Network]. Growth is tightly related to
ageing, as most organisms stop growing after reaching maturation and start to age. While growth is not so
important in an adult organism, those genes that initially functioned to drive growth and are essential for
development may cause havoc in the adult. Interventions that slow down growth such as dietary restriction
also increase lifespan. Therefore there exists an inverse relationship between growth and ageing. A
phenomenon known as antagonistic pleiotropy.
Besides controlling growth, gerontogenes are significantly associated with development [Figure 5 M.
musculus Ageing Gene Network; Figure 6 D. melanogaster Ageing Gene Network; Figure 7 C. elegans
Ageing Gene Network Figure 10 Common Ageing Gene Network]. Both ageing-suppressor genes and
gerontogenes are associated commonly to development, but gerontogenes are commonly and strongly
associated to multicellular organism development, embryo development, epidermis development, neuron
projection development, system development, and developmental maturation [Figure 10 Common Ageing
Gene Network].
The most significant candidate physically interacting with worm gerontogenes is pal-1 which encodes a
transcriptional regulator involved in development. pal-1 also genetically interacts significantly with
gerontogenes. Based on those associations, pal-1 might be a gerontogene as well.
Ageing could be regarded as an extension of development. As such, ageing could be mediated by the
same genes that mediate development as both are unfolding over time. This could also be another
example of antagonistic pleiotropy where changes that are beneficial early in life (i.e. during development)
become detrimental later in life (i.e. during ageing) (Ungewitter & Scrable, 2009).
 
Ageing genes or genes that prolong or antagonize longevity have been studied collectively for common
associations (Kwon, et al., 2010; Fernandes, et al., 2016). However those studies mostly found broad
associations and have not identified specific associations with defined ageing classes like gerontogenes
and ageing-suppressor genes and pinpointed to causal relations in interpretations.
Previous investigations in associations of genes that enhance or suppress the ageing process found p53
signalling, cell cycle, hypoxia response via HIF activation, regulation of autophagy and oxidative
phosphorylation associated with ageing-suppressors. Gerontogenes were found to be associated with
insulin, IGF1 and growth hormone signalling, mTOR signalling and ribosomes (Fernandes, et al., 2016).
However these investigations did not yet discuss much about precise regulations and specific terms as
done here comprehensively. Regulation of p53 as well as p53 controlled genes have been found here to
be associated with both ageing-suppressor genes and gerontogenes [Common Associations with Ageing
Genes Across Species]. p53 actually refers to a family of closely related transcription factors consisting (in
mammals) of p53, p63 and p73, each of which has various isoforms with very distinct effects. It has
homologs in invertebrates and maybe has distant homologs in single cellular organisms. p53 itself has
been assumed to be an oncogene, but also functions as tumour-suppressor (Baker, et al., 1989). Similar
p53 has been repeatedly found to have both ageing-suppressing as well gerontogenic effects. Regulation
of cell cycle is associated with ageing-suppressor genes and gerontogenes. Gerontogenes are
significantly associated with mitotic cell cycle, while ageing-suppressor genes are significantly associated
with meiotic cell cycle [Common Associations with Ageing Genes Across Species]. HIF-1 signalling
pathway is commonly associated with ageing-suppressor genes [Common Associations with Ageing
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Genes Across Species]. Ageing-suppressor genes and gerontogenes both are commonly associated with
oxidative phosphorylation, but regulation of oxidative phosphorylation is associated with gerontogenes,
while oxidative phosphorylation uncoupler activity is associated with ageing-suppressor genes [Common
Associations with Ageing Genes Across Species]. Insulin/insulin-like growth factor and growth hormone
signalling have been all been strongly associated with gerontogenes, while ageing-suppressor genes have
been found to be involved in their negative regulation [Hormone]. Ageing-suppressor genes have been
found here to be positive and gerontogenes to be negative regulators of different forms of autophagy,
where ageing-suppressor genes have been found to be associated with various forms of autophagy itself
[Autophagy]. Gerontogenes were found here to be strongly associated with TOR signalling and its positive
regulation, while ageing-suppressor were found to be associated with its negative regulation [TOR].
Gerontogenes were identified here to be associated with ribosome and its structural constituents
[Common Associations with Ageing Genes Across Species] as well as its positive regulation of ribosomal
biogenesis [Fly] whereas ageing-suppressor genes were found to be associated with negative regulation
of ribosomal biogenesis [Mouse].
Guilt-by-association based on the interactome can predict novel ageing genes as well as processes,
functions and location associated with the ageing process. This was validated by showing that already
known ageing genes are rediscovered (i.e. are among the most significant genes). Other network
topological measures such as betweenness and shortest path can be used as well to identify unknown
ageing genes as well as processes, functions, and locations crucial for lifespan control.
Using defined classes of ageing genes as input for the guilt-by-association applied on the interactome
often resulted in different genes being most significant, though others remain very significant for both
subclasses. It is tempting to speculate that gerontogenes are associated with different genes (complexes,
pathways, etc.) than ageing-suppressor genes. It is at least suspected that different kind of processes can
promote ageing or suppress ageing. However gerontogenes and ageing-suppressor genes can also be
simple activators and repressors of the very same complexes, pathways and processes and vice versa.
The directionality of regulation identified here strongly support this.
While several genes, processes, activities, locations have been associated with ageing genes, why they
might be important in ageing is not yet inferred. Further whether those play any causal role or are more
effectors is not distinguished. Regulatory networks could be employed to infer causality, e.g. transcription
factors and post-translational modifying proteins to some extent. Moreover, a class of genes associated
with longevity (longevity-associated genes) derived from genomic variants associated with centenarians
and supercentenarians could be characterized as well as genes known to be associated with cellular
senescence. In yeast ageing genes could be subdivided to whether they are impacting on replicative or
chronological lifespan. It is not certain to which extent those two types of ageing are overlapping and
whether genes that affect replicative lifespan also affect chronological lifespan and vice versa. It could be
tested whether replicative ageing genes tend to be also chronological ageing genes and the other way
around as well.
The processes, functions (activities) and locations (compartments) that were found to be common to the
known ageing genes and defined subclasses in different species might reveal common mechanisms of
ageing.
2.5   Conclusion
Ageing is under control of genes. Some genes promote ageing (gerontogenes) while other counteract it
(ageing-suppressor genes). Guilt-by-association has been used to identify new candidate genes and
associated processes, activities and locations of specific ageing gene subclasses. Gerontogenes and
ageing-suppressor genes are both commonly associated with certain processes, activities and locations
across species boundaries. Those two classes have quite frequently antagonizing associations.
Gerontogenes are commonly associated with positive regulation of TOR, inflammation, translation,
apoptosis, cellular senescence, growth and development, as well as negative regulation of telomere
maintenance and proteostasis. Ageing-suppressor genes are associated with DNA metabolism (including
DNA repair and telomere maintenance), epigenetics (including DNA methylation), stress response,
regeneration, circadian clock, cytoskeleton, MAPK, and as well as negative regulation of cellular
senescence and mitochondria dysfunction.
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3   Ageing Signatures
Abstract: Ageing is accompanied by profound and discrete changes in gene expression.
Gene expression profiles provide a wealth of data to give insights into the molecular
mechanism of ageing. Transcriptional consensus signatures of ageing in humans
and common biomedical model organisms were established as well as consensus
signatures of accelerated ageing and cellular senescence in humans. Ageing
upregulates transcription regulation, TOR signalling, apoptosis and inflammation
and downregulates Wnt signalling, epigenetics, and proteostasis. Accelerated
ageing upregulates Notch signalling, and downregulates Wnt signalling. Cellular
senescence, just as seen for whole organism ageing, is associated with an
upregulation of inflammation, but also negative regulation of cell cycle and
apoptosis.
3.1   Background
Several genes have been identified that, when mutated, can reduce and/or extend lifespan [Ageing
Genes]. However much about ageing remains unknown and to be explained. New technologies allow the
simultaneous assay of expression levels of thousands of genes. These can be explored to answer the
questions of how and why ageing might occur. With the right experimental design and computational
analysis, differential gene expression between different ages can be obtained with high confidence. The
possibility to profile the entire genome in an unbiased way is a great asset for the study of complex
biological phenomenon such as ageing.
Ageing involves the changes in multiple genes involving multiple processes, activities, and locations, some
of which may not yet be identified but can have a very important role in modulating the ageing process.
Gene expression profiling of wild type (i.e. normal) ageing, and of mutants with accelerated ageing or
increased lifespan may provide insights into potential mechanisms of how ageing operates in organisms
[Molecular Profiling to Decipher Ageing].
During ageing there are myriads of changes that occur on different scales. From whole physiological
(phenotypes that can be observed) down to the molecular level. The level of expression of genes changes
with increasing age in a way that can be assessed via molecular profiling. Ageing gene expression
changes are measured in time series. Hence time-course experiments are necessary in the study of
ageing. Therefore ageing gene expression datasets are basically time series datasets. In order to enable
the identification of age-related trends, studies of the ageing process should examine at least three ages
(young, middle-aged, and old) and ideally many more than this. Choosing only two ages (young vs. old)
risks missing trends that may occur during the lifespan; a peak in midlife followed by a decline to near
youthful levels, for instance, would be missed by an experimental design or computational analysis
including only two ages (Golden & Melov, 2007). If samples of various ages are measured as usual in
studies of ageing in humans it is not obvious what to compare. However one can put together samples
(from individuals with a certain age) into groups to represent certain periods of age. To derive ageing gene
expression molecular signatures one usually compares young versus old, young vs. middle-aged, and
middle-aged vs. old.
Extensive studies in model organisms and humans have identified many genes that exhibit age-dependent
expression changes. In addition, individuals with progeria (accelerated ageing) and in particular
Hutchinson-Gilford progeria syndrome (HGPS) have been profiled. There also exist time series gene
expression profiles of cellular senescence (Kim, et al., 2013) and centenarians.
However, for analysing ageing gene expression data a major difficulty is to define young, middle-aged and
old groups. In humans young (20-30 years), middle-aged (45-55 years), and old (>65 years) were defined
(Nair, 2005). Though this would leave gaps at the ages of 0-20, 30-45 and 55-65 years. In human
everything under 20 years is considered to be developmental, i.e. 0-20 years is considered to be the
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development phase in humans (Somel, et al., 2010). In a somewhat different classification, young was
defined as 15-30 years, middle-aged as 40-55 years and old as 60+ years (Aliper, et al., 2015). In yet
another classification, young was considered to be from 18-30 years while old as 59-76 years (Lanza, et
al., 2008). Finally another classification without any gaps was defined with human development from 0-20
years, young adulthood from 20-40, middle-aged from 40-60 and old age from 60 onwards (Kang, et al.,
2011).
For model organism the subdivision into life stages is similar difficult and ill-defined. Monkey under 5 years
(< 5 years) are considered developing, from 5 to 8 young, middle-aged in the range of 8-12 years, and old
if aged over 12 years. Rat can be defined to be young up to 5 months, middle-aged beyond 11 months and
old between 25-29 months (Takahashi, et al., 1987). Mice are mature adults with 3-6 months, middle-aged
between 10-15 months and old between 18-24 months (Flurkey, et al., 2007). Another schema defines
young (4 month-old), middle-aged (13 month-old), and old (25 month-old) mice (Karelus & Nelson, 1992).
A definition is to declare young mice aged less than 6 months, middle aged mice are aged 6-17 months
and old mice are more than 24 months old (Lesne, et al., 2006). Fruit fly were defined as young (7 days
old), middle-aged (30 days old), and old (50 days old) (Brigui, et al., 1990). In nematode, two-day-old adult
worms were defined as young adults, six-day old adult worms as middle-aged adults, and 10-day old
adults worms as aged adults (Guha, et al., 2014). In yeast a replicative lifespan of 9 generations was
considered as middle-aged and 13.5 generations as old age (Steinkraus, et al., 2008). Gaps in age range
definition can be accommodated by interpolating their boundaries.
Based on this, life stages and phases [Table 1: Life Stages and Phases] as well as age ranges for humans
and common biomedical model organisms were defined [Table 2: Age Ranges].
Table 1: Life Stages and Phases. Subdivision of the life into stages and phases.
Life Stage Phase
in uture Development
Juvenile
Adolescent
Young Adult Adulthood
Middle-Aged Adult
Old Adult
Table 2: Age Ranges. Ranges of ages for specific life stages (Fox, et al., 2006).
Species Development Young Middle-Aged Old Unit
Human 0 - 20 20 - 40 40 - 60 > 60 Years
Monkey 0 - 5 5 - 8 8 - 12 > 12 Years
Rat 0 - 5 5 - 11 11 - 25 > 25 Months
Mouse 0 - 3 3 - 6 6 - 14 > 14 Months
Fly 0 - 7 7 - 30 30 - 50 > 50 Days
Worm 0 - 2 2 - 6 6 - 10 > 10 Days
Yeast 0 - 2 2 - 9 9 - 13 > 14 Generations
DNA microarray and RNA-seq based profiling represent effective methods to analyse cellular or
tissue-specific gene expression on the genome-level as well as prioritize gene candidates (Anand, et al.,
2015). Ageing has been transcriptional profiled in various organisms including human, monkey, rat,
mouse, horse, fish, fly, nematode, and yeast among others. Here it will be focused primarily on human and
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common biomedical model organisms for which significant gene expression profiles of various ages exist
including young and old.
Tissue and age contribute more to the global differences in gene expression than do sex, ethnicity and
inter-individual variation (Kang, et al., 2011). High-throughput gene expression profiles of ageing typically
result in differential expression of hundreds or thousands of genes. To allow for the interpretation of these
changes, sets of genes can be identified that have some common characteristics. This is often referred to
as gene set enrichment, where statistical tests are applied to the molecular signature from those profiles to
identify significant enrichment of groups of genes in these signatures.
The enrichment can be quantitatively measured by some common statistical methods including
Chi-square, Fisher's exact test, Binomial probability, and Hypergeometric distribution (Huang, et al., 2009).
The Fisher Exact Test is a usual method used for gene set enrichment analysis. However, there are
modifications of the Fisher Exact Test available such as the EASE score that allow for the ranking of
biological categories associated with sets of genes from gene list based on the co-occurrence/enrichment
of the category with the gene list (Hosack, et al., 2003).
Enrichment analysis tools can be grouped into at least three different classes based on the difference in
algorithms (Huang, et al., 2009):
1. Singular Enrichment Analysis
2. Gene Set Enrichment Analysis
3. Modular Enrichment Analysis
Singular enrichment analysis takes preselected genes from a signature by some common metrics (like
t-test p-value < 0.05 and fold change > 1.5) and iteratively tests the enrichment of each annotation term
one-by-one in a linear mode. Gene set enrichment analysis in contrast is a "no-cutoff" strategy that takes
all genes from the signature without selecting significant genes. It therefore 1) reduces the arbitrary factors
and 2) uses all information obtained from profiling. Modular enrichment analysis inherits the enrichment
calculation of singular enrichment analysis and incorporates the term-to-term relationships. The
independence assumption of singular enrichment analysis is seriously violated by extensive correlation
between genes (a well recognised phenomenon) (Gatti, et al., 2010). Gene set analysis can be extended
to longitudinal data in order to allow time-course gene set analysis (Hejblum, et al., 2015).
3.2   Methods
Gene expression series, samples, datasets, and platforms (automatically downloaded from the Gene
Expression Omnibus File Transfer Protocol server) were parsed. Lines with null/NaN values were
discarded. Intensity values were interpolated from missing values via mean. All values were
log2-transformed and quantile normalized if necessary (i.e. if not done yet). Individual molecular profiles
were derived from multiple samples within a series [Molecular Profiling to Decipher Ageing]. Platform files
were used to obtain annotation data for the profiles (e.g. sequence identifiers and gene symbols).
The precise definition of a molecular signature is provided in the following which is supported by [Figure 13
Definition of a Molecular Signature]. A molecular signature is derived from RNA, protein, or metabolite
expression profiles and is indicative of a biological transition (e.g. from healthy to diseased or from young
to old). This pattern of expression difference is comprised of unique clusters of RNA, proteins, metabolites
that display differential levels of expression. While a molecular expression profile is the measurement of a
set of molecular entities representing a single biological state, a molecular signature represents the
differences between such states (e.g. old versus young, diseased versus healthy, mutant versus wild-type,
intervened versus unperturbed, etc.). A molecular signature can be represented in various mathematically
formulations just like transcription factor binding motifs can be represented in different ways (e.g. regular
expression, weight matrices, etc.). A molecular signature can be as simple as a set of genes (i.e. set
theory) or more concrete as a vector where each components value represents the expression difference
of a molecular entity such as a RNA. Thus a molecular signature can be a shortlist of most differentially
expressed genes or a vector of fold changes in its most simple representations.
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_Figure 11: Definition of a Molecular Signature.
For each signature differential expression was calculated via the Characteristic Direction method which is
superior to many standard methods of differential expression calculation (Clark & All, 2013; Clark, et al.,
2014). The Characteristic Direction, a geometric approach to differential expression analysis, is a
multivariate approach to determine differentionally expressed genes [Figure 12 Characteristic Direction].
The Characteristic Direction is better able to identify differential expressed genes than univariate
approaches including: fold-change, SAM, Welch's t-test, LIMMA, and DESeq. Characteristic Direction
uses a Linear Discriminant Analysis (LDA) classifier in which probability that a sample x derives from each
of the classes G is modelled with the Bayes' rule by making assumption that class-conditional density is a
multivariate Gaussian and covariance matrix for each class boundary is a hyperplane. Characteristic
Direction naturally incorporates a regularization scheme to deal with the problem of the curse of
dimensionality. The Characteristic Direction method provides an intuitive geometrical picture of differential
expression in terms of a single direction. The square of each component is a measure of importance of
corresponding gene in differential expression. Any gene expression profile can be represented as a point
in this space. The direction can be represented by a unit vector. The relative magnitudes of components of
vector correspond to the relative significance of genes in distinguishing between two biological conditions.
Because direction is represented as a unit vector, the sum of squares of components is equal to unity.
Each square of each component can be interpreted as being equal to fractional contribution of
corresponding gene to the total difference between transcriptional profiles of two biological conditions.
Therefore the Characteristic Direction can be used to rank genes and isolate the most relevance. The
difference between samples can be characterized by a single vector. The magnitude of the vector
quantifies the magnitude of the difference in expression between two groups of samples. The unit vector
parallel to the Characteristic Direction quantifies contribution of each gene to the total difference. The
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Characteristic Direction Method is more sensitive than t-test in recovering differentially expressed genes. It
is also more pronounced when few samples are available for each condition.
Here the characteristics direction coefficients are calculated for each signature where samples are
grouped so that the main discriminating factor is age. If sample size allows (at least more than 3) and
gender annotation is provided gender specific signatures are calculated. The datasets used for deriving
signatures can be requested from the author. Respective profiles (e.g. old vs. young) were used to create
molecular signatures representing certain biological conditions, states, or processes (e.g. ageing). Young
versus old, young versus middle-aged and middle-aged versus old were compared if possible and the
samples can be grouped into those. In the case of a continuum of ages of samples, periods of around 1-6
years (in humans) were defined in such a way that each group has multiple replicates (2-3 or more).
Most dataset used can have several derived signatures (e.g. varying the gender or age ranges).
Signatures for individual tissues were derived including female and male-specific signatures as well as
gender- and tissue-independent consensus signatures. Signatures were generated common to multiple
datasets (i.e. series) across cell types and tissues. For deriving a consensus signature the Characteristic
Direction coefficients were summed up for each gene.
_
Figure 12: Characteristic Direction.
The Principal Angel Enrichment Analysis, a natural extension of the characteristic direction method, was
used to assess the significance of associations with interactions of genes/proteins (derived from BioGRID
Version 3.4.140) as well as processes, activities, locations (as defined in the Gene Ontology (Ashburner,
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et al., 2000)) and chromosomes. p-values were adjusted according to Benjamini-Hochberg (Benjamini &
HochBerg, 1995). q-values were combined via the Z-method (Whitlock, 2005).
The significant results of Principle Angle Enrichment Analysis is visualized as networks by connecting
nodes via the shortest path algorithm and applying force-directed graph layout (Kobourov, 2012). Briefly,
the significant nodes are visualized together as interaction networks. The significance to be associated
with differentially expressed genes are used for the node size. For this q-values were converted to node
size scale by adding to the minimum size of 5 the negative of the exponent of the q-value divided by two.
Similar, nodes that are significantly associated with any gene classes were assigned the colour of the
respective class.
_
Figure 13: H. sapiens Ageing. Network of genes differentially expressed with ageing in humans.
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3.3   Results
Nodes are colour coded in the following way. Upregulated genes are filled red and downregulated genes
are blue. Processes are green, functions are orange, and locations are yellow. Halos indicate respective
significant associations with the same colour code. Nodes to be associated with upregulated and
differential-expressed genes get magenta coloured halos, those that are associated with downregulated
and differential expressed genes obtain violet coloured halos and those that were found to be significant
associated with upregulated as well as downregulated have halos coloured in purple. Physical interactions
are pink, genetic interactions are green and other edges like, is involved in, exhibits and is located in are
grey. Node size represents significance.
3.3.1   Human
3.3.1.1   Normal Ageing
Homo sapiens has been gene expression profiled at different ages. Individual molecular signatures (as
defined by (Wuttke & de Magalhaes, 2011) [Molecular Profiling to Decipher Ageing] of human ageing were
derived from the gene expression profiles. A strict q-value threshold of 5e-10 was utilized to generate
reasonable adequate-sized graph for visualization [Figure 13 H. sapiens Ageing].
Human ageing-upregulated genes are associated with participating in the nuclear envelope organization,
nuclear migration, exhibiting chromatin, actin filament and chaperone binding as well as located in
lysosomal membrane and the aggresome (see discussion for explanation). Human ageing-upregulated
genes are significantly interacting with LTF, APP, AKT1, SUN1, and EP300. Human
ageing-downregulated genes are associated with participating in the MAPK cascade, exhibit
transcriptional activator activity RNA polymerase II core promoter proximal region sequence-specific
binding and being located in transcription factor complex. Human ageing-downregulated genes interact
significantly with APP, EP300, DIO2, TP53, MARCH6, and ELOC. Human ageing-differentially expressed
genes are associated with participating in signal transduction, positive regulation of transcription from RNA
polymerase II promoter, positive/negative regulation of cell proliferation, positive regulation of cell
migration as well as inflammatory response and being located in the extracellular exosome. Human ageing
differentially expressed genes significantly interact with APP and EP300.
3.3.1.2   Accelerated Ageing
Several genetic syndromes confer a phenotype of accelerated ageing. Tissue samples from individuals
with HGPS were transcriptional profiled in various studies. Here a consensus signature was derived from
them representing accelerated ageing in humans and used to find significant associations with a relative
strict threshold (q-value 5e-10) [Figure 14 H. sapiens HGPS].
Accelerated ageing-upregulated genes are associated with being involved in cell adhesion and regulation
of Notch signalling pathway, exhibiting calcium ion binding and being located extracellular (extracellular
matrix, extracellular matrix organization, proteinaceous extracellular matrix, and extracellular space).
Accelerated ageing-downregulated genes are associated with Wnt signalling (WNT4, FZD6, positive
regulation of Wnt signalling pathway, positive regulation of non-canonical Wnt signalling pathway, and
Wnt-protein binding), cell cycle/proliferation (regulation of cell cycle process and positive regulation of cell
proliferation), cellular response to hypoxia and vitamin D as well as proteostasis (proteolysis,
cysteine-type endopeptidase activity, and regulation of autophagy). Accelerated ageing-differentially
expressed genes are associated with positive regulation of extrinsic apoptotic signalling pathway via death
domain receptors, somatic stem cell population maintenance and negative regulation of cell migration.
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_Figure 14: H. sapiens HGPS. Network of genes differentially expressed in accelerated ageing.
3.3.1.3   Cellular Senescence
Cellular senescence can be induced by various mechanisms. Senescence cells have altered
transcriptome in addition to other changed phenotypes that are characteristic for cellular senescence. A
common consensus signature representing the transcriptional changes associated with cellular
senescence by various ways have been established and subjected to the assessment of associations with
a very string q-value threshold (5e-20) [Figure 15 H. sapiens Cellular Senescence].
Cellular senescence upregulated genes are associated with inflammation (inflammation, inflammatory
response, cytokine activity, immune response, and positive regulation of NF-KappaB import into nucleus),
extracellular space and cell-cell signalling, activation of MAPK activity, positive regulation of gene
expression, positive regulation of transcription from RNA polymerase II promoter, negative regulation of
cell proliferation, and extrinsic apoptotic signalling pathway in absence of ligand. Cellular senescence
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downregulated genes are associated with cell cycle (G1S transition of mitotic cell cycle, G2M transition of
mitotic cell cycle, DNA replication, and, cell division), ageing, wound healing, animal organ regeneration,
extracellular matrix structural constituent, extracellular matrix organization, and being located in
nucleus/nucleoplasm. Cellular senescence differentially expressed genes are associated with being
involved in positive regulation of cell proliferation.
_
Figure 15: H. sapiens Cellular Senescence. Network of genes differentially expressed in cellular
senescence.
3.3.2   Rat
Gene expression profiles of Rattus norvegicus with age annotations were utilized to derive a consensus
signature of ageing. A q-value threshold of 5e-2 was used to visualize significant associations [Figure 16
R. norvegicus Ageing].
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Rat ageing-upregulated genes are significantly associated with participating in immune response,
inflammatory response, negative regulation of neurogenesis, exhibiting cytokine activity, being located in
perinuclear region of cytoplasm, extracellular exosome, and being located on chromosome 13. Rat
ageing-downregulated gene are significantly associated with response to nutrient levels, regulation of
reactive oxygen species biosynthetic process, adaptive thermogenesis, cellular response to hormone
stimulus, regulation of transcription from RNA polymerase II promoter and generation of precursor
metabolites and energy, exhibiting oxidative phosphorylation uncoupler activity, are located on the
mitochondrial envelope and are located on chromosome 19. Rat ageing-differentially expressed genes are
significantly associated with ageing and interact with Ubc.
_
Figure 16: R. norvegicus Ageing. Network of genes differentially expressed during ageing in rats.
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3.3.3   Mouse
_
Figure 17: M. musculus Ageing. Network of genes differentially expressed during ageing in mouse.
Gene expression profiles in M. musculus were utilize to generate a murine consensus signature of ageing.
Significant associations (q-value threshold of < 5e-5) are graphed [Figure 17 M. musculus Ageing].
Mouse ageing-upregulated genes are significantly associated with participating in cellular response to
DNA damage stimulus, G2 DNA damage checkpoint, negative regulation of neuron projection
development, and protein dephosphorylation, exhibiting beta-2-microglobulin binding and being located in
extracellular exosome, nucleolus, and stress fiber. Mouse ageing-downregulated genes are significantly
associated with participating in positive regulation of DNA-templated transcription elongation, mRNA
processing, mRNA export from nucleus, regulation of proteasomal protein catabolic process, and protein
deubiquitination, and exhibiting proteasome binding, and being located in proteasome complex and
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transcription export complex. Mouse ageing differentially expressed genes are significantly associated
with polyA RNA binding.
3.3.4   Fly
Drosophila melanogaster has been molecular profiled at different ages by several studies. Those profiles
have been used for deriving a consensus signature of ageing in fly. The significant associations (q-value <
5e-2) are summarized as a graph [Figure 18 D. melongaster Ageing].
Fly ageing-upregulated genes are significantly associated with cellular response to heat, basement
membrane disassembly, cell-cell junction organization, and tissue regeneration. Fly ageing-downregulated
genes are significantly associated with participating in regulation of rho protein signal transduction and
interacting with clu. Fly ageing-differentially expressed genes are significantly associated with participating
in response to hyperoxia.
_
Figure 18: D. melongaster Ageing. Network of genes differentially expressed during ageing in fruit fly.
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3.3.5   Worm
_
Figure 19: C. elegans Ageing. Network of genes differentially expressed during ageing in nematode.
Caenorhabditis elegans was profiled at different life stages. A consensus signature representing ageing of
nematode has been established. Significant associations found within this signature have been graphed
[Figure 19 C. elegans Ageing]. Worm ageing-upregulated genes are significantly associated with
participating in protein dephosphorylation, nucleosome assembly, positive regulation of error-prone
translesion synthesis, exhibiting hormone activity and unfolded protein binding, being located on
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chromosome IV, and physically interacting with hsp-12.2. Worm ageing-downregulated genes are
significantly associated with participating in lipid homeostasis, meiotic nuclear division, and proteolysis,
exhibiting lysozyme activity and folic acid binding, being located on chromosome X, and physically
interacting with act-1.
3.3.6   Yeast
_
Figure 20: S. cerevisiae Ageing. Network of genes differentially expressed during ageing in budding
yeast.
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Saccharomyces cerevisiae gene expressions were profiled throughout its life in various studies. From this
a consensus signature of ageing in budding yeast was created. Significant associations (q-value < 5e-5)
have been found and illustrated in a graph [Figure 20 S. cerevisiae Ageing]. Yeast ageing-upregulated
genes are significantly associated with oxidation-reduction process, response to stress, exhibiting
transferase activity transferring acyl groups and being located in fungal-type vacuole and peroxisomal
matrix. Yeast ageing-downregulated genes are significantly associated with participating in replicative cell
ageing, cell cycle, G1S transition of mitotic cell cycle and actin cytoskeleton organization exhibiting
oxidoreductase activity acting on the CH-OH group of donors NAD or NADP as acceptor, and interacting
with ACT1.
_
Figure 21: Common Ageing. Network of associations with ageing-differentially expressed genes
commonly shared between multiple species.
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3.3.7   Common Ageing Signature Across Species
The consensus signatures of human rat, mouse, fly, worm and yeast have been subjected individually to
Principal Angle Enrichment Analysis. The results for ageing-upregulated and ageing-downregulated were
separately merged by count and combining q-values. Associations that are significant in more than half of
the signatures and have a q-value of < 0.0005 are graphed [Figure 21 Common Ageing].
Genes upregulated with ageing are commonly significantly associated with endopeptidase (endopeptidase
inhibitor activity, negative regulation of endopeptidase activity), inflammation (immune response,
regulation of immune response, and positive regulation of NF-KappaB transcription factor activity), iron
(iron ion transport, iron ion homeostasis), gene regulation (nucleosomal DNA binding, negative regulation
of DNA binding, negative regulation of transcription DNA-templated, regulation of sequence-specific DNA
binding transcription factor activity, positive regulation of sequence-specific DNA binding transcription
factor activity, RNA polymerase II distal enhancer sequence-specific DNA binding, negative regulation of
transcription from RNA polymerase II promoter, and RNA splicing), MAPK (MAPK cascade, activation of
MAPK activity, positive regulation of ERK1 and ERK2 cascade), regulation of TOR signalling, regulation of
cell shape, cellular response to heat, negative regulation of growth, and positive regulation of apoptotic
processes.
Genes downregulated with ageing are commonly significantly associated with apoptosis (regulation of
apoptotic process and negative regulation of neuron apoptotic process), insulin (response to insulin and
insulin receptor binding), learning/memory (learning or memory, associative learning, and long-term
memory), proteostasis (response to unfolded protein, chaperone binding, chaperone-mediated protein
folding, chaperone mediated protein folding requiring cofactor, thiol-dependent ubiquitin-specific protease
activity, protein transport, proteasome binding, recycling endosome), NAD binding, cell cycle, growth
(multicellular organism growth), gene regulation (DNA binding, transcription DNA-templated, regulation of
transcription DNA-templated, transcription regulatory region DNA binding, transcription regulatory region
sequence-specific DNA binding, sequence-specific DNA binding, RNA polymerase II regulatory region
sequence-specific DNA binding, and RNA polymerase II core promoter proximal region sequence-specific
DNA binding), epigenetics (hemi-methylated DNA-binding, double-stranded methylated DNA binding,
promoter-specific chromatin binding, and histone acetyltransferase binding), and Wnt (Wnt signalling
pathway and negative regulation of canonical Wnt signalling pathway) as well as negative regulation of
TOR signalling, and negative regulation of inflammatory response.
3.4   Discussion
Tissue as well as gender-specific signatures were combined to derive consensus molecular signatures of
ageing for human and common biomedical model organisms and subsequently characterized for
associations. A number of categories differentially expressed in the common consensus signatures of
ageing can be interpreted with the current state of knowledge about the ageing process.
3.4.1   Genomic Instability
3.4.1.1   DNA Damage
Ageing-differentially expressed genes are commonly significantly associated with cellular response to
DNA damage stimulus and intrinsic apoptotic signalling pathway in response to DNA damage by p53 class
mediator [Common Ageing Signature Across Species]. More specifically ageing-upregulated genes are
significantly associated with DNA damage response signal transduction by p53 class mediator resulting in
transcription of p21 class mediator [Human]. p21 is upregulated during ageing with a positive characteristic
direction [Human]. Genes downregulated with ageing are significantly associated with positive regulation
of DNA repair [Normal Ageing; Yeast] and base-excision repair as well as nucleotide-excision repair DNA
gap filling [Mouse]. This would mean that DNA repair is downregulated during ageing. Genes
downregulated in cellular senescence are also involved in DNA repair [Cellular Senescence].
It was suggested that human ageing can be triggered by two main mechanisms which are telomere
shortening and DNA damage. Telomere shortening and dysfunction may lead to DNA damage responses
that induce cellular senescence. DNA damage accumulates, along with DNA repair deficiencies, resulting
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in genomic instability and accelerated cellular senescence. Ageing due to telomere shortening or DNA
damage is strongly dependent on p53. Both mechanisms can act cooperatively to increase the overall
level of genomic instability and therefore trigger the onset of ageing phenotypes (Ding & Shen, 2008).
Severe DNA damaged cells can either go into apoptosis or cellular senescence. However organisms have
sophisticated repair systems that can cope with DNA damage.
3.4.1.2   DNA Repair
DNA repair is commonly significantly associated with ageing-differentially expressed genes [Common
Ageing Signature Across Species]. Ageing-downregulated genes are significantly associated with positive
regulation of DNA repair [Human], base-excision repair [Mouse], nucleotide-excision repair DNA gap filling
[Mouse], DNA repair [Yeast], while ageing-upregulated genes are significantly associated with
transcription-coupled nucleotide-excision repair [Mouse] and DNA damage stimulus [Figure 17 M.
musculus Ageing].
DNA damages occur continuously in cells of organisms. Although most of these damages are repaired,
some may accumulate. Especially in non-dividing cells DNA damage could accumulate. Accumulated DNA
damages could interfere with RNA transcription in turn. Therefore the decline in the ability of DNA to serve
as a template for gene expression was suspected to be the primary cause of ageing (Holmes, et al., 1992).
Yet ageing-upregulated genes are also significantly associated with G2 DNA damage checkpoint that is a
cell cycle checkpoint [Mouse] that detects and negatively regulates progression from G2 to M phase in the
cell cycle in response to DNA damage. This could mean that cells are prevented from continuing in the cell
cycle in favour of repairing damage.
The positive associations between age and levels of oxidative stress-generated damage to DNA is related
to an age-dependent decline in DNA repair activity. There is an inverse association between age and DNA
repair activity with a 0.65% decline in activity per year from 18 to 83 years in peripheral blood mononuclear
cells of humans (Lohr, et al., 2015).
Ageing-upregulated genes are significantly associated with being involved in positive regulation of
error-prone translesion synthesis [Figure 17 C. elegans Ageing]. Translesion DNA synthesis contributes to
the accumulation of DNA mutations (Zou, et al., 2016).
3.4.1.3   Chromosomes
Ageing-downregulated genes are commonly significantly associated with chromosome organization and
regulation of chromosome organization [Common Ageing Signature Across Species]. Ageing-upregulated
genes are associated with condensed nuclear chromosome and negative regulation of chromosome
condensation [Human]. Similar senescence downregulated genes are significantly associated with
chromosome segregation, condensed chromosome, chromosome condensation and nuclear chromosome
telomeric region [Cellular Senescence].
Organization of chromosomes has not been much investigated in relation to ageing. It is however clear
that genomes are organized into complex higher-order structure by folding of the DNA into chromatin
fibers, chromosome domains, and ultimately chromosomes. This higher-order organization of genomes is
functionally important for gene regulation and control of gene expression programs. Changes in how
chromatin is globally organized are relevant for physiological and pathological processes. Global
alterations in chromatin structure are crucial for maintenance of genome stability, hence for ageing and
tumourigenesis (Misteli, 2010).
Ageing, accelerated ageing, and cellular senescence all significantly upregulate genes located on
chromosome 2 [Human]. Intriguingly, during development genes located on chromosome 2 are significant
downregulated.
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3.4.1.4   Telomere Attrition
Ageing-downregulated genes are commonly significantly associated with positive regulation of telomerase
activity [Common Ageing Signature Across Species]. Moreover, ageing-downregulated genes are
significantly associated with positive regulation of telomerase RNA localization to Cajal body (a class of
nuclear body that may be involved in transcription) [Mouse], positive regulation of establishment of protein
localization to telomere [Mouse], negative regulation of chromatin silencing at telomere [Yeast], and
telomere tethering at nuclear periphery [Yeast]. Telomerase TERT itself is downregulated during ageing
with a negative characteristics direction [Human]. Therefore, there is a downregulation of telomere
maintenance with ageing. Telomerase activity is directly correlated with the expression of its active
catalytic component (Ahmed & Tollefsbol, 2003). The disappearance of telomerase activity with ageing
could be a natural defence against development of cancer (Ahmed & Tollefsbol, 2003) and/or a natural
limitation of proliferation potential and lifespan.
Ageing-differentially expressed genes interact significantly with APP [Figure 13 H. sapiens Ageing]. APP
encodes the amyloid beta (Abeta) precursor protein. Amyloid protein increases linear with age (30 - 89
years) (Rodrigue, et al., 2012). The aggregated form of Abeta, but not Abeta monomer, can inhibit
telomerase activity both in vitro and in living cells (Wang, et al., 2015). APP transcript has a positive
characteristic direction with ageing [Human]. Ageing and senescence differentially expressed genes (both
up- and down-regulated) significantly interact with APP [Human]. Abeta oligomers inhibit telomerase
activity through binding to DNA-RNA hybrid formed by telomeric DNA and the RNA template of
telomerase, then blocking telomerase elongation of telomeric DNA. Intracellular Abeta localizes at
telomere, and induces cellular senescence and telomere shortening (Wang, et al., 2015).
3.4.2   Epigenetic Alterations
3.4.2.1   Nuclear Organization
The nuclear envelope organization and nuclear migration have been found to be significantly associated
with ageing-upregulated genes [Figure 13 H. sapiens Ageing]. Nuclear organization and nuclear envelope
proteins have been suspected for playing a role in ageing (Ye & Bhalla, 2011).
Ageing-upregulated genes are significantly associated with lamin binding [Human]. The nuclear lamina is a
meshwork of lamins and lamina-associated proteins, which provide mechanical support, control size and
shape of the nucleus, as well as mediate the attachment of chromatin to the nuclear envelope. Abnormal
nuclear shapes are observed in ageing cells. The size of the nuclei increases with age and nuclei assume
an aberrant shape (Brandt, et al., 2008).
3.4.2.2   Chromatin
Ageing-upregulated genes are significantly associated with negative regulation of chromatin silencing
[Human], while chromatin silencing is itself significantly associated with ageing-downregulated genes
[Mouse]. Ageing-downregulated genes are significantly associated with chromatin organization [Common
Ageing Signature Across Species], nuclear chromatin [Mouse], (nuclear) heterochromatin [Mouse],
nuclear euchromatin [Rat] chromatin silencing [Mouse], promoter-specific chromatin binding [Human, Rat],
and negative regulation of chromatin silencing at telomere [Yeast]. Ageing-upregulated genes are
significantly associated with chromatin binding [Human], telomeric heterochromatin assembly [Human],
ATP-dependent chromatin remodelling [Mouse], and covalent chromatin modification [Rat].
Ageing-differentially expressed genes are significantly associated with senescence-associated
heterochromatin focus [Mouse] and pericentric heterochromatin assembly [Human].
There is a age-related loss of repressive heterochromatin which is associated with a loss of gene silencing
in yeast and metazoans (Jiang, et al., 2013). The complex macromolecular structure of chromatin
regulates all nuclear processes requiring access to the DNA primary sequence. Maintenance of chromatin
structure is an integral component to deter premature ageing. Histone modification impact on chromatin
compaction and gene expression and undergo numerous changes during ageing. Lifespan can be robustly
extended by interventions that reverse age-dependent changes in chromatin structure. This all indicates to
a pivotal role of chromatin structure plays during ageing (Feser & Tyler, 2011).
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The differential expression of genes involved in senescence-associated heterochromatin during normal
ageing could be due to that fact that aged cells are more primed to convert into the senescence state, or a
higher proportion of the cells of aged organisms have become already senescence.
Ageing-differentially expressed and upregulated genes are significantly associated with the NuRD
complex [Mouse]. However the crucial components of this complex are actually downregulated [Human,
Mouse]. NuRD (Nucleosome Remodelling Deacetylase) complex is a group of associated proteins with
both ATP-dependent chromatin remodelling and histone deacetylase activities (Xue, et al., 1998; Zhang &
Yinghua, 2010). HDAC1 is significantly associated with downregulated genes in ageing [Human, Mouse],
premature ageing [Human] and senescence [Human]. HDAC1 and HDAC2 are both downregulated as
they have negative characteristic directions [Human, Mouse]. Physiological and premature ageing are
characterized by multiple changes in chromatin structure and accumulation of persistent DNA damage.
NURD chromatin remodelling complex is a key modulator of these ageing-associated chromatin changes.
There is a loss of multiple NURD components during premature and normal ageing including an
ageing-associated reduction in HDAC1 activity. Silencing individual NURD subunits recapitulates
chromatin changes associated with ageing. The structural chromatin changes precede DNA damage
accumulation (Pegoraro, et al., 2009).
3.4.2.3   DNA Methylation
Maintenance of DNA methylation is significantly associated with ageing-upregulated genes [Human], while
DNA methylation itself is significantly associated with both ageing-upregulated [Mouse] and
ageing-downregulated genes [Rat]. Hemi-methylated DNA binding and double-stranded methylated DNA
binding is significantly associated with ageing-downregulated genes [Human; Rat].
DNA methylation is usually associated with epigenetic silencing of genomic loci. Rather than being a
stable modification, DNA methylation and demethylation are dynamic (Kouzmenko, et al., 2010). DNA
methylation increases throughout lifespan (Haghighi, et al., 2014).
3.4.2.4   Histones
Ageing-differentially expressed genes and ageing-downregulated genes are commonly and significantly
associated with histone acetyltransferase binding [Common Ageing Signature Across Species].
Ageing-upregulated genes are significantly associated with histone binding [Human], lysine-acetylated
histone binding [Human], histone deacetylase binding, histone H3 deacetylation [Mouse] and methylated
histone binding [Mouse]. Ageing-downregulated genes are significantly associated with histone
acetyltransferase binding [Common Ageing Signature Across Species; Human; Rat], positive regulation of
histone acetylation [Rat], histone H3-T6 phosphorylation [Human], histone kinase activity H3-T6 specific
[Human], histone demethylase activity [Human], histone demethylase activity H3-K27 specific [Human],
histone H3-K27 demethylation [Human], histone deacetylase binding [Human], and positive regulation of
histone deacetylase activity [Human]. H3K9 acetylation significantly decreases with age (Kawakami, et al.,
2009). H3K27 is associated with transcriptional repression (Ma, et al., 2015).
Senescence upregulated genes are significantly associated with positive regulation of histone
phosphorylation and acetylation, while senescence downregulated genes are significantly associated with
histone phosphorylation and histone kinase activity [Cellular Senescence]. Senescent cells display nuclear
foci of phosphorylated histone H2AX (d Adda di Fagagna, et al., 2003). MSK1 (mitogen- and
stress-activated kinase) mediates histone H3S28 phosphorylation at the INK4AB/ARF locus and
contributes to the rapid transcriptional activation of p15INK4b and p16INK4a (cellular senescent marker) in
human cells despite the presence of the repressive H3K27me3 mark (Culerrier, et al., 2016).
3.4.3   Transcriptional Regulation
Ageing-upregulated genes are commonly significantly associated with positive regulation of NF-KappaB
transcription factor activity [Common Ageing Signature Across Species]. Constitutive activation of
NF-KappaB is a ubiquitous phenomenon among various cell types in the ageing phenotype (Kriete &
Mayo, 2009).
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Ageing-differentially expressed genes interact significantly with EP300 [Figure 13 H. sapiens Ageing].
EP300 is a transcriptional coactivator with histone acetyltransferase activity. EP300 activity attenuates with
age in several tissues in mice (Li, et al., 2002). Its nematode ortholog cbp-1 is an ageing-suppressor gene
and essential for the lifespan extension mediated by dietary restriction.
TP53, the guardian of the genome, is significantly associated with interacting with both up- and
down-regulated genes during ageing and senescence. TP53 is a ortholog of a ageing gene [Figure 13 H.
sapiens Ageing].
Transcription factors like EGR1 were found to be commonly downregulated [Figure 13 H. sapiens Ageing]
and could be responsible to orchestrates age-related gene expression changes. Age-related reduction in
the transcription of Egr1 is due to CpG site-specific change in the methylation in DNA associated with the
promoter region of Egr1 (Penner, et al., 2016).
3.4.4   Post-Transcriptional Processing
During ageing there is a decoupling of transcript and protein levels conserved between primates to yeast.
Ageing-downregulated genes are associated with transcription (Wei, et al., 2015).
mRNA processing and mRNA export from nucleus, polyA RNA binding and transcription export complex
are significantly associated with ageing-downregulated genes [Figure 17 M. musculus Ageing]. This
downregulation might lead to the observed discrepancy in transcript and protein levels.
3.4.5   Proteostasis
Ageing-downregulated genes are significantly associated with exhibiting unfolded protein binding and
being involved in response to unfolded protein [Figure 19 Common Ageing]. Young organisms pose an
efficient response to unfolded proteins but older organisms exhibit an impairment in unfolded protein
response to stresses (Naidoo, et al., 2008).
3.4.5.1   Chaperoning
Ageing-upregulated genes have been found to be significantly associated with exhibiting chaperone
binding [Figure 13 H. sapiens Ageing]. Chaperones have a crucial role in the repair of proteotoxic damage,
which is greatly increased in aged subjects. Upregulation of genes exhibiting chaperone binding during
ageing could block their availability and reduce their ability to repair proteotoxic damage. Hence the
observed increase in proteotoxicity with ageing (Nardai, et al., 2002).
With ageing there is decreased chaperone capacity. The decrease in chaperone capacity may reflect a
direct proteotoxic damage of chaperones or an increase in chaperone occupancy resulting in a "chaperone
overload" due to the increased amount of damaged proteins in aged cells (Nardai, et al., 2002).
3.4.5.2   Aggresome
Ageing-upregulated genes are significantly associated with being located in the aggresome [Figure 13 H.
sapiens Ageing]. The aggresome is an inclusion body formed by dynein-dependent retrograde transport of
aggregated protein on microtubules. Decreased proteolysis is caused by protein aggregates, inclusion
bodies, plaques, lipofuscin, ceroid, and "aggresomes" during oxidative stress, ageing and degenerative
diseases (Grune, et al., 2004).
Protein aggregation is a common feature of several neurodegenerative diseases and to a certain extend of
normal ageing. Not always is it clear, why protein aggregation takes place, however a disturbance in the
balance between protein synthesis and protein degradation appears to be important. Resulting from this is
the accumulation of modified proteins, which have a tendency to form high molecular weight aggregates.
Those aggregates are also called inclusion bodies, plaques, lipofuscin, ceroid, or "aggresome" depending
on their location and what they are composed of. These aggregates are not inert metabolic end products,
but rather actively influence cell metabolism, especially proteasomal activity and protein turnover (Grune,
et al., 2004).
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3.4.5.3   Advanced Glycation Endproducts
RAGE receptor binding is upregulated during ageing [Rat]. This means genes encoding proteins that
interact selectively and non-covalently with the RAGE receptor are upregulated.
RAGE is the receptor for advanced glycation endproducts (AGE) which are increasing with age (Haus, et
al., 2007). AGEs include glycoproteins, i.e. glycans that have been modified non-enzymatically through the
Maillard reaction and are assumed to be side products of metabolism but also considered to have
signalling functions (Ott, et al., 2014). AGEs increase Sirt1 ubiquitination and proteasome-mediated
degradation, hence shorten Sirt1 half-life, and subsequently promote fibronectin (FN) and TGF-beta1
expression (Huang, et al., 2015).
3.4.5.4   Ubiquitin-Proteasome System
The ubiquitin-proteasome system is associated with ageing-downregulated genes with regulation of
proteasomal protein catabolic process, and protein deubiquitination, proteasome binding, as well as
proteasome complex [Figure 17 M. musculus Ageing]. The interplay between molecular chaperones,
ubiquitin/deubiquitinating enzymes and proteasomes is critical in protein homeostasis especially during
both ageing and heat stress (Oling, et al., 2014).
Ageing-upregulated genes are significantly participating in negative regulation of endopeptidase activity
[Figure 11 H. sapiens Ageing] and with this could reduce the extend of proteolysis. Proteasome inhibition
is known to occur during normal ageing and contributes towards age-related increase in oxidative stress
(Ding, et al., 2006).
Commonly to ageing across species is the upregulation of genes that are significantly associated with
exhibiting endopeptidase inhibitor activity [Figure 21 Common Ageing]. Endopeptidase inhibitor activity
stops, prevents or reduces the activity of endopeptidases (any enzyme that hydrolysis non-terminal
peptide bonds in polypeptides) and therefore potential inhibits proteolysis of proteins. Similar protein
transport and proteolysis are commonly downregulated.
Thiol-dependent ubiquitin-specific protease activity is associated commonly with ageing-downregulated
genes [Figure 19 Common Ageing]. This activity catalysis the thiol-dependent hydrolysis of a peptide bond
formed by the C-terminal glycine of ubiquitin and another protein. USP22 is significantly associated with
ageing-downregulated genes. USP22 itself is downregulated during ageing [Normal Ageing] and in
senescence [Cellular Senescence]. USP22 depletion enhances Sirt1 degradation and displays a
combined effects with AGEs to further promote FN and TGF-beta1 expression (Huang, et al., 2015).
3.4.5.5   Lysosome
Ageing-upregulated genes are significantly associated with being located at the lysosomal membrane
[Figure 11 H. sapiens Ageing; Figure 18 S. cerevisiae Ageing]. A wide pool of cytosolic proteins are
selectively degraded in lysosomes, especially by chaperone-mediated autophagy (CMA). Binding of
proteins involved in CMA to a receptor at the lysosomal membrane is a rate limiting step in CMA. If the
receptors at the lysosomal membrane are obstructed due to other proteins are being located at the
lysosomal membrane this could block the process of CMA and possible other lysosomal activities that
mediate repair of damaged cellular components (Kaushik, et al., 2007).
3.4.5.6   Autophagy
Negative regulation of autophagy is associated with ageing differentially expressed genes [Figure 13 H.
sapiens Ageing; Figure 19 C. elegans Ageing; Figure 21 Common Ageing]. The function of autophagy
declines with increasing age (Cavallini, et al., 2008).
Accelerated ageing downregulates proteostasis including proteolysis and autophagy regulation [Figure 14
H. sapiens HGPS]. Proteasome activity and autophagy are impaired in HGPS cells (Gabriel, et al., 2015).
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3.4.6   Cytoskeleton
Ageing-downregulated genes are commonly significantly associated with structural constituent of
cytoskeleton and negative regulation of cytoskeleton organization [Common Ageing Signature Across
Species]. Increased organization of cytoskeleton accompanies ageing. There is an increased organization
of microfilaments into bundles in senescence cells. The age-related increase in cell size is correlated with
increased organisation of the cytoskeleton (Wang & Gundersen, 1984).
3.4.6.1   Actin
Actin was found to be significantly associated with ageing differentially expressed genes in multiple
organisms from human to yeast [Figure 13 H. sapiens Ageing; Figure 19 C. elegans Ageing; Figure 20 S.
cerevisiae Ageing]. Actin is associated with cell movement, cell division and intracellular transport.
Mutants with altered actin dynamics exhibit increased lifespan (Tocchetti, et al., 2010). Alleles that
decrease actin dynamics increase chronological lifespan, while alleles that increase actin dynamics also
enhance chronological lifespan (Gourlay, et al., 2004).
3.4.6.2   Microtubule
Ageing-upregulated genes are commonly significantly associated with microtubule anchoring and
microtubule cytoskeleton organization [Common Ageing Signature Across Species].
Ageing-downregulated genes are commonly significantly associated with microtubule, microtubule
cytoskeleton, and cytoplasmic microtubule [Common Ageing Signature Across Species].
Senescence cells exhibit an increase in the abundance of microtubules per cell and the distribution pattern
is altered through the increase in the number of organization centres (Wang & Gundersen, 1984).
The regulation of cell shape is significantly associated commonly with ageing-upregulated genes [Figure
19 Common Ageing]. Microtubules are ubiquitous cellular components that are involved in the control of
cell structure and function, like cell division, regulation of shape and polarity as well as intracellular
transport among others. Ageing of cells is characterized by the appearance of various cell dysfunctions
(Raes, 1991).
3.4.7   Inflammation
Ageing-differentially expressed genes and especially ageing-upregulated genes are significantly
associated with participating in inflammatory response immune response and exhibiting cytokine activity
[Figure 13 H. sapiens Ageing; Figure 16 R. norvegicus Ageing; Common Ageing Signature Across
Species]. Genes upregulated during accelerated ageing are also significantly associated with regulation of
inflammatory response [Accelerated Ageing]. Inflammation increases with age, hence the existence of the
concept of "inflammageing" (Giunta, 2008).
Ageing-upregulated genes are commonly associated with positive regulation of inflammatory response,
while ageing-downregulated genes are associated with negative regulation of inflammatory response
[Figure 21 Common Ageing]. Thus, ageing overall is associated with enhancement of inflammation.
Cellular senescence upregulates inflammation, negative regulation of cell proliferation and apoptosis,
while downregulates cell cycle, wound healing and regeneration [Cellular Senescence]. Senescence cells
irreversible cease cell cycling (Takahashi, et al., 2007), become resistance to apoptosis (Wang, 1995;
Schauble, et al., 2012; Ryu, et al., 2007) and exhibit a distinct inflammatory phenotype (Kuilman, et al.,
2010; Rodier & Campisi, 2011). Cellular senescence fuels inflammation associated ageing and cancer
progress (Rodier & Campisi, 2011). Inflammatory responses trigger and transmit senescence to
neighbouring cells and activate senescence-associated secretory phenotype (Long, et al., 2016).
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3.4.8   Signalling
3.4.8.1   MAPK
The mitogen-activated protein kinase cascade (MAPK) plays a regulatory role in signal transduction.
Ageing-differentially expressed genes are commonly significantly involved in MAPK cascade, activation of
MAPK activity, inactivation of MAPK activity, activation of MAPKK activity, and positive regulation of MAPK
cascade [Common Ageing Signature Across Species]. Specifically ageing-upregulated genes are
commonly significantly associated with MAPK cascade and activation of MAPK activity [Common Ageing
Signature Across Species].
It was suggested that the age-related decline in antioxidant defence is closely involved with the expression
of Nrf2 (alias NFE2L2/Nfe2l2) and is regulated by the MAPK family (Shih & Yen, 2007). NFE2L2/Nfe2l2
exhibits negative characteristic direction (i.e. is downregulated) in the human and mouse consensus
signature. NFE2L2 is a orthologous to several ageing genes (Tang & Choe, 2015).
3.4.8.2   TOR
Ageing-differentially expressed genes and in particular ageing-upregulated genes are commonly
significantly associated with regulation of TOR signalling [Common Ageing Signature Across Species].
Ageing-downregulated genes are commonly significantly associated with negative regulation of TOR
signalling [Common Ageing Signature Across Species].
AKT1 is significantly associated with ageing-upregulated genes. AKT1 is an ortholog of ageing genes
[Figure 13 H. sapiens Ageing]. AKT1 was found to be associated with longevity (Pawlikowska, et al., 2009;
Nygaard, et al., 2013).
3.4.8.3   Wnt
Wnt signalling pathway is significantly associated with premature ageing-downregulated genes
[Accelerated Ageing] but also commonly with normal ageing-downregulated genes [Common Ageing
Signature Across Species].
More specifically, genes downregulated in premature ageing are associated with positive regulation of
canonical Wnt signalling pathway, non-canonical Wnt signalling pathway, Wnt signalling pathway involved
in somitogenesis, Wnt-protein binding, Wnt-activated receptor activity, WNT4, positive regulation of Wnt
signalling pathway, and positive regulation of canonical Wnt signalling pathway [Accelerated Ageing].
3.4.8.4   Notch
Premature ageing-upregulated genes are significantly associated with being involved in Notch signalling
pathway, regulation of Notch signalling pathway, and Notch signalling involved in heart development, as
well as interacting with NOTCH1 [Accelerated Ageing].
Negative regulation of Notch signalling pathway is significantly associated with ageing-downregulated
genes [Rat]. Cellular senescence upregulated genes significantly interact with NOTCH2NL [Cellular
Senescence].
3.4.9   Regeneration
3.4.9.1   Stem Cells
Ageing-downregulated genes are significantly associated with somatic stem cell division, male germ-line
stem cell asymmetric division, stem cell factor receptor binding, somatic stem cell population maintenance,
hematopoietic stem cell migration [Common Ageing Signature Across Species].
Ageing-upregulated genes are significantly associated with negative regulation of neurogenesis [Figure 16
R. norvegicus Ageing]. Neurogenesis in mammals occurs throughout life (and is assumed to be important
for the laying down of the episodic memory) diminishes significantly with increasing age (Gray, et al.,
2002). Similar ageing-upregulated genes are significantly associated with participating in negative
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regulation of neuron projection development which is any process that decreases the rate, frequency or
extent of neuron projection development [Figure 17 M. musculus Ageing].
Accelerated ageing differentially expresses somatic stem cell population [Accelerated Ageing],
upregulates Notch signalling [Accelerated Ageing] and strongly downregulates Wnt signalling [Accelerated
Ageing; Figure 14 H. sapiens HGPS]. Mutations that cause HGPS affect adult stem cells by interfering with
Notch (induction) and Wnt (suppression) signalling pathway (Meshorer & Gruenbaum, 2008).
3.4.9.2   Wound Healing
Wound healing and response to wound healing are commonly significantly associated with
ageing-differentially expressed genes. More specifically, negative regulation of response to wounding is
commonly significantly associated with ageing-upregulated genes [Common Ageing Signature Across
Species].
Advanced age is commonly a risk factor for delayed wound healing. Impaired wound healing is due to
inherent differences in cellular structure and function that impair tissue repair and regeneration. Cellular
senescence results in slowed or impaired wound healing in the elderly (Thomas, 2001). Impaired wound
healing in aged individuals presents a major clinical and economic problem (Gosain & DiPietro, 2004).
3.4.10   Ions
Ageing-upregulated genes participate in copper ion binding and iron transport [Figure 13 H. sapiens
Ageing] that might be related to the availability of metal ions in the cell. Metal ions are used as cofactors by
enzymes but also lead to the enhanced generation of free radicals (Gutteridge, 1985).
Accelerated ageing upregulates calcium ion binding [Figure 14 H. sapiens HGPS]. Proteins associated
with calcium ion binding were also found to be upregulated in HGPS. More strikingly free cytosolic calcium
is increased in HGPS (Harten, et al., 2011).
3.4.11   Extracellular
Ageing-upregulated genes significantly participate in extracellular matrix organization [Figure 13 H.
sapiens Ageing]. Ageing is accompanied by changes in the composition and structure of the extracellular
matrix, resulting in changes in the mechanics of connective tissues in older individuals. These progressive
dysfunctions facilitate numerous human pathologies and deficits associated with ageing, including
cardiovascular, musculoskeletal and neurodegenerative disorders and diseases (Phillip, et al., 2015).
Accelerated ageing upregulates extracellular entities [Figure 14 H. sapiens HGPS]. The extracellular
matrix dysregulation observed in HGPS is implicated as a factor in disease progression. In HGPS there is
a shift in the inherent extracellular matrix-degrading proteolytic balance in favour of matrix deposition
(Harten, et al., 2011).
Ageing-upregulated genes are significantly located in the extracellular exosome [Figure 13 H. sapiens
Ageing; Figure 16 R. norvegicus Ageing; Figure 17 M. musculus Ageing]. Extracellular exosomes
(exosomes for short) are extracellular vesicles secreted by cells that carry cargo from cells like proteins
and RNAs. Exosomes are used by senescence cells as part of the senescence-associated secretory
phenotype to convey senescence signals (Urbanelli, et al., 2016). Exosomal miRNAs are very predictive
biomarkers of Alzheimer's disease (Lugli, et al., 2015). Salivary exosomal miRNAs are useful ageing
biomarkers as well (Machida, et al., 2015).
3.4.12   Integrins
Cell to extracellular matrix interactions are mediated by integrins. Integrins are adhesion molecules that
regulate a number of processes and developmental events.
Ageing-upregulated genes significantly participate in integrin-mediated signalling [Figure 13 H. sapiens
Ageing]. Integrin signalling mutants life longer, indicating that functional senescence and age-dependent
mortality are influenced by integrin signalling in C. elegans (Hansen, et al., 2005) and D. melanogaster
(Goddeeris, et al., 2003; Nishimura, et al., 2014).
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3.4.13   Hormones
Ageing-downregulated genes are significantly associated with being involved in cellular response to
hormone stimulus [Figure 16 R. norvegicus Ageing]. There is hormone imbalance with increasing age and
aged cells tend to become insensitive to certain hormonal triggers. Ageing-downregulated genes are
significantly associated with being involved in response to nutrient levels [Figure 16 R. norvegicus Ageing].
Older animals might not respond so well to dietary restriction.
Accelerated ageing downregulates the response to hypoxia and vitamin D [Figure 14 H. sapiens HGPS].
HGPS cells reduce expression of vitamin D receptor (VDR). Reconstituting VDR signalling via
1alpha,25-dihydroxyvitamin D3 (1,25D) treatment improves HGPS phenotypes, including nuclear
morphological abnormalities, DNA repair defects, and premature senescence (Kreienkamp, et al., 2016).
Moreover HGPS cells have severe increased hypoxia sensitivity. It is hypothesized that this decreased
stress resistance causes additional depletion of the mesenchymal stem cell pool responsible for replacing
differentiated cells lost to progerin toxicity (Zhang, et al., 2011).
3.4.14   Mitochondrial Dysfunction
3.4.14.1   Mitochondrion
Both ageing-upregulated and downregulated genes are commonly significantly associated with
mitochondrion. Genes downregulated with ageing are much more commonly associated with
mitochondria. More specifically, ageing-downregulated genes are commonly significantly associated with
mitochondrial part, mitochondrial inner membrane, mitochondrial matrix, establishment of protein
localization to mitochondrion, protein localization to mitochondrion, mitochondrial transport, and
mitochondrial transmembrane transport [Common Ageing Signature Across Species]. All this
downregulation could lead to the well known phenomenon of mitochondrial dysfunction that accompanies
ageing.
3.4.14.2   Energy Metabolism
Ageing-downregulated genes are significantly associated with being involved in generation of precursor
metabolites and energy [Figure 16 R. norvegicus Ageing]. This downregulation might further result into
mitochondrial dysfunction. Most of those enzymes are contained in the mitochondria. Mitochondria are
dynamic organelles critical for many cellular processes, including apoptosis but also energy generation.
Indeed changes in the expression of proteins important for biological processes involved in the generation
of precursor metabolites and energy through the breakdown of carbohydrates, lipids and proteins were
observed (Stauch, et al., 2015).
Similar ageing-downregulated genes are significantly associated with exhibiting oxidative phosphorylation
uncoupler activity [Figure 16 R. norvegicus Ageing]. Mitochondrial inefficiency through proton leak,
uncouples substrate oxidation from ADP phosphorylation and compromise as much as 30% of the basal
metabolic rate. Such uncoupling is assumed to protect cells from conditions that favour ROS production,
but also generates heat. Uncoupling can also be achieved through pharmaceutical induction of proton leak
and activity of a class of uncoupler proteins. Pharmaceutics that uncouple or overexpression mitochondrial
uncoupler proteins can extend the lifespan of model organisms (Mookerjee, et al., 2010; Brand, et al.,
2004). Therefore, a downregulation of uncoupler might be associated with negative effects. Further
ageing-downregulated genes are significantly associated with being located in the mitochondrial envelope.
The mitochondrial envelope is the double lipid bilayer enclosing the mitochondrion and separate its
contents from the cell cytoplasm (includes the intermembrane space). Downregulation of genes that
encode products located in this compartment could induce even more mitochondrial dysfunctions (Kalous
& Drahota, 1996; Unknown, 2008; Bratic & Larsson, 2013).
91
3.4.14.3   Reactive Oxygen Species
Ageing-upregulated genes are commonly significantly associated with response to reactive oxygen
species [Common Ageing Signature Across Species]. Ageing-downregulated genes are significantly
associated with being involved in reactive oxygen species metabolic process and regulation of reactive
oxygen species biosynthetic process [Figure 16 R. norvegicus Ageing]. More specifically
ageing-downregulated genes are significantly associated with negative regulation of reactive oxygen
species biosynthetic process [Common Ageing Signature Across Species]. Similar accelerated
ageing-upregulated genes are significantly involved in regulation of reactive oxygen species metabolic
process and in particular positive regulation of reactive oxygen species metabolic process [Accelerated
Ageing].
This could lead to increased synthesis of reactive oxygen species biosynthesis in both normal ageing and
premature ageing. The accumulation of molecular damage from the attack by reactive oxygen species was
once thought to be one cause of ageing (de Castro, et al., 2004).
3.4.14.4   Thermogenesis
Ageing-downregulated genes are significantly associated with being involved in adaptive thermogenesis
[Figure 16 R. norvegicus Ageing]. Also diet-induced thermogenesis is associated significantly with
ageing-downregulated genes [Figure 16 R. norvegicus Ageing].
The ability to regulate body temperature diminishes with age (Prat & Roberge, 1960; Scarpace, et al.,
1994). The capacity for diet-induced thermogenesis declines with age and is virtually absent in old
organisms (Rothwell & Stock, 1983).
3.4.14.5   NAD
Ageing-downregulated genes are commonly significantly associated with exhibiting NAD binding
[Common Ageing Signature Across Species]. Also oxidoreductase activity acting on the CH-OH group of
donors NAD or NADP as acceptor is significantly associated with ageing-downregulated genes [Figure 20
S. cerevisiae Ageing]. The NAD to NADH ratio was found to impact on lifespan in a variety of model
organisms. The intracellular ratio of pyridine nucleotides has been proposed to be at the centre stage of
age-related biochemical changes in organisms and may also help to explain the influence of dietary
restriction and energy-sensing proteins in lifespan (de Carbo, et al., 2009).
NAMPT was found to be commonly downregulated (low negative characteristic direction) in multiple
tissues and might therefore reduce overall tissue NAD levels [Normal Ageing]. NAMPT catalyses the
rate-limiting step in NAD biosynthesis that is critical in energy metabolism, cell senescence and
maintaining lifespan. NAMPT also influences stem cell senescence. Nampt expression is significantly
lower in aged mesenchymal stem cells. Pharmacological inhibition of Nampt young mesenchymal stem
cells are induced to become aged cells. Nampt overexpression attenuates cell senescence in aged
mesenchymal stem cells (Ma, et al., 2017).
3.4.15   Lipid Homeostasis
Ageing-downregulated genes are significantly associated with participating in lipid homeostasis [Figure 19
C. elegans Ageing]. Ageing is accompanied by pronounced deposition of lipids in non-adipose tissues
(including the nervous system). Interventions that promote longevity such as low insulin signalling,
germline loss and dietary restriction, effectively delay ageing in evolutionary divergent organisms, and
diminish the rate of ectopic fat accumulation (Palikaras, et al., 2016).
Ageing-downregulated genes are commonly significantly associated with lipid catabolic process [Common
Ageing Signature Across Species]. Ageing-upregulated genes are commonly significantly associated with
positive regulation of lipid storage [Common Ageing Signature Across Species]
Ageing-upregulated genes are significantly associated with plasma membrane repair [Common Ageing
Signature Across Species]. Plasma membrane repair is the resealing of a cell plasma membrane after
cellular wounding due to for instance, mechanical stress. This might mean that older cells are more
exposed to stress that disrupts the plasma membrane.
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3.4.16   Apoptosis
Ageing upregulated and downregulated genes are commonly significantly involved in apoptotic process
and activation of cysteine-type endopeptidase activity involved in apoptotic process.
Ageing-downregulated genes are associated with apoptotic process whereas ageing-upregulated genes
are specifically associated with positive regulation of apoptotic processes [Figure 21 Common Ageing.
Ageing-upregulated genes are commonly significantly involved in positive regulation of apoptotic process
and positive regulation of apoptotic cell clearance. Ageing-downregulated genes are commonly
significantly involved in regulation of apoptotic process, negative regulation of apoptotic process, and
negative regulation of neuron apoptotic process [Common Ageing Signature Across Species].
Accelerated ageing differentially regulates apoptosis [Figure 14 H. sapiens HGPS]. Proteins associated
with apoptosis were found to be differentially expressed as well in HGPS (Wang, et al., 2012).
Apoptosis plays both positive and negative roles in ageing. Of particular importance is the role in disrupting
tissue homeostasis and promoting neurodegenerative disease (Warner, 1999). RAGE activation increases
reactive oxygen species production which in turn mediates apoptosis (Chuang, et al., 2007).
3.4.17   Memory
Ageing-downregulated genes are commonly associated with memory, long-term memory, and learning or
memory [Figure 21 Common Ageing]. In addition, short-term memory is significantly associated with
ageing-downregulated genes [Normal Ageing].
Aged organisms experience a reduction in both short-term and long-term memory (Zornetzer, et al., 1982).
There are also age-related impairments in reward-based learning (Eppinger, et al., 2010). Older adults
typically perform more poorly than do younger adults on many types of memory tasks. The reduction in the
speed of information processing is a fundamental contributor to normal age-related memory loss (Luszcz
& Bryan, 1999).
3.4.18   Stress Response
Common to ageing-upregulated genes there is a significant association of involvement in the cellular
response to heat [Figure 18 D. melongaster Ageing; Figure 21 Common Ageing]. This might be the
upregulation of negative regulators overall of heat stress response or a compensating response of cells to
the increased proteotoxicity.
In organisms, intracellular and extracellular proteins are constantly subjected to a variety of spontaneous
non-enzymatic modifications that overall affect their structure and function, as well as stability. For
instance, protein oxidation and glycation are tightly linked and are implicated in the development of
numerous pathological consequences of ageing. Although multiple endogenous pathways in the cell can
prevent the formation of modified (oxidized or glycated) proteins, and repair or degrade the abnormal
proteins, abnormal proteins do accumulate with ageing. The heat-shock response (involving the family of
heat shock proteins) represents the quickest and most conserved response to proteotoxic insults
(Verbeke, et al., 2000).
3.4.19   Peroxisome
Ageing-differentially expressed genes are commonly and significantly associated with peroxisome,
peroxisomal part (compartment, i.e. any constituent part of a peroxisome) and peroxisomal matrix.
Specifically ageing-downregulated genes are commonly significantly associated with the peroxisomal
matrix [Common Ageing Signature Across Species]. Further peroxisome proliferator-activated receptor
binding is significantly associated with ageing-downregulated genes.
The peroxisome is a small organelle enclosed by a single membrane, and found in most eukaryotic cells.
Peroxisomes contain peroxidases and other enzymes involved in a variety of metabolic processes
including importantly free radical detoxification as well as lipid catabolism and biosynthesis, and hydrogen
peroxide metabolism. Disturbance in the functions of peroxisome also contributes to ageing (Williams,
2014).
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Peroxisome proliferator-activated receptor is a group of nuclear receptor proteins that function as
transcription factors. PPARA and PPARD are downregulated with ageing but significantly interact with
ageing-upregulated genes [Human]. PPARA polymorphism is associated with ageing (Naito, et al., 2007).
3.4.20   Lifespan/Ageing Controllers
Ageing downregulated genes are significantly associated with being involved in determination of adult
lifespan [Worm] and replicative cell ageing [Figure 20 S. cerevisiae Ageing]. Downregulation of
ageing-suppressor genes could be an effective mechanism of the ageing process.
Accelerated ageing differential and downregulated genes are significantly associated with cell ageing
[Accelerated Ageing]. Cellular senescence also differentially expresses genes involved in cell ageing
[Cellular Senescence].
3.4.21   Growth Regulation
Cell growth is associated with ageing-upregulated genes, while multicellular organism growth, regulation of
cell growth, positive regulation of cell growth are all associated with ageing-downregulated genes. This is
in line with the hypothesis that the developmental growth cessation program is still active during ageing
and leads to loss of functions [Figure 21 Common Ageing].
Downregulated genes are also associated with cellular component organization [Common Ageing
Signature Across Species]. Proper organization of cellular components are necessary for life.
Disorganization of cellular components could be a hallmark of ageing.
3.4.22   Cell Differentiation & Proliferation/Cycle
Ageing-upregulated genes are associated with regulation of differentiation and proliferation. In particular
ageing-upregulated genes are commonly associated with cell differentiation and negative regulation of cell
proliferation [Figure 21 Common Ageing]. The various tissues could have in common to become highly
differentiated and lose proliferation potential. Positive regulation of cell death is also enriched for
association with ageing-upregulated genes with is in line with that the loss of cells in tissues give raise to
organ dysfunction and various age-related diseases, like diabetes and neurodegenerations.
Moreover, cell division and positive regulation of cell cycle is commonly significantly associated with
ageing-downregulated genes, while negative regulation of G1S transition of mitotic cell cycle is commonly
significantly associated with ageing-upregulated genes [Common Ageing Signature Across Species]. This
regulation indicates that the cell cycle is negatively regulated and expected to decline with increasing age.
Downregulation of cell cycle with increasing age, might make some type of cancer less severe with
increasing age, but at the same time reduces regenerative capacity and leads to loss of cells.
Ageing-downregulated genes are significantly associated with participating G1S transition of mitotic cell
cycle [Figure 20 S. cerevisiae Ageing]. Ageing cells have a prolonged cell cycle (Austriaco, 1996).
p21 (CDKN1A) is highly upregulated gene (high positive characteristic direction) during ageing common to
multiple tissues and may prevent regeneration and wound healing [Normal Ageing]. p21 is also
upregulated in accelerated ageing and cellular senescence [Accelerated Ageing; Cellular Senescence].
Furthermore, S100 protein binding was found to be upregulated [Human]. S100 proteins are localized both
in the cytoplasm as well as in the nucleus in a broad spectrum of different cells. They are involved in
regulation of a number of cellular process like cell cycle progression and differentiation. During ageing
tissues become more and more differentiated and cell cycling reduces progressively for certain types of
cells, while it increases in abnormal cells like cancer cells. The class of S100 genes include at least 13
members of which most are located as a cluster on chromosome 1q21. In adults S100 proteins usually
have elevated expression due to nervous system damage, which makes them a potential clinical marker.
 
Previous attempt of deriving a transcriptional consensus signature of ageing identified upregulation of
immune response, lysosome, extracellular region of plasma membrane, glycoprotein signal and negative
regulation of apoptosis, and downregulation of mitochondrion, oxidative phosphorylation, cytoplasm, and
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hydroxylysine/hydroxylation/collagen (de Magalhaes, et al., 2009). Immune response and in particular
inflammation was found here to be commonly associated with ageing-upregulated genes and specifically
the positive regulation of inflammatory activities. Ageing-downregulated genes, on the contrary, are
commonly associated with negative regulation of inflammation. Additionally cellular senescence was also
found to upregulate inflammation and also HGPS upregulates the regulation of inflammation
[Inflammation]. Genes upregulated as well as downregulated with ageing have both been found here to be
commonly significantly associated with mitochondrion. However there are many more significant
associations of ageing-downregulated genes with mitochondria related processes, activities and locations,
indicative of increased mitochondrial dysfunction with ageing [Mitochondrial Dysfunction].
3.5   Conclusion
Here molecular signatures reflecting ageing in humans and model organisms were derived, primarily by
using transcriptomics. Tissue-specific and common consensus signatures were generated. This technique
could be extended to other omics if sufficient data is available (e.g. epigenomics, proteomics,
metabolomics, etc.). Differentially methylated regions and genes could be identified and common
signatures of ageing methylation changes be derived. Similarly, differentially expressed proteins could be
obtained from the proteomics data and common signatures of protein level changes generated.
Furthermore, metabolomics could be used to create common signatures of metabolite levels from
differential expressed metabolites with ageing.
Transcriptional consensus signatures of ageing revealed that ageing is accompanied by upregulation of
inflammation, differentiation and suppression of proliferation, growth retardation, increased apoptosis, and
downregulation of proteostasis.
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4   Dietary Restriction Genes
Abstract: Dietary restriction (DR), limiting nutrient intake from diet without causing
malnutrition, delays the ageing process and extends lifespan in multiple organisms.
The conserved life-extending effect of DR suggests the involvement of fundamental
mechanisms, although these remain a subject of debate. To help decipher the
life-extending mechanisms of DR, a list of genes that if genetically altered disrupt or
prevent the life-extending effects of DR was compiled. These genes were called
DR-essential genes and more than 100 were identified in model organisms such as
yeast, worms, flies, and mice. In order for other researchers to benefit from this first
curated list of genes essential for DR, an online database called GenDR
(http://genomics.senescence.info/diet/) was established. To dissect the interactions
of DR-essential genes and discover the underlying lifespan-extending mechanisms,
a variety of network and systems biology approaches were used to analyse the gene
network of DR. It is here shown that DR-essential genes are more conserved at the
molecular level and have more molecular interactions than expected by chance.
Furthermore, a guilt-by-association method to predict novel DR-essential genes was
employed. In budding yeast, nine genes related to vacuolar functions were
predicated; Here it is experimentally shown that mutations deleting eight of those
genes prevent the life-extending effects of DR. Three of these mutants (OPT2,
FRE6, and RCR2) had extended lifespan under ad libitum, indicating that the lack of
further longevity under DR is not caused by a general compromise of fitness. These
results demonstrate how network analyses of DR using GenDR can be used to
make phenotypically relevant predictions. Moreover, gene-regulatory circuits reveal
that the DR-induced transcriptional signature in yeast involves nutrient-sensing,
stress responses and meiotic transcription factors. Finally, comparing the influence
of gene expression changes during DR on the interactomes of multiple organisms
suggests that DR commonly suppresses translation, while stimulating an ancient
reproduction-related process.
4.1   Background
Dietary restriction (DR) in defined factors (such as calories or specific amino acids) without causing
malnutrition delays the ageing process, protects against age-related diseases (e.g. metabolic and
cardiovascular disease, neurodegeneration and cancer) and extends lifespan in evolutionarily distant
species, from unicellular yeast to rodents (Bishop & Guarente, 2007; Fontana, et al., 2010). Furthermore,
there is evidence that DR delays the ageing process in non-human primates (Kemnitz, 2011) and perhaps
in humans as well (Willcox, et al., 2007a). Caloric restriction in the presence of adequate nutrition is
effective in delaying the effects of ageing. Older age of onset, female sex, lower body weight and fat mass,
reduced food intake, diet quality, and lower fasting blood glucose levels are factors associated with fewer
age-related disorders and with improved survival. Reduced food intake was specifically beneficial in adult
and older primates, but not in younger monkeys (Mattison, et al., 2017; Kumlien, 2017).
While multiple studies in model organisms have shown that DR extends lifespan, the underlying molecular
mechanisms remain largely unknown (Fontana, et al., 2010; Spindler, 2010; de Magalhaes, et al., 2012).
The mechanisms by which DR retards ageing have been shown in model organisms to be mediated by
genetic pathways, many of which are evolutionarily conserved and operate in humans. Considerable
evidence indicates that DR is mediated by discrete signalling events that elicit specific genetic programs
(Bishop & Guarente, 2007; Fontana, et al., 2010; Lakowski & Hekimi, 1998; Partridge, et al., 2005).
Mutations in a number of genes, in fact, have been shown to prevent, shift or disrupt the
lifespan-extending effect of DR, in many cases without altering the lifespan under ad libitum (AL)
conditions. Such genes, which are designated as DR-essential, might specifically interfere with these
signalling cascades and the program that leads to lifespan extension under DR. Understanding the
interactions of such genes in a systematic way may provide important new clues regarding DR-mediated
life-extension mechanisms.
96
In the post-genomic era, the vast amount of omics data provides an opportunity to understand biological
processes in a systematic fashion via data integration, network construction and analyses. Networks in
biology exist on various levels, derived from the interactions between genes, transcripts, proteins and
metabolites, and extending to the interactions between cells, tissues, organs and even between
organisms. Examples at the molecular level are protein-protein interactions, gene-regulatory and
metabolic networks. Biological networks tend to have certain discrete topological properties: They are
usually scale-free (i.e. only a few nodes, termed “hubs”, have many connections, while the majority of
nodes have relatively few connections), modularly composed and hierarchically structured. Scale-free
networks are robust against random perturbation, but at the same time are sensitive to targeted disruption
of the hubs (Barabasi, et al., 2011). The modular composition is due to the presence of groups of highly
interconnected nodes (i.e. clusters) which perform certain biological activities (for instance protein
complexes or pathways) with relatively sparse external connectivity. Lastly, these network modules
associate with one another in a hierarchical manner. The challenge, however, is to integrate and combine
the various networks in order to decipher biological function and gain new insights into the process under
study.
Ageing-associated genes are more conserved at the molecular level (de Magalhaes & Church, 2007) and
have a significantly higher node degree (i.e. number of interactions in a network) than expected by chance.
Human orthologs of ageing-associated genes found in model organisms form a continuous network and
almost all of the hubs are also implicated in several age-related diseases (Budovsky, et al., 2007). The
networks of age-related disease genes and ageing-associated genes significantly overlap and
approximately half of the common genes participate in signal transduction. Additionally, general disease
genes have more connections to ageing genes than expected by chance (Wang, et al., 2009). Numerous
network studies on ageing have been conducted with fruitful results (Promislow, 2004; Witten & Bonchev,
2007; Fortney, et al., 2010; Bell, et al., 2009; Budovsky, et al., 2007; de Magalhaes & Toussaint, 2004; Li,
et al., 2010; Lorenz, et al., 2009; Wang, et al., 2009). To date, however, network studies on DR have been
limited, in part because of a lack of adequate datasets. Therefore, GenDR was constructed, a database of
DR-related genes.
Dietary restriction has been shown to extend lifespan in diverse, evolutionarily distant species, yet its
underlying mechanisms remain unknown. Firstly, a database of genes essential for the life-extending
effects of dietary restriction in various model organisms was constructed and then studied for their
interactions using a variety of network and systems biology approaches. This enabled to predict novel
genes related to dietary restriction, that were validated experimentally in yeast. By comparing large-scale
data compilations (interactomes and transcriptomes) from multiple organisms, it was possible to condense
this omics information to the most conserved essential elements, eliminating species-specific adaptive
responses. These results leads to the rather surprising conclusion that lifespan extension by a restricted
diet commonly may exploit an ancient rejuvenation process derived from gametogenesis.
Since GenDR is the first database of DR-related genes, its utility was assessed by performing the first
network-based dissection of DR using DR-essential genes. DR can induce numerous changes in
organisms, and a variety of different DR regimens have been employed. The rationale is that by
concentrating only on genes essential for DR-induced life-extension it is possible to narrow down the
various DR-related processes to those affecting ageing. The list of DR-essential genes was used to
investigate their evolutionary and network properties and identify common regulators of DR-induced
lifespan extension. Novel DR-essential genes were predicted from the network and tested experimentally
in yeast, which revealed new genes crucial for DR. Then diverse types of data were integrated and a
variety of network and systems biology analyses performed to reveal common pathways and mediators of
DR effects, including putative transcription factors. This work demonstrates the use of network approaches
to study DR mechanisms, and makes list of DR-essential genes available online for other researchers to
use (http://genomics.senescence.info/diet/).
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4.2   Methods
4.2.1   Database Creation
A list of genes, termed DR-essential genes, which if genetically manipulated (knockout by deletion, or
transposition, knockdown by RNA interference, or overexpression of transgenes) interfere with the ability
of DR to extend lifespan in model organisms (budding and fission yeast, nematode, fruit fly, and mouse)
was compiled from the literature. The focus on genes from genetic manipulations experiments means that
the selection procedure for selecting genes related to DR will be more objective and unbiased. Genes
were included if they interfere with at least one kind of DR regimen which also includes by definition a shift
in the response to food concentration at which lifespan is extended (e.g. chico gene). A database (GenDR)
was implemented in the relational database management system MySQL and a webpage interface was
designed (http://genomics.senescence.info/diet/), as for other ageing-related databases (de Magalhaes, et
al., 2005). Each entry in the database contains manually curated comments about literature-based
evidence and the reason for inferring an association with DR. If there are conflicting reports for a given
gene, the policy is to still include the gene in the database but mention all the conflicting reports and then
let visitors make their own mind on how to interpret them. This neutral stance policy is similar to the one
already employed for the GenAge database of ageing-related genes. Literature citations and links to
PubMed are also given. Further, conserved gene expression changes upon DR in mammals are included,
although these have been described in another work (Plank, et al., 2012).
4.2.2   Molecular Evolution
4.2.2.1   Assembling Orthologs
Homologs of genes in the GenDR database were retrieved from the NCBI HomoloGene Database,
Ensembl/BioMart, OrthoMCL (Fischer, et al., 2011), and InParanoid (Ostlund, et al., 2010) by merging.
Genes are either homologous or not, it is a binary assignment, therefore the union was taken by merging
them. For the molecular evolution part specifically only BioMart (Ensembl Genes 57) was used to retrieve
tables of orthologs (homologs between two different species) for Saccharomyces cerevisiae,
Caenorhabditis elegans, Drosophila melanogaster, Mus musculus, Rattus norvegicus, Macaca mulatta
and Homo sapiens. Information about Saccharomyces pombe is not available in Ensembl and this species
was therefore excluded from the following analyses. For calculating the presence of orthologs, Ensembl
protein identifiers were employed to filter for only protein-coding genes. For a given set of genes, here
DR-essential genes, it was counted how many of these genes in one species have also at least one
protein-coding homologous gene in all the other species under study. This was also done for all
protein-coding genes in each genome and given these two values the percentage of presence of
homologs were estimated. All pairwise comparisons for each seed species were averaged and the
Poisson p-values calculated.
4.2.2.2   Calculating Average dN, dS, and dN/dS Ratios
Non-synonymous (dN) and synonymous (dS) nucleotide substitution rates (de Magalhaes & Church, 2007;
Koonin & Wolf, 2010) were retrieved from the Ensembl Compara built 65 for the orthologous pairs between
a rodent (M. musculus), a non-human primate (M. mulatta) and humans (H. sapiens). Orthologs
relationships were restricted to the top hits of InParanoid. In this sense, the number of paralogs is
corrected for which might be a source of bias as big gene families tend to have higher dN/dS ratios. The
average values for dN and dS as well as dN/dS ratios for the orthologous relationships of DR-essential
genes were compared against those without orthologs of DR-essential genes. In order to avoid biases due
to overrepresentation of ancient genes, only genes which had also orthologs in lower model organisms (S.
cerevisiae, C. elegans, or D. melanogaster) were selected. Thus, the comparison was between ancient
genes that are presumably essential for DR versus ancient genes with no known essential role in DR. The
corresponding p-values for differences in dN, dS, and dN/dS were calculated with a Mann Whitney U test.
Invertebrates were not studied because of the difficulty to obtain dN and dS values.
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4.2.3   Molecular Interaction Information
4.2.3.1   Integration
Interactions datasets were retrieved from IntAct (Download 23.01.2011; http://www.ebi.ac.uk/intact/;
Aranda, et al., 2010), DIP (Update 10.10.2010) (Xenarios, et al., 2002), MINT (Version 2010-12-15
updated on 21/12/2010 11:07:00) (Ceol, et al., 2010), BIND (http://baderlab.org/BINDTranslation; Isserlin,
et al., 2011), BioGRID (Release 3.1.72) (Breitkreutz, et al., 2008), MPACT (Guldener, et al., 2006), DroID
(Version 2010_08), Reactome (Haw & Stein, 2012; Croft, et al., 2011; Stein, 2004), HPRD (Version 9)
(Keshava Prasad, et al., 2009), PDZBase (Beuming, et al., 2005), CORUM (Ruepp, et al., 2010),
iRefIndex (05182010) (Razick, et al., 2008), PhosphoSitePlus (Fri Dec 10 13:43:52 EST 2010) (Hornbeck,
et al., 2004), PhosphoGRID (Stark, et al., 2010), I2D (Version 1.8) (Brown & Jurisica, 2007), InteroPORC
(Michaut, et al., 2008), InterologFinder (Wiles, et al., 2010), MiMI (Jayapandian, et al., 2007), (Tarcea, et
al., 2009), PINA (Update March 4, 2010) (Wu, et al., 2009b), YeastNet (Lee, et al., 2007), WormNet (Lee,
et al., 2010), MouseNet (Kim, et al., 2008), and TF-Atlas (Ravasi, et al., 2010) preferentially as PSI-MAT or
simple tab-delimited flat file format. Interactions were aggregated by using a unified schema consisting of
synonyms for each gene/protein, their taxonomy identifiers, interaction type and detection system,
PubMed identifiers for references, as well as source databases. For simplification, interactions between
molecules other than genes, transcripts, or proteins were omitted and only interactions between
genes/transcripts/proteins of the same species were considered.
4.2.3.2   Mapping and Merging
Symbols, names, aliases and various identifiers of genes, transcripts and proteins were in the first
instance mapped to unique Entrez Gene IDs, Ensembl Gene IDs, UniProt IDs and species-specific IDs
(from WormBase, MGI, etc.). Ensembl Gene, UniProt, or species-specific database IDs were if possible
converted into Entrez Gene IDs. In a second iteration collected synonyms from Ensembl, UniProt, and
species-specific database of genes/proteins with missing Entrez Gene IDs were used as queries to map
them to synonymous tables of Entrez. In each mapping the identifier used had always the highest level of
matches. For instance, Entrez Gene IDs were chosen with the highest consensus of all other
database-derived synonymous tables.
The mapped interactions were merged to a directional merged interactome if the source and target
interactors are the same as well as to an undirectional merged interactome in which all interactions
describing the same interacting entities are fused regardless of source or target interactors.
For the integrated, mapped and merged interactions a suitable scoring system was developed.
Interactions gain scores for each experimental system type, each different interaction detection method
that was used, and additionally for each different publication which observed an interaction. Furthermore,
if an interaction involves a post-translational modification event it receives a further score.
4.2.4   Network Analyses
The integrated interaction data was transferred into a relational database, queried with gene lists and
networks visualized via custom Python scripts or with the use of Cytoscape (Cline, et al., 2007).
Each gene (candidate) was assessed for the number of interactions (degree) with genes in the query lists
(seeds), as well as their total interaction number. As a measure of specificity, the ratio of specific
interaction number with the seeds divided by the total number of interactions for each gene (seeds and
candidates) was calculcated, as a percentage, and its corresponding p-value (based on the binomial
distribution) determined. Genes with a binomial p-value < 0.05 were classified as significant interactors.
Whether a set of genes has a higher average degree than expected by chance was determined using a
Mann Whitney U test. An exhaustively leave-one-out test as applied by repeatedly omitting single genes
from the seed list and tested whether the genes were among the significant candidate genes inferred from
the remainder. From this procedure the percentage of retrieval was estimated for each of the seed genes
by successively omitting each gene, one at a time, from the seed list.
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4.2.5   Guilt-by-Association
Interaction information was retrieved from BioGRID (version Version 3.4.140), annotations on processes,
functions, locations, and pathways were retrieved from the NCBI FTP server. The significance to be
associated with DR-essential genes was calculated with the hypergeometric test. Significant associations
plus the DR-essential gene seed list was graphed via automatic force-directed graph layout (Kobourov,
2012).
4.2.6   Correlation of Variables and Multiple Linear Regression
A multiple linear regression analysis was performed in Python focused on human genes that considers
three variables: the degree of each gene in the interaction network, the number of species with orthologs,
and the mean of its dN/dS ratios with three other mammalian species (M. musculus, R. norvegicus and M.
mulatta). Genes with a degree of zero or with no given dN/dS ratios were removed, in order to log
transform the data. A Pearson correlation was applied to first check whether any of those variables are
correlated with each other. Then a regression analysis was conducted, by the method of least squares, of
each variable against other variables first singly and then for a given variable as a function of the other
two. The derived linear equations were used to predict the variables of greatest relevance for the set of
DR-essential genes.
4.2.7   Functional Enrichment Analyses
By a False Discovery Rate (FDR) of <5% gene lists were examined using the DAVID bioinformatics
resource (http://niaid.abcc.ncifcrf.gov/), under default parameters with the corresponding species genome
as reference set, to identify overrepresented categories (Huang, et al., 2007). Gene ontologies were
retrieved from Entrez and gene descriptions for yeast genes from Saccharomyces Genome Database
(SGD; http://yeastgenome.org/; Cherry, et al., 2012).
4.2.8   Combining p-Values
To judge the overall significance of a series of experiments, the p-values were combined via two different
approaches.
The first method is an analytic solution of the Fisher's test (Fischer, 1932). Briefly, the set point whose
probability is equal to that of a set of p-values is the hyperbola:
(P1 · P2 · P3 · ... · Pn) = k
k is the product of a set of p-values k = (x1 · x2 · x3 · … · xn), provided that the events described by these
p-values are independent of one another. The volume under the surface gives the probability of obtaining
a set of p-values as extreme or more extreme than the given set:
k - (k·ln(k))
The alternative approach is the Z-method as described in (Whitlock, 2005), which gives similar, but
somewhat more stringent results.
p-values were corrected for multiple hypothesis testing with the Benjamini-Hochberg method and the
corrected values were denoted as q-values (Benjamini & HochBerg, 1995).
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4.2.9   Lifespan and Vacuolar Morphology Analyses
The replicative lifespan of yeast mutants in the BY4742 (Mat α; his3∆1; leu2∆0; lys2∆0; ura3∆0)
background were measured on different media as described before (Tang, et al., 2008). The ad libitum
(AL) medium was YEPD: yeast extract (1%), peptone (2%), agar (2%), and D-glucose (2%). The dietary
restricted (DR) medium was yeast extract (1%), peptone (2%), agar (2%), and D-glucose (0.5%). For bud
counting, cells were grown at 30°C and dissected every 100 min. Five to six rounds of bud counting were
performed each day. The ageing assay plate was saved at 4°C for overnight and the bud counting was
continued the next day till all cells died, which was diagnosed by either cell lysis or no budding in 2 days.
The vacuolar morphology of yeast mutants under AL and DR were measured by FM4-64 labelling and
chasing (Wang, et al., 1998). Briefly, cells were inoculated into AL or DR liquid media (AL: yeast extract
(1%) peptone plus (2%) D-glucose; DR: yeast extract (1%) peptone plus (0.5%) D-glucose) and incubated
on a shaker (150 rpm) at 30°C overnight. An aliquot of 250 µl of cells were labelled with 6 µl of 2 mg/ml
FM4-64 for 1 hour. After washing off the dye, cells were chased in the corresponding medium for 3 hours
and then photographed.
Significance of mean lifespan changes were assessed with the log-rank test (a.k.a. Mantel-Cox test)
between mutants and wild-type as well as between dietary regimes for each genotype.
4.2.10   RNA Isolation and Microarray Analyses
Wild-type yeast cells (BY4742) were inoculated into AL or DR liquid media and incubated overnight on a
shaker. These seed cultures were then inoculated into fresh media to an initial OD600 of 0.01. Cells were
grown at 30°C for 12 hours. The final OD600 of cultures were 0.85-0.99. Three OD600 units of cells were
collected and lysed with zymolyase. Total RNA was isolated using the Qiagen RNeasy mini kit as
described in (Gebre, et al., 2012). Total RNA obtained was between 60 to 100 µg. RNA samples were
processed and hybridized with GeneChip Yeast genome 2.0 arrays (Affymetrix Inc., Santa Clara, CA) by
Expression Analysis (Durham, NC). The hybridization signals were normalized and analysed with the
Affymetrix statistical algorithms by Expression Analysis. By a two-fold cut-off, out of 5716 probed genes
2587 (45.26%) were differentially expressed, with 1413 genes (24.72%) upregulated and 1174 genes
(20.54%) downregulated. Full results and raw microarray data are available online at GenDR
(http://genomics.senescence.info/diet/Yeast array.zip), GEO (GSE38635), and ArrayExpress
(E-MTAB-1165).
For additional microarray data from yeast (GSE9217), worms (GSE9682), and flies (GSE26726 and
GSE16738), GSE files were retrieved from the GEO database, replicates were averaged and fold
changes calculated via custom Python scripts.
For the microarray data from worms and flies, GSE files were retrieved from the GEO database, replicates
were averaged and fold changes calculated via python scripts (GSE9217 (different levels of glucose for
yeast), GSE9682 (intermittent fasted nematodes), GSE18563 (glucose restricted nematodes), GSE6057
(nematodes in CeMM), GSE26726 (fly transcriptional) and GSE16738 (fly translational)).
4.2.11   Transcription Factor Identification
Transcription factor-target gene interactions were retrieved from YEASTRACT (http://yeastract.com/).
Transcription factors interacting with DR-essential genes were identified and ordered by their specificity or
binomial p-value of the ratio of regulated genes with more than two-fold differentially expression upon DR
relative to the total number of genes regulated by the same transcription factor. The whole genome
(sacCer3) was retrieved from UCSC and regulatory regions (+500 bp sequences from the transcription
start site) annotated. Transcription factor binding sites (TFBS), i.e. motifs, were integrated from SGD,
YEASTRACT, and YFTD (http://biochemie.web.med.uni-muenchen.de/YTFD/YTF alpha 2.htm), as well as
from the literature. Via regular expression it was tested (hypergeometric p-value and FDR q-values)
whether a defined motif is significantly enriched in the regulatory regions of differential expressed (either
up- or down-regulated) genes or set of genes.
The +500 bp sequences of yeast genes, +1500 bp to -500 bp for murine genes and +1000 bp to -500 bp
for human genes, relative to the transcription start site were retrieved from Ensembl. Whole genomes
(sacCer3, ce6, dm3, mm9, hg19) were retrieved from UCSC via worldbase.
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4.2.12   Chromatin Mark Enrichment/Depletion
Data about chromatin modifications (histone acetylation and methylation) were obtained from (Kurdistani,
et al., 2004; Pokholok, et al., 2005; Xu, et al., 2005). Differentially expressed genes (> 2-fold) were
assigned to their value for each chromatin mark. A binomial test between the average upregulated and
downregulated genes as well as between the average differentially expressed and non-differentially
expressed genes was performed. The signal strength for all differentially expressed genes, upregulated
genes, downregulated genes and all other were collected. Then the average values (actually the lists
which give raise to these numbers) of them were compared with a binomial test in order to find which
marks are enriched in up vs. down and delta vs. other.
4.2.13   Interaction Integration
Via a python script for each dataset, gene/protein names/identifiers, experimental system type (genetic or
physical), interaction type (e.g. association, complex formation, etc.) experimental system (e.g. yeast-two
hybrid), post-translational modifications events (e.g. phosphorylation), pmids, and source databases were
extracted and first converted to a unified schema (unique_id_a, unique_id_b, experimental_system_type,
interaction_type, experimental_system, modification, pmid, taxid, source_database), sorted according to
taxonomy identification (taxid) and then subsequently fused.
4.2.14   Chance of Differentially Expression
Whether DR-essential genes are more likely to be differentially expressed than expected by change was
calculated by the hypergeometric test. In mammals a signature derived from genome-wide meta-analysis
of DNA microarrays (Plank, et al., 2012) was employed.
4.3   Results
4.3.1   Construction of GenDR, a Database of DR-Related Genes
A list of DR-essential genes was compiled from the literature. A DR-essential gene was defined as one
which when genetically manipulated in a given organism blocks or disrupts the life-extending effect of DR.
This criterion applies even if it was shown for only a single DR regimen. Over 100 genes were identified,
mostly from the traditional biomedical model organisms [Table 3: Number of DR-Essential Genes and
Orthologs in GenDR]. In mice, for example, one DR-essential gene found so far is the growth hormone
receptor (Ghr) gene of which homozygous knockout mutants were long-lived and DR failed to further
extend their lifespan (Bonkowski, et al., 2006). In the case of yeast, DR-essential genes were annotated
separately for replicative and chronological lifespan. However, both were combined for the analyses
presented below, in order to focus on mechanisms universal to DR. For each gene, its orthologs in other
model organisms and in humans (if any) were retrieved from public databases (see Methods).
A publicly accessible database of DR-essential genes and their orthologs, called GenDR, was created
which offers an important new tool to researchers working on the genetics of DR and of ageing. Although
other studies have emphasized the importance of genes that disrupt life-extending effects of DR (Bishop &
Guarente, 2007; Fontana, et al., 2010; Gems, et al., 2002), to the current knowledge this is the first
compilation of a list of such genes. The GenDR database employs the same system and interface as the
widely used GenAge database of ageing-related genes (de Magalhaes, et al., 2009b). My inclusive
selection criteria allow GenDR to incorporate a broad range of genes. Because information on each gene
and reason(s) for its selection are included, however, researchers are able to focus on subsets of the
database that are most relevant to their work. GenDR will be useful both as an informational website and
as a research tool, and it is freely available online for the research community to use
(http://genomics.senescence.info/diet/).
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Table 3: Number of DR-Essential Genes and Orthologs in GenDR. Number of genes reported in
different model organisms to be essential for DR and their orthologs identified by the use of
Ensembl, HomoloGene, InParanoid and OrthoMCL.
Species Genes Genes+Orthologs
Fission yeast 6 54
Budding yeast 70 170
Nematode 42 137
Fruit fly 19 187
House mouse 1 218
Norway rat 0 217
Rhesus monkey 0 200
Human 0 226
A DR-essential gene can be described by:
1. Mutation interferes with effect of DR to extend lifespan (obligatory)
2. Mutant is not sick and capable of lifespan extension (obligatory)
3. Evolutionary conserved / under evolutionary positive selection (optional)
4. Change in activity under DR (optional)
5. Interact on physical or genetic level with other DR-essential genes (optional)
Whereas only criteria number one and two are obligatory, the others are optional and are very useful to
infer/identify further DR-essential genes. Gene expression profiles, interaction networks, molecular
evolution data will be used to further prioritize potential DR-essential genes and identify crucial regulators.
The second criteria is used to discriminate from false-positives. Mutants should still be capable exhibiting
lifespan extension via other interventions which are assumed not to work via DR signalling. Thus, proving
that the mutation does not just renders the animal in general sick and unable to life longer. RNAi against
genes such as pat-4 and pat-6 abrogated DR-induced lifespan, but as the animals appeared to be very
unhealthy they were not classified as DR-essential (Hansen, et al., 2005).
4.3.2   GenDR Is Enriched in Conserved Longevity Genes and Pathways
Given that DR works across diverse model organisms, it is expected that GenDR can guide the search for
evolutionarily conserved longevity mechanisms. Therefore, GenDR is analysed at three levels: the
sequences of genes/proteins, the interactome, and enriched pathways.
To test whether GenDR reflects the conserved effects of DR on longevity, the molecular evolution of genes
essential for DR was investigated. In agreement with the hypothesis, the percentage of orthologs of
DR-essential genes across all tested species is higher than expected by chance [Figure 22 DR Genes Are
Molecular Conserved and Form a Tight Network A]. Likewise, the average dN/dS ratio, a measure of
molecular evolution rate, as well as dN and dS rates, for DR-essential gene orthologs in mammalian
species pairs were lower than expected by chance [Figure 23 DR-Essential Genes Have Low dN/dS
Ratios]. As such, it appears that indeed DR is evolutionarily conserved at the genetic level.
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_Figure 22: DR Genes Are Molecular Conserved and Form a Tight Network. A, The proportion of
genes (shown as percentages) with orthologs from multiple species in the specified organisms is in all
cases higher (by 10-30%) for DR-essential genes than expected by chance. B, The average degree
(number of interactions) for DR-essential genes and DR-essential gene orthologs (the
ortholog-complemented set) is higher than the interactome-wide average which serves as control. C,
The average percentage of specificity in interconnectivity (100× specific interactions with seed genes/all
interactions) of DR-essential genes to each other is higher than for other genes in interactomes, and
complementation with orthologs of DR-essential genes from other species further increases the
specificity of interconnectivity. ns, P>0.05; *, P<0.05; **, P<0.01; ***, P<0.001.
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_Figure 23: DR-Essential Genes Have Low dN/dS Ratios. Mammalian DR-essential orthologs have
lower dN/dS ratio than expected by chance.
Homology has been calculated based on sequence via the Smith and Waterman method (Smith &
Waterman, 1981).
_
Figure 24: DR-Essential Gene Orthologs in Humans Form a Scale-Free Network. Degree
distribution of human ortholog-complemented DR-essential gene network, as a log-log plot: i.e.
log[degree (k)] is plotted against the log of the number of nodes with degree k (n).
Interaction networks of DR-essential genes plus their orthologs were created by integrating molecular
interaction information from various sources: physical, genetic and other interactions such as regulatory
relationships were retrieved from public databases (see Methods). The human orthologs of DR-essential
genes form an interaction network in which the total interactions appear to follow approximately a power
law distribution [Figure 24 DR-Essential Gene Orthologs in Humans Form a Scale-Free Network]. This is
consistent with a scale-free network in which only a few nodes (often called “hubs”) are highly connected.
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In other words, a few hubs contribute highly to the DR network connectivity, as has been observed in other
biological networks (Budovsky, et al., 2007; Wang, et al., 2009).
_
Figure 25: DR-Essential Genes Are More Conserved Than Ageing Genes. DR-essential genes
have a higher abundance of orthologs than ageing genes.
DR-essential genes as well as their orthologs have a higher node degree than expected by chance when
compared to the whole interactome [Figure 22 DR Genes Are Molecular Conserved and Form a Tight
Network B]. Thus, DR-essential genes tend to be located in the centre of the interactome rather than in the
periphery. As anticipated, DR-essential genes interact with each other more than expected by chance
[Figure 22 DR Genes Are Molecular Conserved and Form a Tight Network C]. Adding orthologs to the
DR-essential gene seed lists (orthology complementation) increased the specificity (interaction with seed
genes/total interactions) of the connections between seed genes and enabled the generation of interaction
networks for species with few or no known DR-essential genes, such as mammals. DR-essential as well
as ageing genes are significantly enriched for signalling genes. Nonetheless, DR-essential genes are even
more evolutionarily conserved than ageing genes [Figure 25 DR-Essential Genes Are More Conserved
Than Ageing Genes] and have a higher average degree than signalling genes [Figure 26 DR Genes Have
a Higher Node Degree Than Ageing & Signalling Genes], indicating that these properties (evolutionary
conservation and high degree) are not secondary effects expected for subsets of ageing genes and
signalling genes, respectively.
One issue, however, is that the finding of higher conservation and interconnectivity for DR-essential genes
compared to other genes might reflect a selection bias of researchers, who tend to study genes that have
orthologs in multiple species and/or those in pathways associated with DR. Because node degree,
presence of orthologs and sequence conservation are thought to be related, the correlations among these
variables for human genes were investigated. It was found that log(degree) and number of species with
orthologs are positively correlated (Pearson correlation coefficient, r = 0.36; p<1e-200), which implies that
the higher the number of connections (i.e. interactions) of a human gene the higher the number of species
which have orthologs of that gene. Similarly, log(degree) was weakly negatively correlated with log(dN/dS)
(r = -0.08; p<1e-11), indicating that genes with more connections have slightly lower dN/dS ratios and
hence more conserved sequences. Finally, the log(ortholog number) was also found to be negatively
correlated with log(dN/dS) (r = -0.24; p<1e-100), suggesting that genes which have orthologs across many
species also tend to have lower dN/dS ratios, as expected. An interpretation of these results is that genes
with high degree (more connectivity) tend to also have high numbers of orthologs and low dN/dS ratios.
This makes sense, since important hubs in the network have more constraints limiting their evolutionary
divergence. Next, multiple linear regression analysis (with log-transformed data) was performed to derive
equations relating each of these three variables as a function of the other two. The equations was used to
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determine whether DR-essential gene orthologs have higher or lower values than predicted from the other
two variables. The results reveal that DR-essential gene orthologs have an average degree much higher
than expected (73 vs. 12), a slightly higher number of species with orthologs (10 vs. 9) and dN/dS ratios
higher than the expected value (0.08 vs. 0.04). Thus, a high node degree appears to be the most critical
feature of DR-essential gene orthologs.
_
Figure 26: DR Genes Have a Higher Node Degree Than Ageing & Signalling Genes. DR-essential
genes exhibit a high average node degree relative to ageing genes or signalling genes.
To ascertain which processes and functions are common to the DR gene network, DR-essential genes
plus their significant interactors (p<0.05 according to specificity of interaction with DR-essential genes, as
described in the Materials and Methods) for each species were subjected to functional enrichment analysis
using DAVID (Database for Annotation, Visualization and Integrated Discovery). Common to all
DR-essential gene interaction networks in yeast, worm and fly were the terms ageing (p<1e-27) and
mitochondrion (p<1e-10). Terms common to ortholog-complemented networks in yeast, worms, flies, mice
and humans were categories related primarily to phosphorylation signalling, among others. Kinase
signalling and protein phosphorylation are also dramatically suppressed in very long-lived PI3K-null mutant
worms (Shmookler Reis, et al., 2012; Tazearslan, et al., 2009). It was then asked which genes among the
significant interaction partners were common to multiple organisms. Although no homologous group was
significant at False Discovery Rate (FDR) < 0.05 (which appears to be too strict for comparisons across
multiple species), by the more relaxed criterion of having a binomial p-value < 0.05, four homologous
groups were nominally significant: CAB39, the genes encoding 14-3-3 proteins, sirtuins, and AHCY
encoding S-adenosylhomocysteinase.
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4.3.3   Guilt-by-Association Discovers Novel Vacuolar DR-Essential Gene
Functions
To predict novel DR-essential candidate genes a guilt-by-association strategy was used (de Magalhaes &
Toussaint, 2004). Essentially, the logic behind this approach is that a gene with more interactions than
expected by chance with genes associated with a given process (i.e. DR-mediated lifespan extension) is
likely to also play a role in that process (see Methods). The candidate genes with highest significance in
their connectivity to DR-essential genes were YGR272C (EFG1; Exit From G1) in Saccharomyces
cerevisiae, B0280.10 (pot-1; Protection of Telomeres 1 (Pot1) homolog) in Caenorhabditis elegans, and
Akt1 (serine-threonine kinase involved in insulin-like signalling) in Drosophila melanogaster. After
orthologous complementation, among the highly significant candidate genes were, for example, PAI3
(essential Proteinase A inhibitor) in S. cerevisiae, hcf-1 (human host cell factor (HCF-1) homolog) in C.
elegans, CG7333 (an organic cation transmembrane transporter) in D. melanogaster, Raf1 (MAP kinase
kinase kinase) in Mus musculus, and ACD (involved in telomere maintenance and meiosis) in humans. In
yeast, worm, and fruit fly, respectively, 372, 1317, and 202 genes were significant at a p-value < 0.05.
After orthologous complementation there were 264 genes significant in yeast, 228 in worm, 743 in fruit fly,
2576 in mouse, and 996 in humans.
Table 4: Lifespan and Vacuolar Changes of Novel DR-Essential Genes. Vac = Vacuole; r = round; f
= fragmented. Ratio = Ratio of mRNA levels (DR/AL) in WT.
Mutant
GbA p
-value
Mean /
max. AL
lifespan,
(N)
Mean /
max. DR
lifespan,
(N)
AL, mutant
vs. WT,
log-rank
p-value
DR vs.
AL,
log-rank
p-value
Vac
AL
Vac
DR
Vac
∆ Ratio
wild-type NA 26.4/47
(51)
31/54
(50)
NA 0.002 r r NA NA
vps20∆ 0.02 22.07/38
(30)
18.27/34
(30)
0.09 0.052 NA NA NA 1.56
fre6∆ 0.022 30.07/46
(30)
28/42
(30)
0.043 0.173 r f 29
->
14
0.85
rcr2∆ 0.019 31.27/45
(30)
24.96/45
(25)
0.008 0.048 r f/r 52
->
18
3.22*
ydl180w∆ 0.043 27.67/44
(30)
28.2/46
(25)
0.262 0.596 f f/r NA 2.25*
opt2∆ 0.048 32.6/51
(15)
25.43/39
(30)
0.007 0.015 f f NA 0.05*
gtr1∆ 0.037 16.93/23
(15)
18.73/29
(15)
4.50e-9 0.208 r f NA 2.77*
dap2∆ 0.013 21.27/30
(15)
19.93/32
(15)
0.001 0.969 r f 60
-> 1
1.22
slm4∆ 0.049 23.87/48
(15)
23.4/36
(15)
0.793 0.597 r f 44
->
16
3.28*
yol092w∆ 0.043 20.8/34
(15)
27.4/42
(15)
0.087 0.062 f f NA 0.33*
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_Figure 27: DR Vacuole-Associated Genes Are Required for DR Lifespan Extension and Normal
Vacuolar Morphology. A, Survival curves of wild-type and rcr2∆ mutant strains measured on AL/YEPD
and DR media. The units of age (X axis) are generations. Mean and maximum lifespans as well as
sample sizes are listed in [Table 4: Lifespan and Vacuolar Changes of Novel DR-Essential Genes. B,
Vacuolar morphology on AL and DR media of wild-type and rcr2∆. Left panel: DIC images showing the
cells; middle panel: TRITC-fluorescent images showing the vacuoles; right panel: overlay of cell and
vacuole images.
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In order to assess the sensitivity and specificity of this guilt-by-association concept, a leave-one-out test
was applied (Owen, et al., 2003). By omitting one of the DR-essential genes from the seed list and
checking whether the removed gene was among the significant candidate genes (i.e. predicted correctly),
a measure was obtained for sensitivity of the guilt-by-association method in the form of the percentage of
genes which were recovered (i.e. rediscovered). This method achieved a recovery rate of 40% in yeast,
12% in worm and 50% in fruit fly. The lower recovery rate for worms compared to the other species (and
the higher p-values) is possibly because C. elegans had the lowest number of known interactions at the
time of analysis.
To test the new candidate genes, and thus to validate the usefulness of GenDR and DR network analyses
as tools for ageing research, the role in DR of some of the yeast candidates were experimentally
assessed. Vacuole-related terms were among the most significant discrete clusters of terms in the
DR-essential network of yeast (Enrichment Score: 5.2; q-value < 2×1e-5). The guilt-by-association method
predicted nine yeast genes whose protein products are on the vacuolar membrane and are non-essential
for viability. Therefore, it was decided to focus on the mutants of these genes, and let the replicative
lifespan and vacuolar morphology of these nine mutants on AL and DR be measured [Table 4: Lifespan
and Vacuolar Changes of Novel DR-Essential Genes; Figure 27 DR Vacuole-Associated Genes Are
Required for DR Lifespan Extension and Normal Vacuolar Morphology]. Eight of the nine mutants that
were analysed exhibited an impaired lifespan extension by DR (i.e. are DR-essential genes). Five of the
nine mutations altered the extent of DR-induced vacuole fragmentation. While the vacuolar morphology of
wild-type and rcr2∆ are indistinguishable in AL, their morphologies in DR media are different; wild-type had
some cells with a few vacuolar vesicles (equal or less than 5/cell) but rcr2∆ cells had 6 or more vacuolar
vesicles/cell [Figure 27 DR Vacuole-Associated Genes Are Required for DR Lifespan Extension and
Normal Vacuolar Morphology]. Similar to mutants (erg6∆, nyv1∆, etc.) with highly fragmented vacuoles
under DR (Tang, et al., 2008), rcr2∆ had a shortened lifespan on DR [Figure 27 DR Vacuole-Associated
Genes Are Required for DR Lifespan Extension and Normal Vacuolar Morphology]. Deletion of OPT2 or
FRE6 showed results similar to rcr2∆ and all had an extended lifespan on AL [Table 4: Lifespan and
Vacuolar Changes of Novel DR-Essential Genes].
Further DR-essential genes in mouse [Figure 28 M. musculus DR-Essential Gene Network], fly [Figure 29
D. melanogaster DR-Essential Gene Network], nematode [Figure 30 C. elegans DR-Essential Gene
Network], and yeast [Figure 31 S. cerevisiae DR-Essential Gene Network] are predicted as well as
significantly associated processes, functions, locations, and pathways.
Guilt-by-association was used to generate the networks with q-value threshold of 0.05 for the respective
species. The shortest path algorithm was used to connect unconnected nodes. Processes are coloured
green, functions are orange and locations are yellow. This results in networks of physical and genetic
interaction as well as functional edges of DR-essential genes and their significant associations (q-value <
0.05). Nodes representing DR-essential genes are golden. Processes are light green, functions are
orange, locations are yellow, and pathways are white. Physical interactions are pink, genetic interactions
are green and other edges like, is involved in, participates in, exhibits and is located in are grey. Node size
is proportional to the 10+log10 of the q-value of being associated with DR-essential genes.
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_Figure 28: M. musculus DR-Essential Gene Network.
Mouse DR-essential genes are significantly associated with physical interaction with Ep300, genetic
interaction with Cby1, involved in epigenetics, exhibit beta-catenin binding, and located in growth hormone
receptor complex.
111
_Figure 29: D. melanogaster DR-Essential Gene Network.
Fly DR-essential genes physically interact with InR, genetically interact with Akt1, involved in lifespan
control, participate in longevity, exhibit deacetylase activities, and being located in TSC1-TSC2 complex.
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_Figure 30: C. elegans DR-Essential Gene Network.
Worm DR-essential genes are significantly associated with physical interaction with col-20, genetic
interaction with bar-1, involved in ageing/lifespan/senescence, exhibiting MAPK-related activities, and
being located in insulin-responsive compartment.
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_Figure 31: S. cerevisiae DR-Essential Gene Network.
Yeast DR-essential genes physically interact with VPS21, genetically interact with SCH9, participate in
longevity regulating pathway - multiple species, exhibit NAD-dependent histone deacetylase activity, and
are located in fungal-type vacuole membrane.
114
_Figure 32: Network of Associations Common to DR-Essential Gene Across Species.
Next nodes that are commonly significant in multiple (two or more) species by a common relaxed threshold
of 0.05 were identified and graphed [Figure 32 Network of Associations Common to DR-Essential Gene
Across Species].
DR-essential genes are commonly significantly associated with ageing/lifespan/longevity, IIS, TOR,
MAPK, and Wnt.
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4.3.4   Differential Expression of DR-Essential Genes upon DR
For the purpose of gaining insights into which processes on the global scale are affected by DR,
microarray data was generated in yeast under DR (see Methods) and those genes more than two-fold
differentially expressed were examined using DAVID by retrieving terms and clusters with FDR < 5%. DR
up-regulated genes were associated with heat response, mitochondria, peroxisome, transcription, mRNA
processing, zinc binding, carbohydrate metabolism, sporulation, vacuole, and mitochondrial ribosomes,
while DR down-regulated genes were related to ribosome/translation, nitrogen, sterol and one-carbon
metabolism as well as DNA replication.
This comparison of mRNA levels between yeast cells cultured in AL and DR media, as ascertained on
microarrays, also furnished further support for the involvement of the predicted vacuolar DR-essential
genes. Of the 9 predicted vacuolar DR-essential genes, 6 were differentially regulated by more than
two-fold either up or down [Table 4: Lifespan and Vacuolar Changes of Novel DR-Essential Genes.
Strikingly, OPT2 which had the strongest effect on lifespan when deleted (around 30% mean and
maximum lifespan extension), was also among the genes most strongly (20-fold) down-regulated by DR
[(Lin, et al., 2002) and DNA microarray data generate in this study here; see Table 4: Lifespan and
Vacuolar Changes of Novel DR-Essential Genes]. OPT2 is differential expressed in numerous intervention
which impact on lifespan (Aghajan, et al., 2010; Chattopadhyay, et al., 2009; Lin, et al., 2002; Reinke, et
al., 2006).
As changes in expression of DR-essential genes via genetic manipulations mimic and/or abolish the
lifespan extension conferred by DR, one interpretation is that DR-essential genes normally mediate DR
effects by changing their expression or activity level in response to DR. As an approximation to investigate
this, large-scale microarray expression profiles of yeast, worm (Honjoh, et al., 2009) and fly (Bauer, et al.,
2010; Zid, et al., 2009) was employed. Numerous DR-essential genes change in their activity either at the
transcriptional or translational level in response to DR. Of note among genes differentially expressed
during DR, only two DR-essential homologous groups are shared in common by yeast, worm and fly:
homologs of a fatty acid elongase, and S-adenosylmethionine synthetase activity. Experimental data
support the importance of these two categories for which GenDR and DR-induced differential expression
agree: (1.) worms with RNAi-suppressed fatty acid elongase activity have increased lifespan, and
long-lived C. elegans mutants tend to have shorter fatty acid chains in proportion to their longevities
(Shmookler Reis, et al., 2011); and (2.) knockdown of the nematode SAM synthetase gene, sams-1,
extends adult lifespan (Hansen, et al., 2005; Steinkraus, et al., 2008b), and also in yeast SAM1 deletion
extends lifespan (Smith, et al., 2008). However, DR-essential genes in yeast are no more likely to be
differentially expressed than expected by chance (30 of 70 DR-essential genes among the
DR-differentially expressed genes; hypergeometric p-value = 0.6) at a threshold of two-fold change.
4.3.5   Comparing DR Interactomes
The validation of vacuole mutants and the responses of DR-essential genes to longevity manipulations
support the biological relevance of predictions based on the DR interactome. To further study conserved
mechanisms of DR-induced life-extension, next interactome and transcriptome data were integrated and
analysed [Figure 33 Comparative Interactomics of DR]. The interactomes of yeast, worm and fly were
integrated with their respective DR triggered gene expression changes and condensed interaction
networks were generated via the ExprEssence algorithm (Warsow, et al., 2010). These networks were
further condensed until the representative graph contained approximately 1,000 genes. Two graphs for
each species were created, one containing only startups (induced interactions), while the other contained
only shutdowns (suppressed interactions), thus partitioning the interactions of up- and down-regulated
genes, respectively.
Next, DAVID was used to retrieve the functionally enriched terms for each graph, retaining only the terms
common to either all startups or all shutdown networks which surpass a q-value < 0.05. Subsequently,
p-values were combined across all three species (Table 5: Changed Interactions by DR Common to
Invertebrates; see Methods). Suppressed interactions were enriched for terms associated with translation
such as ribonucleoprotein, structural molecule activity and ribosome. This is consistent with previous
observations that downregulation of translation or ribosomes extends lifespan in diverse organisms from
yeast to mammals (Steffen, et al., 2008; Hansen, et al., 2007; Kapahi, et al., 2004; Selman, et al., 2009).
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_Figure 33: Comparative Interactomics of DR. Comparing the influence of gene expression changes
upon DR, in multiple interactomes. The interactomes of yeast, worm, and fly were integrated with gene
expression information upon DR and condensed interaction networks generated via the ExprEssence
algorithm (Step 1). Interaction networks restricted to either suppressed or stimulated interactions for
each species were created (Step 2). The suppressed and stimulated networks were then separately
compared for common significant functional enrichments (Step 3). Functional terms which were
common to suppressed and induced interactions upon DR in yeast, worm, and fly are listed with their
respective p-values [Table: 5 Changed Interactions by DR Common to Invertebrates; Table: 6 Changed
Interactions by DR Common to Invertebrates and Mammals].
Stimulated interactions mostly occurred between genes involved in modifying chromatin structure such as
chromatin regulator, chromatin modification, and chromosome organization, genes associated with
117
reproductive developmental/cellular processes as well as cell cycle and stress response. Strikingly, the
majority of these genes associated with cell cycle are involved in meiosis with p-values of <1e-19, <1e-46,
and <1e-5 for yeast, worm, and fly, respectively. In accordance with the functional enrichment analysis of
DR-essential networks, the comparative interactomics changes suggest that DR both stimulates and
suppresses interactions associated with phosphoproteins and nucleus [Table 6: Changed Interactions by
DR Common to Invertebrates]. To unravel the relationship between these two broad terms all kinases and
phosphoproteins in yeast known to be localized in the nucleus were identified (using Gene Ontology
annotation), that are either up- or down-regulated upon DR. The induced and suppressed nuclear kinases
are significantly enriched for meiosis (each q-value < 1e-4). While most of the induced nuclear kinases are
positive regulators, the suppressed nuclear kinases are mainly negative regulators of meiosis, indicating
that DR in yeast promotes the initiation of meiosis. Interestingly, yeast genes associated to meiosis,
according to Gene Ontology (161 genes), had an overall average gene expression increase of 2.7 upon
DR (higher than expected by chance; Mann Whitney U test p-value = 0.002) and together with all their
interaction partners were on average two-fold upregulated (Mann Whitney U test p = 0.003). Induced
nuclear phosphoproteins (i.e. substrates of kinases) are enriched for protein phosphatases (q-value <
1e-23), ER-nuclear signalling (q-value < 1e-4), MAPK signalling, Mn (q-value < 1e-4), sexual
reproduction/reproductive cellular process (q-value < 6e-3/0.03), while suppressed nuclear
phosphoproteins were only enriched for protein phosphatases (q-value < 1e-10).
Table 5: Changed Interactions by DR Common to Invertebrates. Induced and suppressed
interactions common to yeast, worm and fly. The functional enriched terms for either up- or
downregulated interactions associated to the DR-induced gene expression changes of multiple
species (budding yeast, nematode, fruit fly) are listed.
Terms associated to stimulated
interactions p-value
Terms associated to
suppressed interactions p-value
phosphoprotein 1.55e-51 phosphoprotein 5.26e-97
nucleus 1.72e-46 ribonucleoprotein 5.15e-87
nucleotide-binding 5.61e-42 ribonucleoprotein complex 1.55e-86
ATP-binding 1.48e-39 cytoplasm 7.21e-74
cell cycle 5.82e-36 nucleus 1.54e-45
kinase 5.5e-35 nucleotide-binding 2.46e-42
serine/threonine-protein kinase 9.92e-33 ribosome 3.68e-37
cell cycle process 6.53e-30 RNA-binding 7.55e-32
reproductive developmental process 1.65e-22 structural molecule activity 3.92e-28
chromatin regulator 5.85e-14 ATP-binding 6.94e-27
chromatin modification 1.35e-13 ATP 9.92e-17
chromosome organization 3.07e-13 nucleotide binding 4.7e-09
ATP 1.92e-11 ubl conjugation 9.5e-09
reproductive cellular process 4.51e-11
repressor 1.33e-08
coiled coil 2.82e-08
cellular response to stress 3.88e-08
cellular protein catabolic process 6.82e-08
negative regulation of gene expression 4.17e-07
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Table 6: Changed Interactions by DR Common to Invertebrates and Mammals. Induced and
suppressed interactions common to yeast, worm, fly and mammals. The functional enriched terms
for either up- or downregulated interactions common to the DR-induced gene expression changes
in budding yeast, nematode, fruit fly and mammals (meta-analytic signature).
Common terms of induced interactions p-value
Common terms of
suppressed interactions p-value
phosphoprotein 7.30e-64 phosphoprotein 2.32e-116
nucleotide-binding 3.51e-50 non-membrane-bounded
organelle
2.49e-89
ATP-binding 1.31e-45 intracellular
non-membrane-bounded
organelle
2.49e-89
active site:Proton acceptor 4.27e-32 cytoplasm 4.85e-84
reproductive developmental process 8.89e-30 nucleotide-binding 1.14e-54
transcription regulation 1.88e-24 nucleus 6.20e-53
transferase 6.69e-23 regulation of cellular protein
metabolic process
4.92e-46
phosphotransferase 7.58e-17 RNA-binding 2.00e-37
negative regulation of macromolecule
metabolic process
2.40e-13 structural molecule activity 2.73e-37
negative regulation of gene expression 1.82e-12 ATP-binding 3.01e-36
negative regulation of nucleobase,
nucleoside, nucleotide and nucleic acid
metabolic process
1.64e-11 ATP 1.10e-23
negative regulation of nitrogen
compound metabolic process
1.73e-11 nucleotide binding 5.09e-23
negative regulation of transcription 2.23e-11 kinase 2.32e-18
negative regulation of macromolecule
biosynthetic process
4.77e-11 stress response 5.07e-17
mutagenesis site 1.34e-10 purine ribonucleotide
binding
9.49e-15
regulation of transcription from RNA
polymerase II promoter
1.78e-10 ribonucleotide binding 9.49e-15
ubl conjugation 2.70e-06 purine nucleotide binding 1.38e-13
•  
binding site:ATP 1.50e-12
•  
nucleotide
phosphate-binding
region:ATP
3.01e-12
•  
phosphotransferase 3.94e-12
•  
nuclear lumen 1.74e-10
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An interaction network of these kinases in yeast and their direct interaction partners restricted only to direct
physical interactions in the nucleus was generated [Figure 34: Nuclear Phosphorylation Network of Yeast].
IME2, which is the second most upregulated nuclear kinase upon DR, acts on the induced transcription
factors IME1 and NDT80 as well as on the suppressed SUM1. In C. elegans, induced kinases were also
enriched among other terms for female meiosis (q-value < 0.03). In line with the enrichment of
reproduction-related terms in the DR-essential network in Drosophila, induced kinases restricted to the
nucleus were enriched for female gamete generation/sexual reproduction/regulation of cell
cycle/multicellular organism reproduction (q-value < 5e-3/0.02/0.02/0.02. Finding upregulation of
reproduction-related genes is surprising given the known suppressive effect of DR on reproduction
(Shanley & Kirkwood, 2000).
_
Figure 34: Nuclear Phosphorylation Network of Yeast. DR-upregulated genes are shown in red and
downregulated genes in green. Kinases are marked by a golden halo.
To extend the approach to mammals, the transcriptional signatures of DR in mammals (Hong, et al., 2010;
Swindell, 2008a; Swindell, 2008b; Swindell, 2009), which are about 1348 genes, were utilized and pseudo
intensities generated of 2.0 and 0.5 corresponding to genes which are consistently across tissues and
experimentally settings up- and downregulated (the default is set to 1.0). Among the terms identified to be
consistently significantly (p-value < 0.05) associated to the induced interactions in yeast, worm, fly and
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mammals were phosphorylation-related terms and reproductive developmental process [Table 6: Changed
Interactions by DR Common to Invertebrates and Mammals].
The DR-essential genes networks in S. cerevisiae and C. elegans were enriched for sporulation/meiosis
and meiosis respectively, although the latter was not significant. Reproduction-associated genes such as
mes-4 are also significant interaction partners of DR-essential genes (total = 17; specific = 4; specificity =
0.24; p-value = 9.87e-05).
In C. elegans induced meiotic related kinases were air-2 (Aurora/Ipl1 Related kinase), kgb-1 (Kinase,
GLH-Binding), mek-1 (MAP kinase kinase or Erk Kinase), plk-1 (POLO Kinase), zen-4 (Zygotic epidermal
Enclosure defective).
In fruit fly, reproduction associated induced genes were, for instance Axn (Axin), CDC2, cycE (Cyclin E),
TOP1 (Topoisomerase 1) and dap (dacapo) as well as CDC2 (Cell division control protein 2 homolog),
Ikb1 (DmeI_CG9374), baz (bazooka), koko (kokopelli), put (punt), sax (saxophone).
dDnmt2 (MT2), its interaction partner Ipod as well as psq and 3 isoforms of lola were translational
upregulated upon DR. Rbf is downregulated on the transcriptional level.
There was even an enrichment for stem cell division (q-value = 7.0e-3) in the DR-induced nuclear kinases
of Drosophila.
Even mammals induce expression of nuclear kinases which were enriched for response to DNA damage
stimulus (q-value = 2.4e-2): Csnk1e (casein kinase 1, epsilon), Cdkn1a (p21), Foxo3h, Gtf2h1 (p62, which
is related to autophagy) and Msh2 (mutS homolog 2).
DR induces the expression of genes annotated with embryogenesis (23 in mice); however it did not reach
significance.
In the mammalian interaction network of DR-differentially expressed genes the most upregulated term was
acetylation (p-value = 3.9e-15; q-value = 8.04e-13). Reproductive developmental processes was among
the terms of the induced interactions in mammals (p-value = 0.037; q-value = 0.48). Among the
upregulated genes in this category were Cited2, Pten, Msh2, Dld (dihydrolipoamide dehydrogenase),
Nrip1 (nuclear receptor interacting protein 1) and Hsd17b4 (hydroxysteroid (17-beta) dehydrogenase 4).
To mention there are two DR-induced transcription factors associated to reproductive development:
ZBTB16 and FOXO3 (a DR-essential ortholog).
4.3.6   Transcription Factors Governing the DR Signatures from Yeast to
Mammals
To ascertain the underlying cause of differential expression upon DR gene regulatory networks
(transcription factor - target gene interactions (Abdulrehman, et al., 2011; Balaji, et al., 2006)) were utilized
to identify candidate transcription factors responsible for the differential expression upon DR. The criteria
were, firstly, factors which regulate DR-differentially expressed genes with a high specificity, and secondly,
interact with DR-essential genes either at the physical or genetic level.
In yeast, transcription factors which had very high specificity (i.e. specific / total interactions in %) for
controlling DR-induced genes were in addition to nutrient-sensing, e.g. Msn2/4 (26%), Gis1 (53%), Mig1
(40%), and stress-responsive transcription factors, such as Hsf1 (34%), which are known to be important
for DR-induced lifespan extension, strikingly also meiotic transcription factors, like Ime1 (41%), Ume1
(75%), Ume6 (38%) and Ndt80 (26%).
Sequences (500 bp upstream) of the promoter regions in yeast of the more than two-fold differentially
expressed genes were scanned/examined for motif enrichment (hypergeometric test) and indeed
upregulated genes are significant enriched for the STRE (stress-response element; p-value =
0.0034/5.67e-4), PDS (post-diauxic shift) element (p-value = 3.89e-7/3.37e-3), URS1 (upstream regulatory
sequence; p-value = 1.09e-3), MSE (middle-sporulation element; p-value = 3.85e-3) including the motifs of
Ume6 (p = 6.71e-6), Ime1 and Ndt80 (p = 0.013324). Motifs of Ume6, Ime1 and Ndt80 were highly
enriched in the promoters of DR-induced genes, while the motif of the repressor of meiosis initiation,
Rme1, is significant enriched in the downregulated gene promoters [Table 7: TFBSs Enriched in Yeast
DR-Differentially Expressed Genes]. Interestingly, URS1 as well as motifs of Ume6, Sum1, Ndt80 and
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Ime1 are even enriched in the upstream sequences of DR-essential genes [Table 8: TFBSs Enriched in
Yeast DR-Essential Genes]. Also in another signature of DR (Lin, et al., 2002), meiotic binding motifs were
significantly enriched in the 500 bp upstream regions of induced genes. For instance, YGNCACAAAW
(NDT80) was present in 11 DR-induced genes of the 14 genes in the genome harbouring such a motif
(p-value = 0.0025, q-value = 0.029). In this signature Ime1 and Ndt80 had also a high specificity to
regulate DR-differentially expressed genes [Figure 37 Transcriptional Regulation of DR in Yeast]. NDT80
transcript level increase as function of the strength of restriction (Lee & Lee, 2008) and were found to be
2.6-fold elevated in the DNA microarray data generated in this study at 0.5% glucose concentration.
Table 7: TFBSs Enriched in Yeast DR-Differentially Expressed Genes. Meiotic transcription factor
binding sites are significantly enriched in the promoters of DR-differentially expressed genes.
Factor Motif Targets #Up #Down Up p-value Down p-value
Ume6 TSGGCGGCTAW 56 25 10 6.71e-6 0.32
URS1 DSGGCGGCND 216 68 31 3.57e-5 0.83
Ime1 TRGSCGSCKA 78 27 13 0.0008 0.42
MSE HDVKNCACAAAAD 122 35 13 0.0084 0.26
Ndt80 YGNCACAAAA 77 23 10 0.0133 0.76
Rme1 GWACCTCAARA 8 0 5 1 0.00041
Table 8: TFBSs Enriched in Yeast DR-Essential Genes: Meiotic transcription factor binding sites
are significantly enriched in the promoters of DR-essential genes.
Factor Motif p-value
URS1 GGCGGC 0.0009
Ume6 SGCGGYWV 0.002
Sum1 GYGWCASWAAW 0.009
Ndt80 YGNCACAAAA 0.04
Ime1 TRGSCGSCKA 0.04
In C. elegans the p53 homolog CEP-1 is associated to reproduction and its motif (RCWWGYYY) is
significant enriched (p-value = 0.048) in the regulatory regions (+800 to -500) of the DR-induced genes
(glucose restriction (Lee, et al., 2009), > 1.5-fold-change). The top cluster of terms enriched in the 907
DAF-16/FOXO target genes is multicellular organism reproduction (q-value = 7.9e-5) (Schuster, et al.,
2010). Among them is for instance the single lamin gene in C. elegans lmn-1 that is ubiquitous, expressed
in all cells except in cells undergoing spermatogenesis. The 98 progeric genes in C. elegans which shorten
long-lived daf-12 mutants lifespan are significantly enriched for larval development (p-value = 4.5e-10;
q-value = 8.4e-8), and reproductive developmental process (p-value = 3.3e-9; q-value = 2.5e-7). dFOXO is
a positive regulator of sexual reproduction related genes in an Insulin/IGF-like signalling mutant as
evidenced by a high enrichment of sexual reproduction associated genes (q-value = 4.7e-2) among those
genes that are physically bound by dFOXO, downregulated in short-lived dFOXO-/- mutant and
upregulated in long-lived dominant-negative insulin receptor overexpression mutants (Alic, et al., 2011).
Next the mammalian promoter regions of DR-differentially expressed genes were scanned for enrichment
of cis-regulatory elements and again factors interacting with DR-essential orthologs which are associated
to reproductive processes had a high significant enrichment of their motifs in the regulatory sequences of
the upregulated genes in the mammalian DR signature [Table 9 TFBSs Enriched in Mammalian
DR-Differentially Expressed Genes].
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_Figure 35: Transcriptional Regulation of DR in Yeast: Transcription factors identified via
guilt-by-association to regulate DR-differentially expressed genes.
Table: 9: TFBSs Enriched in Mammalian DR-Differentially Expressed Genes: Reproductive
development-related factors are enriched in the promoters of the mammalian DR signature. The
binding sites of transcription factors involved in reproductive development are significantly
enriched in the promoter regions of DR-upregulated genes in mammals.
Factor Motif
# All
motif
# Delta
motif
#
Up
#
Down
Up
p-value
Down
p-value
Delta
p-value
Foxo3 TTGTTTAC 1182 58 26 23 0.006 0.300 0.005
Zbtb16 TACTGTAC 548 27 14 8 0.007 0.632 0.028
Ppara AGGTCAWAGGTCA 13 1 1 0 0.012 1 0.071
Nr5a1 YCAAGGYC 6006 268 100 135 0.030 0.178 0.110
FOXA1 TGTTTGC 4271 169 78 77 0.0001 0.211 0.002
The target genes of Zbtb16 are mostly enriched for reproductive development process (p-value = 1.8e-2)
and acetylation (p-value = 1.9e-2): Msh2, Pten, Nrip1, Atp5a1 (acetylated in liver mitochondria from fasted
mice but not from fed mice), Plekhf1, Pura (transcription factor that activates c-Myc). The only significant
target gene of Ppara with a perfect match of its consensus sequence is Narf (nuclear prelamin A
recognition factor), which is interesting as the only nuclear proteins which are prenylated in mammalian
cells are prelamin A and B encoded by LMNA, a gene associated to heterochromatin organization and
premature ageing.
As enrichment for the motifs of reproduction-related transcription factors was found even in the promoter
regions of DR-essential genes and lower dS values than expected by chance, it was tested whether this is
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a conserved feature of DR-essentiality even in humans. Indeed, DR-essential orthologs were enriched for
the motifs of defined factors [Table 10 TFBSs Enriched in Human DR-Essential Gene Orthologs].
Table 10: TFBSs Enriched in Human DR-Essential Gene Orthologs: Reproductive
development-related factors are enriched in the promoters of human DR-essential gene orthologs.
The binding sites of transcription factors involved in reproductive development are significantly
enriched in the promoter regions of mammalian DR-essential gene orthologs.
Factor Motif # All motif # Delta motif p-value
TP63 RRRCWYGYYY 7652 67 0.003
FOXA1 TGTTTGC 4271 37 0.007
HSF1 ATGGAABD 5807 49 0.008
FOXO3 TTGTTTAC 768 9 0.010
ZBTB16 TACTGTAC 351 4 0.042
TP63 is a DR-essential ortholog and itself regulates DR-essential gene orthologs. PPARA and CITED2 are
also direct target genes of p63, whereas PPARA regulates specific TP63 isoforms (Pozzi, et al., 2009).
_
Figure 36: TP63 and ZBTB16 Interactions: TP63 and ZBTB16 are significant interaction partners of
DR-essential genes and targeted by CDK2/Ime2. Genes up- or downregulated upon DR are in red and
green, respectively, while genes which were enriched for up- and downregulation are in yellow.
DR-essential orthologs are marked by a golden halo.
Heat shock factor 1 (HSF1) and FOXO3 are DR-essential orthologs while ZBTB16 is novel. The
mammalian factors identified on the basis of sequence analysis are also significant interaction partners in
the networks of DR-essential orthologs in mouse with Foxo3 (p-value = 7.14e-9), Hsf1 (p-value = 1.41e-7)
and Zbtb16 (p-value = 7.36e-4) as well as in humans with HSF1 (p-value = 0.017), ZBTB16 (p-value =
0.020), TP63 (p-value = 0.041). ZBTB16 and TP63, both are targets of CDK2, the mammalian Ime2
homolog [Figure 36 TP63 and ZBTB16 Interactions].
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ZBTB16 is downregulated by TP63 RNAi, indicating that it is either a direct or indirect target gene of TP63.
DR-essential NNMT1 is right upstream of ZBTB16 in mouse and humans. ZBTB16 and TP63 are
coexpressed in stem cells (Majo, et al., 2008). TP63, BMI1 and ZBTB16 mediate proliferation potential of
cells via parallel pathways through various gene transcription and silencing programs (Senoo, et al.,
2007).
TP63 bound genes are enriched for response to nutrient levels (22 genes of 551; q-value: 3.2e-4) and
regeneration (p-value = 1.3e-3) as well as negative regulation of cell differentiation (q-value = 8.1e-3) and
reproductive developmental process (p-value = 1.8e-2) (Barton, et al., 2010); (Vigano, et al., 2006). Genes
identified to harbour a TP63 consensus sequence within 800 bp of their transcription start sites (TSS) are
enriched for reproductive developmental process p-value = 2.7e-2 (CITED2, DDX25, CENPI, CEP57,
EIF2B2, FOXA1, PDE3A as well as NOTCH1), vacuole/lysosomal genes (ACP2, ADRB2, CTNS) and
nucleolus. Zbtb16 target genes with a recognition sequence within 800 bp of the TSS are enriched for
zinc-finger (q-value = 2.2e-2; p-value = 7.5e-5), RhGAP (p-value = 8.6e-4) and gamete generation / sexual
reproduction (p-value = 4.7e-3) with for instance Oct4, Dnmt3l, Cctc, and Pparg.
4.3.7   DR-Essential Genes Are Triggered by Lifespan-Extending Spermidine
Comparing different longevity interventions for their commonly regulated processes may allow us to
pinpoint the gene expression changes most essential for lifespan extension. Similar to DR, treatment with
the polyamine spermidine extends lifespan in multiple model organisms such as yeast, worm, fruit fly, as
well as in human cells in vitro (Eisenberg, et al., 2009).
It was found that, in yeast (Chattopadhyay, et al., 2009), spermidine treatment causes differential
expression of DR-essential genes more often than expected by chance: at a threshold of two-fold change,
15 of the 70 DR-essential genes were among the 727 spermidine-differentially expressed genes
(hypergeometric p-value = 0.003). This effect appears to be very specific as there was no enrichment
observed among genes induced by spermine, another polyamine, which has not to the current knowledge
been shown to affect lifespan. Moreover, DR and spermidine signatures regulate an overlapping set of
genes (far more likely than expected by chance): at two-fold change, 323 of 727 spermidine-differentially
expressed genes were among the 2560 DR-differentially expressed genes (hypergeometric p-value =
4e-4), whereas genes regulated by DR and spermine did not overlap more than expected by chance at
any cut-off (e.g. hypergeometric p-value = 0.69 for two-fold changes).
Comparison of the transcriptional signatures of DR (derived from DNA microarray data of this study here)
and spermidine treatment by looking for common functional enrichment terms among genes differentially
expressed with DR and spermidine, indicates that both DR- and spermidine-upregulated genes are highly
enriched in sexual sporulation (q-value < 1e-3), peroxisome (q-value = 1e-3), mitochondrion (q-value <
0.02) and ubiquitin conjugation pathway (q-value < 1e-3) and downregulated genes are enriched in sterol
metabolic process (q-value < 0.05) as well as pentose transmembrane transporter activity (q-value =
0.014). The set of common functional terms enriched by both spermidine and DR treatments (at a
1.5-fold-change threshold) revealed that both induce autophagy, heat response and sporulation.
Spermidine treatment leads to both a significant induction and suppression of sporulation/meiosis genes
and strikingly similar to DR, induces NDT80 expression.
4.3.8   Proteins and Chromatin Marks Associated to DR-Differentially Genes
DR-differentially expressed genes were scanned in yeast for enrichment and depletion of
chromatin-associated proteins and chromatin modifications (Kurdistani, et al., 2004; Pokholok, et al., 2005;
Xu & AL, 2005) and it was found that indeed they are enriched and depleted for specific DNA-binding
proteins as well as histone acetylation and methylation marks. For DNA-binding proteins their
overrepresentation was examined in the two-fold differentially expressed genes with a hypergeometric
test. DR- and spermidine-induced genes were most strongly enriched for Ume6 and Sum1, respectively.
Specifically for chromatin marks, the comparisons up versus down and differential versus non-differential
(two-fold) was tested (by a binomial test). DR-induced genes were enriched and DR-suppressed genes
were depleted for H3, H3K4me1/me2 / K14ac / K14me3/K27ac / K56ac / H4K8ac (p-values:
2.1e-2/2.0e-10/2.9e-4/8.7e-3/1.7e-15/9.6e-10), H2BK11ac/K16ac (p-values: 9.6e-10/5.6e-10) and Gcn4
125
binding (p-value = 7.3e-4), while it was vice versa for H3K9ac/K18ac/K36me3 (p-values:
5.3e-4/5.03e-7/2.33e-9) and H4K79me3 (p-value = 4.6e-4).
Spermidine treatment, which extends lifespan of multiple species, is also associated with specific
chromatin marks on the differentially expressed genes, but it appears to oppose global histone mark
changes on the up- vs. downregulated genes by DR in the opposite manner, while enriched or depleted in
the same direction by the comparison differential vs. others. For instance, the differentially expressed
genes (both up- and downregulated genes) by DR and spermidine are enriched for H3K56ac by 0.012
and 0.022 but greatly depleted on other non-differentially expressed genes by 0.0098 and -0.0026,
respectively (binomial p-values: 0.002 and 0.03).
4.4   Discussion
4.4.1   Molecular Conservation of DR-Essential Genes
The findings here show that DR-essential genes are conserved at the molecular level, interact with each
other more than expected by chance and therefore allow identification of novel candidates via the
guilt-by-association principle.
DR-essential genes interact with phosphorylation-related and ageing genes. Nutrient-sensing signalling is
intrinsically coupled to growth regulation and a link between growth and DR signalling pathways is
well-established (de Magalhaes, et al., 2012). Some growth programs are differentially important in various
organisms that may be reflected in other effectors downstream DR in different species. In addition, terms
associated with translation were suppressed in the comparison of the interactomes of multiple species
[Table 5: Changed Interactions by DR Common to Invertebrates], again in line with previous findings (de
Magalhaes, et al., 2012).
DR may be considered to act as a nutritional stressor. Gluconeogenesis genes located at subtelomeric
regions are known to be upregulated by stress (Mak, et al., 2009) via evolutionarily conserved epigenetic
control (Smith, et al., 2011). In fact, key enzymes and factors of gluconeogenesis are induced by DR which
may sequester TORC1 (Brown, et al., 2010) away from its normal functioning membranes (i.e. vacuolar
and endosome membrane, etc.).
Rpd3 deacetylation mediates Ume6 transcriptional repression activity (Rundlett, et al., 1998), which is
converted to an activator by Ime1 binding and Ime2 phosphorylation. DR-essential HSF1 is already known
to be involved in gametogenesis in mammals and even to be essential for meiosis (Akerfelt, et al., 2010;
Bierkamp, et al., 2010; Le Masson, et al., 2011; Metchat, et al., 2009). Inducible HSF1-binding sites are
associated with histone acetylation (Guertin & Lis, 2010).
The finding that DR-essential genes are molecular conserved reflects the observation that DR extends
lifespan in various evolutionary distant related organisms (yeast, worm, fly, spider, fish, dog, hamster,
mouse, rats, monkeys, etc.).
Via the guilt-by-association concept novel DR-essential genes were identified primarily implicated in drug
detoxification, transition metal ion homeostasis and vacuolar trafficking / endocytosis, as well as a
potential role of S-adenosylhomocysteinase as a common interactor of DR-essential genes in yeast,
worm, fly and mammals. Several DR-essential genes change their expression level upon DR, some even
across species, such as genes encoding the S-adenosylmethionine synthetase activity. DR-differentially
expressed genes are associated with specific chromatin marks on AL, some are even shared with lifespan
extending spermidine treatment.
Here it was found that S-adenosylmethionine synthetase is commonly differentially expressed upon DR,
while S-adenosylhomocysteinase is commonly interacting specifically with DR-essential genes in multiple
organisms.
Kinase signalling is dramatically suppressed in very long-lived PI3K mutant worms, and
S-adenosylhomocysteinase, several insulin-like peptides, and DAF-15 all turn up in proteomics and
phosphoproteomic studies.
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A common theme of longevity mutants is the silencing of multiple signalling pathways, which is also
evident in an attenuation of total kinase activity resulting in proteome-wide reduced phosphorylation in, for
instance, strong alleles of age-1 mutants (Shmookler Reis, et al., 2009).
It is clear that diet alters epigenetic marks (i.e. chemical tags such as acetyl or methyl groups) and results
in an altered chromatin state. Stress alters the methylation state of histones in fruit fly with
transgenerational inheritable effects (Seong, et al., 2011). The lifespan prolonging effect of DR is inherited
to the next generation in rotifer (Kaneko, et al., 2010). Deficiencies in H3K4 trimethylase complex
components ASH-2, WDR-5 or SET-2 in parental generation extend lifespan of descendants up until the
third generation (Greer, et al., 2011). Moreover, diet has also been shown to alter gene expression
transgenerationally in mammalian species (Flintoft, 2011; Ng, et al., 2010). In humans the rate of mortality
is affected in a transgenerational manner by food intake in the parental generation (Kaati, et al., 2007).
Food intake in one generation influences genes expression (Benyshek, et al., 2006), glucose and
cholesterol metabolism (Benyshek, et al., 2006; Carone, et al., 2010) and β-cell function (Ng, et al., 2010)
in the subsequent generation in mammals. Thus, dietary intake affects chromatin marks that may not be
completely erased between generations. The lifespan prolonging effect of DR can be mimicked or blocked
by α-lipoic acid supplementation during AL, which exerts a memory effect of the previous feeding regimen
in feeding switch experiments (Merry, et al., 2008) and is associated with an altered proteome acetylation
state, with a hyperacetylated state linked to longevity. Taken together this evidence indicates that an
altered chromatin state in DR is its principal major lifespan extending mechanism across species
boundaries, but why and how?
4.4.2   Differential Expressed DR-essential Genes
Numerous DR-essential genes and their orthologs exhibit the expected change already either on the
transcriptional or translational level. However, this was not observed at the genome-scale at all cutoffs.
For commonly used cutoffs, DR-essential genes are not more likely to be differentially expressed than
expected by chance. The problem here may be that in yeast there are at least 3 different longevity
definitions used in the literature and at least as many different versions of DR. If one focused on just one,
say replicative lifespan (the bud counting assay), and moderate glucose withdrawal (0.5%), a significant
enrichment might be seen. The microarray data showed that numerous DR-essential genes are
differentially regulated by DR. Moreover, other longevity manipulations such as spermidine treatment also
differentially regulate DR-essential genes. Thus the systems biology analysis here can be expanded to
other organisms and be predicted that longevity might converge on influencing intracellular polyamine
levels.
4.4.3   PI3K
PI3K activity positively regulates organismal reproduction and developmental progression. However, at
the cellular level it inhibits the expression of reproductive (i.e. germline) genes in the somatic cells. Thus
ectopic downregulation of PI3K ceases organismal reproduction, but induces germline-trait-like expression
in the soma. Fascinating, PI3K tightly regulates gametogenesis in mammals.
4.4.4   FOXOs Regulate Entry Into Gametogenesis
FoxOs promote organismal longevity in invertebrates, and in humans single nucleotide polymorphisms in
FOXO3 are associated with extreme longevity (Kenyon, 2010).
Foxo1 mediates some aspects of the DR effect (Yamaza, et al., 2010). PI3K signalling regulates stability
and subcellular localization of Foxos, including Foxo1 (Goertz, et al., 2011). FoxOs control key aspects in
stem cell maintenance as they regulate self-renewal in hematopoietic and neural stem cells (Paik, et al.,
2007; Tothova, et al., 2007; Renault, et al., 2009). FoxOs, particular Foxo3 co-ordinately regulates neural
stem cell homeostasis through genes influencing stress response and oxygen metabolism (Renault, et al.,
2009; Paik, et al., 2007). FoxOs regulate hematopoietic stem cell differentiation and assist long-term
maintenance by protecting against oxidative stress.
FoxO function in male and female germ-line shares some similarity. FoxOs evolved to control
gametogenesis within the gonad itself. Whereas Foxo1 is highly expressed in undifferentiated
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spermatogonia, Foxo3 is highly expressed in primordial oocytes, in which it serves to retrain their growth
(John, et al., 2008). Foxo3 function in female germ line maintenance (Castrillon, et al., 2003; John, et al.,
2007; John, et al., 2008; Brenkman & Burgering, 2003), while Foxo1 controls multiple steps of
spermatogenesis, from SSC proliferation and self-renewal to progression of spermatogenesis, including
meiosis. Spermatogonial stem cell (SSC) are capable of self-renewal and immortal growth. Foxo1
specifically marks mouse gonocytes and a spermatogonia subset with stem cell potential. Foxo1 was
required for both spermatogonial stem cells homeostasis and initiation of spermatogenesis. Combined
deficiency of Foxo1, Foxo3, and Foxo4 resulted in a severe impairment of SSC self-renewal and a
complete block of differentiation, indicating that Foxo3 and Foxo4 contribute to SSC function. PI3K
controls both SSC maintenance and differentiation. The PI3K-Akt pathway is the principal pathway
regulating Foxo1 subcellular localization and activity in the context of spermatogenesis. FoxOs appear to
control a network of genes unique to spermatogenesis. FoxOs join the growing network of transcription
factors - including Zbtb16 and Taf4b - that control early steps of spermatogenesis, including SSC
self-renewal (Buaas, et al., 2004; Falender, et al., 2005).
Forkhead transcription factors control crucial steps in embryogenesis and are essential for the
development of all germ layers and organs (Lehmann, et al., 2003). Foxo3-/- mice exhibit signs of
accelerated ageing and have global follicular activation, therefore become prematurely infertile too
(Castrillon, et al., 2003). Primordial follicles (which are in pre-meiotic phase) might be regarded as being in
a state of developmental arrest. To maintain this arrest, FoxO3a is apparently necessary. Forced FoxO
activation induces also an reversible arrest in C. elegans, Drosophila (Kramer, et al., 2003) and in
mammalian cells (Kops, et al., 2002). In general FoxOs are capable of causing a reversible arrest. Stem
cells are an example of reversible arrested cells that can re-enter proliferation and/or differentiation.
FoxO-regulated genes are required for the maintenance of satellite cells, which include p27Kip1 and
p130/Rb2, both of which are also required for muscle differentiation (Bois & Grosveld, 2003).
The unique genetic requirement for Foxo1 in males and Foxo3 in females mirrors their high expression at
discrete cellular stages in spermatogenesis or oogenesis.
FoxOs together with ZBTB16 control early steps of spermatogenesis. Foxo1 and ZBTB16 were always
coexpressed during spermatogenesis, where their expression was restricted to undifferentiated
spermatogonia. ZBTB16 indirectly regulates mTOR activity (Fraser, et al., 2002).
Foxo1 transcriptome in male germ cells was distinct from that in other cell types, for which genes
regulating oxidative stress resistance were rendered as major targets (Tothova, et al., 2007; Renault, et
al., 2009; Paik, et al., 2009).
GnRH (gonadotropin-releasing hormone) regulates FOXOs. FOXOs regulate LHB subunit expression.
Foxo targets GADD45, FasL, p21Cip1 and p27Kip1. Foxo3a mediates GADD45 and FasL expression in
response to GnRH. GnRH is an essential regulator of the reproductive processes by stimulating the
synthesis of LH (Luteinizing Hormone) and FSH (Follicle-Stimulating Hormone) in pituitary gonadotropes,
thereby regulating gametogenesis and steroidogenesis (Stavrou, 2011).
4.4.5   ZBTB16
Loss-of-function mutations in ZBTB16 also called promyelocytic leukemia zinc finger protein (PLZF) cause
an age-dependent loss of germ-line stem cells leading to sterility. ZBTB16 is expressed in germ-line stem
cells and is required for their self-renewal. ZBTB16 facilitates transcriptional repression through
recruitment of chromatin modifying enzymes to specific DNA sequences.
4.4.6   eor-1
Blasting ZBTB16 identified blmp-1 as the closest sequence homolog, which directly regulates cep-1/p63.
However, eor-1 is the C. elegans ortholog of mammalian ZBTB16 (Zhang, et al., 1999). ZBTB16 does
influence developmental patterning and Hox gene expression in mouse (Barna, et al., 2000).
Epidermal growth factor (EGF) promotes cell division and cellular differentiation in developing animals.
EGF acts through phospholipase Cy and IP3 receptor signalling maintains pharyngeal and body wall
muscle formation in ageing adults and delays accumulation of lipofuscin-enriched ageing pigments within
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intestinal cells. EGF also acts through RAS/ERK pathway to regulate protein homeostasis by promoting
antioxidants gene expression, stimulating activity of the ubiquitin proteasome system (UPS) and
repressing expression of small heat shock protein chaperones. Effects of EGF signalling on lifespan are
largely independent of IIS, as effect of, EGF signalling mutants on lifespan are largely independent of
DAF-2 and DAF-16 mutants. However, these two signalling pathways have multiple points of overlap,
coordination and cross talk. IIS and EGF signalling respond to environment and to developmental timing,
respectively. let-23 loss-of-function mutant had a decreased lifespan when raised at 20 degree Celsius.
eor-1 is oocyte enriched. eor-1 and eor-2 act downstream or in parallel to SynMuv/Rb pathway to promote
RAS/ERK-dependent transcription. EOR-1 interacts with SynMuv B pathway component LIN-36, a
possible histone deacetylase complex component (Thomas & Horvitz, 1999; Walhout, et al., 2000; Howard
& Sundaram, 2002). SynMuv gene products could antagonize Ras signalling in part by binding to and
inhibiting activity of positively acting transcriptional regulators such as EOR-1. LIN-36 EOR-1 interaction
could also be involved in positive role of some SynMuv N genes (Chen & Han, 2001). eor-1 regulates
cooperatively Hox-dependent patterning (Howard & Sundaram, 2002).
4.4.7   Transcription Factor Mediated Rejuvenation Triggered by Dietary
Restriction
TP63 overexpression increases ROS levels and ROS sensitivity (Ellisen, et al., 2002). The optimal
consensus motif of p63 consists of a C(T)TG core and an AT-rich 5' and 3' flanking sequence (Ortt &
Sinha, 2006), which differentiates it from its paralog p53. The consensus motif gene that are regulated by
p63 were identified (Perez, et al., 2007). p53 gene family target genes were predicated from gene
expression profiles of mutants and pattern matching (Sbisa, et al., 2007). The function of its homolog TP53
in ageing is controversial. Moderate overexpression of p53 in fruit fly can lead to lifespan extension (Hur &
Walker, 2009), while Dmp53-null mutants develop into adults, but display mild defects in longevity and
reproduction (Lee, et al., 2003). In fruit fly the process of meiotic recombination instigates programmed
activation of p53 in the germ line (Lu, et al., 2010b). Fly p53 regulates neural stem cell self-renewal
(Ouyang, et al., 2011). Expression of short and long p53 isoforms may maintain a balance between tumor
suppression and tissue regulation (Maier, et al., 2004).
4.4.8   Characterization of DR-Essential Genes
Here a class of genes that is essential for the lifespan extending effect of dietary restriction was defined
and members in different species compiled and characterized at the level of molecular evolution and
molecular interactions. Those DR-essential genes were found to be more conserved than expected by
chance and more likely to interact with each other, indicating that they are evolutionary conserved and
acting together in a network. Based on this assumption, a guilt-by-association method utilizing the
interactome was used to predict novel DR-essential genes in multiple model organisms and humans by
performing orthologous complementation. Top candidate genes that were further restricted by filtering for
processes and location associated with DR-differentially expressed genes (autophagy and
lysosome/vacuole) were tested in lifespan experiments (by Fusheng Tang). 8 of 9 mutants were found to
affect lifespan and several were DR-essential. Further mutant cells tend to exhibit changed vacuoles.
DR-essential genes were found to be more likely to be differential expressed under DR than expected by
chance. And the effect of spermidine, which is assumed to be a DR mimetic that induces autophagy just
like DR were found to differentially express DR-essential genes far more likely than expected by pure
chance. Interaction networks were integrated with transcriptomics data of DR and commonly stimulated
and suppressed interactions identified via comparative approach across species. Potential transcription
factors governing the DR-triggered gene expression changes were identified.
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4.4.9   A Database and Analysis of Genes Essential for DR Life-Extending
Effects
Understanding the genetic basis of DR is of great importance not only to help elucidate mechanisms of
ageing but also to understand how diet can influence ageing, longevity, health, and age-related diseases,
which may have major human therapeutic applications (Bishop & Guarente, 2007; de Magalhaes, et al.,
2012). DR-essential genes are no doubt crucial pieces of the puzzle to solve the mechanism of DR
(Bishop & Guarente, 2007; Fontana, et al., 2010; Gems, et al., 2002), but to date they have not been
studied as a unified system. To address the need for a more systematic study of the mechanisms of
DR-conferred lifespan extension, GenDR was created, the first database of DR-essential genes and
indeed the first database of DR-related genes.
GenDR provides manually curated information on genetic mutations which interfere with the pro-longevity
effect of DR as well as their respective homologous genes in the major model organisms and humans.
Because different genes appear to be important in different regimens and there are conflicting findings
regarding some of them, different DR regimens across multiple model organisms are covered, allowing
researchers to focus on their preferred system. With the growing importance of network biology, functional
genomics and systems biology to study ageing and DR (de Magalhaes, et al., 2012), GenDR will be a
valuable tool for researchers to study the genetic and molecular mechanism of DR as evidenced by the
validation of vacuole mutants [Figure 27: DR Vacuole-Associated Genes Are Required for DR Lifespan
Extension and Normal Vacuolar Morphology] and gene regulatory inference.
The study of the molecular evolution of DR-essential genes [Figure 22 DR Genes Are Molecular
Conserved and Form a Tight Network] showed conservation at the molecular level reflecting the
observation that DR extends lifespan in various evolutionarily distant organisms. Interestingly,
DR-essential genes had lower dN/dS ratios than expected purely by chance, as well as lower dN and dS
values. This could indicate that natural selection has constrained not only the amino acid sequences, but
also the nucleotide sequences which may include regulatory elements. The molecular interaction data
support the observation that DR-essential genes are conserved across vast evolutionary distances, as
genes with relatively high degree, i.e. hubs, are more ancient and evolve more slowly than genes that
encode non-hub proteins (Fraser, et al., 2002; Eisenberg & Levanon, 2003; Saeed & Deane, 2006). One
caveat of this analysis is that these results may also reflect a bias in the selection of genes, as researchers
tend to study genes which have orthologs and have been shown to affect DR in other organisms. Similarly,
the result that DR-essential genes interact with each other more than expected by chance might also be
affected by selection bias, as genes studied in the context of DR are often part of similar or closely
interacting biological pathways (e.g. insulin/IGF1 signalling and TOR). Also, both DR mechanism and
ageing-effect genes tend to be enriched for signal transduction genes, especially those which are well
known to be highly conserved (Kim, 2007).
4.4.10   Network Analyses Reveal Novel DR-Essential Genes and Candidate
Mechanisms
The network analyses here successfully predicted novel DR-essential genes in yeast. This illustrates that it
is possible to associate in silico genes that are of interest in a DR context, with other, little-known genes,
and derive testable new hypotheses. Network analyses based on GenDR have therefore the capacity to
implicate new genes related to lifespan extension by DR. In particular, eight novel vacuole-related
DR-essential yeast genes that impair DR-mediated longevity when deleted were identified, of which three
(OPT2, FRE6, and RCR2) extended lifespan in AL and prevented any further lifespan extension by DR.
Although the genome-wide frequency of DR-essential genes is unknown, finding 8/9 of such genes with
3/9 extending lifespan in AL is likely much more than expected by chance and illustrates the utility of the
here employed method.
These genes had been previously implicated in drug detoxification (OPT2), transition metal ion
homeostasis (FRE6) and endosomal-vacuolar trafficking of plasma membrane proteins (RCR2, VPS20,
GTR1, SLM4) as well as a vacuolar membrane protein DAP2, plus a protein of unknown function
(YDL180W). Comparing localizations of the proteins encoded by these genes with the known DR-essential
genes in the database revealed endocytosis as one target of DR [Figure 7 Localization of Vacuole-Related
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DR Proteins & Lipids in Yeast Cells]. Moreover, the different effects on lifespan of mutants missing these
newly identified DR-essential genes [Table 4: Lifespan and Vacuolar Changes of Novel DR-Essential
Genes] prompted the speculation on the function of each endocytic step in longevity.
Figure 37: Localization of Vacuole-Related DR-Essential Proteins and Lipids in Yeast Cells. In
response to environmental triggers such as DR, membrane transporters (Opt2 and others) on the
plasma membrane are endocytosed through lipid rafts (ergosterol/sphingolipids) after ubiquitinylation.
On early endosomes, proteins and lipids are sorted to late endosomes, Golgi, or other organelles. In
late endosomes, different endosomal sorting complexes required for transport (ESCRT) push the target
proteins with their membranes into the lumen of late endosome, or multivesicular bodies (MVB).
Matured MVB can fuse with vacuoles, within which proteases and lipases (Atg15) degrade target
proteins and lipids. In mammalian cells, maturation of late endosomes is essential for activation of the
master regulator for growth, the mammalian target of rapamycin 1 (mTORC1). In yeast cells, TORC1
suppresses meiotic transcription factors which are normally only active during gametogenesis
(Colomina+Al:2003). The inhibitory effects of DR on TORC1 thus activate these rejuvenation genes.
EE: early endosome. LE: late endosome. MVB: multivesicular body. Black arrows indicate movement of
vesicles. DR-essential proteins are labelled in their localized organelles. Localization data were
extracted from the SGD database. Ypt7 localization on late endosomes was reported by
(Balderhaar+Al:2010). Green arrows indicate activation and a red line indicates an inhibitory effect.
Cells take up nutrients through plasma membrane transporters including oligopeptidase transporter Opt2
and ferrous transporter Fet3. Secretion and endocytosis determine the fate of these transporters
depending on environmental cues [Table 5 Changed Interactions by DR Common to Invertebrates]. Both
secretion and endocytosis depend on the lipid composition of membranes. Blocking ergosterol synthesis
(erg6∆) halts the degradation of Tat2, the high-affinity transporter of tryptophan, and traps it in late
endosomes (or multivesicular bodies) (Umebayashi & Nakano, 2003). Nutrient transporters destined for
degradation in vacuoles are ubiquitinated by Rsp5 (a DR-essential ortholog of C. elegans WWP-1
(Carrano, et al., 2009)) on the plasma membrane or endosomes (Nikko & Pelham, 2009). Ubiquitinated
cargoes are sorted to late endosomes, where endosomal sorting complexes required for transport
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(ESCRT) work sequentially to encapsulate the ubiquitinated transporters within the endosomal lumen.
Vps20 is a component of ESCRT III, which seals the membranes (Babst, 2011). The identification of
VPS20 as a DR-essential gene may suggest the involvement of late endosomes in longevity. In support of
this possibility, a screen for mutants that shorten yeast chronological lifespan also revealed a critical role of
the late endosome (Fabrizio, et al., 2010; Longo, et al., 2010).
For several of the mutants tested the lifespan was shorter than wild-type, which indicates that these genes
are required for normal longevity and especially for the response to DR (perhaps due to their involvement
in endocytosis). There are also four mutants (opt2∆, rcr2∆, vps20∆, fre6∆) with a shorter lifespan on DR
than on AL [Table 4: Lifespan and Vacuolar Changes of Novel DR-Essential Genes], comparable to the
“inverse DR” effect reported for erg6∆, ypt7∆, and nyv1∆ mutants (Tang, et al., 2008). These mutants are
all likely to be blocked in the maturation of late endosomes. Deletion of Rcr2 or blockage of ergosterol
synthesis (erg6∆) led to accumulation of endocytic vesicles (or a special subset of apparent vacuoles as
visualized by the dye FM4-64) that are unable to fuse with other vacuoles, and to the apparent formation of
highly fragmented vacuoles [Figure 27: DR Vacuole-Associated Genes Are Required for DR Lifespan
Extension and Normal Vacuolar Morphology B]; also see Figure 4B of (Tang, et al., 2008)). The fact that
deletion of the plasma membrane transporter OPT2 also results in fragmented vacuoles (Aouida, et al.,
2009) may indicate improper fusion between late endosome and vacuoles. The maturation of late
endosomes also depends on the proton gradient across the membrane, which is maintained by a
membrane H(+)-ATPase. FRE6 deletion could impair metal-ion efflux and consequently decrease
cytosolic iron and copper levels (Kakinuma, et al., 1981). Copper ions control the activity of membrane
H(+)-ATPase (Kakinuma, et al., 1981). As such, endocytosis appears to be essential for normal lifespan
under AL and especially for the lifespan extension response under DR conditions. Endocytosis may for
instance remove damaged plasma membrane proteins, and in higher organisms even intercellular debris.
In addition to implicating the plasma membrane/endosome/vacuole pathway as one target of DR, the
longevity of three mutants (opt2∆, fre6∆, and rcr2∆) under AL [Table 4: Lifespan and Vacuolar Changes of
Novel DR-Essential Genes] reveals a putative novel controlling mechanism of the target of rapamycin
complex 1 (TORC1). OPT2 and FRE6 exhibit negative genetic interactions with TOR1 (Chan, et al., 2000)
and TCO89 (Costanzo, et al., 2010), respectively, both of which encode components of TORC1. A
negative genetic interaction usually suggests a cooperative relationship (Costanzo, et al., 2010). Rcr2
interacts with Ypt7 in a yeast 2-hybrid assay (Ito, et al., 2001). While it is not known to be true in yeast, the
mammalian ortholog of Ypt7, Rab7, is essential for mammalian TORC1 activation (Flinn, et al., 2010). It is
thus tantalizing to speculate that TORC1 may be partially inactivated in opt2∆, fre6∆, or rcr2∆ strains.
Considering that part of TORC1 is on the vacuolar and endosomal membranes (Sturgill, et al., 2008), it is
not surprising to observe that some vacuolar membrane mutants affect the activity of TORC1. Another
beneficial effect of opt2∆ in longevity might be the uptake of life-extending polyamines (see also (Eldakak,
et al., 2010)).
4.4.11   Transcriptional Changes upon DR and Their Regulators
There was only a slight enrichment of DR-essential genes among those differentially expressed during
DR. This is not unexpected, since DR-essential genes are likely to lie upstream in the DR longevity
pathway, whereas most genes expressed differentially upon DR would tend to lie downstream in an
effector cascade. It is also possible that many DR-essential genes mediate their effects on lifespan via
transient expression, changes in protein levels, or in biochemical activities that are not reflected in
analyses of mRNA levels. The fact that it was not differentiated between the various DR regimens would
also dilute the enrichment of essential genes shared by multiple pathways. Nonetheless, numerous
DR-essential genes show strong changes at the transcriptional and/or translational level, which may
correspond to a respective change in the activity level, or might represent a compensatory response to
changes in regulation at other levels. For instance, the only validated DR-essential gene in mammals Ghr,
extends lifespan if deleted and is also found to be downregulated upon DR (Plank, et al., 2012).
Among the DR-essential homologs commonly differentially expressed in all examined species were fatty
acid elongases, which extend lifespan when downregulated in C. elegans (Shmookler Reis, et al., 2011).
In addition, DR regulates S-adenosylmethionine synthetase activity at the transcriptional/translational level
in multiple species; its product, S-adenosylmethionine (SAM), is the methyl donor for most methylation
reactions. A common significant interactor of DR-essential genes was S-adenosylhomocysteinase
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catalysing the reversible hydrolysis of S-adenosylhomocysteine (SAH), which in turn is a competitive
inhibitor of methyltransferases. SAM and SAH levels, acting via DR-essential NNT1/NNMT encoding
nicotinamide-N-methyltransferase (Anderson, et al., 2003), would impact NAD+ metabolism and
consequently NAD(+)-dependent protein deacetylases (sirtuins) which were also common interactors of
DR-essential genes. SAM and SAH levels might also exert pervasive effects via the control of
DR-essential ergosterol biosynthesis in yeast, sterol modifications in C. elegans (influencing dauer
formation), DNA methylation in mammals, as well as histone methylation and polyamine synthesis in all
species.
It is clear that diet alters epigenetic marks, resulting in an altered chromatin state that affects gene
expression (Jaenisch & Bird, 2003; Burdge, et al., 2007). The study here provides evidence pointing to a
fundamental role of chromatin in DR. Chromatin organization was among the most enriched categories of
DR-essential orthologous networks in mammals, and most strikingly several terms related to chromatin
were enriched among DR-stimulated interactions in the interactomes in multiple species [Table 5 Changed
Interactions by DR Common to Invertebrates]. Modified chromatin structure has been proposed as an
underlying mediator of ageing from yeast to humans (Feser & Tyler, 2011), and is known to be influenced
by diet (Vaquero & Reinberg, 2009). Taken together, the evidence implies that an altered chromatin state
in DR is a major component of its lifespan-extending mechanism, conserved across diverse species.
Clearly DR works via a conserved mechanism, but how does it interfere with the ageing process? A
phenomenon that is at least equally ancient and conserved is the intergenerational/meiotic reversal of all
age-related changes that had accumulated, and the restoration of lifespan for progeny (Unal, et al., 2011).
Yeast rejuvenation occurs during sporulation (the equivalent of the mammalian gametogenesis) (Unal, et
al., 2011), when transient activation of Ime1 or Ndt80 rejuvenates cells and resets their age to “zero”
(Unal, et al., 2011). Here it was found that both Ime1 (1.4-fold) and Ndt80 (2.7-fold) are induced upon DR,
leading to the speculation that DR may act on ageing via a mild, continuous form of “rejuvenation”. This
would explain why switching the feeding regimen leads to a change in the state, rather than the rate, of
ageing – i.e. it lowers the mortality level almost immediately (Mair, et al., 2003).
It was proposed that polyamine biosynthesis may be essential for meiosis and sporulation (Brawley &
Ferro, 1979). Spermidine and/or spermine are, in fact, required for sporulation (Tabor, 1981) and transition
into meiosis (Tabor, 1981). Polyamine concentration declines with age in yeast and human cells.
Supplementation with spermidine increased lifespan in yeast, worms, flies, and human cells, and a
polyamine-rich diet (as well as probiotics that induce polyamine production) decreased mortality in mice
(Matsumoto, et al., 2011; Soda, et al., 2009). Spermidine treatment results in hypoacetylation of H3K9,
H3K14, and H3K18, probably via inactivation of histone acetyltransferases. Inactivation of the responsible
histone acetyltransferases extended replicative lifespan and suppressed lifespan extension by spermidine.
While spermidine treatment leads to global histone hypoacetylation, histones on specific promoters such
as those of autophagy-related genes were actually hyperacetylated and induced in expression (Eisenberg,
et al., 2009). Increasing acetylation levels of H4K5 and H4K12 via deletion of DR-essential protein
deacetylase RPD3 also increased lifespan in yeast and Drosophila. Glucose and nitrogen regulate the
switch from histone deacetylation to acetylation of early meiosis genes (Pnueli, et al., 2004). It is
interesting to note that spermidine could only effectively extend replicative lifespan in yeast when
treatment was initiated at old ages (Eisenberg, et al., 2009), indicating that it works via a single round of
light rejuvenation. Strikingly, genes differentially expressed by DR and spermidine treatment have certain
chromatin marks in common, including histone acetylations, while on the global scale they lead to
opposing effects (data not shown). As such, it appears that spermidine might be a downstream component
of the DR-mediated lifespan extension and chromatin remodelling induced by DR awakens meiotic
rejuvenation programs. Intriguingly, induction of interactions between genes annotated with
reproduction-related terms was the key shared feature of the comparison of DR interactomes from yeast,
worms and flies.
Given the multitude of changes induced by DR, the study of DR-essential genes and their networks is an
important new tool to distinguish those genes and processes that are the “drivers” of the life-extending
effects of DR from those that are mere “passengers”. The GenDR database will therefore be valuable for
numerous researchers and this work demonstrates that DR is suited for a network-guided approach. As
anticipated, DR-essential genes are conserved at the molecular level and interact with each other more
than expected by chance. Crucially, this work demonstrates how gene network analyses of DR allow the
133
identification of novel candidates that can be tested experimentally. These results also indicate important
roles for genes involved in endosomal/vacuolar trafficking in DR lifespan extension and provide new
intriguing candidates for further studies in yeast such as OPT2, FRE6, and RCR2. Genome-wide
expression data provide further clues of which genes and processes are regulated by DR, and their
systematic integration in interaction networks was initiated in this study. Moreover, gene-regulatory
relationships and sequence-based inference both point to an important role of meiotic transcription factors
in DR. Finally, by comparing the effects of DR on the interactomes of multiple species, it was discovered
that DR suppresses translation while stimulating chromatin reorganization and a defined meiosis-related
rejuvenation process, across phyla separated by a billion years of evolution. Many questions still remain.
What is the nature of the rejuvenation processes utilized by DR to extend lifespan? What is the exact role
of polyamines in DR-induced rejuvenation? Are intracellular polyamine levels increased upon DR? And
what factors correspond to the mammalian counterpart(s) of NDT80? It is hoped that the efforts in
establishing GenDR will help to unravel the secrets of DR-conferred lifespan extension.
4.5   Contribution
Daniel Wuttke did the computational part and Fusheng Tang (Ph.D.; Associated Professor of Applied
Science; University of Arkansas at Little Rock, USA) did the experimental part. Co-authors in (Wuttke, et
al., 2012) revised the text written by Daniel Wuttke.
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5   Dietary Restriction Signatures
Abstract: Dietary restriction is the most powerful non-genetic intervention known to retard the
basic ageing process. Understanding how DR interferes with the ageing process
would be useful for understanding ageing and developing alternative interventions.
Dietary restriction gene expression profiles in human and common biomedical
model organisms were utilized to generate molecular signatures (list of genes with
differential expression metrics) representing the effect of dietary restriction on the
level of gene expression and to identify the associated genes and functional
categories enriched in the signatures. DR was found to commonly differentially
regulate the circadian clock, stress response, apoptosis and proteolysis. DR
specifically upregulates genes involved in chromatin silencing and downregulates
inflammation.
5.1   Background
Dietary restriction (DR) reprograms the transcriptome, epigenome and metabolome in a way that slows
down ageing [Molecular Profiling to Decipher Ageing]. Although it is known that the intervention increases
lifespan from yeast to primates [Dietary Restriction, Dietary Restriction Genes] the exact mechanism is not
understood. Physiological responses to dietary restriction are cell-type specific and variable throughout the
lifespan (Schafer, et al., 2015). Many studies in multiple types of tissues and varied regimens have
performed transcriptionally profiling. Several attempts on establishing consensus signatures of dietary
restriction have been made previously Molecular Profiling to Decipher Ageing]. Analysis of previous
studies on dietary restriction in mouse identified gene expression changes that are shared among multiple
tissues (Swindell, 2009). A common response to dietary restriction in diverse tissues and species was
sought to be identified. Thereby gene expression data from eight tissues of mice subjected to dietary
restriction was analysed. From this a common transcription signature was identified that includes
functional categories of mitochondrial energy metabolism, inflammation and ribosomal structure. Such
signature was detected in flies, rats and monkeys on dietary restriction suggesting to be aspects of DR
that are evolutionary conserved (Barger, et al., 2015). Meta-analysis of microarray dietary restriction
studies in mammals found genes and processes that are robustly altered such as growth hormone
signalling, lipid metabolism, and immune response (Plank, et al., 2012).
Whole-genome transcriptional profiling of DR in seven mouse strain in white adipose tissue,
gastrocnemius muscle, heart and brain neocortex lead to the the identification of tissue-specific genes that
change in expression in multiple strains with DR. Subset of those genes could be used to validate potential
pharmacological DR-mimentics (Barger, et al., 2017). Publically available microarray data was used to
analyse the expression responses to DR in males from seven mouse strains and four tissues.
Strain-specific responses were identified in respect to C57BL/6 mice. Further species-specific responses
were found (Swindell, et al., 2018).
The transcriptional response to DR have been studied for mRNAs widely, but not so much for microRNAs
(miRNAs). miRNA response induced by DR can regulate important factors in processes such as longevity
and ageing and is an integral component of the cellular response to DR (Orom, et al., 2012). DR induces a
profound change in abundance of circulating miRNAs linked to growth and insulin signalling, indicating that
miRNAs are involved in the mechanisms of DR. About 70% of the plasma miRNAs detected were
conserved between monkey and humans (Schneider, et al., 2017). The microRNA expression in mouse
breast tissue before and after DR have been characterized where several changes in the miRNA
expression profiles were found. Specifically mir203 was found to be highly induced by DR. caveolin-1 as
well as p63 are direct targets of mir203 in vivo during DR (Orom, et al., 2012).
DR is accompanied by a slowing of the progression of normal, age-related changes in transcript levels. DR
resulted in the downregulation of genes primarly involved in cell growth, metabolism and reproduction
(Pletcher, et al., 2002).
DNA methylation could play an important role in mediating the effects of DR because its sensitivity to the
effects of nutrition and it can affect gene expression memory over time. Genome-wide changes in DNA
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methylation, gene expression and lipidomics in response to DR and ageing in female mouse liver. DR is
generally strongly protective against age-related DNA methylation changes. During ageing under DR, DNA
methylation becomes targeted to gene bodies and is associated with reduced gene expression,
specifically of genes involved in lipid metabolism (Hahn, et al., 2017). Methylomes from mice subjected to
lifespan-extending conditions, including Prop1df/df dwarfism, DR or rapamycin were analysed in order to
examine whether epigentic aging signatures are slowed down by these interventions. Mice treated with
these lifespan-extending interventions were significantly younger in epigenetic age than untreated, wild
type age-matched controls (Wang, et al., 2017).
Human maximum lifespan is substantially greater if compared to that of closely related primate species.
The human transcriptome state, relative to other primate transcriptomes, does not match that of the DR
mice or mice treated with resveratrol, but resembles the transcriptome state of ad libitum feed mice.
Transcriptome changes induced by DR in mice are enriched among gene exhibiting age-related changes
in primates, concentrated in specific expression patterns, and can be linked to defined functional pathways
such as insulin signalling, cancer and immune response. Therefore the evolution of human longevity was
likely independent of DR-induced lifespan extension mechanisms (Zhao, et al., 2014).
Expression of hundreds of genes exhibit a different response between young and old men upon DR. There
is a downregulation of genes involved in the immune system in young but not old men. Immune
response-related genes were higher expressed in old compared to young men. Most potential upstream
regulators were controlling the immune response (Van Bussel, et al., 2016).
Physiological responses to DR are cell-type specific and variable throughout the lifespan. The influence of
long-term DR on the CA1 hippocampal region was examined via mRNA sequencing and NanoString
nCounter analysis. One year of DR feeding suppresses age-dependent changes of almost one thousand
genes functionally associated with synaptic transmission including calcium signalling, long-term potential
and Creb signalling. By comparing the influence of DR on transcriptional profiles at younger-adult and
older-adult a conserved upregulation of proteome quality control and calcium buffering genes was
identified. Expression of putative neuroprotective factors is also evaluated by DR in adulthood even though
the global DR-specific expression profiles at younger and older age are highly diverged (Schafer, et al.,
2015).
All those studies traditional utilized univariate methods for determining differential expression. Here in this
work in contrary to previous work a multivariate approach is utilized to calculate differential expression for
a greater amount of profiles. Using this approach tissue-common species-specific consensus signatures
are generated for humans as well as the major biomedical model organisms. These consensus signatures
are analysed for their significant associations. Moreover associations common to the signatures of all
species considered here are derived as well.
Therefore, molecular consensus signatures [Molecular Profiling to Decipher Ageing] of dietary restriction in
humans as well as model organisms were derived and sought for the major contributors and functional
categories governing the effect of DR on ageing. More precisely, the effect of dietary restriction on the
gene expression was extensively investigated in humans and various model organisms including rat,
mouse, fly, nematode and yeast.
5.2   Methods
Gene expression signatures [Molecular Profiling to Decipher Ageing] were generated and characterized as
described in [Ageing Signatures]. Briefly, gene expression profiles were downloaded from the NCBI Entrez
Gene Expression Omnibus Gene File Transfer Protocol (FTP) server, parsed and annotated wit the
respective platforms. Columns and rows that only had null/NaN (Not a Number) values were discarded.
Other missing values were mean interpolated. Data was log2-transformed and quantile normalized if data
was not yet log transformed and normalized. Here however, samples from dietary restriction individuals
were contrasted via the Characteristic Direction with those on ad libitum diet to derive signatures
representing the effect of dietary restriction on the transcriptome level [Figure 38 Dietary Restriction
Signature]. The utilized datasets can be requested from the author. Differential expression was assessed
with the characteristic direction method (Clark, et al., 2014) as detailed in [Ageing Signatures].
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_Figure 38: Dietary Restriction Signature.
Physical and genetic interactions were derived from BioGRID (Version 3.4.140) (Breitkreutz, et al., 2008),
while processes, functions and locations were utilized from the Gene Ontology (Ashburner, et al., 2000)
and downloaded from the NCBI FTP server. The Principal Angle Enrichment Analysis (Clark, et al., 2015)
was applied for identifying significant associations. The p-values were corrected for multiple hypothesis
testing via the Benjamini-Hochberg method (resulting in q-values) (Benjamini & HochBerg, 1995). The
most significant associations of the up- and down-regulated and differentially expressed genes given a
defined q-value cut-off were connected by the shortest path algorithm and graphed via automatic
force-directed graph layout (Kobourov, 2012) as well as colour coded as described below. q-values were
converted to node size scale by adding to the minimum size of 5 the negative of the exponent of the
q-value divided by two.
Nodes were colour coded in the following way. Upregulated genes are filled red, downregulated genes are
blue. Processes are green, functions are orange, and locations are yellow. Halos indicate respective
significant associations with the same colour code. Nodes to be associated with upregulated and
differential expressed genes get magenta coloured halos, those that are associated with downregulated
and differential expressed genes obtain violet coloured halos and those that were found to be significant
associated with upregulated as well as downregulated have halos coloured in purple. Physical interactions
are pink, genetic interactions are green and other edges like, involved in, exhibits and is located in are
grey. Node size represents significance. The methods used here are more detailed explained in [Ageing
Signatures].
5.3   Results
5.3.1   Human
The significant associations (q-value < 5e-2) of genes that differentially expressed under dietary restriction
in Homo sapiens are graphed as a network [Figure 39 H. sapiens Dietary Restriction].
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Human DR-upregulated genes are significantly associated with participating in chromatin silencing and
immune response, exhibit PolyA RNA binding and protein binding involved in protein folding, are located
in nucleosome and nuclear chromatin, as well as interact with SPRED1. Human DR-downregulated genes
significantly associate with participating in transcription from RNA polymerase II promoter, positive
regulation of transcription DNA-templated, regulation of progesterone biosynthetic process, apoptotic
process, NAD biosynthetic process, exhibit hemi-methylated DNA-binding and are located in Golgi
apparatus. Human DR differentially expressed genes are significantly associated with participating in
signal transduction, exhibiting DNA binding and being located in extracellular exosome.
_
Figure 39: H. sapiens Dietary Restriction. Network of genes differentially expressed upon DR in
humans.
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_Figure 40: R. norvegicus Dietary Restriction. Network of genes differentially expressed upon DR in
rat.
5.3.2   Rat
Rattus norvegicus is the classic model organisms in which dietary restriction was discovered originally
(McCay, 1933). Gene expression profiles of rats under ad libitum fed and under dietary restriction
conditions were used to derive a consensus signature of dietary restriction for the rat. The significant
associations (q-value < 5e-10) with this signatures are graphed [Figure 40 R. norvegicus Dietary
Restriction].
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Rat DR-upregulated genes are significantly associated with participating in circadian rhythm, negative
regulation of circadian rhythm, negative regulation of transcription regulatory region DNA binding, histone
H3 deacetylation, and regulation of neurogenesis, exhibiting histone methyltransferase binding,
transcription factor binding and ubiquitin binding, and being located in the perinuclear region of cytoplasm.
Rat DR-downregulated genes are significantly associated with participating in ageing, positive regulation
of protein targeting to the mitochondrion, positive regulation of I-kappaB kinase NF-KappaB signalling,
inflammatory response, positive regulation of apoptotic process, aggresome assembly, exhibiting
chemokine activity, and being located in extracellular exosome, as well as the aggresome.
_
Figure 41: M. musculus Dietary Restriction. Network of genes differentially expressed upon DR in
mouse.
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5.3.3   Mouse
Mus musculus is another rodent model organisms that has been extensively used for studying the lifespan
extending effect of DR and a plethora of gene expression profiles are publicly available. Murine gene
expression profiles have been combined into a molecular signature of ageing in mouse and assessed for
significant associations (q-value < 5e-5) [Figure 41 M. musculus Dietary Restriction].
Mouse DR-upregulated genes are significantly associated with participating in circadian regulation of gene
expression, reproductive process, rhythmic process, negative regulation of cysteine-type endopeptidase
activity involved in apoptotic process, and histone H3 deacetylation. Mouse DR-downregulated genes are
significantly associated with participating in entrainment of circadian clock, Notch signalling pathway, cell
differentiation, multicellular organism development, negative regulation of transcription from RNA
polymerase II promoter, and chaperone mediated protein folding requiring cofactor. Mouse
DR-differentially expressed genes are significantly associated with participating in circadian rhythm,
transcription DNA-templated, being located in extracellular exosome, perinuclear region of cytoplasm,
mitochondrion, and mitochondrial inner membrane.
_
Figure 42: D. melanogaster Dietary Restriction. Network of genes differentially expressed upon DR
in fruit fly.
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5.3.4   Fly
Drosophila melanogaster have been profiled for the effect of dietary restriction protocols on the gene
expression level. The consensus signature of dietary restriction in fruit fly has been investigated for
significant associations (q-value < 5e-2) and graphed here [Figure 42 D. melanogaster Dietary
Restriction].
_
Figure 43: C. elegans Dietary Restriction. Network of genes differentially expressed upon DR in
nematode.
Fly DR-upregulated genes are significantly associated with participating in negative regulation of Notch
signalling pathway and body morphogenesis. Fly DR-downregulated genes are significantly associated
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with participating in humoral immune response in chorion and exhibiting transferase activity transferring
acyl groups other than amino-acyl groups. Fly DR-differentially expressed genes are significantly
associated with participating in proteolysis.
_
Figure 44: S. cerevisiae Dietary Restriction. Network of genes differentially expressed upon DR in
budding yeast.
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5.3.5   Worm
Caenorhabditis elegans have been gene expression profiled under dietary restriction regimens. From
those a consensus signature of representing dietary restriction in nematode have been established. The
significant associations (q-value < 5e-2) found in this signature have been graphed [Figure 43 C. elegans
Dietary Restriction].
Worm DR-upregulated genes are significantly associated with participating in determination of adult
lifespan, proteolysis, and fatty acid metabolic process and exhibiting NAD binding and being located in
nucleosome. Worm DR-downregulated genes are significantly associated with participating in innate
immune response, cystathionine gamma-synthase activity, proteolysis involved in cellular protein catabolic
process and exhibiting hormone activity. Worm DR-differentially expressed genes are significantly
associated with being located in lysosome.
5.3.6   Yeast
Saccharomyces cerevisiae under different levels of glucose have been profiled. A consensus signature of
dietary restriction in budding yeast have been created and subjected to Principle Angle Enrichment
Analysis with a q-value threshold of 5e-5 [Figure 44 S. cerevisiae Dietary Restriction].
Yeast DR-upregulated genes are significantly associated with participating in meiotic DNA recombinase
assembly, transposition RNA-mediated and being located in retrotransposon nucleocapsid. Yeast
DR-downregulated genes are significantly associated with participating in response to stress, sporulation
resulting in formation of a cellular spore, meiotic cell cycle, ribosome disassembly, exhibiting
transcriptional repressor activity RNA polymerase II core promoter proximal region sequence-specific
binding and being located in condensed nuclear chromosome.
5.3.7   Common DR-Signature Across Species
The consensus signature of human, rat, mouse, fly, worm and yeast have been subjected to Principle
Angle Enrichment Analysis individually and results combined. The common associations are graphed
[Figure 45 Common Dietary Restriction].
DR-upregulated genes are significantly associated with participating in transcription DNA-templated and
DNA-templated negative regulation of transcription as well as being located in nucleus and nucleoplasm
[Figure 45 Common Dietary Restriction]. DR-downregulated genes are significantly associated with
participating in response to glucocorticoid, positive regulation of cell death, positive regulation of ERK1
and ERK2 cascade, and positive regulation of gene expression, exhibiting transcription factor binding and
being located in extracellular exosome [Figure 45 Common Dietary Restriction]. DR-differentially
expressed genes are significantly associated with participating in response to stress, circadian rhythm,
apoptotic process, lysosome and proteolysis [Figure 45 Common Dietary Restriction].
144
_Figure 45: Common Dietary Restriction. Network of associations with DR-differentially expressed
genes commonly shared between multiple species.
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5.4   Discussion
Molecular signatures representing dietary restriction, an intervention known to modify the basic ageing
process, were derived for humans as well as common biomedical model organisms. Consensus
signatures were created and characterised for their significant associations from various sources.
5.4.1   Ageing and Lifespan Determination
DR-differentially expressed genes are significantly associated with being involved in cell ageing and in
particular positive regulation of cell ageing [Mouse]. DR-upregulated genes are significantly associated
with participating in determination of adult lifespan [Figure 43 C. elegans Dietary Restriction] and being
involved in chronological cell ageing [Rat], while DR-downregulated genes are commonly significantly
associated with participating in ageing [Human; Figure 40: R. norvegicus Dietary Restriction; Common
DR-Signature Across Species] which may mean that DR upregulates ageing-suppressor genes and
downregulates gerontogenes in order to mediate its anti-ageing effect.
Further DR-downregulated genes are significantly associated with being involved in cellular senescence
[Mouse]. DR reduces senescence cell frequency (Wang, et al., 2010).
5.4.2   Chromatin
DR-upregulated genes are significantly associated with participating in chromatin silencing and being
located in nucleosome and nuclear chromatin [Figure 38 H. sapiens Dietary Restriction]. DR-upregulated
genes are significantly associated with chromatin silencing, while DR-downregulated genes are
significantly associated with chromatin silencing at rDNA [Human].
During ageing, changes in chromatin state that alter the gene transcription have been postulated to cause
the expression of genes that are normally silenced, leading to deleterious age-related effects on cellular
physiology. Loss of silencing with age has been well documented (Sedivy, et al., 2008; Berger, 2007;
Dang, et al., 2009; Feser & Tyler, 2011; Han & Brunet, 2012; De Cecco, et al., 2013; Kim, et al., 1999;
Smeal, et al., 1996; Wood, et al., 2010; Maxwell, et al., 2011). Dietary restriction delays the age-related
loss of gene silencing, suggesting that the loss of gene silencing is a component of normal ageing (Jiang,
et al., 2013). DR-downregulated genes are commonly significantly associated with exhibiting
hemi-methylated DNA-binding as well as double-stranded methylated DNA-binding [Common
DR-Signature Across Species]. DR counteracts the decrease of DNA methylation at promoter and intron
regions (Kim, et al., 2016). Further supporting this, it was found that genes that respond to dietary
restriction also exhibit age-related changes in DNA methylation (Ions, et al., 2013).
DR-upregulated genes are significantly associated with participating in histone H3 deacetylation, negative
regulation of transcription regulatory region DNA binding, histone H3 deacetylation and exhibiting
methyltransferase binding [Figure 40 R. norvegicus Dietary Restriction; Figure 41 M. musculus Dietary
Restriction]. H3K2me3, H3R2me2, H3K79me3, and H4K20me2 tend to disappear with age but are
partially restored by both DR and rapamycin treatment. However both DR and rapamycin treatment also
have significant impact on H3K27ac, H4K16ac, H4R2me2 and H3K56ac which do not change as the
animal ages (Gong, et al., 2015).
DR-upregulated genes are significantly associated with participating in RNA-mediated transposition and
being located in retrotransposon nucleocapsid [Figure 44 S. cerevisiae Dietary Restriction].
Transpositional elements are mobile genetic elements, that are highly enriched in heterochromatin and
constitute a large percentage of the DNA content of eukaryotic genes. Transcripts of many genes native to
heterochromatic regions and transpositional elements increase with age, while dietary restriction
represses the age-related increase (Wood, et al., 2016).
5.4.3   RNA Interference
DR-differentially expressed genes are significantly associated with pre-miRNA processing [Worm].
DR-downregulated genes are significantly associated with gene silencing by RNA as well as positive
regulation of pri-miRNA transcription from RNA polymerase II promoter [Human].
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This agrees with the findings that the knockout of specific microRNAs extend the lifespan via dietary
restriction (Vora, et al., 2013). Even more important is the observation that microRNA are actually
necessary for the lifespan extending effect of DR (Smith-Vikos, et al., 2014).
5.4.4   Protein Homeostasis
DR differentially expressed genes are commonly significantly associated with participating in proteolysis
and being located in proteasome and lysosome [Figure 42 D. melanogaster Dietary Restriction; Figure 41
C. elegans Dietary Restriction; Figure 45 Common Dietary Restriction].
DR-upregulated genes are significantly associated with participating in protein folding [Figure 39 H.
sapiens Dietary Restriction] while DR-downregulated genes are significantly associated with exhibiting
chaperone mediated protein folding requiring a cofactor [Figure 41 M. musculus Dietary Restriction]. The
heat shock proteins are responsible for correct protein folding. They are classified HSPs with chaperone
functions (five classes) and small heat shock proteins, which are mostly cofactors of the larger HSPs. The
primary chaperone HSPs are HSP60, HSP70 and HSP90. There are mitochondrial versions of these
called mortalin (mitoHSP70) and TRAP-1 (HSP90). Several chaperones are encoded by
ageing-suppressor genes. The folding and assembly of proteins is essential for protein function, the
long-term health of the cell, and longevity of the organism (Karady, et al., 2013). DR-downregulated genes
are significantly associated with participating in aggresome assembly and being located in the aggresome
[Figure 40 R. norvegicus Dietary Restriction]. Dietary restriction seems to reduce the load of protein
misfolding and damage. Indeed dietary restriction was found to confer a general protective effect against
proteotoxicity and promotes longevity by a mechanisms involving the heat shock factor (Steinkraus, et al.,
2008b). HSF1 was found to have a positive characteristic direction in the consensus signature of dietary
restriction of human, mouse and rat [Human; Rat; Mouse].
DR-upregulated genes are significantly associated with participating in ubiquitin binding [Figure 40 R.
norvegicus Dietary Restriction]. Ageing increases the levels of ubiquitinated proteins and dietary restriction
significantly reduces these age-related increases (Zhang, et al., 2007).
5.4.5   Hormone
DR-downregulated genes are significantly associated with exhibiting hormone activity [Figure 39 H.
sapiens Dietary Restriction; Figure 40 R. norvegicus Dietary Restriction; Figure 41 M. musculus Dietary
Restriction; Figure 43: C. elegans Dietary Restriction]. Dietary restriction is well known to exhibit a
systemic effect via modulating hormonal signalling including certain endocrine systems (Herlihy, et al.,
1990). Several hormones and associated signalling mediators encoded by gerontogenes such as those
related to growth hormone, insulin-like growth factor and insulin among others are commonly reduced
upon dietary restriction (Chiba, et al., 2007).
DR-upregulated genes are significantly associated with participating in response to glucocorticoid [Figure
45 Common Dietary Restriction]. Elevated plasma glucocorticoid levels have a causal role in rapid
deterioration following reproduction in semelparous vertebrate species. This is because they induce a
Cushing type syndrome to mobilise protein in order to support the once cycle of reproduction.
Glucocorticoids can promote ageing in vertebrate species. However periods of moderately elevated
plasma glucocortcoid levels may retard the ageing process in mammals (Masoro, 1995).
DR-downregulated genes are significantly associated with participating in regulation of progesterone
biosynthetic processes [Figure 39 H. sapiens Dietary Restriction]. Progesterone administration enhances
memory in aged mice (Lewis, et al., 2008) independent of the progesterone receptor (Frye & Walf, 2010).
5.4.6   Signalling
Notch signalling pathway and more specifically negative regulation of Notch signalling pathway is
associated with DR-downregulated genes [Figure 41 M. musculus Dietary Restriction; Figure 42 D.
melanogaster Dietary Restriction]. The Notch signalling pathway was also found to be downregulated
upon resveratrol supplementation that is a DR mimetic (Konings, et al., 2014).
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Surprisingly common to DR-upregulation is a very specific association to positive regulation of the ERK1
and ERK2 cascade. This could mean that DR enhances MAPK signalling [Figure 45 Common Dietary
Restriction].
5.4.7   Metabolism
Response to fatty acid and unsaturated fatty acid biosynthetic process are commonly significantly
associated with DR-differentially expressed genes. Fatty acid metabolic process, fatty acid biosynthetic
process, and long-chain fatty acid biosynthetic process are commonly upregulated [Figure 39 H. sapiens
Dietary Restriction; Figure 40 R. norvegicus Dietary Restriction; Figure 41 M. musculus Dietary
Restriction; Figure 42 C. elegans Dietary Restriction; Figure 45 Common Dietary Restriction].
Fatty acid chain length and susceptibility to oxidation correlates with longevity (Shmookler Reis, et al.,
2011). The amount and type of dietary fatty acids can also profoundly affect lifespan (Jolly, et al., 2001).
The effect of a restricted diet to modify the proton leak and membrane potential as well as reactive oxygen
species generation rate can be stimulated by a range of non-esterified free fatty acids acting on the
adenine nucleotide translocase to enhance protonophoric activity. Adenine nucleotide translocase is the
dominant proton leak channel induced under dietary restriction. Therefore mobilised free fatty acids in
mitochondria of dietary restriction fed animals enhance the proton leak and reduce reactive oxygen
species generation (Ash & Merry, 2011).
DR downregulated genes are significantly associated with cystathionine gamma-synthase activity [Figure
43 C. elegans Dietary Restriction] as well as de novo L-methionine biosynthetic process [Worm].
DR-upregulated genes are significantly associated with methionine synthase reductase activity [Mouse].
The transsulfuration pathway is a highly conserved mechanism of metabolising sulfur-containing amino
acids, methionine and cysteine. Cystathionine beta-synthase is encoded by an ageing-suppressor gene
and DR-essential (Kabil, et al., 2011). Restriction of methionine is sufficient to extend lifespan (Johnson &
Johnson, 2014).
DR-upregulated genes exhibit NAD binding [Figure 43 C. elegans Dietary Restriction] and
DR-downregulated genes are significantly associated with participating in NAD biosynthetic metabolism
[Figure 39 H. sapiens Dietary Restriction]. DR involves a NAD(+)-dependent mechanism as well as a shift
toward oxidative metabolism (Moroz, et al., 2014).
5.4.8   Reproduction
DR-upregulated genes are significantly associated with participating in reproductive process [Figure 41 M.
musculus Dietary Restriction; Figure 41 S. cerevisiae Dietary Restriction]. Overexpression of
reproduction-related transcription factors is capable of reversing ageing (Unal, et al., 2011).
5.4.9   Apoptosis
DR-upregulated [Figure 41 M. musculus Dietary Restriction; Figure 45 Common Dietary Restriction] and
DR-downregulated genes are significantly associated with participating in apoptotic process [Figure 39 H.
sapiens Dietary Restriction; Figure 45 Common Dietary Restriction]. DR is known to favour apoptosis over
proliferation (Dunn, et al., 1997).
Dietary restriction induces the apoptosis of malignant cells and may also induces apoptosis of senescence
cells as dietary restriction reduces senescence cell number. Cancer incidence increases progressively
with age. Interventions that retard the rate of ageing simultaneously retard the incidence of many forms of
cancer. Dietary restriction especially is known to be a non-invasive manipulation that retards most
physiological and molecular indices of ageing as well as the incidence of spontaneous and chemically
induced tumours (Muskhelishvili, et al., 1995; Wachsman, 1996). Adult-onset, short-term DR reduces
frequencies of senescence cells (Wang, et al., 2010). While DR removes malignant and senescence cells
via apoptosis, it does prevent cell death of healthy cells such as neurons (Shruthi, et al., 2016).
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5.4.10   Golgi
DR-upregulated genes are commonly significantly associated with being located in the Golgi Apparatus
[Common DR-Signature Across Species]. The volume of the Golgi apparatus perikaryon increases
significantly with age. The mean percentage of perikaryal volume occupied by the Golgi apparatus
decreases with age (Ledda, et al., 2001).
Specifically DR-upregulated genes are significantly associated with retrograde transport endosome to the
Golgi apparatus [Human] that is the directed movement of membrane-bounded vesicles from endosomes
back to the trans-Golgi network. It is possible that misfolded proteins are send back to the Golgi Apparatus
for refolding.
5.4.11   Stem Cells
DR-upregulated genes are commonly significantly associated with being involved in regulation of
neurogenesis [Figure 40 R. norvegicus Dietary Restriction; Common DR-Signature Across Species],
where negative regulation of neurogenesis specifically is significantly associated with DR-downregulated
genes [Rat]. Dietary restriction promotes adult neurogenesis (Kitamura, et al., 2006).
DR downregulated genes are significantly associated with stem cell division [Rat]. Positive regulation of
hematopoietic stem cell proliferation is significantly associated with differentially expressed genes during
ageing [Rat] and negative regulation of hematopoietic stem cell differentiation is associated with
ageing-upregulated genes [Mouse]. Hematopoietic senescence is postponed and stem cell function is
enhanced by DR (Chen, et al., 2003).
5.4.12   Inflammation
DR-upregulated genes are significantly associated with participating in the immune response [Figure 39 H.
sapiens Dietary Restriction]. Food restriction delays the loss of several cellular immune functions (Byun, et
al., 1995).
DR-downregulated genes are significantly associated with participating in positive regulation of I-kappaB
kinase NF-KappaB signalling and inflammatory response, as well as exhibiting chemokine activity [Figure
40 R. norvegicus Dietary Restriction]. Dietary restriction downregulates NF-kappaB (Singh, et al., 2015).
DR downregulates genes associated with innate immunity [Figure 43 C. elegans Dietary Restriction]. A
reduction in chronic inflammation is widely observed under dietary restriction feeding conditions (Ye &
Keller, 2010).
5.4.13   Mitochondria
DR-differentially expressed genes are significantly associated with mitochondria [Figure 39 H. sapiens
Dietary Restriction; Figure 39 R. norvegicus Dietary Restriction; Figure 41 M. musculus Dietary
Restriction; Figure 43 C. elegans Dietary Restriction]. DR-downregulated genes are significantly
associated with participating in positive regulation of protein targeting to the mitochondrion [Figure 40 R.
norvegicus Dietary Restriction].
The mitochondrion is a major hub in the gene expression programme under lifespan-promoting
interventions such as dietary restriction, genetic DR mimetics, heat shock and hydrogen peroxide
(Sharma, et al., 2011). Mitochondria enlarge under dietary restriction feeding and dietary restriction retards
the age-dependent loss of mitochondria (Weindruch, et al., 1980).
Response to reactive oxygen species is commonly associated with genes upregulated during DR
[Common DR-Signature Across Species]. Also positive regulation of superoxide anion generation and
positive regulation of membrane potential are significantly associated with genes differentially expressed
upon DR [Rat].
Restricted feeding regimens that extend the lifespan lower the rate of mitochondrial reactive oxygen
species generation. Mitochondria from different tissues adapt to DR feeding with a lowered membrane
potential that results from an enhanced proton leak (Ash & Merry, 2011).
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5.4.14   Circadian Rhythm
DR-differentially expressed genes, DR-downregulated genes and DR-upregulated genes are significantly
associated with controlling the circadian rhythm, circadian regulation of gene expression and rhythmic
process [Figure 39 H. sapiens Dietary Restriction; Figure 40 R. norvegicus Dietary Restriction; Figure 41
M. musculus Dietary Restriction; Figure 45: Common Dietary Restriction]. This may be interpreted as that
the circadian clock is modulated by DR. Circadian rhythms are generated by an intrinsic cellular
mechanisms (involving transcriptional feedback loops) that controls a large array of physiological and
metabolic processes.
There is an erosion in the robustness of circadian rhythms during ageing. Further disruption of the clock by
genetic ablation of specific genes is associated with ageing-related phenotypes. Intracellular pathways
including nutrient sensors impinge cellular and epigenetic mechanisms that control the ageing processes
also control the circadian clock (Orozco-Solis+Sassone-Corsi, 2014).
5.4.15   Growth/Differentiation/Development
DR downregulates the regulation of cell growth and differentiation. Further, DR downregulates genes are
commonly associated with multicellular organism development [Figure 41 M. musculus Dietary Restriction;
Common DR-Signature Across Species].
Dietary restriction retards growth and development (Masoro, 1996). If ageing is an extension of
development, DR may retard ageing by retarding the developmental program that drives ageing.
5.4.16   Stress Response
DR commonly and significantly upregulates genes involved in cellular responses to (oxidative) stress, the
response to osmotic stress, and fluid shear stress and atherosclerosis [Figure 45 Common Dietary
Restriction; Common DR-Signature Across Species]. Further DR-downregulated genes are significantly
associated with oxidative stress induced senescence, and DNA damage/telomere stress induced
senescence [Human].
It is well known that chronic stress and prolonged activation of defence pathways have deleterious
consequences for the cell (Lin, et al., 2007; Walter & Ron, 2011; Lamech & Haynes, 2015; Roth, et al.,
2014). Dietary restriction is shown to be beneficial as it induces the cellular stress response machinery
(Bhadra, et al., 2016).
5.4.17   Gene Regulation
DR upregulated as well as DR downregulated genes are commonly associated with processes, activities
and location related to gene regulation, especially at the level of transcription [Figure 39 H. sapiens Dietary
Restriction; Figure 40 R. norvegicus Dietary Restriction; Figure 41: M. musculus Dietary Restriction; Figure
41 C. elegans Dietary Restriction; Figure 42: S. cerevisiae Dietary Restriction; Figure 45 Common Dietary
Restriction]. This indicates that transcription factors could be identified that exerts the ageing retarding
effect of dietary restriction. DR downregulated genes are commonly significantly associated with
epigenetic regulation of gene expression [Common DR-Signature Across Species]. DR up- and
down-regulated genes are both commonly significantly associated with circadian regulation of gene
expression [Common DR-Signature Across Species].
Gene regulation is one mechanisms underlying the response to dietary restriction (Ions, et al., 2013). It
may modulate the circadian clock, silence genes epigenetically and utilize specific transcription factors to
exert ageing counteracting mechanisms.
 
Previous attempt to establish a consensus signature of dietary restriction found overexpression of lipid
metabolism and circadian rhythm, and underexpression of sterol biosynthesis and innate immune
response (Plank, et al., 2012). Here metabolism of lipids and lipoproteins as well as lipid biosynthetic
process are found to be commonly associated with genes upregulated upon DR [Common DR-Signature
Across Species]. Circadian clock was identified here as modulated by DR differential expression
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[Circadian Rhythm]. Genes associated with sterol biosynthesis are downregulated in DR conditions
[Mouse]. Further, while the innate immune response seems to be modulated (commonly significantly
associated with both up- and down-regulated genes upon DR) positive regulation of inflammatory
response was found to be commonly associated with DR-downregulated genes [Common DR-Signature
Across Species].
In future extension of the work presented here different regimens could be differentiated (e.g. different
strengths of DR and types of DR). Also the overlap of those signatures with the respective ageing
signatures could be explored.
As dietary restriction has been assumed to work via a common mechanism across taxa, there might be a
common consensus signature representing the influence of dietary restriction on the gene expression
patterns shared among phylogenetically distinct species.
5.5   Conclusion
Dietary restriction affects the transcriptome commonly by modulating ageing genes directly, as well as
those associated with chromatin, protein homeostasis, specific hormones, Notch signalling, metabolism of
fatty acids, methionine and NAD, reproduction-related genes, apoptosis, inflammation, neurogenesis,
mitochondria and Golgi, as well as the circadian rhythm, developmental genes, stress response, and
commonly gene expression regulation.
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6   Small Molecule Predictions
Abstract: Small molecules with the potential to intervene with the ageing process were
identified via a variety of approaches. Guilt-by-association applied on the
drug-protein/gene interactions and gene signature (list of genes with corresponding
differential expression metrics) matching was utilized to identify potential drugs that
can slow down or reverse ageing. This method was able to retrieve known as well
as novel ageing interfering drug candidates.
6.1   Background
Thousands of genes in model organisms and some in humans are known to effect the lifespan [Ageing
Genes]. More and more small molecules that extend longevity similar to genetic perturbations are been
discovered. Many small molecules are recognised that exert their effect by affecting specific targets that
are for instance proteins encoded by genes. Here it was hypothesized that by utilizing knowledge about
distinct classes of ageing genes drugs can be identified that are potential geroprotectors. Additionally
ageing and interventions that impact on ageing trigger distinct patterns of gene expression level (so-called
molecular signatures) [Molecular Profiling to Decipher Ageing]. This can be leveraged to identify small
molecules that mimic or reverse certain biological states, conditions, or processes [Anti-Ageing Drugs].
Here it is sought to find drugs that interfere with the ageing process by performing gene signature
matching. Specifically here small molecules were identified that for example reverse age-related gene
expression changes or mimic lifespan-extending interventions (such as dietary restriction) at the gene
expression level.
Ageing counteracting drugs can be identified by utilizing signatures associated with ageing and drug
signatures that either reverse or mimic those effects at the level of the transcriptome. Anti-ageing drugs
can be found by gene expression matches that either reverse ageing, HGPS, cellular senescence, and
age-related diseases or mimic the effect of dietary restriction as well as long-lived mutants. In silico
methods for screening and ranking possible geroprotectors were developed. For this, changes in the
activated and suppressed pathways involved in ageing and longevity can be constructed using the gene
expression and epigenetic profiles of tissue from young and old individuals. Possible interventions are
selected and rated according to their ability to regulate age-related changes and minimize the differences
in signalling (Zhavoronkov, et al., 2014). Public gene expression repositories can be transformed into
disease diagnosis databases. Such a database can be used to construct a disease-drug connectivity map.
The statistical significance of the link between a disease and a drug is based on the intersection of the
disease-related genes and drug-related genes using for instance a hypergeometric test (Huang, et al.,
2010).
Compound signatures can be detected on the Connectivity Map (CMap) which provides gene expression
profiles of cell cultures incubated with various compounds (Lamb, 2007). The Connectivity Map is a
large-scale compendium of functional perturbations in cultured human cells that are coupled to a
gene-expression readout. L1000 is a new gene expression profiling method that dramatically lowers cost
of generating profiles by only probing for around 1000 "landmark" genes and inferencing the expression of
others. The Connectivity Map includes over 1.3 million publicly accessible L1000 profiles. The CMap
facilitates the discovery of connections between genes, drugs, and diseases as well as small-molecule
mechanism and annotation of genetic variants (Subramanian, et al., 2017). Various substances such as
drugs, dietary supplements, nanomaterials, metabolites and hormones that have shown to extend the
lifespan have also been transcriptionally profiled. This work establishes feasibility and utility of a truly
comprehensive small molecule predictions for targeting ageing.
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6.2   Methods
Guilt-by-association, as described previously [Ageing Genes], was applied to drug-protein/gene
interventions derived from the Drug Gene Interaction Database (Griffith, et al., 2013). Human homologs of
ageing genes or specific subclasses of ageing genes were used as seeds. Homologous genes were
retrieved from NCBI HomoloGene via the File Transfer Protocol. The hypergeometric test was used and
corrected for multiple hypothesis testing via the Benjamini-Hochberg method (Benjamini & Hochberg,
1995). A significance threshold of 0.05 as q-value was utilized for generating the seed drugs of the
network.
Physical and genetic interactions of genes/proteins were utilized from BioGRID (Version 3.4.140)
(Breitkreutz, et al., 2008). Briefly here networks were generated by retrieving the first degree interactors
plus applying shortest path for connecting the unconnected nodes. Shortest path was calculated between
each unconnected node and all other nodes where the input of the shortest path algorithm is as source
each unconnected node and as target all other connected nodes and from this calculating the shortest
path between the unconnected node and all other connected nodes. Nodes representing drugs are
coloured pink, gerontogenes coloured red and ageing-suppressors are coloured blue while those that are
were found to be both gerontogene and ageing-suppressor gene are brown. Other nodes without known
association are grey. Molecular signatures [Molecular Profiling to Decipher Ageing] were generated as
described in [Ageing Signatures]. Briefly, here compounds gene expression profiles (which are gene
expression profiles of cells in culture that were supplemented with that specific compound derived from the
Connectivity Map (Lamb, 2007)) were used to derive small molecule/drug signatures (by processing gene
expression profiles and calculating differential expression metrics including characteristic direction (Clark,
et al., 2014) for each gene, as described previously [Ageing Signatures]. Each drug treatment was applied
to a cell type with a particular dose for a defined duration. Datasets can be requested from the author.
Those signatures were used in combination with previous derived signatures about ageing [Ageing
Signatures] and dietary restriction [Dietary Restriction Signatures] to find (via pattern matching based on
cosine similarity) drugs that reverse ageing or mimic the effect of lifespan-extending interventions. The
score was calculated from the cosine similarity according to:
similarity = cos(0) = A × B / (||A||||B|||)
Where A and B are the vectors to be compared with each other. Positive score indicates mimicking, while
a negative score indicates reversing/opposing [Figure 46 Molecular Signature Matching]. Reversing is the
reverse of similarity (i.e. distance). Results are visualized as graphs by applying force-directed graph
layout (Kobourov, 2012) and coloured as described in the legends. Node size represents significance by
converting q-values via log10 transformation and adding to the minimum size of 10 in the case of ageing
genes. For gene expression pattern matching, the node size represents significance by multiplying the
absolute value of the cosine similarity with 1000. For specific gene class targeting drugs, the seed genes
and significant drugs identified via guilt-by-association were connected with each other via shortest path
algorithm. For signature reversing or mimicking drugs, all interaction partners of the reversing/mimicking
drug were retrieved first and all nodes connected with each other via shortest path algorithm. For
unconnected drugs (i.e. no know target genes) the three most similar drugs (based on cosine similarity)
were identified and made explicit as edges.
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_Figure 46: Molecular Signature Matching.
6.3   Results
6.3.1   Ageing Genes Targeting Drugs
Many genes were found to influence lifespan in model organisms as well as in humans [Ageing Genes].
The human genes combined with human homologs of model organisms ageing genes were used as seeds
for guilt-by-association to find drugs that target ageing genes [Figure 47 Ageing Gene Targeting Drugs].
Everolimus, Carboplatin, Azd5363, Bmn673 and E7449 are the most significant associations with ageing
genes [Figure 47 Ageing Gene Targeting Drugs].
6.3.1.1   Gerontogenes Targeting Drugs
Most drugs inhibit functions. Therefore gerontogenes (a subset of ageing genes that promote ageing)
[Ageing Genes] were used as seeds for the guilt-by-association of drugs [Figure 48: Gerontogenes
Targeting Drugs].
The most significant drugs targeting gerontogenes are Everolimus, Azd5363, and MK-2206 [Figure 48
Gerontogenes Targeting Drugs].
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6.3.1.2   Ageing-Suppressor Genes Targeting Drugs
Certain drugs work via the activation of specific targets. Thus ageing-suppressors genes (a subset of
ageing genes that suppress ageing) [Ageing Genes] were utilized for the guilt-by-association [Figure 49
Ageing-Suppressor Targeting Drugs].
Here the most significant drug targeting ageing-suppressors is Carboplatin [Figure 49 Ageing-Suppressor
Targeting Drugs].
6.3.1.3   DR Genes Targeting Drugs
Drugs that target dietary restriction-essential genes were identified by using guilt-by-association [Figure 52
Dietary Restriction-Essential Genes Targeting Drugs].
DR-essential genes are most significantly associated with NVP-BGT226, Azd5363, MK-2206, Xl765 and
Everolimus [Figure 52 Dietary Restriction-Essential Genes Targeting Drugs].
155
_Figure 47: Ageing Gene Targeting Drugs. Drugs that target ageing genes. Nodes are grey by default,
gerontogenes are filled light red, ageing-suppressor genes are filled light blue, ageing genes are purple,
and drugs are pink. Physical interactions are pink, genetic interactions are green and drug-protein
interactions are purple. Node size represents significance.
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_Figure 48: Gerontogenes Targeting Drugs. Drugs that target gerontogenes were identified via
guilt-by-association. Nodes are grey by default, gerontogenes are filled light red, ageing-suppressor
genes are filled light blue, ageing genes are purple, and drugs are pink. Physical interactions are pink,
genetic interactions are green and drug-protein interactions are purple.
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_Figure 49: Ageing-Suppressor Genes Targeting Drugs. Drugs that target ageing-suppressor genes
were identified via guilt-by-association. Nodes are grey by default, gerontogenes are filled light red,
ageing-suppressor genes are filled light blue, ageing genes are purple, and drugs are pink. Physical
interactions are pink, genetic interactions are green and drug-protein interactions are purple. Node size
represents significance.
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_Figure 50: Dietary Restriction-Essential Targeting Drugs. Drugs that target dietary restriction
essential genes were identified via guilt-by-association. Nodes are grey by default, gerontogenes are
filled light red, ageing-suppressor genes are filled light blue, ageing genes are purple, and drugs are
pink. Physical interactions are pink, genetic interactions are green and drug-protein interactions are
purple. Node size represents significance.
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_Figure 51: (******) Ageing Reversing Drugs. Drugs that reverse ageing gene expression. Nodes are
grey by default, upregulated genes are filled light red, downregulated genes are filled light blue, and
drugs are pink. Physical interactions are pink, genetic interactions are green, drug-protein interactions
are purple, and drug similarity edges are golden. Node size is proportional to the absolute value of the
cosinus similarity.
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_Figure 52: (††††††) HGPS Reversing Drugs. Drugs that reverse HGPS gene expression were
identified via pattern matching. Nodes are grey by default, upregulated genes are filled light red,
downregulated genes are filled light blue, and drugs are pink. Physical interactions are pink, genetic
interactions are green, drug-protein interactions are purple, and drug similarity edges are golden. Node
size is proportional to the absolute value of the cosinus similarity.
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_Figure 53: (‡‡‡‡‡‡) Senescence Reversing Drugs. Drugs that reverse cellular senescence were
identified via pattern matching. Nodes are grey by default, upregulated genes are filled light red,
downregulated genes are filled light blue, and drugs are pink. Physical interactions are pink, genetic
interactions are green, drug-protein interactions are purple, and drug similarity edges are golden. Node
size is proportional to the absolute value of the cosinus similarity.
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_Figure 54: (§§§§§§) DR Mimetics. Dietary restriction mimicking drugs were identified via pattern
matching. Nodes are grey by default, upregulated genes are filled light red, downregulated genes are
filled light blue, and drugs are pink. Physical interactions are pink, genetic interactions are green,
drug-protein interactions are purple, and drug similarity edges are golden. Node size is proportional to
the absolute value of the cosinus similarity.
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6.3.2   Ageing Reversing Drugs
Reversing the gene expression associated with ageing may reverse the age-related changes and
therefore counteract ageing [Ageing Signatures]. Drugs that reverse the tissue-independent common
consensus signature of ageing in human were depicted as an interaction network in the following [Figure
47 Ageing Reversing Drugs].
The drugs that reverse the ageing gene expression signatures across tissues the most are Nu-1025,
Estradiol, Ly-294002, Sirolimus and Clofibrate [Figure 47 Ageing Reversing Drugs].
6.3.3   HGPS Reversing Drugs
Hutchinson-Gilford progeria syndrome (HGPS) is one of most severe progeroid syndromes that represent
accelerated/premature ageing [Ageing Signatures]. Drugs that reverse the consensus signature of HGPS
are identified [Figure 52 HGPS Reversing Drugs].
The drugs that reverse the ageing gene expression signatures of HGPS the most are Clofibrate,
arachidonic acid, Genistein, Benserazide, and Nu-1025 [Figure 52 HGPS Reversing Drugs].
6.3.4   Senescence Reversing Drugs
Cellular senescence is hallmark of ageing in most mammals. Senescence cells exert negative effects on
tissue homeostasis and secrete inflammatory as well as cancer promoting signals [Ageing Signatures]. A
consensus signature of senescence is a consensus signature of various forms of cellular senescence such
as replicative and stress-induced cellular senescence. Drugs that reverse the consensus signature of
senescence were found [Figure 53 Senescence Reversing Drugs].
Azathioprine, Geldanamycin, Pentamidine, Arachidonic Acid, and Ly-294002 are the drugs that reverse
the gene expression signatures associated with senescence the most [Figure 53 Senescence Reversing
Drugs].
6.3.5   DR Mimetics
Dietary restriction, as the most robust non-genetic intervention that is known to retard ageing across
species boundaries, elicits a transcriptional signature that interferes with the ageing process. Drugs that
mimic the effect of dietary restriction based on the contribution of each individual gene within a signature
were found and depicted in the following manner [Figure 54 DR Mimetics].
Mesalazine, 4,5-Dianilinophthalimide, Nocodazole, Verapamil (Dexverapamil), 3-Aminobenzamide are the
drugs with the most similar gene expression profile to dietary restriction [Figure 54 DR Mimetics].
6.4   Discussion
Via graph theory and gene expression pattern matching, drug candidates were identified that target
ageing genes, specific subclasses of ageing genes and dietary restriction-essential genes as well as
potentially reverse ageing, HGPS, senescence and mimic dietary restriction at the level of the
transcriptome.
Several drugs were found to be shared among the results of these different investigations. It was also
noted that many small molecules that are known to extend lifespan were among the results such as
sirolimus. Sirolimus, also known as rapamycin, is a macrolide immunosuppressant (Streit, et al., 1996).
Sirolimus was found to target ageing and DR-essential genes, reverse ageing, mimic DR, reverse HGPS
and has an effect on reversing cellular senescence [Ageing Genes Targeting Drugs; DR Genes Targeting
Drugs; Ageing Reversing Drugs; DR Mimetics; HGPS Reversing Drugs; Senescence Reversing Drugs].
Therefore rapamycin (sirolimus) was re-identified to mimic the effect of DR and reverse the gene
expression patterns associated with ageing. However, other drugs were found that are higher ranked than
rapamycin and represent potential candidates for drugs that are similar or more effective than rapamycin.
Everolimus is a rapamycin derivative which is an allosteric mTOR inhibitor (Raimondo, et al., 2016).
Everolimus reverses ageing and HGPS as well as targets ageing genes (gerontogenes and
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ageing-suppressors) and DR-essential genes [Ageing Reversing Drugs; HGPS Reversing Drugs; Ageing
Genes Targeting Drugs; Gerontogenes Targeting Drugs; Ageing-Suppressor Genes Targeting Drugs].
Carboplatin is a platinum containing anticancer drug (Jangir & Mehrotra, 2014). A combination therapy
with Carboplatin is expected to result in life extension of cancer patients (Sato, et al., 2006). Carboplatin
targets ageing genes, more specifically ageing-suppressor genes [Ageing-Suppressor Genes Targeting
Drugs].
AZD5363, an inhibitor of protein kinase B (AKT) and affects PI3K/mTOR (Choi, et al., 2016). AZD5363
targets ageing genes, but more specifically gerontogenes and DR-essential genes [Gerontogenes
Targeting Drugs; DR Genes Targeting Drugs].
BMN673 is a PARP inhibitor (Dai, et al., 2016). BMN673 targets ageing, specifically ageing-suppressor
genes [Ageing-Suppressor Genes Targeting Drugs]. E7449 is a potent PARP1/2 inhibitor that also inhibits
PARP5a/5b (McGonigle, et al., 2015). E7449 similar to BMN673 specifically targets gerontogenes
[Gerontogenes Targeting Drugs].
NU-1025 is a PARP-1 inhibitor (Li & Osborne, 2008) that exhibits neuroprotective activity (Kaundal, et al.,
2006). NU1025 conveys neuroprotection associated with reversal of NAD depletion and reduction in DNA
fragmentation (Kaundal, et al., 2006). Nu-1025 reverses ageing, senescence and HGPS [Ageing
Reversing Drugs; HGPS Reversing Drugs; Senescence Reversing Drugs]. It might not work via the DR
mechanism.
Estradiol is a steroid hormone (Botelho, et al., 2009) and the primary female sex hormone (Stoeva, 1989).
Estradiol reverses ageing, HGPS and senescence as well as mimics DR [Ageing Reversing Drugs; DR
Mimetics; HGPS Reversing Drugs; Senescence Reversing Drugs]. However, estradiol is a potent
carcinogen in postmenopausal women.
LY-294002 is a phosphoinositide 3-kinase (PI3K) inhibitor (McDowell, et al., 2004). LY-294002 reverses
ageing, HGPS and senescence in addition to mimic DR [Ageing Reversing Drugs; DR Mimetics; HGPS
Reversing Drugs; Senescence Reversing Drugs].
Clofibrate is an established PPARalpha ligand (Wang, et al., 2013) that is used as antidiuretic drug
(Tarpey & Mendoza, 1980) and has anticancer activity (Wang, et al., 2013). Clofibrate reverses ageing,
HGPS and senescence [Ageing Reversing Drugs; HGPS Reversing Drugs; Senescence Reversing
Drugs].
Arachidonic acid is a precursor of prostaglandins, is released by phospholipase A2 (Yoshida, et al., 2007).
Arachidonic acid reverses ageing, HGPS and senescence [Ageing Reversing Drugs; HGPS Reversing
Drugs; Senescence Reversing Drugs].
Genistein is a phytoestrogen that has estrogenic activity (Kwon, et al., 2007). Genistein interacts with
oestrogen receptors alpha and beta and elicits reproductive effects in developing rodents (Soucy, et al.,
2006). Genistein reverses ageing, HGPS and senescence while also mimicking DR [Ageing Reversing
Drugs; DR Mimetics; HGPS Reversing Drugs; Senescence Reversing Drugs].
Benserazide is commonly used for Parkinson's disease, which is an age-related neurodegenerative
condition. It is used in combination with L-DOPA as a peripheral aromatic L-amino acid decarboxylase
inhibitor. Benserazide acts also in the central nervous system (Shen, et al., 2003). Benserazide reveres
ageing, HGPS, and senescence as well as mimics DR [Ageing Reversing Drugs; DR Mimetics; HGPS
Reversing Drugs; Senescence Reversing Drugs].
Azathioprine is used as an anti-inflammatory agent (Moeslinger, et al., 2006). Azathioprine reverses
ageing, HGPS and senescence [Ageing Reversing Drugs; HGPS Reversing Drugs; Senescence
Reversing Drugs].
Geldanamycin is a ligand of the heat shock protein 90 (Li, et al., 2012). Geldanamycin reveres ageing,
HGPS, and senescence as well as mimics DR [Ageing Reversing Drugs; DR Mimetics; HGPS Reversing
Drugs; Senescence Reversing Drugs].
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Pentamidine is a antiprotozoal agent used for the treatment of Pneumocystis jirovecii pneumonia (Arino, et
al., 2012). Pentamidine reverses ageing, HGPS and senescence [Ageing Reversing Drugs; HGPS
Reversing Drugs; Senescence Reversing Drugs].
MK-2206 is a allosteric Akt inhibitor that also inhibits tumour growth (Sangai, et al., 2012). MK-2206
mimics DR and reverses ageing as well as targets ageing genes, specifically DR-essential genes and
gerontogenes [DR Mimetics; Ageing Reversing Drugs; DR Genes Targeting Drugs; Gerontogenes
Targeting Drugs].
NVP-BGT226 is a dual inhibitor of PI3K and mTOR (Fokas, et al., 2012). NVP-BGT226 reverses ageing,
HGPS and senescence as well as targets ageing genes, specifically gerontogenes and DR-essential
genes [Ageing Reversing Drugs; HGPS Reversing Drugs; Senescence Reversing Drugs; Gerontogenes
Targeting Drugs; DR Genes Targeting Drugs].
XL765, also known as SAR245409, is a potent and highly selective pan inhibitor of class PI3Ks (alpha,
beta, gamma, and delta) with activity against mTOR (Yu, et al., 2014). XL765 targets ageing genes,
including gerontogenes and DR-essential genes [Gerontogenes Targeting Drugs; DR Genes Targeting
Drugs].
Mesalazine is a standard first line treatment for moderately active ulcerative colitis (Buckland & Bodger,
2008). Mesalazine mimics DR [DR Mimetics].
4,5-Dianilinophthalimide is a EGF family tyrosine kinase receptor inhibitor (Yen & Soong, 1996). It is
considered for use in treatment of Alzheimer's disease, an age-related neurodegenerative disease
(Hennessy & Buchwald, 2005). 4,5-Dianilinophthalimide mimics DR [DR Mimetics].
Nocodazole is a synthetic anti-tubulin agent (Samson, et al., 1979) used as anticancer drug (Attia, et al.,
2015). Nocodazole mimics DR and reverses senescence [DR Mimetics; Senescence Reversing Drugs].
Dexverapamil is a competitive inhibitor of the P-glycoprotein efflux pump (Wilson, et al., 1995).
Dexverapamil mimics DR [DR Mimetics];
3-Aminobenzamide is a potent inhibitor of poly(ADP-ribose)synthetase (Masiello, et al., 1985).
3-Aminobenzamide mimics DR [DR Mimetics].
Other known geroprotectors like metformin (Bulterijs, 2011) target specifically gerontogenes, reverse
ageing and mimic DR [DR Mimetics]. Metformin extends the lifespan of model organisms from
invertebrates to rodents (Anisimov, et al., 2011; Mair, et al., 2011).
Quercetin is a flavonoid that acts as an antioxidant and occurs in foods mainly as glycosides (Olthof, et al.,
2000). Quercetin is a well known senolytic. Here it was found that quercetin mimics DR and reverses
senescence (Malavolta, et al., 2016) [DR Mimetics; Senescence Reversing Drugs].
The application of wortmannin, a PI3K inhibitor, could extend the lifespan (MacKay, et al., 2012).
Wortmannin reverses ageing, senescence and progeria [Ageing Reversing Drugs; Senescence Reversing
Drugs; HGPS Reversing Drugs].
Trichostatin A (TSA) is a potent and specific histone deacetylase inhibitor with promising antitumour
activity (Sanderson, et al., 2004). Trichostatin A was found to extend the lifespan of D. melanogaster by
promoting hsp22 gene transcription, and affecting the chromatin morphology at the locus of the hsp22
gene (Tao, et al., 2004). TSA increases lifespan in both long- and short-lived fruit fly lines, with variable
degrees (up to 25%) (Zhao, et al., 2005). Among the small molecules that reverse premature ageing was
trichostatin A. Trichostatin A among other compounds were found to have the potential to also mimic the
gene expression changes induced by dietary restriction. Trichostatin A reverses ageing and HGPS
[Ageing Reversing Drugs; HGPS Reversing Drugs].
In the network of dietary restriction-essential genes there is a cluster of drugs that target histone
deacetylases [Figure 50 Dietary Restriction-Essential Genes Targeting Drugs]. Caloric restriction induces
a hyperactylation state, thus it may work via inhibiting protein deacetylases. This links to lipoic acid given
as dietary supplement to extend group survival (Merry, et al., 2008).
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Several drugs could have not been found via interactomics alone as there are is no obvious enrichment
for ageing genes. The utilization of gene expression data enables to find drugs for which there are even
no known target genes or interactions.
There seem to be at least two categories of drugs; those that work via DR or those that counteract ageing,
HGPS and senescence. This is similar to what was observed regarding genes in respect to DR. Some
genes (DR essential) if perturbed affect lifespan, i.e. interferes with ageing via the DR mechanism while
others do not affect lifespan but do not work via the DR pathways.
Drug combination could be predicated as well. Those could be more powerful in reversing ageing-related
gene expression changes completely than single compounds are capable of.
6.5   Conclusion
Graph theory was used to find small molecules that target specific ageing gene classes such as
gerontogenes and ageing-suppressor genes as well as DR-essential genes. Further gene expression
matching based on calculation of the cosine similarity/distance was utilized to find drugs that reverse or
mimic the molecular signatures related to ageing, HGPS, cellular senescence and dietary restriction.
Previous known geroprotectors were rediscovered and put into context while novel small molecules with
potential geroprotector activity were predicted. Similar to what was discovered in genetic experiments it
appears that small molecule that affect the lifespan are of two kind: Those that work via DR signalling and
those that do not.
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7   Discussion
This section is a critical examination of the findings in the light of the previous state of the subject as
outlined in the background, and makes judgements as to new insights gained from the work. Overall, this
work shows that it is possible to make predictions about ageing and interventions to retard ageing from
omics data.
The introduction defined what is ageing, age and ageing biomarkers as well as interventions to intervene
with ageing such as dietary restriction (DR) and pharmacologically with anti-ageing drugs. In the following
various interrelated disciplines involving the use of computer science such as computational biology,
bioinformatics, functional genomics, and systems biology have been explained and described how they
relate to each other [Figure 1 Overlapping Fields] and lastly the important concepts of molecular profiling
and signatures has been defined (Wuttke & de Magalhaes, 2011).
The approach undertaken starts from the genome by classifying those genes that are associated with
ageing (inferred from gene manipulation experiments) and applied graph theory, to biological networks in
order to characterize those genes already known to be associated with ageing and predict novel ageing
genes, not yet implicated in the ageing process. Ageing genes can be subdivided into the defined classes
of gerontogenes and ageing-suppressor genes.
Following that analysis other omics data such as transcriptomics are explored and molecular signatures of
ageing have been derived in order to investigate gene activities. A particular class of ageing genes that
are necessary for the lifespan extending effect of dietary restriction, so called DR-essential genes, is
defined and used as an indicator for seeking novel interventions. Subsequently molecular signatures of
dietary restriction were derived and characterized. Next, drugs that target ageing genes and specific
subclasses of ageing genes have been identified. Signatures of small molecules have been derived and
used to identify (via pattern matching) anti-ageing compounds that are highly likely to interfere with the
ageing process, perhaps more effectively than previous interventions.
7.1   Genes that Govern Ageing
In this thesis ageing genes (sometimes also referred to as longevity genes) have been subclassified into
gerontogenes and ageing-suppressor genes. Another class of ageing-associated genes, called
DR-essential genes (or DR genes for short) have been defined as well. Further a class of genes that were
found to be associated with exceptional longevity, i.e. longevity-associated genes and cellular senescence
were proposed. In the following is the taxonomy used in this study:
• Ageing-Associated Gene
• Ageing Gene (a.k.a. Longevity Gene or Longevity Assurance Gene or
Longevity/Ageing-Regulating Gene)
• Gerontogene (a.k.a. Anti-Longevity/Pro-Ageing Gene)
• Genuine Gerontogene
• Uncertain Gerontogene
• Ageing-Suppressor Gene (a.k.a. Pro-Longevity/Anti-Ageing Gene)
• Genuine Ageing-Suppressor Gene
• Uncertain Ageing-Suppressor Gene
• DR Gene (a.k.a. DR-Essential Gene)
• Longevity-Associated Gene
• Cellular Senescence Gene
 
Ageing genes and DR-essential genes have been identified by gain- and loss-of-function genetic
experiments. Ageing-differentially expressed and longevity-associated genes have been primarily
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identified via measuring transcript levels and genotyping genomes respectively (both via either
low-throughput or high-throughput experiments). Many longevity regulating pathways reveal anti-ageing
and ageing-promoting effects and therefore change lifespan, depending on the biological and
environmental context (Honjoh & Nishida, 2011). Thus, the distinction into those defined classes might not
always be so clear cut. Those cases where an ageing gene can both act as a genuine gerontogene and a
genuine ageing-suppressor gene or has no effect in different contexts is challenging this simplification.
As age-related diseases are caused by ageing it is not surprising that mutations that slow down ageing
also postpone age-related diseases (Kenyon, 2010). Another class to be considered are the age-related
disease genes. It would be intriguing to know to what extent age-related disease genes and ageing genes
overlap and whether either one interacts with the other. Genes associated with age-related disease were
shown to be informative as providing prior knowledge for identifying longevity-associated genes (Fortney,
et al., 2015).
Age-related disease and normal ageing are often differentiated and assumed to be governed by separate
molecular mechanisms. Molecular profiling may substantiate or reject this proposal (Pereira, et al., 2007).
In this work, drugs predicted to intervene with ageing were associated with the treatment of several
age-related diseases including neurodegeneration and cancer [Small Molecule Predictions].
Mutations that extend the lifespan also frequently prevent tumour cell growth (Pinkston, et al., 2006). It
would be interesting to investigate how far is the parallel between gerontogenes/ageing-suppressor genes
and proto-oncogene/tumour-suppressor genes. Are gerontogenes more likely to be proto-oncogenes while
ageing-suppressor genes tend to be tumour-suppressor genes or vice versa or is their relationship
non-trivial if there is any?
Ageing genes frequently interact with multiple signalling and metabolic pathways (Curtis, et al., 2006).
Here DR-essential genes in particular but also ageing genes were found to have a higher node degree
than expected by chance, even higher than signalling genes.
Several genetic pathways regulate organism longevity and act by modifying gene expression. Many more
genes are subjected to age-associated transcriptional regulation. Dietary restriction is capable of
preventing some age-related gene expression changes. Manipulating the expression of some age-related
genes can robustly extend an organism's lifespan. Homologous genes in other organisms tend to have
similar functions. The activity of many transcription regulatory elements are linked to biological age as
opposed to chronological age, suggesting that orderly and tightly controlled regulatory pathways are active
during ageing. An intricate program of gene expression controls progression through the different stages in
development. Ageing is genetically determined and environmentally modulated (Seroude, 2002). The
finding of this research here on ageing genes and consensus molecular transcriptional signatures found
repeatedly growth and development tightly linked to ageing. In particular gerontogenes are positive
regulators of growth while ageing-suppressors are negative regulators [Ageing Genes].
The results of these predictions regarding DR-essential genes were reproduced and validated in other
studies (Kitamura, et al., 2006; Bohnert & Kenyon, 2017). This further and independently confirms the
validity of these predictions.
7.2   Age-Related Changes
There are myriads of age-related changes continuously happening in organisms. Those kind of changes
can be classified into discrete categories. There have been attempts to define those classes of age-related
changes, but none is comprehensive enough to include all kinds of age-related change (Lopez-Otin, et al.,
2013). First of all changes are happening on different scales. There are changes happening at the level of
the whole physiology down to the molecular level. To classify the different scales the following taxonomy is
used:
• Physiological Change
• Organ-Level Change
• Tissue-Level Change
• Cellular Change
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• Organelle-Level Change
• Molecular Change
With the interactome and transcriptome as well as most other omics data the entities are only acting at the
molecular level of genes, transcripts, protein/RNA products and small molecules (including metabolites).
However, via the shared associations it is possible to obtain some insights into the changes at the level of
the other scales as they are composed hierarchically of those molecular building blocks.
Sometimes these changes are called "damages", but this is often misleading as those changes are not all
damaging. Damage is something very subjective. It might be a correct description for certain changes at
the molecular level such as DNA damage, but those are just resulting into mutations and sometimes
required for the immune system to generate antibody variety, during recombination of genomes in meiosis
and for evolution. In addition, changes that are happening to proteins can be oversimplified and just
attributed as damages (though they are often just modifications). However, cells use those modifications
as ways of signalling for example regarding oxidation and glycation of proteins. Overall it should be
avoided to attribute every age-related change as damage.
1. Genomic Instability (Molecular)
• Nuclear DNA Mutation (Molecular)
• Telomere Attrition (Molecular)
• Mitochondrial DNA Mutation (Molecular)
2. Epigenetic Alteration (Molecular)
3. Transcript/Protein Decoupling (Cellular)
4. Proteostasis Loss (Cellular)
• i.e. Loss of Protein Homeostasis
• Lysosomal Dysfunction (Organelle-level)
• Proteasome Dysfunction (Molecular)
5. Nutrient Sensing Deregulation (Cellular)
6. Signalling Alteration (Molecular)
7. Mitochondrial Dysfunction (Organelle-level)
8. Intercellular Communication Alteration (Physiological)
• Immunosenescence (Physiological)
9. Cellular Senescence (Cellular)
10. Stem Cell Exhaustion (Physiological)
11. Cycle Alteration (Molecular - Physiological)
7.3   Genomic Instability
7.3.1   Nuclear DNA
7.3.1.1   DNA Repair
Ageing genes are involved in DNA repair and in particular ageing-suppressor genes are involved in
response to DNA damage and various DNA repair forms [Figure 10 Common Ageing Gene Network].
Genes differentially expressed during ageing are also involved in DNA repair [Ageing Signatures]. Genes
upregulated during ageing are commonly associated to the response to DNA damage [Ageing Signatures;
Figure 21 Common Ageing], while genes downregulated with ageing are associated with positive
regulation of DNA repair. DNA repair is also downregulated in cellular senescence [Ageing Signatures].
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DR-essential genes are involved in regulation of DNA repair, DNA double-strand break repair, positive
regulation of DNA repair, UV-damage excision repair, DNA synthesis involved in DNA repair, pyrimidine
dimer repair by nucleotide-excision repair, single strand break repair [Dietary Restriction Genes].
Therefore DR-essential genes are involved in DNA repair and its positive regulation.
Ageing genes (both gerontogenes and ageing-suppressor genes) are commonly involved in DNA repair,
DNA double-strand break repair, double-strand break repair via homologous recombination, and
recruitment and ATM-mediated phosphorylation of repair and signalling proteins at DNA double strand
breaks. Ageing genes (gerontogenes and ageing-suppressor genes together) are commonly involved in
double-strand break repair, nucleotide excision repair, base excision repair, and nucleotide-excision repair
DNA damage recognition. Gerontogene are commonly involved in global genome nucleotide excision
repair GG-NER. Ageing-suppressor genes are involved in DNA repair complex, TP53 regulates
transcription of DNA repair genes, double-strand break repair via nonhomologous end joining,
transcription-coupled nucleotide excision repair TC-NER, DNA synthesis involved in DNA repair, gap-filling
DNA repair synthesis and ligation in TC-NER, mismatch repair, mismatch repair (MMR) directed by
MSH2:MSH3 MutSbeta, nucleotide-excision repair factor 1 complex, meiotic mismatch repair,
nucleotide-excision repair complex, base-excision repair, mismatch repair complex, SUMOylation of DNA
damage response and repair proteins, mismatch repair (MMR) directed by MSH2:MSH6 MutSalpha,
nucleotide excision repair, and homology directed repair [Ageing Genes].
Genes differentially expressed during ageing and upon DR are commonly involved in DNA repair [Ageing
Signatures; Dietary Restriction Signatures]. Gap-filling DNA repair synthesis and ligation in TC-NER is
downregulated upon DR. Though DR-downregulated genes were associated with double-strand break
repair via non-homologous end joining in humans, which may mean that there are fewer DNA
double-strand breaks occurring under DR, or/and it is downregulated in favour of the more exact
homologous repair mechanism. Regardless, DR is associated with reduced DNA mutations [Dietary
Restriction Signatures]. DR-essential genes are involved in regulation of DNA repair, positive regulation of
DNA repair, DNA synthesis involved in DNA repair DNA double-strand break repair, recruitment and
ATM-mediated phosphorylation of repair and signalling proteins at DNA double strand breaks, single
strand break repair, UV-damage excision repair, and pyrimidine dimer repair by nucleotide-excision repair
[Dietary Restriction Genes].
Cellular senescence downregulates DNA repair, DNA synthesis involved in DNA repair, and regulation of
DNA repair. Genes upregulated in cellular senescence are involved in negative regulation of DNA repair
[Ageing Signatures].
DNA repair is mostly associated with ageing-suppressor genes, and differentially expressed during ageing
and under DR conditions. Cellular senescence suppresses the repair of DNA, which may lead to
enhanced DNA damage in senescence cells and a negative feedback loop that locks senescence cells
down.
7.3.1.2   Telomere Attrition
Ageing genes are involved in telomere maintenance. Gerontogenes negatively regulate telomere
maintenance, while ageing-suppressor genes positively regulate telomere maintenance and telomerase
activity [Ageing Genes]. In particular ageing-suppressor genes are commonly associated with participating
in telomere maintenance (including telomere maintenance via recombination) and being located in the
nuclear chromosome telomeric region [Figure 10 Common Ageing Gene Network]. Ageing is observed to
downregulate telomere maintenance and the positive regulation of telomerase maintenance [Ageing
Genes]. DR downregulates senescence induced by DNA damage or telomere stress [Ageing Signatures].
Additionally, positive regulation of telomerase activity is significantly and commonly associated with
downregulation during ageing [Ageing Signatures]. More specifically ageing-differentially expressed genes
are involved in positive regulation of establishment of protein localization to telomere [Figure 17 M.
musculus Ageing], while ageing-downregulated genes are involved in positive regulation of telomere
maintenance via telomerase as well as telomere tethering at the nuclear periphery [Figure 17 M. musculus
Ageing; Figure 20 S. cerevisiae Ageing]. TERT itself is downregulated in the human consensus signature.
Telomere capping and telomere organization are associated with DR-downregulated genes in humans that
may reflect a lower level of repair required for the well-maintained telomeres under dietary restriction
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conditions [Figure 39 H. sapiens Dietary Restriction]. Telomere shortening is happening during normal
ageing as observed in both human and mice (Blasco, 2007). Dietary restriction of amino acids other than
methionine increases telomerase activity and prevents telomere shortening in rats (Tanrikulu-Kucuk &
Ademoglu, 2012). Dietary restriction can also enhance telomere maintenance without increased
telomerase activity (Wang, et al., 2010), probably via recombination.
7.3.1.3   Nuclear Envelope
The nuclear envelope is a double lipid bilayer enclosing the nucleus.
Ageing genes (both gerontogenes and ageing-suppressor genes) are commonly located in the nuclear
envelope. Ageing-suppressor genes are involved in nuclear envelope organization, nuclear envelope
reassembly, and initiation of nuclear envelope reformation [Ageing Genes].
Genes downregulated during ageing are commonly located in nuclear envelope and involved in nuclear
envelope breakdown. The nuclear envelope and nuclear envelope organization is significantly associated
with ageing-upregulated genes [Figure 13 H. sapiens Ageing].
DR-essential genes are involved in nuclear envelope organization [Dietary Restriction Genes]. Genes
differentially expressed (both up- and down-regulated) during DR are located in the nuclear envelope.
Genes upregulated upon DR are involved in nuclear envelope breakdown. Genes downregulated upon DR
are involved in nuclear envelope organization, nuclear envelope reassembly, and initiation of nuclear
envelope reformation [Dietary Restriction Signatures].
Ageing genes are located in the nuclear pore and involved in nuclear pore organization. More specifically
ageing-suppressor genes are located in the nuclear pore inner ring and make up structural constituent of
nuclear pore [Ageing Genes]. Genes downregulated with ageing are involved in nuclear pore organization
as well as are located in nuclear pore, structural constituent of nuclear pore, nuclear pore central transport
channel, and nuclear pore cytoplasmic filaments. Cellular senescence downregulated genes are involved
in nuclear pore complex disassembly [Ageing Signatures].
Ageing-suppressor genes are majorly involved in nuclear envelope and there are changes happening in
the expression of genes involved in the nuclear envelope both during ageing and upon DR. Ageing
downregulates nuclear envelope breakdown, while DR upregulates this process. Upregulation of nuclear
envelope breakdown might enable the replacement of long-lived proteins associated with the nuclear
envelope such as nuclear pore complexes. Nuclear envelope alterations occur during physiological and
premature ageing. The resulting nuclear envelope defects are causal for stem cell dysfunctions (Espada,
et al., 2008).
7.3.1.4   Chromosomes
Ageing genes are involved in chromosome organization and regulation of chromosome organization.
Gerontogenes are involved in negative regulation of chromosome organization. Ageing-suppressor genes
are also significantly associated with being involved in chromosome organization and regulation of
chromosome organization. Ageing-suppressor genes are associated with chromosome centromeric
region, condensed chromosome, chromosome segregation, and chromosome organization involved in
meiotic cell cycle [Ageing Genes]. Genes downregulated with ageing are involved in chromosome
organization and regulation of chromosome organization and positive regulation of chromosome
organization. Cellular senescence downregulates genes that are involved in chromatin organization
[Ageing Signatures]. DR upregulates chromosome organization while downregulating nuclear
chromosome [Dietary Restriction Signatures].
Chromosome organization appears to be an ageing-suppressing process that is downregulated during
ageing and in cellular senescence, but upregulated upon DR.
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7.3.2   Mitochondrial DNA
Gerontogenes and ageing-suppressors are involved mitochondrial genome maintenance. Gerontogene
are commonly involved in mitochondrial DNA repair and replication. Ageing-suppressor genes are also
involved in mitochondrial DNA repair and replication [Ageing Genes]. Genes upregulated upon DR are
involved in regulation of mitochondrial DNA metabolic process [Ageing Signatures].
 
Therefore, it seems like that DNA repair involves ageing-suppressor genes, is downregulated during
ageing, and might be modulated by DR via positive regulation. Similar ageing-suppressor genes promote
telomere maintenance, while gerontogenes counteract maintenance of telomerase. Ageing downregulates
telomere maintenance.
7.4   Epigenetic Alterations
Epigenetic changes involve DNA methylation and hydroxymethylation as well as post-translational
modifications of histones such as methylation, acetylation, ubiquitination, and phosphorylation among
others and chromatin remodelling. Epigenetic modifications vary greatly over the course of development
and ageing, but are remarkable consistent between individuals and between mice and humans.
7.4.1   Chromatin
Ageing genes are commonly involved in chromatin silencing and particular chromatin silencing at rDNA.
Ageing genes including gerontogenes and ageing-suppressor genes are commonly involved in chromatin
and chromatin organization as well as covalent chromatin modification. Ageing-suppressor genes are
involved in chromatin binding regulation of chromatin organization and negative regulation of chromatin
organization [Ageing Genes]. Ageing-suppressor genes are commonly associated with chromatin
including nuclear chromatin, chromatin binding and NAD-dependent histone deacetylase activity [Figure
10 Common Ageing Gene Network]. Ageing-suppressor genes are associated with chromatin silencing at
rDNA nuclear telomeric heterochromatin and nuclear telomeric heterochromatin chromatin silencing at
silent mating-type cassette [Figure 8 S. cerevisiae Ageing Gene Network]. Gerontogenes also exhibit
chromatin binding (Figure 5 M. musculus Ageing Gene Network). Overall ageing genes are commonly
associated with chromatin, chromatin binding, covalent chromatin modification, regulation of chromatin
organization and histone modifications [Figure 10: Common Ageing Gene Network].
Genes differentially expressed with ageing are commonly involved in chromatin, chromatin binding,
covalent chromatin modification and chromatin organization. Genes downregulated with ageing are
involved in chromatin silencing, Orc1 removal from chromatin, and regulation of chromatin organization
[Ageing Signatures]. Ageing-upregulated genes are associated with chromatin binding [Figure 13 H.
sapiens Ageing].
DR-essential genes are commonly associated with deacetylase activity, histone deacetylation, and histone
H3 deacetylation [Figure 32 Network of Associations Common to DR-Essential Gene Across Species].
However the DR state is associated with global hyperacetylation [Anti-Ageing Drugs]. Acetylation of H3 at
lysine 9, 27, 56 is 20-30% higher in dietary restriction animals (Kawakami, et al., 2012). A cluster of
deacetylase inhibitors was found to target DR genes [DR Genes Targeting Drugs]. Others sites or only a
specific target site subset might be more deacetylated, for instance sirtuins act on lysine 16 of histone H4
(Fraga & Esteller, 2007).
Genes differentially expressed upon DR are commonly involved in chromatin and chromatin organization.
Genes upregulated upon DR are involved commonly in covalent chromatin modification. Genes
downregulated upon DR are commonly involved in nuclear chromatin, chromatin binding,
promoter-specific chromatin binding, chromatin modifying enzymes, chromatin remodelling, and
ATP-dependent chromatin remodelling [Dietary Restriction Signatures; Figure 40 R. norvegicus Dietary
Restriction]. DR-upregulated genes are associated with nucleosome [Figure 43 C. elegans Dietary
Restriction] and chromatin silencing [Figure 39 H. sapiens Dietary Restriction].
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Therefore, it appears that chromatin suppression counteracts ageing and ageing downregulates chromatin
silencing, while DR upregulates chromatin silencing.
7.4.2   DNA Methylation
Ageing-suppressor genes are commonly involved in DNA methylation, DNA methylation involved in
embryo development, and maintenance of DNA methylation. Gerontogenes are commonly involved in
regulation of DNA methylation [Ageing Genes].
Genes upregulated during ageing are involved in maintenance of DNA methylation [Ageing Signatures;
Figure 17 M. musculus Ageing]. Genes upregulated during cellular senescence are involved in DNA
methylation as well as DNA methylation or demethylation. Genes downregulated upon DR are commonly
involved in DNA methylation as well as DNA methylation or demethylation [Dietary Restriction Signatures;
Figure 39 H. sapiens Dietary Restriction].
Ageing-suppressor genes are involved in DNA hypermethylation or more specifically in hypermethylation
of CpG island [Ageing Genes]. Genes upregulated during ageing as well as upon DR are involved in
hemi-methylated and double-stranded methylated DNA binding [Ageing Signatures; Dietary Restriction
Signatures; Figure 40 R. norvegicus Dietary Restriction].
Ageing is associated with global hypomethylation and loci specific hypermethylation (Johnson, et al.,
2012). DR counteracts the age-related hypomethylation (Kim, et al., 2016; Ions, et al., 2013). Both
gerontogenes and ageing-suppressor genes act on DNA methylation. Gerontogenes tend to be acting like
regulators of DNA methylation.
7.4.3   Histone Modifications
Ageing genes are involved in histone binding and regulation of histone modification [Ageing Genes].
Ageing-suppressor genes, gerontogenes and genes upregulated with ageing or upon DR are all also
associated with histone modification [Ageing Genes; Ageing Signatures; Dietary Restriction Signatures].
Histone H4K16 acetylation, H4K20 trimethylation and H3K4 trimethylation all increase with age, while
H3K9 methylation and H3K2 trimethylation decrease (Fraga & Esteller, 2007; Han & Brunet, 2012).
Chromatin remodelling complexes such as NuRD decrease with ageing (Pegoraro, et al., 2009; Pollina &
Brunet, 2011) and other like HP1alpha increase with ageing (Happel, et al., 2008).
7.4.3.1   Histone Acetylation
Ageing genes are involved in regulation of histone acetylation, negative regulation of histone acetylation,
histone deacetylase complex, and NAD-dependent histone deacetylase activity. Ageing-suppressor genes
suppress histone acetylation and enhance histone deacetylation. Ageing-suppressor genes are associated
with histone deacetylation and histone deacetylase activity [Ageing Genes].
Genes downregulated with ageing and upon DR exhibit histone acetyltransferase binding [Figure 13 H.
sapiens Ageing; Dietary Restriction Signatures]. DR-essential genes are associated with histone
deacetylation, histone deacetylase activity, histone H3 deacetylation, histone deacetylase activity H3-K9
specific, NAD-dependent histone deacetylase activity, and NAD-dependent histone deacetylase activity
H3-K9 specific [Dietary Restriction Genes]. DR downregulates histone acetyltransferase binding [Figure
39 H. sapiens Dietary Restriction; Figure 40 R. norvegicus Dietary Restriction], but upregulates histone
deacetylase binding, histone H3 deacetylation and histone methyltransferase binding [Dietary Restriction
Signatures]. DR-upregulated genes are associated with histone deacetylase binding, but also in particular
with histone H3 deacetylation [Figure 40 R. norvegicus Dietary Restriction; Figure 41 M. musculus Dietary
Restriction] and more specific with positive regulation of histone deacetylation [Figure 41 M. musculus
Dietary Restriction]. Moreover, DR-upregulated genes are associated with histone H3 and H4 acetylation
[Figure 41 M. musculus Dietary Restriction].
Trichostatin A is a potent and specific histone deacetylase inhibitor that was found to mimic the gene
expression of changes induced by dietary restriction while also reversing the gene expression changes
associated with ageing and Hutchinson–Gilford progeria syndrome (HGPS) [Figure 45 Ageing Reversing
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Drugs; Figure 52 HGPS Reversing Drugs; Figure 54 DR Mimetics]. Trichostatin A increases the lifespan of
model organisms such as Drosophila and leads to the induction of heat shock proteins (Tao, et al., 2004).
The acetylation and deacetylation is majorly governed by ageing-suppressor genes.
7.4.3.2   Histone Methylation
Ageing genes are located in histone methyltransferase complex, are involved in histone H3-K4 methylation
as well as exhibit histone-lysine N-methyltransferase activity and histone methyltransferase activity H3-K4
specific. Gerontogenes are associated with histone methylation (histone methyltransferase activity,
histone-lysine N-methyltransferase activity, and histone methyltransferase activity H3-K9 specific) [Ageing
Genes].
Genes downregulated with ageing are involved in demethylation, macromolecule methylation, protein
demethylation, histone demethylation, histone lysine demethylation, and histone H3-K27 demethylation as
well as histone demethylase activity, demethylase activity, and histone demethylase activity H3-K27
specific. Genes differentially expressed and upregulated upon DR exhibit histone methyltransferase
binding [Ageing Signatures]. DR-upregulated genes are associated with methyltransferase activity [Figure
40 R. norvegicus Dietary Restriction] and histone methyltransferase binding [Figure 41 M. musculus
Dietary Restriction].
Histone methylation/demethylation seems mostly governed by gerontogenes. Ageing downregulates
demethylation, while DR upregulates methyltransferases.
7.4.3.3   Histone Phosphorylation
Ageing-suppressor genes are commonly associated with positive regulation of histone phosphorylation,
while gerontogenes are involved in histone phosphorylation itself [Ageing Genes].
Ageing differential expresses (both up and down) histone phosphorylation. Genes differentially expressed
with ageing (up- and downregulated genes together) exhibit histone kinase activity and are involved in
regulation of histone phosphorylation as well as positive regulation of histone phosphorylation. Genes
downregulated during ageing are associated with histone-threonine phosphorylation, histone H3-T6
phosphorylation and exhibit histone kinase activity H3-T6 specific. Cellular senescence differentially
expresses histone phosphorylation (in particular histone-serine phosphorylation), downregulates histone
kinase activity, and upregulates histone H2A phosphorylation, regulation of histone phosphorylation and
positive regulation of histone phosphorylation [Ageing Signatures. DR-essential genes exhibit histone
kinase activity [Dietary Restriction Genes].
Therefore, histone phosphorylation appears ambiguous regarding its affects on ageing/lifespan. Certain
histone phosphorylation seem to be gerontogenic (and associated with cellular senescence such as H2A
phosphorylation), while others may by ageing-suppressive (e.g. H3-T6) depend on the type of histone and
residues that are modified.
7.4.3.4   Chromatin Remodelling
Ageing genes including gerontogenes, ageing suppressor genes and also DR-essential genes are all
involved in chromatin remodelling [Ageing Genes]. Genes upregulated with ageing are involved in
chromatin remodelling too [Ageing Signatures]. Genes downregulated with DR are involved in chromatin
remodelling and specifically ATP-dependent chromatin remodelling as well as chromatin remodelling at
centromere [Dietary Restriction Signatures]. Further, DR-essential genes are also involved in chromatin
remodelling [Dietary Restriction Genes].
The NuRD complex that is a histone deacetylase complex associated is with both gerontogenes and
ageing-suppressor genes as well as ageing-upregulated genes [Figure 17 M. musculus Ageing] and
DR-essential genes. Piccolo NuA4 histone acetyltransferase complex is associated with gerontogenes
[Ageing Genes] and DR-downregulated genes are associated with NuA4 histone acetyltransferase
complex too [Figure 41 M. musculus Dietary Restriction]. MLL5-L complex is also associated with genes
downregulated upon DR [Figure 41 M. musculus Dietary Restriction].
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7.5   Proteostasis Loss
Proteostasis (i.e. protein homeostasis) involves synthesis, folding, processing, trafficking, aggregation,
disaggregation and degradation of proteins (Powers, et al., 2009). Loss of protein homeostasis during
ageing may lead to impaired protein solubility and cellular dysfunction (Reis-Rodrigues, et al., 2012). All
cells exhibit a number of quality control mechanisms to preserve the stability of their proteome.
Post-translational protein modification is associated with ageing-downregulated genes and de novo
post-translational protein folding is associated with ageing-upregulated genes [Ageing Signatures].
7.5.1   Translation
Protein biosynthesis occurs via translation at ribosomes. Ageing genes are commonly associated with the
ribosome. Ribosomal protein S6 kinase activity in particular is associated with gerontogenes. Translation
is commonly associated with gerontogenes as well. More specifically gerontogenes are associated with
participating in translational initiation, tRNA aminoacylation for protein translation, formation of translation
preinitiation complex, and regulation of translational initiation, exhibiting translation initiation factor activity
and being located in the eukaryotic translation initiation factor 3 complex [Ageing Genes; Figure 7 C.
elegans Ageing Gene Network].
It seems important to note that gerontogenes do not only strongly associate with ribosome binding and
translation, but with the regulation of translation and in particular positive regulation of translation.
Gerontogenes are associated with all phases of positive regulation of translation from initiation through
elongation to termination, including exhibiting translation elongation factor activity [Ageing Genes].
Gerontogenes are also associated with translational frame-shifting that is a mechanism whereby different
proteins may result from a single mRNA molecule, due to a change in the parsing of three nucleotides per
codon relative to an initiating AUG codon [Ageing Genes]. To the contrary, ageing-suppressor genes are
associated with the negative regulation of ribosome biogenesis as well as circadian regulation of
translation [Ageing Genes].
Genes downregulated with ageing are associated with translation and regulation of translation, while
genes differentially expressed with ageing are involved in positive regulation of translation [Ageing
Signatures]. Structural constituent of ribosomes and translation are associated with ageing-differentially
expressed and downregulated genes [Figure 17 M. musculus Ageing] as well as is tRNA aminoacylation
for protein translation [Figure 20 S. cerevisiae Ageing]. Ageing downregulated genes are also associated
with selenocysteine incorporation [Figure 13 H. sapiens Ageing]. These associations with downregulation
could be just be part of the general decline of function.
Genes upregulated upon DR are associated with regulation of translation and genes differentially
expressed with ageing are associated with circadian regulation of translation (similar to ageing-suppressor
genes). However, DR-downregulated genes are associated with cytosolic small ribosomal subunit [Figure
39 H. sapiens Dietary Restriction], and therefore DR could suppress translation by limiting a ribosomal
subunit. DR essential genes are associated with being involved in translation, regulation of translation,
positive regulation of translation, negative regulation of translational initiation and even regulation of
mitochondrial translation, and being located in the eukaryotic translation initiation factor 4F complex
[Dietary Restriction Genes].
Therefore overall ageing does not seem to work by transcriptionally regulating the translational machinery,
but rather translation appears to be a modulator (like dietary restriction utilizes) to affect something that
mediates ageing.
Ageing genes and ageing-suppressor genes in particular are associated with being involved in
post-translational protein modification [Figure 5 M. musculus Ageing Gene Network].
7.5.2   Chaperoning
Molecular chaperones are a class of proteins that assist the covalent folding/unfolding and
assembly/disassembly of other micromolecular structures. Most chaperones, but not all, are heat-shock
proteins that are expressed in response to elevated temperatures or cellular stresses.
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Ageing genes are commonly associated with chaperone-mediated protein folding requiring a cofactor
[Figure 10 Common Ageing Gene Network]. Ageing-suppressor genes are associated with iron chaperone
activity and positive regulation of chaperone-mediated protein complex assembly. Ageing-suppressor
genes are also associated with the endoplasmic reticulum unfolded protein response [Ageing Genes;
Figure 19 C. elegans Ageing] .
Ageing-differentially expressed genes are associated with chaperone binding [Figure 13 H. sapiens
Ageing]. Protein binding involved in protein folding and chaperone mediated protein folding requiring a
cofactor are commonly associated with ageing-differentially expressed genes. Protein folding is commonly
associated with ageing-downregulated genes [Figure 10 Common Ageing Gene Network].
Ageing-upregulated genes have been found to be significantly associated with exhibiting chaperone
binding [Figure 13 H. sapiens Ageing]. Common to ageing-upregulated genes there is a significant
association of being involved in the cellular response to heat [Figure 18 D. melongaster Ageing; Figure 21
Common Ageing].
DR-upregulated genes are associated with protein binding involved in protein folding, and
chaperone-mediated protein folding [Figure 39 H. sapiens Dietary Restriction]. DR-downregulated genes
exhibit chaperone mediated protein folding requiring cofactor [Dietary Restriction Signatures].
Ageing-suppressor genes are commonly involved in protein repair [Ageing Genes]. DR-essential genes
are involved protein repair as well [Dietary Restriction Genes]. Protein repair is the process of restoring a
protein to its original state after damage by for instance oxidation or spontaneous decomposition of
residues.
7.5.3   Aggregates
If proteins are misfolded they tend to form various kinds of aggregates. These aggregates accumulate and
disrupt cellular function.
The aggresome is associated with ageing genes and aggresome assembly is associated with
gerontogenes [Ageing Genes]. Genes upregulated with ageing are commonly significantly associated with
being located in the aggresome [Ageing Signatures; Figure 13 H. sapiens Ageing]. DR-essential genes
and DR-downregulated gene are both significantly associated with aggresome and aggresome assembly.
Ageing-suppressor genes significantly interact with APP [Ageing Genes]. Further, ageing-differentially
expressed genes (up and down) [Ageing Signatures; Figure 13 H. sapiens Ageing; Figure 13 M. musculus
Ageing] and DR-downregulated genes (but not upregulated genes) [Dietary Restriction Signatures]
interact significantly with APP.
Gerontogenes promote aggresome assembly, while DR downregulates the assembly of aggresomes. The
association of amyloid beta with ageing-suppressor genes might indicate that ageing-suppressors prevent
the deleterious affect of amyloid beta or that amyloid beta suppresses the activity of ageing-suppressor
genes, as it is the case for telomerase. The downregulation of genes interacting with APP upon DR could
be due to a less need to handle amyloid beta aggregates.
7.5.4   Proteolytic Systems
There are two primary proteolytic systems in cells that destroy damaged or misfolded proteins. These are
the ubiquitin-proteasome system and the lysosomal autophagy. Both the ubiquitin-proteasome system and
autophagy decline with ageing (Rubinsztein, et al., 2011; Tomaru, et al., 2012).
7.5.5   Ubiquitin Proteasome System
Ageing genes are associated with negative regulation of proteolysis. Ageing-suppressor genes are
associated with being involved in regulation of protein ubiquitination [Figure 6 D. melanogaster Ageing
Gene Network] and ubiquitin-dependent protein catabolic processes [Figure 7 C. elegans Ageing Gene
Network; Figure 10 Common Ageing Gene Network]. Ageing-suppressor genes are significantly
associated with Cul4A-RING E3 ubiquitin ligase complex. Proteasome-mediated ubiquitin-dependent
protein catabolic process is associated with ageing-suppressor genes [Ageing Genes].
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Proteasome binding, and being located in the proteasome complex are both associated with
ageing-downregulated genes [Figure 17 M. musculus Ageing]. Ageing-upregulated genes are significantly
participating in negative regulation of endopeptidase activity [Figure 13 H. sapiens Ageing]. Protein
polyubiquitination is associated with ageing-differentially expressed genes. Ubiquitin protein ligase binding
is associated with ageing-downregulated genes [Ageing Signatures].
The ubiquitin-proteasome system is associated with ageing-downregulated genes with regulation of
proteasomal protein catabolic process, and protein deubiquitination, and exhibiting proteasome binding, as
well as proteasome complex [Ageing Signatures; Figure 17 M. musculus Ageing]. Positive regulation of
protein ubiquitination is associated with DR-essential genes [Dietary Restriction Genes] and the ubiquitin
protein ligase binding was found to be associated with DR-upregulated genes [Dietary Restriction
Signatures].
7.5.6   Ubiquitin
Ageing genes (gerontogenes and ageing-suppressor genes together) are commonly involved in
proteasome-mediated ubiquitin-dependent protein catabolic process and positive regulation of
proteasomal ubiquitin-dependent protein catabolic process. Ageing genes (both gerontogenes and
ageing-suppressor genes) are commonly involved in protein ubiquitination and exhibit ubiquitin protein
ligase binding as well as ubiquitin-like protein ligase binding. Gerontogenes do not have any unique
associations with ubiquitin-related processes, function, or locations. Ageing-suppressor genes however
are commonly involved in ubiquitin-dependent protein catabolic process, protein ubiquitination involved in
ubiquitin-dependent protein catabolic process, thiol-dependent ubiquitin-specific protease activity, ubiquitin
ligase complex, ubiquitin-protein transferase activity, positive regulation of ubiquitin-protein transferase
activity, ubiquitin-like protein transferase activity, ubiquitin-like protein-specific protease activity, ubiquitin
mediated proteolysis, ubiquitin mediated degradation of phosphorylated Cdc25A, autodegradation of the
E3 ubiquitin ligase COP1, ubiquitinyl hydrolase activity, thiol-dependent ubiquitinyl hydrolase activity,
deubiquitination, and protein deubiquitination [Ageing Genes]. DR-essential genes commonly exhibit
ubiquitin protein ligase binding and ubiquitin-like protein ligase binding. Protein ubiquitination involved in
ubiquitin-dependent protein catabolic process, ubiquitin conjugating enzyme binding, ubiquitin conjugating
enzyme activity, ubiquitin-like protein conjugating enzyme binding, ubiquitin-like protein conjugating
enzyme activity, ubiquitin protein ligase binding, ubiquitin-like protein ligase binding, positive regulation of
ubiquitin-protein transferase activity, ubiquitin-specific protease binding, ubiquitin mediated proteolysis,
positive regulation of protein ubiquitination, positive regulation of protein ubiquitination involved in
ubiquitin-dependent protein catabolic process, deubiquitination, and protein ubiquitination are all
associated with DR-essential genes [Dietary Restriction Genes].
Ageing-differentially expressed genes (up- and down-regulated genes together) are commonly involved in
regulation of protein ubiquitination, protein polyubiquitination, ubiquitin mediated proteolysis, and positive
regulation of proteasomal ubiquitin-dependent protein catabolic process. Ageing differentially expressed
genes (both up- and down-regulated genes) are commonly involved in ubiquitin protein ligase binding and
ubiquitin-like protein ligase binding. Genes upregulated with ageing are involved in protein ubiquitination
and positive regulation of protein ubiquitination. Genes downregulated with ageing are involved in
thiol-dependent ubiquitin-specific protease activity, ubiquitin-like protein-specific protease activity,
ubiquitin-dependent protein catabolic process, ubiquitin-dependent degradation of cyclin D and cyclin D1,
ubiquitinyl hydrolase activity, thiol-dependent ubiquitinyl hydrolase activity, deubiquitination, and protein
deubiquitination. Genes upregulated in HGPS are involved in protein K48-linked ubiquitination. Cellular
senescence up- and down-regulated genes are both commonly involved ubiquitin binding and
ubiquitin-like protein binding. Genes upregulated in cellular senescence are involved in ubiquitin protein
ligase binding, ubiquitin-like protein ligase binding, ubiquitin-like protein-specific protease activity,
thiol-dependent ubiquitin-specific protease activity, thiol-dependent ubiquitinyl hydrolase activity,
regulation of ER-associated ubiquitin-dependent protein catabolic process, negative regulation of
ER-associated ubiquitin-dependent protein catabolic process, ubiquitinyl hydrolase activity,
deubiquitination, protein K11-linked deubiquitination, protein K63-linked deubiquitination, and protein
K48-linked deubiquitination. Genes downregulated in cellular senescence are involved in protein
ubiquitination, negative regulation of protein ubiquitination, regulation of protein ubiquitination, positive
regulation of protein ubiquitination, ubiquitin-dependent protein catabolic process, proteasome-mediated
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ubiquitin-dependent protein catabolic process, regulation of proteasomal ubiquitin-dependent protein
catabolic process, positive regulation of proteasomal ubiquitin-dependent protein catabolic process,
negative regulation of proteasomal ubiquitin-dependent protein catabolic process, protein ubiquitination
involved in ubiquitin-dependent protein catabolic process, regulation of protein ubiquitination involved in
ubiquitin-dependent protein catabolic process, positive regulation of protein ubiquitination involved in
ubiquitin-dependent protein catabolic process, regulation of ubiquitin protein ligase activity, positive
regulation of ubiquitin protein ligase activity, negative regulation of ubiquitin protein ligase activity,
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle, positive regulation of
ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition, negative regulation of
ubiquitin-protein ligase activity involved in mitotic cell cycle, positive regulation of ubiquitin-protein ligase
activity involved in regulation of mitotic cell cycle transition, nuclear ubiquitin ligase complex, regulation of
ubiquitin-protein transferase activity, positive regulation of ubiquitin-protein transferase activity, negative
regulation of ubiquitin-protein transferase activity, and protein deubiquitination [Ageing Signatures].
Genes differentially expressed upon DR (up- and down-regulated genes together) are commonly involved
in protein ubiquitination, ubiquitin-dependent protein catabolic process. There are no ubiquitin-related
processes, functions, or locations that are associated commonly to DR-upregulated and
DR-downregulated genes. Genes downregulated upon DR commonly exhibit ubiquitin protein ligase
binding and ubiquitin-like protein ligase binding. Genes upregulated upon DR are commonly exhibit
ubiquitin binding and ubiquitin-like protein binding, as well as are involved in regulation of protein
ubiquitination, negative regulation of protein ubiquitination, and deubiquitination [Dietary Restriction
Signatures].
Ubiquitin-related processes, functions and locations seem to be specific for ageing-suppressor genes.
Protein ubiquitination could be upregulated during ageing because of the greater amount of misfolded and
modified proteins, that have to be tagged for degradation, but are overloading the protease/lysosomal
systems. In DR conditions, in contrast, the levels of misfolded and adversarial modified proteins is much
lower and create therefore less need to ubiquitinate proteins. Overall, ageing does downregulate more
ubiquitin-related processes, functions and locations than it upregulates, while DR does upregulate more
than it downregulates. Similar to ageing, cellular senescence downregulates many more ubiquitin-related
processes, functions and locations than it upregulates. All this indicates that ubiquitination is generally a
protective and ageing-suppressing process. Some ubiquitinations are very specific for signalling though
and could have ageing promoting effects.
7.5.7   Proteolysis
Ageing genes are commonly involved in proteolysis. Ageing-suppressor genes are commonly involved in
ubiquitin mediated proteolysis. Gerontogenes are involved in negative regulation of proteolysis [Ageing
Genes].
Genes differentially expressed with ageing are commonly involved in proteolysis, and negative as well as
positive regulation of proteolysis. Genes upregulated with ageing are involved in regulation of proteolysis,
regulation of membrane protein ectodomain proteolysis and negative regulation of proteolysis. Genes
downregulated with ageing are involved in cellular protein catabolic process and regulation of proteolysis
involved in cellular protein catabolic process [Ageing Signatures]. Genes upregulated with DR are also
involved in proteolysis [Dietary Restriction Signatures].
7.5.8   Proteases
Ageing genes are commonly involved in Ub-specific processing proteases, ubiquitin-like protein-specific
protease activity, and thiol-dependent ubiquitin-specific protease activity. Protease binding and Ub-specific
processing proteases are associated with gerontogenes. Ub-specific processing proteases, ubiquitin-like
protein-specific protease activity, and thiol-dependent ubiquitin-specific protease activity, protease binding,
ubiquitin-specific protease binding, and SUMO-specific protease activity are all associated with
ageing-suppressor genes [Ageing Genes]. DR-essential genes are significantly associated with
Ub-specific processing proteases and ubiquitin-specific protease binding [Dietary Restriction Genes].
179
Genes differentially expressed with ageing are involved in Ub-specific processing proteases. Genes
downregulated with ageing commonly exhibit protease binding, ubiquitin-like protein-specific protease
activity, thiol-dependent ubiquitin-specific protease activity [Ageing Signatures]. Genes upregulated in
HGPS exhibit protease binding. Genes upregulated upon DR are involved in Ub-specific processing
proteases [Dietary Restriction Signatures].
HGPS differentially expressed genes (both up and downregulated genes) are involved in proteolysis,
regulation of proteolysis and positive regulation of proteolysis. Genes downregulated in HGPS are
involved in negative regulation of proteolysis [Ageing Signatures].
7.5.9   Proteasome
Ageing genes are commonly involved in proteasome-mediated ubiquitin-dependent protein catabolic
process, exhibit proteasome-activating ATPase activity, and are located in proteasome regulatory particle
base subcomplex as well as nuclear proteasome complex. Ageing-suppressor genes are commonly
associated with proteasome complex, proteasome accessory complex, proteasome regulatory particle,
proteasome 19S regulatory particle PA700, and proteasome regulatory particle base subcomplex [Ageing
Genes].
Genes downregulated with ageing commonly exhibit ageing proteasome binding and are located in the
proteasome complex [Ageing Signatures]. Proteasome, proteasome-mediated ubiquitin-dependent protein
catabolic process, antigen processing - ubiquitination and proteasome degradation, GLI3 is processed to
GLI3R by the proteasome, and degradation of GLI1 by the proteasome are all downregulated during
ageing. Genes downregulated in cellular senescence are involved in proteasome-mediated
ubiquitin-dependent protein catabolic process [Ageing Signatures].
DR-essential genes are involved in degradation of GLI1 by the proteasome [Dietary Restriction Genes].
Genes upregulated upon DR are involved in proteasome-mediated ubiquitin-dependent protein catabolic
process [Dietary Restriction Signatures].
7.5.10   Autophagy
Ageing genes (both gerontogenes and ageing-suppressor genes) are commonly involved in animal
autophagy, CVT pathway, regulation of autophagy, and positive regulation of macroautophagy.
Gerontogenes are commonly associated with negative regulation of autophagy and macroautophagy.
Ageing-suppressor genes are commonly associated with autophagy, regulation of autophagy, mitophagy,
Pink1/Parkin mediated mitophagy, and, macroautophagy, and nucleophagy (including piecemeal
microautophagy of nucleus and late nucleophagy) [Ageing Genes].
Ageing genes commonly are associated with regulation of autophagy, where ageing-suppressor genes are
associated with autophagy including macroautophagy and mitophagy as well as positive regulation of
autophagy. Gerontogenes on the other hand negatively regulate autophagy [Figure 10 Common Ageing
Gene Network].
Ageing-differentially expressed genes (up- and down-regulated genes together) are commonly involved in
animal autophagy and regulation of chaperone-mediated autophagy. Genes upregulated with ageing are
involved in autophagy and negative regulation of autophagy. Genes differentially expressed in HGPS are
involved in regulation of autophagy. Genes differentially expressed in cellular senescence (both up- and
down-regulated genes) are involved in regulation of autophagy. Genes downregulated in cellular
senescence are involved in regulation of autophagy, positive regulation of autophagy, regulation of
macroautophagy, and positive regulation of macroautophagy [Ageing Signatures].
DR-essential genes are commonly involved in autophagy, animal autophagy, CVT pathway,
macroautophagy, positive regulation of macroautophagy, piecemeal microautophagy of nucleus, and late
nucleophagy [Figure 32 Network of Associations Common to DR-Essential Gene Across Species].
DR-essential genes are also involved in yeast autophagy, regulation of autophagy, positive and negative
regulation of autophagy, mitophagy, regulation of macroautophagy, glycophagy, pexophagy, and
reticulophagy [Dietary Restriction Genes].
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Autophagy is associated with DR-upregulated genes and negative regulation of macroautophagy is
associated with DR-downregulated genes [Dietary Restriction Signatures]. Genes differentially expressed
upon DR (both up- and down-regulated genes) are commonly involved in animal autophagy. Late
endosomal microautophagy is associated with DR-differentially expressed genes (up- and down-regulated
genes together). Chaperone-mediated autophagy, protein targeting to vacuole involved in autophagy, and
protein targeting to lysosome involved in chaperone-mediated autophagy are associated with
DR-downregulated genes. Regulation of chaperone-mediated autophagy is associated with
DR-upregulated genes [Dietary Restriction Signatures].
DR modulates autophagy. The downregulation of chaperone-mediated autophagy and protein targeting to
lysosome as well as overexpression of regulation of chaperone-mediated autophagy upon DR can be
attributed to a reduced need of misfolded or modified proteins. DR-essential genes are strongly
associated with various forms of autophagy and notably both forms of nucleophagy.
Rapamycin suppresses translation while it induced autophagy via inhibition of TOR. Rapamycin targets
both ageing and DR-essential genes, reverses ageing, mimics DR, reverses HGPS and cellular
senescence. Overexpression of LAMP2, encoding the receptor for chaperone-mediated autophagy,
prevents age-related decline in autophagic activity and improves hepatic function with ageing (Zhang &
Cuervo, 2008). Spermidine selectively induces macroautophagy by inhibiting certain histone acetylases
and extends the lifespan in yeast, worm, fly, mouse and human cells in culture (Eisenberg, et al., 2009;
Eisenberg, et al., 2016). Resveratrol can also trigger autophagy by activating histone deacetylases and
extends the lifespan of nematode worms (Morselli, et al., 2009). The positive effects of either spermidine
or resveratrol are lost when essential autophagic modulators are inactivated. Protein hypoacetylation
seems to be necessary for lifespan extension with these interventions.
 
Proteostasis is altered with ageing (Koga, et al., 2011). Chronic expression of unfolded, misfolded or
aggregated proteins contribute to age-related pathologies, such as Alzheimer's disease, Parkinson's
disease and cataracts (Powers, et al., 2009).
7.6   Nutrient Sensing Deregulation
Growth (both organismal and cellular) need to be coordinated according to nutrient availability. Metabolism
is regulated at multiple levels by hormone actions, via feedback and control mechanisms. The
somatotropic axis consists of growth hormone (GH), insulin-like growth factors (IGF-I and IGF-II) as well as
their associated carrier proteins and receptors. Other hormones such as insulin, leptine, glucocorticoids
and thyroid hormones are involved in modulating GH and/or IGF-I synthesis and availability (Renaville, et
al., 2002). IGF-I uses the same receptors as insulin. Therefore, it is common to refer to this pathway
collectively as Insulin/IGF-I signalling (IIS).
7.6.1   Growth Hormone
Gerontogenes are involved in somatotropin secreting cell development and differentiation. Growth
hormone receptor binding, signalling, and signalling pathway are commonly associated with
ageing-suppressor genes. However, gerontogenes are involved in growth hormone secretion, growth
hormone receptor binding, and positive regulation of growth hormone secretion. Gerontogenes are also
involved in growth hormone-releasing hormone activity, growth hormone-releasing hormone receptor
binding, and growth hormone-releasing hormone receptor activity [Ageing Genes].
DR-essential genes are also involved in somatotropin secreting cell differentiation. DR-essential genes are
involved in growth hormone receptor complex, growth hormone receptor activity, growth hormone receptor
signalling, growth hormone receptor signalling pathway, and negative regulation of growth hormone
secretion [Dietary Restriction Genes].
Genes differentially expressed with ageing (up- and down-regulated genes together) are commonly
involved in growth hormone receptor signalling, response to growth hormone, and cellular response to
growth hormone stimulus [Ageing Signatures].
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Genes upregulated upon DR are involved in growth hormone receptor signalling, while positive regulation
of growth hormone secretion and response to growth hormone are associated with DR-differentially
expressed genes and accelerated ageing differentially expressed genes, respectively [Dietary Restriction
Signatures].
7.6.2   Insulin/IGF Signalling
Ageing genes (gerontogenes and ageing-suppressor genes together) are commonly associated with
regulation of insulin receptor signalling pathway and positive regulation of insulin-like growth factor
receptor signalling pathway. Ageing genes (both gerontogenes and ageing-suppressor genes) are
commonly involved in signalling by insulin receptor, insulin receptor signalling pathway, insulin receptor
signalling cascade, insulin receptor recycling, positive and negative regulation of insulin receptor signalling
pathway, insulin-like growth factor receptor binding, insulin-like growth factor receptor signalling pathway,
and signalling by type 1 insulin-like growth factor 1 receptor IGF1R. Ageing-suppressor genes are
commonly involved in insulin signalling pathway, signalling by type 1 insulin-like growth factor 1 receptor
IGF1R, and negative regulation of insulin secretion involved in cellular response to glucose stimulus.
Gerontogenes are commonly involved in regulation of insulin secretion insulin binding, insulin receptor
binding, insulin receptor complex, insulin-activated receptor activity, insulin receptor substrate binding, and
cellular response to insulin stimulus [Ageing Genes].
Genes differentially expressed during ageing (up- and down-regulated together) exhibit regulation of
insulin secretion involved in cellular response to glucose stimulus, insulin binding, insulin-like growth factor
receptor binding, negative regulation of insulin receptor signalling pathway, negative regulation of cellular
response to insulin stimulus, and positive regulation of insulin secretion involved in cellular response to
glucose stimulus. Ageing-differentially expressed genes (up- and down-regulated together) are involved in
regulation of insulin secretion and insulin resistance. Genes downregulated during ageing exhibit insulin
receptor binding, response to insulin, and cellular response to insulin stimulus. Genes upregulated during
ageing are associated with insulin-like growth factor binding, regulation of cellular response to insulin
stimulus, and regulation of insulin receptor signalling pathway [Ageing Signatures].
DR-essential genes are associated with regulation of insulin secretion, glucagon-like peptide-1 GLP1
regulates insulin secretion, insulin receptor signalling pathway, insulin receptor signalling cascade,
insulin-activated receptor activity, signalling by insulin receptor, insulin-like growth factor receptor
signalling pathway, and signalling by type 1 insulin-like growth factor 1 receptor IGF1R [Dietary Restriction
Genes]. Unsurprisingly dietary restriction genes are associated with insulin receptor signalling pathway
and insulin receptor binding [Figure 29 D. melanogaster DR-Essential Gene Network].
Genes differentially expressed upon DR (up- and down-regulated genes together) exhibit insulin-like
growth factor II binding and are involved in regulation of insulin secretion and response to insulin.
DR-differentially expressed genes (both up- and down-regulated genes) are involved in regulation of
insulin-like growth factor IGF transport and uptake by insulin-like growth factor binding proteins IGFBPs,
insulin signalling pathway, insulin resistance, regulation of insulin receptor signalling pathway, negative
regulation of insulin receptor signalling pathway, and negative regulation of cellular response to insulin
stimulus. DR-upregulated genes exhibit insulin receptor binding, insulin-like growth factor binding and
insulin-like growth factor I binding [Dietary Restriction Signatures].
IGF1 is associated with downregulated genes during development and associated with differentially
expressed genes in HGPS. IGF1R is associated with upregulated genes during ageing. IGF2 receptor
(IGF2R) and binding proteins (IGF2B1/2/3) are associated with upregulated genes during development,
but associated with downregulated genes in HGPS. IGF2BP1 is associated with downregulation during
ageing [Ageing Signatures]. IGF2 is associated with genes downregulated upon DR [Dietary Restriction
Signatures].
Gerontogenes are associated with somatotropin secreting cell development and differentiation [Figure 5
M. musculus Ageing Gene Network] as well as the insulin receptor signalling pathway [Figure 7 C. elegans
Ageing Gene Network], insulin-activated receptor activity, insulin-like growth factor receptor binding and
insulin stimulus [Figure 10 Common Ageing Gene Network].
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Ageing-differentially expressed genes are associated with insulin receptor binding, the cellular response to
insulin stimulus, insulin-like growth factor receptor signalling pathway, and positive regulation of insulin
secretion. Ageing-upregulated genes are associated with cellular response to insulin stimulus, and
insulin-like growth factor I binding. Ageing-downregulated genes are associated with negative regulation of
insulin receptor signalling pathway [Ageing Signatures; Figure 13 H. sapiens Ageing].
GH and IGF1 levels decline during normal ageing as well as in a premature ageing model (Schumacher, et
al., 2008). Suppression of IIS at the transcript level during ageing could be a compensation for the
declining hormone levels, but at the same time promoting ageing with all its negative downstream side
effects.
7.6.3   TOR
Ageing genes (both gerontogenes and ageing-suppressor genes) are commonly involved mTOR signalling
pathway and energy dependent regulation of mTOR by LKB1-AMPK. Ageing genes (gerontogenes and
ageing-suppressor genes together) are commonly involved in TORC1 signalling and positive regulation of
TOR signalling. Gerontogenes are commonly involved in TOR signalling, mTOR signalling, and
mTORC1-mediated signalling as well as located in TOR, TORC1, and TORC2 complex.
Ageing-suppressor genes are commonly involved in negative regulation of TOR and TORC1 signalling
[Ageing Genes].
Genes upregulated during development are involved in regulation of TOR signalling. Genes differentially
expressed during ageing (both up- and down-regulated genes) are involved in regulation of TOR
signalling. Genes downregulated during ageing are involved in mTOR signalling pathway and negative
regulation of TOR signalling [Ageing Signatures].
DR-essential genes are commonly involved in TOR signalling, mTOR signalling, mTOR signalling
pathway, energy dependent regulation of mTOR by LKB1-AMPK, negative regulation of TOR signalling, as
well as TOR and TORC1 complex [Dietary Restriction Genes]. Genes differentially expressed upon DR
(up- and down-regulated genes together) are involved in regulation of TOR signalling. DR-differentially
expressed genes (both up- and down-regulated genes) are involved in TOR signalling and participate in
PI3K/Akt/mTOR signalling pathway. Genes upregulated upon DR are involved in mTOR signalling
pathway. Genes downregulated upon DR interact with MTOR, RICTOR, and RPTOR, are involved in
TORC1 signalling, mTOR signalling, and mTORC1-mediated signalling, as well as TORC1 and TORC2
complex [Dietary Restriction Signatures].
From this it is clear that TOR signalling is gerontogenic, regulated already during development,
upregulated during ageing and downregulated upon DR.
7.6.4   AMPK
Ageing genes (both gerontogenes and ageing-suppressor genes) are involved in AMPK signalling
pathway. Ageing-suppressor genes commonly participate in AMPK inhibits ChREBP transcriptional
activation activity [Ageing Genes]. Genes downregulated during ageing are commonly involved in AMPK
signalling pathway [Ageing Signatures]. DR-essential genes are commonly participating in energy
dependent regulation of mTOR by LKB1-AMPK. AMPK signalling pathway and AMPK inhibits ChREBP
transcriptional activation activity are associated with DR-essential genes [Dietary Restriction Genes].
Genes upregulated upon DR are commonly involved in AMPK signalling pathway [Dietary Restriction
Signatures].
The adenosine monophosphate-activated protein kinase (AMPK) function as a nutrient sensor that
mediates signalling from nutrient scarcity (such as created under DR conditions) and catabolism to retard
ageing systems. AMPK is therefore like a sensor of cellular energy levels. A high cellular ratio of AMP/ATP
triggers the phosphorylation and hence activation of AMPK. Activated AMPK in turn phosphorylates a wide
array of target proteins including ChREBP (Carbohydrate Response Element Binding Protein), which
inactivation by phosphorylation reduces transcription of key enzymes of glycolytic and lipogenic pathways
(Cheung, et al., 2000; Kawaguchi, et al., 2002; Hardie, et al., 2003; Hardie, 2004). AMPK activation may
mediate the lifespan-extending and health-promoting effect of metformin which was found here to target
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specifically gerontogenes, to reverse ageing gene expression changes and to mimic the gene expression
signature of DR.
7.6.5   Sirtuins
Genes downregulated with ageing are interacting with SIRT1 [Ageing Signatures]. SIRT2, SIRT4, and
SIRT5 and are all downregulated during ageing [Ageing Signatures]. Genes upregulated in cellular
senescence are participating in SIRT1 negatively regulates rRNA expression [Ageing Signatures].
DR-essential genes commonly participate in SIRT1 negatively regulates rRNA expression [Dietary
Restriction Genes]. Genes downregulated upon DR are participating in SIRT1 negatively regulates rRNA
expression [Dietary Restriction Signatures].
Sirtuins are also nutrient sensors that sense the NAD/NADH ratio. Sirtuins are a class of enzymes that
possess either mono-ADP-ribosyltransferase or NAD-dependent deacetylase activity (class III) that
among other targets deacetylates histones and epigenetically silence gene expression. When glucose is
low, NAD is high (compared to low NADH), then the activity of SIRT1 is high which in turn reduces the
activity of its target genes such as ribosomal genes.
7.6.6   FOXOs
FoxO signalling pathway is commonly associated with both gerontogenes and ageing-suppressor genes.
AKT-mediated inactivation of FOXO1A is commonly associated with gerontogenes [Ageing Genes].
Genes differentially expressed (both up- and down-regulates genes) during ageing or cellular senescence
are participating in FoxO signalling pathway. Genes downregulated in cellular senescence interact with
FOXO1 and FOXO3 [Ageing Signatures]. DR-essential genes participate in FoxO signalling pathway and
AKT-mediated inactivation of FOXO1A [Dietary Restriction Genes]. Genes upregulated upon DR are
commonly participating in FoxO signalling pathway [Dietary Restriction Signatures].
FOXO signalling pathway contains both positive and negative regulators of FOXO transcription factors.
FOXO3 is a DR-essential genes. FOXO1A also mediates the anticancer effect of DR.
7.7   Signalling Alteration
7.7.1   MAPK
Ageing genes (gerontogenes and ageing-suppressor genes together) are commonly involved in activation
of MAPK activity and ERK/MAPK targets. Ageing genes (both gerontogenes and ageing-suppressor
genes) are commonly involved in MAPK signalling pathway, MAPK family signalling cascades, negative
regulation of MAPK pathway, gastrin-CREB signalling pathway via PKC and MAPK, and FCERI mediated
MAPK activation. Gerontogenes are commonly involved in MAPK signalling pathway and MAPK1/MAPK3
signalling. Ageing-suppressor genes are commonly involved in MAPK cascade, MAPK signalling pathway,
activation of MAPKK activity, MAPK6/MAPK4 signalling, MAPK JNK signalling, MAPK ERK1/2 signalling,
MAPK1 ERK2 activation, MAP2K and MAPK activation, RAF-independent MAPK1/3 activation, regulation
of stress-activated MAPK cascade, MAPK targets nuclear events mediated by MAP kinases, and negative
feedback regulation of MAPK pathway. Therefore, ageing-suppressor genes are strongly associated with
MAP kinase activity [Ageing Genes; Figure 10 Common Ageing Gene Network].
Ageing downregulated genes are also associated with MAPK cascade [Figure 21 Common Ageing].
Genes differentially expressed during ageing (both up- and down-regulated genes together) are commonly
involved in MAPK signalling pathway, MAPK family signalling cascades, and positive regulation of MAPK
cascade. Genes differentially expressed during ageing (both up- and down-regulated genes) are
commonly involved in Inactivation of MAPK activity, activation of MAPKK activity, and negative regulation
of MAPK cascade. Genes upregulated during ageing are commonly involved in regulation of
stress-activated MAPK cascade, regulation of MAPK cascade, activation of MAPK activity, positive
regulation of stress-activated MAPK cascade, and positive regulation of ERK1 and ERK2 cascade. Genes
downregulated during ageing are commonly involved in Gastrin-CREB signalling pathway via PKC and
MAPK. Genes differentially expressed during ageing (both up- and down-regulated genes) are commonly
involved in MAPK signalling pathway, and regulation of MAPK cascade [Ageing Signatures].
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DR-essential genes are commonly involved in activation of MAPK activity, MAPK6/MAPK4 signalling
[Dietary Restriction Genes]. Genes downregulated upon DR are associated with MAPK cascade,
activation of MAPK activity, positive regulation of MAPK cascade, and positive regulation of ERK1 and
ERK2 cascade [Dietary Restriction Signatures; Figure 45 Common Dietary Restriction].
MAPK signalling seems to have more associations with ageing-suppressor genes, but ageing-suppressor
are also involved in negative regulation of MAPK signalling. Therefore MAPK appears to have both
gerontogenic as well as ageing-suppressing functions. However MAPK signalling is enhanced during
ageing and suppressed upon DR. This may indicate that its gerontogenic activities outcompete its
ageing-suppressing activities. It was suggested that the main pathway used by spermidine to trigger its
effects is the MAPK pathway (Minois, 2014). Both ageing as well as DR appear to modulate MAPK
signalling (Zhen, et al., 1999).
7.7.2   Wnt
Ageing genes (both gerontogenes and ageing-suppressor genes) are commonly involved in Wnt signalling
pathway. Ageing genes (gerontogenes and ageing-suppressor genes together) are commonly involved in
signalling by Wnt. Ageing-suppressor genes are commonly involved in TCF dependent signalling in
response to WNT [Ageing Genes].
Genes differentially expressed during ageing (up- and down-regulated genes together) are involved in
repression of WNT target genes and Wnt signalling pathway calcium modulating pathway. Genes
differentially expressed during ageing (both up- and down-regulated genes) are involved in regulation of
Wnt signalling pathway, regulation of canonical Wnt signalling pathway, negative regulation of Wnt
signalling pathway, positive regulation of Wnt signalling pathway, and positive regulation of canonical Wnt
signalling pathway. Genes upregulated during ageing are involved in regulation of non-canonical Wnt
signalling pathway, negative regulation of non-canonical Wnt signalling pathway, and regulation of Wnt
signalling pathway planar cell polarity pathway. Genes downregulated during ageing are commonly
involved in Wnt signalling pathway, regulation of Wnt signalling pathway, regulation of canonical Wnt
signalling pathway, negative regulation of Wnt signalling pathway, negative regulation of canonical Wnt
signalling pathway, beta-catenin independent WNT signalling, cell-cell signalling by Wnt, and
WNT5A-dependent internalization of FZD4. Genes downregulated during ageing are interacting with
WNT1, exhibit Wnt-protein binding, and are involved in signalling by Wnt, Wnt signalling pathway, Wnt
signalling network, canonical Wnt signalling pathway, non-canonical Wnt signalling pathway, negative
regulation of canonical Wnt signalling pathway, cell-cell signalling by Wnt, presenilin action in Notch and
Wnt signalling, TCF dependent signalling in response to WNT, regulation of Wnt-mediated beta catenin
signalling and target gene transcription, beta-catenin independent WNT signalling, WNT5A-dependent
internalization of FZD4, negative regulation of TCF-dependent signalling by WNT ligand antagonists, Wnt
signalling pathway planar cell polarity pathway, canonical Wnt signalling pathway involved in positive
regulation of apoptotic process, and canonical Wnt signalling pathway involved in negative regulation of
apoptotic process [Ageing Signatures].
DR-essential genes are involved in Wnt signalling pathway and canonical Wnt signalling pathway [Dietary
Restriction Genes]. Genes downregulated upon DR are commonly involved in regulation of canonical Wnt
signalling pathway, regulation of Wnt signalling pathway, negative regulation of canonical Wnt signalling
pathway, and negative regulation of Wnt signalling pathway [Dietary Restriction Signatures].
Certain aspects of Wnt signalling appear to be gerontogenic, while others are ageing-suppressing.
Overall, Wnt signalling is greatly suppressed during ageing. DR clearly desuppresses Wnt signalling. Wnt
signalling may also be DR-essential.
7.7.3   Notch
Gerontogenes are commonly associated with Notch signalling pathway. Gerontogenes interact with
NOTCH1 and are participating in Notch-mediated HES/HEY network and positive regulation of Notch
signalling pathway. Ageing-suppressor genes are involved in Notch receptor processing, presenilin action
in Notch and Wnt signalling and negative regulation of Notch signalling pathway [Ageing Genes].
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Genes downregulated during ageing are involved in presenilin action in Notch and Wnt signalling,
regulation of Notch signalling pathway, and negative regulation of Notch signalling pathway. Genes
downregulated in HGPS are interacting with NOTCH3. Genes upregulated in HGPS are interacting with
NOTCH1 and NOTCH2, exhibit Notch binding, and are involved in Notch receptor processing, Notch
signalling pathway, regulation of Notch signalling pathway, positive regulation of Notch signalling pathway,
signalling by NOTCH, signalling by NOTCH1, signalling by NOTCH1 in cancer, signalling by NOTCH1
PEST domain mutants in cancer, signalling by NOTCH1 HDPEST domain mutants in cancer, signalling by
NOTCH1 HD domain mutants in cancer, constitutive signalling by NOTCH1 HDPEST domain mutants,
constitutive signalling by NOTCH1 PEST domain mutants, signalling by NOTCH1 t(7;9)(NOTCH1:M1580
K2555) translocation mutant, constitutive signalling by NOTCH1 HD domain mutants, constitutive
signalling by NOTCH1 t(7;9)(NOTCH1:M1580 K2555) translocation mutant, signalling by NOTCH2,
signalling by NOTCH3, signalling by NOTCH4, Notch signalling involved in heart development, activated
NOTCH1 transmits signal to the nucleus, and NOTCH2 activation and transmission of signal to the
nucleus [Ageing Signatures].
Genes upregulated upon DR are commonly involved in Notch signalling pathway and negative regulation
of Notch signalling pathway. DR-upregulated genes are involved in regulation of Notch signalling pathway.
DR-downregulated genes are involved in Notch signalling pathway, presenilin action in Notch and Wnt
signalling, signalling by NOTCH1, and activated NOTCH1 transmits signal to the nucleus [Dietary
Restriction Signatures].
Notch signalling is gerontogenic. HGPS extensively positively regulates Notch signalling. However, normal
ageing also activates Notch signalling, while DR shuts down Notch.
7.8   Mitochondrial Dysfunction
Mitochondria are crucial organelles for energy production via oxidative phosphorylation. During ageing, the
efficacy of the respiratory transport chain diminishes, resulting in increased electron leakage, enhanced
ROS generation and reduced ATP synthesis (Green, et al., 2011). With increasing age some mitochondria
become dysfunctional.
7.8.1   Reactive Oxygen Species
Progressive mitochondrial dysfunction can result in an increased production of free radicals and reactive
oxygen species (Harman, 1965).
Ageing genes (gerontogenes and ageing-suppressor genes together) are involved in superoxide radicals
degradation and age-dependent response to reactive oxygen species. Gerontogenes are commonly
involved in reactive oxygen species metabolic process and response to reactive oxygen species [Ageing
Genes]. Ageing-suppressor genes are commonly associated with removal of superoxide radicals [Figure
10 Common Ageing Gene Network] as well as oxidoreductase activity acting on superoxide radicals as
acceptor [Ageing Genes]. Ageing-suppressor genes are commonly involved in regulation of reactive
oxygen species metabolic process, negative regulation of reactive oxygen species biosynthetic process,
and detoxification of reactive oxygen species [Ageing Genes]. Ageing-suppressor genes are associated
with negative regulation of reactive oxygen species, metabolic processes and removal of free radicals
[Ageing Genes; Figure 5: M. musculus Ageing Gene Network].
Genes differentially expressed with ageing (up- and down-regulated genes together) are involved in
reactive nitrogen species metabolic process, reactive oxygen species biosynthetic process, negative
regulation of reactive oxygen species metabolic process, reactive oxygen species metabolic process,
negative regulation of reactive oxygen species biosynthetic process, cellular response to reactive nitrogen
species, and detoxification of reactive oxygen species. Genes differentially expressed with ageing (both
up- and down-regulated genes) are involved in response to reactive oxygen species, cellular response to
reactive oxygen species, regulation of reactive oxygen species metabolic process, and regulation of
reactive oxygen species biosynthetic process [Ageing Signatures]. Ageing-downregulated genes are
significantly associated with being involved in regulation of reactive oxygen species, biosynthetic
processes and generation of precursor metabolites and energy [Figure 16 R. norvegicus Ageing] as well
as exhibiting oxidoreductase activity acting on the CH-OH group of donors with NAD or NADP as the
186
acceptor [Ageing Signatures; Figure 20 S. cerevisiae Ageing]. Genes upregulated with ageing are
commonly involved in regulation of reactive oxygen species biosynthetic process, positive regulation of
reactive oxygen species biosynthetic process, and positive regulation of reactive oxygen species
metabolic process [Ageing Signatures]. HGPS downregulated genes are involved in removal of superoxide
radicals, response to oxygen radical, and cellular response to oxygen radical [Ageing Signatures].
DR-essential genes are commonly associated with the response to oxidative stress [Figure 29 D.
melanogaster DR-Essential Gene Network; Figure 32 Network of Associations Common to DR-Essential
Gene Across Species] and regulation of reactive oxygen species metabolic process [Dietary Restriction
Genes]. Genes differentially expressed upon DR (up- and downregulated genes) are commonly involved
in reactive oxygen species metabolic process. Genes downregulated upon DR are commonly involved in
response to reactive oxygen species, regulation of reactive oxygen species metabolic process, regulation
of reactive oxygen species biosynthetic process, positive regulation of reactive oxygen species
biosynthetic process, and positive regulation of reactive oxygen species metabolic process [Dietary
Restriction Signatures].
Overall, gerontogenes do enhance free radical generation, while ageing-suppressor suppress radical
generation and enhance free radical removal. Ageing promotes generation of free radical, but DR
suppresses the generation of free radicals. Accelerated ageing suppresses the combating of free radicals.
7.8.2   Mitochondrial Integrity & Biogenesis
Gerontogenes are commonly associated with the mitochondrion and in particular the mitochondrial inner
membrane. Ageing-suppressor genes are also involved in mitochondrion organization and regulation of
the mitochondrial membrane potential [Ageing Genes; Figure 10 Common Ageing Gene Network].
Ageing downregulated genes are associated with being located in the mitochondrion and the mitochondrial
envelope, but also with the tricarboxylic acid cycle, mitochondrial translation and the mitochondrial large
ribosomal subunit [Ageing Signatures]. To the contrary, DR-upregulated genes are associated with being
located in the mitochondrion. DR-downregulated genes are significantly associated with participating in
positive regulation of protein targeting to the mitochondrion [Dietary Restriction Signatures].
Ageing-suppressor genes are commonly associated with mitophagy, the autophagic process in which
mitochondria are transported to the vacuole/lysosome and degraded in response to changing cellular
conditions [Ageing Genes]. Mitochondrial fission is associated with ageing-suppressor genes and
DR-upregulated genes [Ageing Genes; Dietary Restriction Signatures], while regulation of mitochondrial
fission is associated with gerontogenes [Ageing Genes].
Ageing genes (gerontogenes and ageing-suppressor genes together) are involved in transcriptional
activation of mitochondrial biogenesis [Ageing Genes]. DR-essential genes are involved in mitochondrial
biogenesis and transcriptional activation of mitochondrial biogenesis [Dietary Restriction Genes].
Ageing-suppressor genes are involved in mitochondrial fission and positive regulation of mitochondrial
fission. Gerontogenes are involved in regulation of mitochondrial fission and negative regulation of
mitochondrial fission. In contrast, gerontogenes are associated with mitochondrial fusion and
ageing-suppressor genes in negative regulation of mitochondrial fusion [Ageing Genes].
Genes upregulated during development are involved in regulation of mitochondrial fission and positive
regulation of mitochondrial fission. Genes downregulated during ageing are commonly involved in
regulation of mitochondrial fission. Positive regulation of mitochondrial fission is associated with
ageing-downregulated genes. Similar genes downregulated in cellular senescence are involved in
regulation of mitochondrial fission and positive regulation of mitochondrial fission [Ageing Signatures].
Genes upregulated with DR are involved in mitochondrial fission [Dietary Restriction Signatures].
Therefore, it appears that mitochondrial biogenesis is associated with ageing genes and may be
DR-essential. Promotion of fission may antagonize ageing, while fusion accelerates it. Although
development positively regulates fission, ageing and cellular senescence negative regulate fission of
mitochondria. DR counteracts ageing and promotes mitochondrial fission.
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7.9   Cellular Senescence
Ageing genes (gerontogenes and ageing-suppressor genes together) are associated with
senescence-associated secretory phenotype (SASP). Ageing genes (both gerontogenes and
ageing-suppressor genes are involved in cellular senescence. Ageing-suppressor genes are associated
with negative regulation of cellular senescence, replicative senescence, oxidative stress induced
senescence and DNA damage/telomere stress induced senescence. Gerontogenes are involved in animal
organ senescence, replicative senescence, oxidative stress-induced premature senescence, oncogene
induced senescence, DNA damage/telomere stress induced senescence, regulation of cellular
senescence, positive/negative regulation of cellular senescence, formation of senescence-associated
heterochromatin foci (SAHF) senescence-associated secretory phenotype [Ageing Genes].
Genes differentially expressed with ageing are commonly involved in senescence and cellular
senescence. Senescence-associated heterochromatin focus is also associated with ageing-differentially
expressed gene. Genes upregulated with ageing are involved in oncogene induced senescence [Ageing
Signatures].
Genes differentially expressed in cellular senescence (both up- and down-regulated genes) are involved in
senescence, cellular senescence, DNA damage/telomere stress induced senescence, and
senescence-associated secretory phenotype. Genes upregulated in cellular senescence are involved in
oxidative stress induced senescence, oncogene-induced cell senescence, regulation of cellular
senescence, positive regulation of cellular senescence, formation of senescence-associated
heterochromatin foci, senescence-associated heterochromatin focus, and senescence-associated
heterochromatin focus assembly [Ageing Signatures].
DR-essential genes are involved in animal organ senescence, cellular senescence, stress-induced
premature senescence, oxidative stress induced senescence, senescence-associated secretory
phenotype, negative and positive regulation of cellular senescence [Dietary Restriction Genes]. Genes
downregulated upon DR are involved in senescence, cellular senescence, oxidative stress induced
senescence, DNA damage/telomere stress induced senescence, and senescence-associated secretory
phenotype. Further regulation of phagocytosis is commonly associated with DR-downregulated genes,
while phagocytosis recognition and engulfment is commonly associated with DR-upregulated genes
[Dietary Restriction Signatures].
Ageing genes are surprisingly strongly involved in cellular senescence where ageing-suppressors are
negative regulators and gerontogenes are positive regulators of senescence and various facets/aspects of
cellular senescence. Clearly cellular senescence is a gerontogenic process as also evident from
experiments that genetically or pharmacological elimination of senescence cells in rodent model
organisms increases health and lifespan. Unsurprisingly, but also reinsuring, cellular senescence itself
greatly upregulates various aspects of cellular senescence.
Surprisingly again and similar to ageing genes, DR-essential genes are associated with cellular
senescence. Confirming this association on the genetic level, the gene activity changes upon DR indicate
that DR does not only modulate aspects of cellular senescence but also clearly downregulates cellular
senescence. Note that DR genes can be proven by both gain- and loss of function experiments that
cancel out the lifespan extending effect of DR. Therefore, it is expected to have both positive and negative
regulators, i.e. modulators of the ageing processes via the DR mechanisms. More interestingly DR genes
are associated with stress-induced premature senescence. So while ageing genes also modulate the
genetic mechanisms of replicative senescence, DR genes modulate cellular senescence and in particular
in the response to stress.
The number of senescence cells increases with age, although it might not be true for all types of tissues
(Wang, et al., 2009b). Dietary restriction is effective in delaying cellular senescence (de Cabo, et al., 2015)
and reducing the number of senescence cells (Wang, et al., 2010). The accumulation of senescent cells
with ageing can reflect an increased rate of generation of senescence cells an/or a decreased rate of
clearance that could be the consequence of an attenuated immune response and/or overwhelmed immune
system. This could mean that DR does maybe not only reduce the rate of generation of cellular
senescence but it could also increase the rate that senescence cells are actively removed. Indeed there is
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evidence that senescence cells, just like senescence tumour cells, are under strict immune surveillance
and efficiently removed by phagocytosis (Hoenicke & Zender, 2012; Kang, et al., 2011b; Xue, et al., 2007).
The p16(INK4a)/Rb and p19(ARF)/p53 are the most established pathways among the different
mechanisms that implement cellular senescence. p16(INK4a) and p19(ARF) are encoded by the same
gene CDKN2A/Cdkn2a. CDKN2A/Cdkn2a is commonly upregulated in mammalian consensus signatures
of ageing. The levels of p16(INK4a) and, to a lesser extent also p19(ARF), correlate with the chronological
age of all essential tissues analysed in both human (Ressler, et al., 2006) and mice (Krishnamurthy, et al.,
2004). Further, ageing genes (both gerontogenes and ageing-suppressor genes) interact significantly
specifically with CDKN2A and CDKN2A is also associated with DR-downregulated genes.
7.10   Stem Cell Exhaustion
Ageing is accompanied with decline in the regenerative potential of tissues that results in the most
obvious phenotypes such as greying of the hair. Several biological immortal organisms exhibit unlimited
regenerative abilities.
Ageing genes (gerontogenes and ageing-suppressor genes together) are commonly involved in germ-line
stem cell division. Ageing-suppressor genes are commonly involved in positive regulation of stem cell
proliferation. Hematopoietic stem cell proliferation and negative regulation of hematopoietic stem cell
differentiation are associated with ageing-suppressor genes as well. Neurogenesis is associated with
gerontogenes, while positive regulation of neurogenesis is associated with ageing-suppressor genes.
Germ-line stem-cell niche homeostasis is associated with gerontogenes [Ageing Genes].
Ageing-differentially expressed genes are associated with stem cell development and male germ-line stem
cell asymmetric division [Ageing Signatures]. Genes that are differentially expressed with ageing (both up-
and down-regulated with ageing) are commonly involved in stem cell differentiation and neurogenesis.
Genes differentially expressed with ageing (up- and down-regulated with ageing together) are commonly
involved in regulation of stem cell proliferation, including positive regulation of stem cell proliferation and
regulation of neurogenesis. Genes upregulated with ageing are commonly involved in negative regulation
of neurogenesis [Ageing Signatures; Figure 16 R. norvegicus Ageing]. Hematopoietic progenitor cell
differentiation and positive regulation of hematopoietic stem cell proliferation, differentiation and migration
are associated with ageing-upregulated genes. Ageing-upregulated genes are associated with
hematopoietic progenitor cell differentiation and positive regulation of hematopoietic stem cell migration
[Ageing Signatures].
Genes differentially expressed in HGPS are involved in stem cell population maintenance, stem cell
proliferation, stem cell differentiation, regulation of stem cell differentiation, positive regulation of stem cell
differentiation, and signalling events mediated by stem cell factor receptor c-Kit. Genes upregulated in
HGPS are involved in stem cell development, stem cell division, somatic stem cell division, neuronal stem
cell population maintenance, and negative regulation of stem cell differentiation. Genes downregulated in
HGPS are involved in stem cell fate commitment, somatic stem cell population maintenance,
hematopoietic stem cell differentiation, regulation of stem cell proliferation, hematopoietic stem cell
proliferation, positive/negative regulation of stem cell proliferation, signalling pathways regulating
pluripotency of stem cells, and transcriptional regulation of pluripotent stem cells [Ageing Signatures].
DR-essential genes are involved in male germ-line stem cell asymmetric division and neuronal stem cell
population maintenance [Dietary Restriction Genes]. Genes differentially expressed upon DR (up- and
down-regulated genes together) are commonly involved in regulation of stem cell proliferation including
positive regulation of stem cell proliferation. DR-upregulated genes are commonly associated with
regulation of neurogenesis. DR-upregulated genes are associated with negative regulation of
hematopoietic stem cell differentiation [Dietary Restriction Signatures].
Stem cell related processes and functions are mostly associated with ageing-suppressors genes in
particular positive regulation of stem cell maintenance. Ageing does downregulate stem cell maintenance.
Accelerated ageing in particular greatly modulates stem cell processes and functions including
downregulation of stem cell maintenance and stemness. Notable, DR modulates stem cell regulation and
may therefore enhance stem cell functions. From the data alone it is clear that stem cells are counteracting
ageing. Somatic stem cell maintenance including neurogenesis diminishes significantly with increasing
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age (Gray, et al., 2002). Hematopoiesis declines with age that results in a diminished production of
adaptive immune cells, leading to immunosenescence and increased likelihood of developing in anemia
and myeloid malignancies (Shaw, et al., 2010).
7.11   Intercellular Communication Alteration
Ageing in multicellular organisms involves also changes in the communication between cells and systemic
factors that include endocrine, paracrine neuroendocrine, and neuronal factors. The most notable is that of
the phenomenon designated as inflammageing that is a slowly developing proinflammatory phenotype that
accompanies ageing in mammals (Salminen, et al., 2012).
Ageing genes (gerontogenes and ageing-suppressor genes together) are involved in regulation of
inflammatory response and positive regulation of inflammatory response. Gerontogenes are involved in
inflammatory response, inflammatory mediator regulation of TRP channels, positive regulation of acute
inflammatory response, and positive regulation of leukotriene production involved in inflammatory
response. Ageing-suppressor genes are involved in acute inflammatory response, negative regulation of
inflammatory response, regulation of cytokine production involved in inflammatory response, negative
regulation of respiratory burst involved in inflammatory response, and DExH-box helicases activate type I
IFN and inflammatory cytokines production. Further I-kappaB kinase activity and complex are associated
with gerontogenes. Ageing-suppressor genes are associated with negative regulation of cytokine
production, regulation of cytokine secretion involved in immune response, regulation of cytokine
production involved in inflammatory response and macrophage cytokine production. Gerontogenes are
associated with the cellular response to cytokine stimulus, positive regulation of cytokine
secretion/production and myeloid leukocyte cytokine production involved in immune response, cytokine
activity and receptor binding [Ageing Genes].
Genes differentially expressed during ageing (up- and down-regulated genes together) are commonly
involved in positive regulation of acute inflammatory response, regulation of inflammatory response to
antigenic stimulus, positive regulation of inflammatory response to antigenic stimulus, positive regulation of
acute inflammatory response to antigenic stimulus, inflammatory mediator regulation of trp channels,
leukocyte migration involved in inflammatory response, and chronic inflammatory response. Genes
differentially expressed during ageing (both up- and down-regulated genes) are commonly involved in
inflammatory response, and regulation of acute inflammatory response. Genes downregulated during
ageing are commonly involved in negative regulation of inflammatory response. Genes upregulated during
ageing are commonly involved in acute inflammatory response, regulation of inflammatory response, and
positive regulation of inflammatory response, as well as participate in inflammatory bowel disease.
Ageing-upregulated genes are associated with cytokine activity [Ageing Signatures].
Genes differentially expressed in cellular senescence (both up- and down-regulated) are involved in
inflammatory response and regulation of inflammatory response. Genes differentially expressed in cellular
senescence (up- and down-regulated genes together) are involved in the IPAF inflammasome. Genes
upregulated in cellular senescence are involved in acute inflammatory response, regulation of acute
inflammatory response, positive regulation of inflammatory response, positive regulation of acute
inflammatory response, inflammatory response to antigenic stimulus, acute inflammatory response to
antigenic stimulus, inflammatory cell apoptotic process, inflammatory response to wounding, wound
healing involved in inflammatory response, connective tissue replacement involved in inflammatory
response wound healing, CLEC7A inflammasome pathway, inflammatory mediator regulation of TRP
channels, and inflammatory bowel disease [Ageing Signatures].
DR genes are associated with macrophage cytokine production and cytokine receptor activity [Dietary
Restriction Genes]. Genes differentially expressed upon DR are commonly involved in regulation of
cytokine production involved in inflammatory response. Genes downregulated upon DR are involved in
acute inflammatory response, regulation of inflammatory response, regulation of acute inflammatory
response, and positive regulation of inflammatory response, as well as participates in inflammatory bowel
disease. DR-upregulated genes are associated with the regulation of cytokine production and regulation of
cytokine production involved in the inflammatory response. DR-downregulated genes are associated with
a positive regulation of the inflammatory response, positive regulation of macrophage cytokine production,
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positive regulation of cytokine secretion and cytokine activity. Chronic inflammatory response and chronic
inflammatory response to antigenic stimulus are downregulated upon DR [Dietary Restriction Signatures].
From this, it is clear that inflammation (especially chronic inflammation) is gerontogenic, i.e. promoted by
gerontogenes and counteracted by ageing-suppressors. Ageing as well as cellular senescence promote
inflammation, whereas DR downregulates inflammation.
7.12   Rhythm Alteration
Organisms have biological clocks. Some clocks such as the telomeres and epigenetic DNA methylation
clock are linear but entrained by cycles. Telomeres are shortened with each cell cycle, while the epigenetic
DNA methylation clock is entrained by something else unknown as it is also observed (i.e. it ticks also) in
postmitotic tissues. Biological cycles are rhythms that are molecular, physiological, or behavioural events
recurring and are practically an ubiquitous property of all living beings. In fact, rhythmicity coordinates
biological systems and synchronizes them with the external environment. Biological rhythms occur on
different time scales/orders. A simple division is in three classes: A) Ultradian, B) Circadian, and C)
Infradian. Ultradian cycles are of a short duration (within seconds, minutes or hours), while the circadian
rhythm has a period of just about a day, and the infradian rhythm are longer than a day, e.g. month or year
(i.e. circannual) (Lamont & Amir, 2017).
Hormonal activities as well as metabolism undergo cycles of different scales. The circadian rhythm is the
most obvious as it follows day night cycles and determines the sleep wake cycle of many organisms.
Ageing genes are commonly involved in rhythmic behaviour. Ageing genes (both gerontogenes and
ageing-suppressors genes) are involved in circadian rhythm, locomotor rhythm and arrhythmogenic right
ventricular cardiomyopathy. Gerontogenes are associated with circadian rhythm/behaviour,
positive/negative regulation of circadian sleep/wake cycle, circadian sleep/wake cycle non-REM sleep,
positive regulation of circadian sleep/wake cycle non-REM sleep and entrainment of the circadian clock by
the photoperiod. Ageing-suppressors are commonly involved in circadian rhythm. Ageing-suppressor
genes are involved in rhythmic process, rhythmic behaviour, circadian rhythm, regulation of circadian
rhythm, positive regulation of circadian rhythm, circadian sleep/wake cycle sleep positive regulation of the
circadian sleep/wake cycle, circadian regulation of gene expression, circadian regulation of translation,
circadian behaviour, circadian clock, BMAL1/CLOCK NPAS2 activates circadian gene expression,
regulation of timing of cell differentiation and rhythmic synaptic transmission [Ageing Genes; Figure 5 M.
musculus Ageing Gene Network; Figure 6 D. melanogaster Ageing Gene Network]. Genes downregulated
during ageing are commonly involved in circadian rhythm, regulation of circadian rhythm, circadian
entrainment, and negative regulation of circadian sleep/wake cycle sleep [Ageing Signatures].
DR-essential genes are associated with rhythmic processes, the circadian rhythm, locomotor rhythm,
circadian entrainment, and the circadian regulation of gene expression and negative regulation of
circadian sleep/wake cycle sleep [Dietary Restriction Genes]. DR-differentially expressed genes (both up-
and down-regulated genes) are commonly involved in circadian regulation of gene expression.
DR-differentially expressed genes (up- and down-regulated genes together) are commonly involved
circadian regulation of translation. Genes downregulated upon DR are commonly involved in circadian
rhythm and circadian clock as well as participate in BMAL1/CLOCK NPAS2 activates circadian gene
expression. Genes upregulated upon DR are commonly involved in circadian rhythm, circadian
entrainment, regulation of circadian rhythm, and negative regulation of circadian rhythm [Dietary
Restriction Signatures; Figure 39 H. sapiens Dietary Restriction; Figure 40 R. norvegicus Dietary
Restriction; Figure 41 M. musculus Dietary Restriction; Figure 42 D. melanogaster Dietary Restriction;
Figure 45 Common Dietary Restriction].
Both gerontogenes and ageing-suppressor genes are associated with circadian rhythmicity, where the
associations are more extensively for ageing-suppressor genes which may indicate that circadian
rhythmicity is in general suppressing ageing. This is further supported with the observation that circadian
rhythmicity is downregulated with ageing. However, DR does modulate the circadian clock as up- and
down-regulated genes have both multiple associations with circadian rhythmicity. It could mean that
circadian rhythmicity has also gerontogenic impact that could involve the timing of age-related changes
via rhythmic activities that affect the telomere/telomerase system and maybe also the epigenetic clock or
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other timings systems. Epigenetic modulation in turn cause changes in transcription and subsequently
translation (i.e. gene expression) thereby determining the changes in the phenotype as observed with an
ageing organism. This could consequently lead to most of the classes of age-related changes (from
molecular, cellular, up to physiological changes). This is not mutually exclusive with the possibility that
those other classes of age-related changes are influencing the epigenetic landscape as well. Instances of
this could be for example the mechanisms of accelerated ageing and interventions such dietary restriction
and pharmaceutical agents that modulate the rate of ageing and lead to a change in the lifespan.
Ageing may simple change gene activities such as gerontogenes become enhanced and
ageing-suppressor genes are suppressed. It may also upregulate other genes involved in the same
process as gerontogenes and downregulate other genes involved in the processes of ageing-suppressor
genes. The utilization of gain- and loss-of-function (as here used with specific subclasses of ageing
genes) may be capable of helping to dissect which classes of age-related changes are more causal and
which are merely effects. Targeting causal changes for interventions is expected to interfere with the
ageing process more effectively (and therefore greatly extend lifespan) than targeting effects that lead to
modest lifespan extensions.
Clearly among the many discussed results the main novel results are that there are clear subclasses of
ageing genes, namely gerontogenes and ageing-suppressor genes. Those classes have different shared
significant associations and are antagonizing each other in common superclasses of their associations
(i.e. in positive vs. negative regulation of the same processes/activities). Further a specific subclass of
ageing genes is responsible and essential for the effect of dietary restriction to extend lifespan. It was
shown here that ageing genes and in particular DR-essential genes are conserved on the molecular level
more than expected by chance. Further ageing genes and DR-essential genes are also interacting with
each other more than expected purely by chance. The study showed that by utilizing a simple graph
theory based method such as guilt-by-association on node degree is effective in predicting novel
members of a class of interest (here DR-essential genes) with a high accuracy as validated experimentally
within this study. Beyond this the results show that consensus signatures of ageing, HGPS, cellular
senescence and dietary restriction, derived with a multivariate approach allows to identify differential
expression and significant associations that enable to gather rich insights into possible molecular
mechanisms of ageing and its interference. For examples associations that are shared among ageing,
HGPS and cellular senescence and how they are contrasted with the effect of dietary restriction as well as
what they share in common with the associations with specific ageing classes such as gerontogenes and
ageing-suppressors. Lastly this study showed that anti-ageing pharmaceutical agents can be
computational predicted by at least two ways. A) by applying the guilt-by-association concept on
gene/protein - drug associations as well as B) by matching the here derived consensus signatures with
those of small molecules. Thereby it is possible to identify components that target specific class of ageing
genes and reverse ageing, HGPS, cellular senescence or mimic the effect of dietary restriction.
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8   Conclusions
8.1   Contributions
This thesis classifies ageing genes into gerontogenes and ageing-suppressor genes as well as
DR-essential genes (in multiple species). Those gene classes are compared and contrasted based on
graph approaches utilizing the guilt-by-association principle and the shortest path. Their common
associations across species are identified. New members of discrete classes were predicted and
experimentally validated by collaborators. Molecular signatures of ageing, HGPS, cellular senescence as
well as dietary restriction and small molecules were derived.
First, this was the first attempt and the most holistic approach to characterize ageing genes and the
changes that happen to gene activities during ageing and under DR feeding with an emphasis on
identifying small molecule manipulators of ageing as far as known. In this work molecular signatures were
derived with a multivariate approach that takes the interactions of genes into account, while most of the
ageing-related transcriptional signatures published so far were only based on univariate approaches for
determining differential expression. In addition to a superior method of differential expression calculation,
the consensus signatures generated here are also based on much greater number of profiles than all
previous attempts as it included more than 27 datasets for ageing (de Magalhaes, et al., 2009a) and 21
datasets for dietary restriction (Plank, et al., 2012).
The methodologies described here could be utilized in the future for researching other gene classes
related to ageing such as longevity-associated genes or senescence-associated genes or related to other
phenomena such as cancer and stemness or stem cell ageing.
Secondly, significant structured data as knowledge was curated in the process of this work which was
used in other investigations into the genomics of ageing and its manipulation by diet, e.g. GenAge,
GenDR, Digital Ageing Atlas, LongevityMap among others (Tacutu, et al., 2013; Wuttke, et al., 2012;
Craig, et al., 2015; Budovsky, et al., 2013).
Thirdly, many predictive associations were discovered by the approach adopted here, such as a number of
strongly statistical significant associations were put in the context with previous knowledge including
known classes of age-related changes. Some results reported here in this thesis have been published
(Wuttke & de Magalhaes, 2011; Wuttke, et al., 2012; de Magalhaes, et al., 2012; Fuellen, et al., 2012;
Johnson, et al., 2012; Plank, et al., 2012; Wuttke & de Magalhaes, 2012; Debonneuil, et al., 2013; Tacutu,
et al., 2013; Fuellen, et al., 2013; Craig, et al., 2015).
Fourthly, this research reviewed ageing, dietary restriction, anti-ageing drugs, and the interrelated
disciplines on the intersection of computer science and biology [Computational Approaches; Figure 1
Overlapping Fields]. It also reviewed and documented molecular profiling and signatures of ageing and
manipulations of ageing in order to identify anti-ageing interventions.
Lastly, using the results on classes of ageing genes including those essential for DR and the molecular
signatures of ageing and dietary restriction, small molecules were predicted that target ageing gene
subclasses and/or reverse the molecular signatures associated with ageing, HGPS, and senescence, as
well as mimic the molecular signature of dietary restriction. With this concrete interventions to
experimental test are established. Based on this molecular background experimental evaluation of these
anti-ageing strategies is now feasible.
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8.2   Summary
Developing an understanding of the mechanisms that underpin the ageing process has been a persistent
effort throughout the recorded history. Ageing is one of the hugest enigma of mankind since a very long
time. In the post-genomic era with the rapid increase in biological data and computational capacity, it
becomes possible to decipher the ageing process, at least at the molecular level. However its reverse
engineering requires a highly systematic and holistic approach that is able to integrate diverse data with
relevance to ageing from the molecular level up to that of the whole of physiology, considering eventually
also the demographic and population level (Fuellen, et al., 2010; Fuellen, et al., 2012; Fuellen, et al.,
2013).
Ageing is a process that is controlled by genes, but is also highly malleable by the environment. Those
ageing genes can be classified into gerontogenes and ageing-suppressor genes based on whether their
activity promotes or suppresses the ageing process, respectively. Those classes of ageing genes have
different strong associations [Ageing Genes]. Gerontogenes are primarily involved in development and
growth, the somatropic axis as well as epigenetics (including histone methylation), protein translation,
neuron death, and inflammation [Ageing Genes]. Ageing-suppressor genes on the contrary are involved in
DNA metabolism (including DNA repair and telomere maintenance), nuclear envelope, chromosome
organization, epigenetics (including histone (de)acetylation and chromatin silencing), protein homeostasis,
stress response, and cytoskeleton [Ageing Genes].
Even more interesting is that those two classes of genes antagonize the very same associations.
Gerontogenes are involved in positive regulation while ageing-suppressor genes are involved in negative
regulation of cell proliferation. Gerontogenes are strongly positively associated with translation while
ageing suppressor genes are negatively associated with it [Ageing Genes]. Therefore besides having
different strong associations, they show clear antagonistic behaviour among their significant associations
[Ageing Genes].
Dietary restriction, the most powerful non-genetic intervention that interferes with ageing, is also mediated
by specific genes, termed here DR genes, which when manipulated abolish the effect of DR to extend
lifespan. DR genes are involved in autophagy, stress response, gene regulation, metabolism, growth and
development, apoptosis and epigenetics [Dietary Restriction Genes].
Transcriptomic data from different tissues of different ages can be used to identify robust molecular
consensus signatures that reflect observations on ageing. The here established consensus signatures of
ageing identified interesting associations that confirm what is known about ageing as well as reveal novel
relations [Ageing Signatures].
Ageing-upregulated genes are strongly associated with DNA damage, nuclear envelope organisation, the
aggresome, apoptosis as well as inflammation and exosomes. These ageing-upregulated genes reflect
reduced genomic instability, epigenetic alterations, loss of proteostasis, mitochondrial dysregulation, and
altered intercellular communications with trend to inflammation. Exosomes are a novel aspect not well
studied in context of ageing [Ageing Signatures]. Ageing-downregulated genes are linked to DNA binding,
metabolism, neurogenesis, hormone response, and transcription as well as the MAPK cascade. This
reflects epigenetic alterations, stem cell exhaustion, and altered intercellular communications as well.
MAPK signalling seems interesting as it appears to have more frequent associations compared to other
well known age-related pathways [Ageing Signatures].
Data on transcriptomic experiments involving dietary restricted individuals and fully fed individuals was
presented. This data from various organisms were used to establish consensus signatures representing
the effect of DR on the transcriptome [Dietary Restriction Signatures]. DR differentially expressed genes
are associated with the stress response, circadian clock, apoptosis and proteolysis systems including
autophagy and the ubiquitin-proteasome system. The DR-upregulated genes are primary involved in
negative regulation of transcription while the downregulated genes are commonly involved in
glucocorticoid response, signalling and transcription factors [Dietary Restriction Signatures].
There are a number of instances in which associations of gerontogenes are shared with
ageing-upregulated genes and/or DR-downregulated genes, while associations with ageing-suppressor
genes are shared with ageing-downregulated genes and/or DR-upregulated genes. For instance
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gerontogenes are associated with inflammation, ageing upregulates inflammation, while DR
downregulates inflammation. Those associations on the transcript level closely represent the trends
observed at other levels of gene expression as well as at the whole physiology level. These were
discussed extensively for each class of age-related change. Another instance is related to autophagy.
Ageing-suppressor genes are associated with autophagy, ageing differentially expresses negative
regulation of autophagy, while autophagy is associated with DR-upregulated genes and negative
regulation of autophagy is associated with gerontogenes and downregulated in DR. It is clear that chronic
inflammation is detrimental, but its persistent observation associated with ageing is attenuated under DR
conditions, while autophagy is beneficial and attenuated during ageing, but induced by DR feeding.
Gene expression is changing (i.e. genes are changing in their activity level) during ageing, HGPS and
senescence as well as in DR feeding. Using ageing genes classes and molecular signatures of ageing,
HGPS, and senescence as well as DR, drugs can be identified that target specific ageing genes classes,
reverse ageing-related signatures or mimic the response to DR. Within this context a number of small
molecules have been identified. Some of these were already known as geroprotectors such as rapamycin,
metformin and quercetin, while others are novel but have the potential to ameliorate age-related diseases
and/or to modify pathways implicated in lifespan control [Small Molecule Predictions].
8.3   Future Research Directions
A logical extension of this work would be the generation of other molecular signatures [Molecular Profiling
to Decipher Ageing]. Other omics data other than transcriptomics such as epigenomics and proteomics as
well as metabolomics could be used to generate signatures of other types of biological entities. For
epigenomics and proteomics, but only to a certain degree applicable to metabolomics data, it is possible to
map the signatures to genes as done here for gene transcripts. For proteomics this is rather
straightforward as just like transcripts they are encoded by genes. For epigenetic data such as DNA
methylation profiles, these can be mapped to genes that are located in with or closely nearby within a
certain genomic distance. However, one would lose information for those differentially methylated
locations that are in intergenic regions. A similar problem exist for metabolomics where metabolites can be
mapped to genes whose gene products are known to bind these molecules. However, it is not necessary
to map all kind of entities to genes.
Another line of research extensions would be the utilization of coexpression (correlation matrices) that can
be derived from the gene expression profiles. These can be used to infer causality via network reverse
engineering (Opgen-Rhein & Strimmer, 2007). The guilt-by-association as well as the Principal Angle
Enrichment Analysis can be extended to the utilization of these coexpression or/and causality relations
derived from such profiles [Types of Signatures].
In the research described here, a number of tissue-specific signatures were derived, but combined to
consensus signatures for easier interpretation. The tissue-specific signatures could be used to investigate
the associations that are common to a certain tissue types, as it is known that ageing utilizes also
non-autonomous mechanisms and certain tissue unique effects [Tissue-Specific Signatures].
A class of non-ageing genes can be curated in order to predict ageing genes with classifiers. Hallmarks of
ageing co-occur and are interconnected, determining the exact causal network is a challenge. Causal
network inference is therefore needed for disentangling causality from effects. As ageing is a
phenomenon that is nearly universal and also evolutionary conserved apparently, hallmarks that are not
common to all ageing organisms might be less likely related to causality.
Data linking specific ages or age ranges with phenotypes, changes and disease are abundant in the
biomedical literature. A knowledge base has been proposed to incorporate such data in a way that it can
be searched and reasoned over (Geifman & Rubin, 2012; Geifman & Rubin, 2013). Whole-genome gene
expression studies have typically found hundreds to thousands of differential expressed genes (i.e.
profiles) during ageing and in response to dietary restriction or other lifespan extending interventions. A
key open question is which subset of genes mediate longevity. The emergence of huge volumes of omics
data may enable computational approaches to reverse-engineer the process of ageing from data.
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